,term_1_umls_name,term_2_umls_name,sentence,term_1_umls_synonyms,term_2_umls_synonyms,pipeline,relation,evidence_count,Treat/Cause_str,is_correct,
0,((amino(imino)methyl)(methyl)amino)acetic acid,363-364 edemas,Creatine kinase levels were markedly elevated at 15 809 U/L. MRI of the right thigh revealed intermuscular and intramuscular oedema.,"((amino(imino)methyl)(methyl)amino)acetic acid;(alpha-methylguanido)acetic acid;(n-methylcarbamimidamido)acetic acid;(α-methylguanido)acetic acid;alpha-methylguanidino acetic acid;creatin;creatine;creatine (substance);creatines;glycine, n-(aminoiminomethyl)-n-methyl-;kreatin;methylglycocyamine;n-(aminoiminomethyl)-n-methylglycine;n-amidinosarcosine;n-carbamimidoyl-n-methylglycine;n-methyl-n-guanylglycine","363-364 edemas;[d]dropsy;[d]dropsy (context-dependent category);[d]dropsy (situation);[d]edema;[d]edema (context-dependent category);[d]edema (situation);[d]edema nos;[d]edema nos (context-dependent category);[d]edema nos (situation);[d]oedema;[d]oedema (situation);[d]oedema nos;[d]oedema nos (situation);dropsies;dropsy;dropsy, nos;edema;edema (diagnosis);edema (finding);edema (morphologic abnormality);edema (nos);edema (observable entity);edema (physical finding);edema - lesion;edema - symptom;edema interstitial;edema nos;edema nos (finding);edema, nos;edema, unspecified;edemas;edematous;hydrops;hydrops (morphologic abnormality);hydrops, nos;interstitial edema;interstitial oedema;oedema;oedema - lesion;oedema - symptom;oedema nos;oedema nos (finding);oedema, nos;oedema, unspecified;oedemas;oedematous;swelling due to excess fluid;swelling/edema;waterlogged;watery swelling",chemdis,cause,1,cause,0,
1,((amino(imino)methyl)(methyl)amino)acetic acid,arrhythmia,Previous anecdotal reports have linked creatine to the development of arrhythmia.,"((amino(imino)methyl)(methyl)amino)acetic acid;(alpha-methylguanido)acetic acid;(n-methylcarbamimidamido)acetic acid;(α-methylguanido)acetic acid;alpha-methylguanidino acetic acid;creatin;creatine;creatine (substance);creatines;glycine, n-(aminoiminomethyl)-n-methyl-;kreatin;methylglycocyamine;n-(aminoiminomethyl)-n-methylglycine;n-amidinosarcosine;n-carbamimidoyl-n-methylglycine;n-methyl-n-guanylglycine",arrhythmia,chemdis,cause,1,cause,1,
2,((amino(imino)methyl)(methyl)amino)acetic acid,hypomagnesemia,"Laboratory tests detected hypomagnesemia, as well as elevated levels of creatine kinase and lactate dehydrogenase.","((amino(imino)methyl)(methyl)amino)acetic acid;(alpha-methylguanido)acetic acid;(n-methylcarbamimidamido)acetic acid;(α-methylguanido)acetic acid;alpha-methylguanidino acetic acid;creatin;creatine;creatine (substance);creatines;glycine, n-(aminoiminomethyl)-n-methyl-;kreatin;methylglycocyamine;n-(aminoiminomethyl)-n-methylglycine;n-amidinosarcosine;n-carbamimidoyl-n-methylglycine;n-methyl-n-guanylglycine",hypomagnesemia,chemdis,cause,1,cause,0,
3,((amino(imino)methyl)(methyl)amino)acetic acid,rhabdomyolysis,"Recently, it caused several cases of delayed rhabdomyolysis in humans and elevated serum creatine kinase (CK) activities in laboratory mice (Mus musculus) in a dose-response study.","((amino(imino)methyl)(methyl)amino)acetic acid;(alpha-methylguanido)acetic acid;(n-methylcarbamimidamido)acetic acid;(α-methylguanido)acetic acid;alpha-methylguanidino acetic acid;creatin;creatine;creatine (substance);creatines;glycine, n-(aminoiminomethyl)-n-methyl-;kreatin;methylglycocyamine;n-(aminoiminomethyl)-n-methylglycine;n-amidinosarcosine;n-carbamimidoyl-n-methylglycine;n-methyl-n-guanylglycine",rhabdomyolysis,chemdis,cause,1,cause,0,
4,(+)-aldosterone,heart failure,"Hyperkalemia is a potentially life-threatening condition that patients with heart failure or chronic kidney disease, especially those taking renin-angiotensin-aldosterone system inhibitors, are at high risk of developing.","(+)-aldosterone;(11β)-11,21-dihydroxy-3,20-dioxopregn-4-en-18-al;11beta,21-dihydroxy-3,20-dioxo-4-pregnen-18-al;11beta,21-dihydroxy-3,20-dioxopregn-4-en-18-al;aldosterona;aldosterone;aldosterone (substance);aldosterone preparation;aldosterone preparation (product);aldosterone preparation (substance);aldosterone product;aldosterone-containing product;aldosteronum;pregn-4-en-18-al, 11,21-dihydroxy-3,20-dioxo-, (11beta)-;product containing aldosterone;product containing aldosterone (medicinal product)",heart failure,chemdis,cause,1,cause,0,
9,(-)-(r)-epinephrine,necrosis,"The myocardium showed patchy necrosis with or without calcification, Spontaneous mortality was maximum following acute adrenaline shock (25 %) while electric shock caused mortality in 17 percent animals.","(-)-(r)-epinephrine;(-)-3,4-dihydroxy-α-((methylamino)methyl)benzyl alcohol;(r)-(-)-adnephrine;(r)-(-)-adrenaline;(r)-(-)-epinephrine;(r)-(-)-epirenamine;1,2-benzenediol, 4-(1-hydroxy-2-(methylamino)ethyl)-, (r)-;4-(1-hydroxy-2-(methylamino)ethyl)-1,2-benzenediol;4-[(1r)-1-hydroxy-2-(methylamino)ethyl]-1,2-benzenediol;adrenal;adrenaline;adrenaline (product);adrenaline (substance);adrenaline - chemical;adrenaline - chemical (substance);adrenaline [card];adrenaline [cardiovascular use];adrenaline [cardiovascular use] (product);adrenaline [cardiovascular use] (substance);adrenaline [resp];adrenaline [resp] (product);adrenaline [resp] (substance);adrenaline preparation;adrenaline product;adrenaline product (product);adrenaline-containing product;adrénaline;epinefrin;epinefrina;epinephrin;epinephrine;epinephrine (medication);epinephrine (substance);epinephrine (substance) [ambiguous];epinephrine [cardiovascular use];epinephrine [cardiovascular use] (product);epinephrine [resp];epinephrine [resp] (product);epinephrine preparation;epinephrine preparation (product);epinephrine preparation (substance);epinephrine product;epinephrine-containing product;epinephrinum;product containing adrenaline;product containing epinephrine;product containing epinephrine (medicinal product);sympathomimetics epinephrine;sympathomimetics epinephrine (medication);therapeutic epinephrine",necrosis,chemdis,cause,1,cause,1,
10,(-)-cholesterol,(neoplasms) or (cancers),"Physical inactivity, low fruit and vegetable intake, high fast food consumption and high cholesterol are predominant causes of cardiovascular disease and some cancers.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)","(neoplasms) or (cancers);(neoplasms) or (cancers) (disorder);[x]mal neo w'out specfctn/site;[x]malignant neoplasm without specification of site;[x]malignant neoplasm without specification of site (disorder);^cancer;ca;ca - cancer;ca - unspecified site;ca - unspecified site nos;ca - unspecified site nos (disorder);cancer (diagnosis);cancer (nos);cancer nos;cancer, nos;cancer, unspecified site;cancers;mal neo w'out specfctn/site;malig neop of unspec site;malig neop of unspec site nos;malignancies;malignancy nos;malignancy, unspecified site;malignant growth;malignant neoplasm (diagnosis);malignant neoplasm of unspecified site;malignant neoplasm of unspecified site (disorder);malignant neoplasm of unspecified site nos;malignant neoplasm of unspecified site nos (disorder);malignant neoplasm without specification of site;malignant neoplastic disease;malignant neoplastic disease (disorder);malignant tumor;malignant tumor (disorder);malignant tumoral disease;malignant tumors;malignant tumour;malignant tumour (disorder);malignant tumours;neoplasm malignant;neoplasm/cancer;neoplasms - malignant;neoplasms, malignant;neoplastic disease, malignant;tumor; malignant, unclassified;tumor; unclassified, malignant",chemdis,cause,1,cause,1,
11,(-)-cholesterol,3-00 cardiovascular disorders: general terms,"Familial hypercholesterolemia is a rare disorder characterized by high cholesterol levels and early cardiovascular disease.___Data from inter- and intrapopulation studies have clearly demonstrated that as total and LDL cholesterol levels increase, cardiovascular disease risk increases.___In fact, high-protein, low-carbohydrate diets may add additional risk to individuals with cardiovascular disease due to their high fat and cholesterol content combined with decreased intake of fruits, vegetables, whole grains, and other nutrients related to cardiovascular risk.___Now, in the high-saturated fat, low-fibre supermarket age, this may be a disadvantage and predisposes consumers to high serum cholesterol and increased risk of cardiovascular disease.___Physical inactivity, low fruit and vegetable intake, high fast food consumption and high cholesterol are predominant causes of cardiovascular disease and some cancers.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)","3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,cause,5,cause,1,
12,(-)-cholesterol,3-10 heart diseases: general terms,"Obesity is a risk factor for multiple serious health problems in adults, including heart disease, hardening of the arteries, high cholesterol, high blood pressure, certain types of cancer, stroke, diabetes, muscle and bone disorders and gallbladder disease.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)","3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",chemdis,cause,1,cause,1,
13,(-)-cholesterol,[x]inj bl vess unsp body reg,"Experimental induction of marked hyperlipemia and hypercholesterolemia by feeding a high fat egg yolk-rich diet (supplemented with cholesterol, choleate, and thiouracil), and use of viosterol to cause vascular injury, led to severe atherosclerosis, coronary occlusion, and myocardial infarction.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)","[x]inj bl vess unsp body reg;[x]injury of blood vessel(s) of unspecified body region;[x]injury of blood vessel(s) of unspecified body region (disorder);blood injuries vessel;blood vessel injuries;blood vessel injury;blood vessel injury nos;blood vessel; injury;d-40 injuries of the blood vessels;inj bl vess unsp body reg;injuries of the blood vessels;injuries, vascular;injuries, vascular system;injury blood vessel;injury of blood vessel;injury of blood vessel (diagnosis);injury of blood vessel (disorder);injury of blood vessel(s) of unspecified body region;injury of blood vessel, nos;injury to blood vessel nos;injury to blood vessel nos (disorder);injury to blood vessels;injury to blood vessels of unspecified site;injury, vascular;injury, vascular system;injury; blood vessel;system injuries, vascular;system injury, vascular;vascular injuries;vascular injury;vascular injury nos;vascular system injuries;vascular system injury;vessel injury",chemdis,cause,1,cause,0,
14,(-)-cholesterol,adult onset diabetes,"The increased risk of coronary heart disease associated with type 2 diabetes may be partially explained by dyslipidemia characterized by high plasma triacylglycerol (TAG), low HDL cholesterol, and a predominance of atherogenic small dense LDLs.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)","adult onset diabetes;adult onset diabetes mellitus;adult-onset diabetes;adult-onset diabetes mellitus;adult-onset; diabetes;aodm;diabete type 2;diabetes mellitus (adult onset);diabetes mellitus (niddm);diabetes mellitus - adult ons;diabetes mellitus - adult onset;diabetes mellitus -adult onset;diabetes mellitus maturity onset;diabetes mellitus non insulin dependent;diabetes mellitus non insulin-dep;diabetes mellitus non-insulin-dependent;diabetes mellitus nos late onset;diabetes mellitus type 02;diabetes mellitus type 2;diabetes mellitus type 2 (disorder);diabetes mellitus type ii;diabetes mellitus, adult onset;diabetes mellitus, adult onset type;diabetes mellitus, adult-onset;diabetes mellitus, ketosis resistant;diabetes mellitus, ketosis-resistant;diabetes mellitus, maturity onset;diabetes mellitus, maturity-onset;diabetes mellitus, non insulin dependent;diabetes mellitus, non-insulin dependent;diabetes mellitus, non-insulin-dependent;diabetes mellitus, noninsulin dependent;diabetes mellitus, noninsulin-dependent;diabetes mellitus, slow onset;diabetes mellitus, slow-onset;diabetes mellitus, stable;diabetes mellitus, type 2;diabetes mellitus, type ii;diabetes mellitus: [adult onset] or [noninsulin dependent];diabetes mellitus: [adult onset] or [noninsulin dependent] (disorder);diabetes non-insulin dependent;diabetes type 2;diabetes type ii;diabetes, adult onset;diabetes, ketosis resistant;diabetes, maturity onset;diabetes, maturity-onset;diabetes, type 2;diabetes, type ii;diabetes; adult-onset;diabetes; maturity-onset;diabetes; niddm;diabetes; non-insulin-dependent;diabetes; nonketotic;diabetes; type ii;diabetes;adult onset;diabetes;non insulin depend;diabetes;type 2;ketosis resistant diabetes;ketosis-resistant diabetes mellitus;late onset diabetes;maturity onset diabetes;maturity onset diabetes mellit;maturity onset diabetes mellitus;maturity-onset diabetes;maturity-onset diabetes mellitus;maturity-onset; diabetes;mod;ncdmm;niddm;niddm - non-insulin dependent diabetes mellitus;niddm diabetes mellitus;niddm-non-ins dep diabetes mel;niddm; diabetes;non insulin dependent diabetes;non-ins-dep diabetes mellitus;non-insulin dependent diabetes;non-insulin dependent diabetes mellitus;non-insulin-dependent diabetes;non-insulin-dependent diabetes mellitus;non-insulin-dependent; diabetes;noninsulin dependent diab.mell;noninsulin dependent diabetes;noninsulin dependent diabetes mellitus;noninsulin-dependent diabetes;noninsulin-dependent diabetes mellitus;nonketotic; diabetes;slow-onset diabetes mellitus;stable diabetes mellitus;t2dm - type 2 diabetes mellitus;type 2 diabetes;type 2 diabetes mellitus;type 2 diabetes mellitus (diagnosis);type 2 diabetes mellitus non-insulin dependent;type ii diabetes;type ii diabetes mellitus;type ii diabetes mellitus (disorder);type ii; diabetes",chemdis,cause,1,cause,0,
15,(-)-cholesterol,angiopathy,"Elevated serum cholesterol, a major cause of vascular disease, has been strongly correlated with eating greater than normal amounts of cholesterol and saturated fatty acids.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)","angiopathy;angiopathy, nos;blood vessel disease;blood vessel disorder;blood vessels; disorder;blood-vessels--diseases;disease (or disorder); blood vessels;disease (or disorder); vascular;disease, vascular;diseases, vascular;disorder of blood vessel;disorder of blood vessel (disorder);disorder vascular;disorder; vascular;section 3-8 vascular diseases;unspecified vascular problem;vasc;vascular (extracardiac) disorders;vascular dis;vascular disease;vascular disease (disorder);vascular disease or syndrome;vascular disease, nos;vascular diseases;vascular diseases and syndromes;vascular disorder;vascular disorder nos;vascular disorder, nos;vascular disorders;vascular problem;vascular problem, nos;vascular system disorders;vascular system disorders (diagnosis);vascular; disorder;vascular_nos;vascular_nos problem;vasculopathy",chemdis,cause,1,cause,1,
16,(-)-cholesterol,arteries coronary occluded,"Experimental induction of marked hyperlipemia and hypercholesterolemia by feeding a high fat egg yolk-rich diet (supplemented with cholesterol, choleate, and thiouracil), and use of viosterol to cause vascular injury, led to severe atherosclerosis, coronary occlusion, and myocardial infarction.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)","arteries coronary occluded;artery coronary occlusion;coronary (artery) occlusion;coronary artery occluded;coronary artery occlusion;coronary artery occlusion (diagnosis);coronary occlusion;coronary occlusion (disorder);coronary occlusion nos;coronary occlusion, nos;coronary occlusions;occlusion coronary;occlusion coronary artery;occlusion, coronary;occlusion;coronary;occlusions, coronary",chemdis,cause,1,cause,0,
17,(-)-cholesterol,atherosclerosis,"These differences in lipid levels and experimental atherosclerosis are thought to arise from 1) increased endogenous triglyceride synthesis, present in serum as very low-density lipoproteins; 2) impaired clearance of these lipoproteins; 3) slowed turnover of cholesterol into bile acids; and 4) possible changes in aortic connective tissue metabolism.___Experimental induction of marked hyperlipemia and hypercholesterolemia by feeding a high fat egg yolk-rich diet (supplemented with cholesterol, choleate, and thiouracil), and use of viosterol to cause vascular injury, led to severe atherosclerosis, coronary occlusion, and myocardial infarction.___Dietary fats containing saturated fatty acids at the beta-position tend to raise plasma total and LDL-cholesterol, which, of course, contribute to atherosclerosis and coronary heart disease.___Not only hypercholesterolemia but also low levels of high density lipoprotein cholesterol are critical risk factors for atherosclerosis and related diseases.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",atherosclerosis,chemdis,cause,4,cause,1,
18,(-)-cholesterol,body fails to respond to insulin,"Insulin resistance syndrome is the theory that glucose intolerance, hyperinsulinemia, increased very low density lipoprotein triglyceride level, decreased high density lipoprotein cholesterol level, and hypertension are proposed consequences of insulin resistance.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)","body fails to respond to insulin;drug resistance to insulin;drug resistance to insulin (disorder);insulin resistance;insulin resistance (diagnosis);insulin resistance (disorder);resistance, insulin",chemdis,cause,1,cause,0,
19,(-)-cholesterol,"cardiovascular syndrome, metabolic","The metabolic syndrome (MetS) is manifested by a lipid triad which includes elevated serum triglycerides, small LDL particles, and low high-density lipoprotein (HDL) cholesterol, by central obesity (central adiposity), insulin resistance, glucose intolerance and elevated blood pressure, and it is associated with an increased risk of type 2 diabetes and coronary heart disease.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)","cardiovascular syndrome, metabolic;cardiovascular syndromes, metabolic;dysmetabolic syndrome x;dysmetabolic syndrome x (diagnosis);equine metabolic syndrome;insulin resistance syndrome x;metabolic cardiovascular syndrome;metabolic syndrome;metabolic syndrome x;metabolic syndrome x (disorder);metabolic syndromes;metabolic x syndrome;reaven syndrome x;reaven's syndrome;syndrome metabolic;syndrome x (metabolic);syndrome x insulin resistance;syndrome x, dysmetabolic;syndrome x, insulin resistance;syndrome x, metabolic;syndrome x, reaven;syndrome, metabolic;syndrome, metabolic cardiovascular;syndrome, metabolic x;syndromes, metabolic;x syndrome, metabolic",chemdis,cause,1,cause,1,
20,(-)-cholesterol,"cholesterol level, high","Patients with the following features are candidates for LMD therapy: have clinical CHD and a low-density lipoprotein cholesterol (LDLC) level > 3.0 mmol/l despite optimum non-pharmacological intervention, or suffer from familial hypercholesterolaemia (FH) or equivalent severe, monogenic disorder, or have a 10-year risk of an acute clinical coronary event of > 20% (or > 30% risk if extrapolated to the age of 60 years) owing to the presence of the hyperlipidaemia alone or in combination with contributory risk factors.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)","cholesterol level, high;cholesterol levels, high;cholesterol, elevated;cholesterols, elevated;elevated cholesterol;elevated cholesterols;elevated total cholesterol;high blood cholesterol level;high cholesterol levels;hypercholesteraemia;hypercholesteremia;hypercholesteremias;hypercholesterolaemia;hypercholesterolaemia, nos;hypercholesterolemia (diagnosis);hypercholesterolemia (disorder);hypercholesterolemia (elevated plasma cholesterol);hypercholesterolemia, nos;hypercholesterolemias;increased total cholesterol;level, high cholesterol;levels, high cholesterol",chemdis,cause,1,cause,0,
21,(-)-cholesterol,coronary heart disease,"For many years, it has been recognized that elevated serum cholesterol is a risk factor associated with atherosclerosis and coronary heart disease, the latter being a major cause of death in Western countries.___Dietary fats containing saturated fatty acids at the beta-position tend to raise plasma total and LDL-cholesterol, which, of course, contribute to atherosclerosis and coronary heart disease.___Their consumption has been peddled to supposedly raise the level of blood cholesterol, thereby increasing the risk of coronary heart disease.___There are elderly persons at increased risk of coronary heart disease due to elevated LDL cholesterol, lowered HDL cholesterol, or both.___While cholesterol is produced naturally by our bodies, a high blood concentration of certain types of cholesterol is a predisposing factor for coronary heart disease.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",coronary heart disease,chemdis,cause,5,cause,1,
22,(-)-cholesterol,diabetes,"Hypercholesterolemia, also called high cholesterol, is a form of hyperlipidemia, which may be a consequence of diet, obesity or diabetes.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",diabetes,chemdis,cause,1,cause,1,
23,(-)-cholesterol,dis metab,"Obesity is a metabolic disorder that can lead to adverse metabolic effects on blood pressure, cholesterol, triglycerides and insulin resistance and also increases the risk of coronary heart disease, ischemic stroke and type 2 diabetes mellitus.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)","dis metab;disease, metabolic;disease;metabolic;diseases, metabolic;disorder of metabolism nos;disorder of metabolism nos (disorder);disorder; metabolism;disorder;metabolic;general; metabolic disorder;generalised metabolic disorder;generalized metabolic disorder;generalized metabolic disorder (disorder);md - metabolic disorders;metab dis;metabolic derangement;metabolic disease;metabolic disease (disorder);metabolic disease, nos;metabolic diseases;metabolic disorder;metabolic disorder nos;metabolic disorder, nos;metabolic disorder, unspecified;metabolic disorder; general;metabolic disorders;metabolic disorders (diagnosis);metabolic disorders (disorder);metabolic disorders: general;metabolism disorder;metabolism disorder nos;metabolism disorders;metabolism--disorders;metabolism; disorder;metabolism; disorder, general;rndx metabolic;rndx metabolic (diagnosis);thesaurismoses;thesaurismosis;unspecified disorder of metabolism",chemdis,cause,1,cause,1,
24,(-)-cholesterol,dyslipidaemia,"After an 8-year follow up period, the Bogalusa Heart Study showed that children with low high density lipoprotein cholesterol, high triglyceride levels and high body mass index had a notably increased occurrence of dyslipidemia as adults.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",dyslipidaemia;dyslipidemia;dyslipidemia (diagnosis);dyslipidemia (disorder);dyslipidemias;high blood cholesterol/triglycerides,chemdis,cause,1,cause,1,
25,(-)-cholesterol,fatty infiltration of liver,Cholesterol feeding induced marked hepatic steatosis (HS) characterized by the whitish appearance of the liver.,"(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",fatty infiltration of liver;fatty liver;hepatic steatosis;liver steatosis,chemdis,cause,1,cause,1,
26,(-)-cholesterol,glucose intolerance,"Insulin resistance syndrome is the theory that glucose intolerance, hyperinsulinemia, increased very low density lipoprotein triglyceride level, decreased high density lipoprotein cholesterol level, and hypertension are proposed consequences of insulin resistance.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",glucose intolerance,chemdis,cause,1,cause,0,
27,(-)-cholesterol,high cholesterol,Familial hypercholesterolemia is a rare disorder characterized by high cholesterol levels and early cardiovascular disease.,"(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",high cholesterol;high cholesterol level;hypercholesterolemia,chemdis,cause,1,cause,1,
28,(-)-cholesterol,hyperglycemia,Metabolic syndrome is characterized by hypertension; hyperglycemia; hypertriglyceridemia; reduced high-density lipoprotein cholesterol levels and abdominal obesity.,"(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",hyperglycemia,chemdis,cause,1,cause,0,
29,(-)-cholesterol,hyperlipidemia,"Hypercholesterolemia, also called high cholesterol, is a form of hyperlipidemia, which may be a consequence of diet, obesity or diabetes.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",hyperlipidemia,chemdis,cause,1,cause,1,
30,(-)-cholesterol,hypertension,"Metabolic syndrome is characterized by hypertension; hyperglycemia; hypertriglyceridemia; reduced high-density lipoprotein cholesterol levels and abdominal obesity.___The 3 factors are hypertension, smoking, and high levels of cholesterol in the blood.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",hypertension,chemdis,cause,2,cause,0,
31,(-)-cholesterol,hypertriglyceridemia,"It is most frequently accompanied by hypertriglyceridemia, reduced HDL cholesterol levels, abdominal obesity, insulin resistance and by a series of other metabolic alterations predictive of an impaired endothelial function and increased susceptibility to thrombosis.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",hypertriglyceridemia,chemdis,cause,1,cause,0,
32,(-)-cholesterol,hypothyroidism/myxedema,"The high cholesterol content of an atheroma, the frequent occurrence of myocardial infarction with high serum cholesterol, the extensive arteriosclerotic changes in diseases with high serum cholesterol (nephrosis, myxedema) and the occurrence of cholesterol deposits in the aorta in some animals fed with cholesterol are the principal arguments for the lipid theory of arteriosclerosis.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)","hypothyroidism/myxedema;hypothyroidism/myxoedema;mucin in skin;myxedema;myxedema (diagnosis);myxedema (disorder);myxedema nos;myxedema, nos;myxedemas;myxoedema;myxoedema, nos",chemdis,cause,1,cause,0,
33,(-)-cholesterol,inactivity,"Physical inactivity, low fruit and vegetable intake, high fast food consumption and high cholesterol are predominant causes of cardiovascular disease and some cancers.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)","inactivity;inactivity, physical;physical inactivity",chemdis,cause,1,cause,0,
34,(-)-cholesterol,obesity,"Hypercholesterolemia, also called high cholesterol, is a form of hyperlipidemia, which may be a consequence of diet, obesity or diabetes.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",obesity,chemdis,cause,1,cause,1,
35,(-)-cholesterol,plaques,Atherosclerosis is the deposition of plaques containing cholesterol and lipids in arterial walls.,"(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",plaques,chemdis,cause,1,cause,0,
36,(-)-cholesterol,weight loss,"Some studies have reported substantial weight loss, signs of dehydration, raised serum concentrations of uric acid and cholesterol, etc. during Ramadan.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",weight loss,chemdis,cause,1,cause,0,
37,(-)-cocaine,3-00 cardiovascular disorders: general terms,"Once playing a vital role in medicine as a local anesthetic, decades of research have established that cocaine has the ability to cause irreversible structural damage to the heart, greatly accelerate cardiovascular disease, and initiate sudden cardiac death.","(-)-cocaine;(1r,2r,3s,5s)-2-methoxycarbonyltropan-3-yl benzoate;2-methyl-3β-hydroxy-1αh,5αh-tropane-2β-carboxylate benzoate (ester);8-azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1r-(exo,exo))-;[1r-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester;benzoylmethylecgonine;benzoylmethylecgonine (substance);beta-cocain;blow;coca;cocain;cocaina;cocaine;cocaine (product);cocaine (schedule i substance);cocaine (substance);cocaine in any form;cocaine product;cocaine substance;cocaine-containing product;cocainum;coke;kokain;l-cocain;l-cocaine;methyl [1r-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate;methyl benzoylecgonine;neurocaine;product containing cocaine;product containing cocaine (medicinal product);snow","3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,cause,1,cause,1,
38,(-)-cocaine,arrhythmia,"Cocaine has also been shown to block K+ channels, increase L-type Ca2+ channel current, and inhibit Na+ influx during depolarization, all possible causes for arrhythmia.","(-)-cocaine;(1r,2r,3s,5s)-2-methoxycarbonyltropan-3-yl benzoate;2-methyl-3β-hydroxy-1αh,5αh-tropane-2β-carboxylate benzoate (ester);8-azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1r-(exo,exo))-;[1r-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester;benzoylmethylecgonine;benzoylmethylecgonine (substance);beta-cocain;blow;coca;cocain;cocaina;cocaine;cocaine (product);cocaine (schedule i substance);cocaine (substance);cocaine in any form;cocaine product;cocaine substance;cocaine-containing product;cocainum;coke;kokain;l-cocain;l-cocaine;methyl [1r-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate;methyl benzoylecgonine;neurocaine;product containing cocaine;product containing cocaine (medicinal product);snow",arrhythmia,chemdis,cause,1,cause,1,
39,(-)-cocaine,atherosclerosis,"Among these, cocaine may lead to MI by causing coronary artery vasoconstriction and accelerated atherosclerosis, and by initiating thrombus formation.","(-)-cocaine;(1r,2r,3s,5s)-2-methoxycarbonyltropan-3-yl benzoate;2-methyl-3β-hydroxy-1αh,5αh-tropane-2β-carboxylate benzoate (ester);8-azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1r-(exo,exo))-;[1r-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester;benzoylmethylecgonine;benzoylmethylecgonine (substance);beta-cocain;blow;coca;cocain;cocaina;cocaine;cocaine (product);cocaine (schedule i substance);cocaine (substance);cocaine in any form;cocaine product;cocaine substance;cocaine-containing product;cocainum;coke;kokain;l-cocain;l-cocaine;methyl [1r-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate;methyl benzoylecgonine;neurocaine;product containing cocaine;product containing cocaine (medicinal product);snow",atherosclerosis,chemdis,cause,1,cause,1,
40,(-)-cocaine,blood clot,"Among these, cocaine may lead to MI by causing coronary artery vasoconstriction and accelerated atherosclerosis, and by initiating thrombus formation.","(-)-cocaine;(1r,2r,3s,5s)-2-methoxycarbonyltropan-3-yl benzoate;2-methyl-3β-hydroxy-1αh,5αh-tropane-2β-carboxylate benzoate (ester);8-azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1r-(exo,exo))-;[1r-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester;benzoylmethylecgonine;benzoylmethylecgonine (substance);beta-cocain;blow;coca;cocain;cocaina;cocaine;cocaine (product);cocaine (schedule i substance);cocaine (substance);cocaine in any form;cocaine product;cocaine substance;cocaine-containing product;cocainum;coke;kokain;l-cocain;l-cocaine;methyl [1r-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate;methyl benzoylecgonine;neurocaine;product containing cocaine;product containing cocaine (medicinal product);snow",blood clot;blood clots;thrombi;thrombus,chemdis,cause,1,cause,1,
41,(-)-cocaine,cardiac death,"Once playing a vital role in medicine as a local anesthetic, decades of research have established that cocaine has the ability to cause irreversible structural damage to the heart, greatly accelerate cardiovascular disease, and initiate sudden cardiac death.","(-)-cocaine;(1r,2r,3s,5s)-2-methoxycarbonyltropan-3-yl benzoate;2-methyl-3β-hydroxy-1αh,5αh-tropane-2β-carboxylate benzoate (ester);8-azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1r-(exo,exo))-;[1r-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester;benzoylmethylecgonine;benzoylmethylecgonine (substance);beta-cocain;blow;coca;cocain;cocaina;cocaine;cocaine (product);cocaine (schedule i substance);cocaine (substance);cocaine in any form;cocaine product;cocaine substance;cocaine-containing product;cocainum;coke;kokain;l-cocain;l-cocaine;methyl [1r-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate;methyl benzoylecgonine;neurocaine;product containing cocaine;product containing cocaine (medicinal product);snow","cardiac death;cardiac deaths;cardiac; death;death, cardiac;death; cardiac",chemdis,cause,1,cause,1,
42,(-)-cocaine,"cardiomyopathies, dilated","Additionally, cocaine use has been associated with left ventricular hypertrophy, myocarditis, and dilated cardiomyopathy, which can lead to heart failure if drug use is continued.","(-)-cocaine;(1r,2r,3s,5s)-2-methoxycarbonyltropan-3-yl benzoate;2-methyl-3β-hydroxy-1αh,5αh-tropane-2β-carboxylate benzoate (ester);8-azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1r-(exo,exo))-;[1r-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester;benzoylmethylecgonine;benzoylmethylecgonine (substance);beta-cocain;blow;coca;cocain;cocaina;cocaine;cocaine (product);cocaine (schedule i substance);cocaine (substance);cocaine in any form;cocaine product;cocaine substance;cocaine-containing product;cocainum;coke;kokain;l-cocain;l-cocaine;methyl [1r-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate;methyl benzoylecgonine;neurocaine;product containing cocaine;product containing cocaine (medicinal product);snow","cardiomyopathies, dilated;cardiomyopathy congestive;cardiomyopathy dilated;cardiomyopathy, dilated;cardiomyopathy; cardiomyopathy, dilated;cardiomyopathy;congestive;ccm - congestive cardiomyopath;ccm - congestive cardiomyopathy;cocm - congestive cardiomyop;cocm - congestive cardiomyopathy;cocm congestive (dilated) cardiomyopathy;congestive (dilated) cardiomyopathy;congestive cardiomyopathy (diagnosis);congestive cardiomyopathy (disorder);congestive dilated cardiomyopathy;dcm - dilated cardiomyopathy;dilated cardiomyopathies;dilated cardiomyopathy;dilated cardiomyopathy (diagnosis);heart; dilatation, cardiomyopathy;primary dilated cardiomyopathy;primary dilated cardiomyopathy (disorder);stretched and thinned heart muscle",chemdis,cause,1,cause,1,
43,(-)-cocaine,heart failure,"Additionally, cocaine use has been associated with left ventricular hypertrophy, myocarditis, and dilated cardiomyopathy, which can lead to heart failure if drug use is continued.","(-)-cocaine;(1r,2r,3s,5s)-2-methoxycarbonyltropan-3-yl benzoate;2-methyl-3β-hydroxy-1αh,5αh-tropane-2β-carboxylate benzoate (ester);8-azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1r-(exo,exo))-;[1r-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester;benzoylmethylecgonine;benzoylmethylecgonine (substance);beta-cocain;blow;coca;cocain;cocaina;cocaine;cocaine (product);cocaine (schedule i substance);cocaine (substance);cocaine in any form;cocaine product;cocaine substance;cocaine-containing product;cocainum;coke;kokain;l-cocain;l-cocaine;methyl [1r-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate;methyl benzoylecgonine;neurocaine;product containing cocaine;product containing cocaine (medicinal product);snow",heart failure,chemdis,cause,1,cause,1,
44,(-)-cocaine,mi,"Among these, cocaine may lead to MI by causing coronary artery vasoconstriction and accelerated atherosclerosis, and by initiating thrombus formation.","(-)-cocaine;(1r,2r,3s,5s)-2-methoxycarbonyltropan-3-yl benzoate;2-methyl-3β-hydroxy-1αh,5αh-tropane-2β-carboxylate benzoate (ester);8-azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1r-(exo,exo))-;[1r-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester;benzoylmethylecgonine;benzoylmethylecgonine (substance);beta-cocain;blow;coca;cocain;cocaina;cocaine;cocaine (product);cocaine (schedule i substance);cocaine (substance);cocaine in any form;cocaine product;cocaine substance;cocaine-containing product;cocainum;coke;kokain;l-cocain;l-cocaine;methyl [1r-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate;methyl benzoylecgonine;neurocaine;product containing cocaine;product containing cocaine (medicinal product);snow",mi,chemdis,cause,1,cause,1,
45,(-)-cocaine,thrombosis,"There is many clinical states that can lead to multiple thrombosis i.e. essential trombocytosis, hiperhomocysteinaemia, depletion of antitrombin III, cocaine abuse etc.","(-)-cocaine;(1r,2r,3s,5s)-2-methoxycarbonyltropan-3-yl benzoate;2-methyl-3β-hydroxy-1αh,5αh-tropane-2β-carboxylate benzoate (ester);8-azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1r-(exo,exo))-;[1r-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester;benzoylmethylecgonine;benzoylmethylecgonine (substance);beta-cocain;blow;coca;cocain;cocaina;cocaine;cocaine (product);cocaine (schedule i substance);cocaine (substance);cocaine in any form;cocaine product;cocaine substance;cocaine-containing product;cocainum;coke;kokain;l-cocain;l-cocaine;methyl [1r-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate;methyl benzoylecgonine;neurocaine;product containing cocaine;product containing cocaine (medicinal product);snow",thrombosis,chemdis,cause,1,cause,1,
46,(±)-flecainide,supraventricular tachycardia,We report three consecutive cases of flecainide intoxication in children with supraventricular tachycardia (SVT) in our hospital from 2017 to 2019.,"(±)-flecainide;benzamide, n-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)-;flecaine;flecainida;flecainide;flecainide (medication);flecainide (product);flecainide (substance);flecainide product;flecainide-containing product;flecainidum;flécanide;n-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide;product containing flecainide;product containing flecainide (medicinal product)",supraventricular tachycardia,chemdis,cause,1,cause,0,
47,619-61c carbohydrates,3-00 cardiovascular disorders: general terms,"In fact, high-protein, low-carbohydrate diets may add additional risk to individuals with cardiovascular disease due to their high fat and cholesterol content combined with decreased intake of fruits, vegetables, whole grains, and other nutrients related to cardiovascular risk.","619-61c carbohydrates;carbohydrate;carbohydrate (substance);carbohydrate agent;carbohydrate agent (substance);carbohydrate product;carbohydrate product (product);carbohydrate product (substance);carbohydrate, nos;carbohydrate-containing product;carbohydrates (medication);carbs;product containing carbohydrate;product containing carbohydrate (product);saccharide;saccharides","3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,cause,1,cause,,
48,619-61c carbohydrates,3-10 heart diseases: general terms,These results indicate that the consumption of sucrose can increase blood lipids that are considered to be risk factors in heart disease and that males and carbohydrate-sensitive individuals may be more susceptible than others to the effects of sucrose.,"619-61c carbohydrates;carbohydrate;carbohydrate (substance);carbohydrate agent;carbohydrate agent (substance);carbohydrate product;carbohydrate product (product);carbohydrate product (substance);carbohydrate, nos;carbohydrate-containing product;carbohydrates (medication);carbs;product containing carbohydrate;product containing carbohydrate (product);saccharide;saccharides","3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",chemdis,cause,1,cause,1,
51,619-61c carbohydrates,dysfunction endothelial,"The high-carbohydrate, high-fat diet produced obesity, dyslipidemia, hypertension, impaired glucose tolerance, hepatic steatosis, infiltration of inflammatory cells in the liver and the heart, higher cardiac stiffness, endothelial dysfunction, and higher plasma markers of oxidative stress with lower expression of markers for oxidative stress and apoptosis in the liver.","619-61c carbohydrates;carbohydrate;carbohydrate (substance);carbohydrate agent;carbohydrate agent (substance);carbohydrate product;carbohydrate product (product);carbohydrate product (substance);carbohydrate, nos;carbohydrate-containing product;carbohydrates (medication);carbs;product containing carbohydrate;product containing carbohydrate (product);saccharide;saccharides",dysfunction endothelial;dysfunctions endothelial;endothelial dysfunction,chemdis,cause,1,cause,1,
52,619-61c carbohydrates,dyslipidaemia,"The high-carbohydrate, high-fat diet produced obesity, dyslipidemia, hypertension, impaired glucose tolerance, hepatic steatosis, infiltration of inflammatory cells in the liver and the heart, higher cardiac stiffness, endothelial dysfunction, and higher plasma markers of oxidative stress with lower expression of markers for oxidative stress and apoptosis in the liver.","619-61c carbohydrates;carbohydrate;carbohydrate (substance);carbohydrate agent;carbohydrate agent (substance);carbohydrate product;carbohydrate product (product);carbohydrate product (substance);carbohydrate, nos;carbohydrate-containing product;carbohydrates (medication);carbs;product containing carbohydrate;product containing carbohydrate (product);saccharide;saccharides",dyslipidaemia;dyslipidemia;dyslipidemia (diagnosis);dyslipidemia (disorder);dyslipidemias;high blood cholesterol/triglycerides,chemdis,cause,1,cause,1,
53,619-61c carbohydrates,fatty infiltration of liver,"The high-carbohydrate, high-fat diet produced obesity, dyslipidemia, hypertension, impaired glucose tolerance, hepatic steatosis, infiltration of inflammatory cells in the liver and the heart, higher cardiac stiffness, endothelial dysfunction, and higher plasma markers of oxidative stress with lower expression of markers for oxidative stress and apoptosis in the liver.","619-61c carbohydrates;carbohydrate;carbohydrate (substance);carbohydrate agent;carbohydrate agent (substance);carbohydrate product;carbohydrate product (product);carbohydrate product (substance);carbohydrate, nos;carbohydrate-containing product;carbohydrates (medication);carbs;product containing carbohydrate;product containing carbohydrate (product);saccharide;saccharides",fatty infiltration of liver;fatty liver;hepatic steatosis;liver steatosis,chemdis,cause,1,cause,1,
54,619-61c carbohydrates,"fatty liver, nonalcoholic","High carbohydrate, high fat-fed rats showed visceral obesity with hypertension, insulin resistance, cardiovascular remodelling, and nonalcoholic fatty liver disease.___The high-carbohydrate, high-fat diet-fed rats showed the symptoms of metabolic syndrome leading to cardiovascular remodeling and nonalcoholic fatty liver disease.","619-61c carbohydrates;carbohydrate;carbohydrate (substance);carbohydrate agent;carbohydrate agent (substance);carbohydrate product;carbohydrate product (product);carbohydrate product (substance);carbohydrate, nos;carbohydrate-containing product;carbohydrates (medication);carbs;product containing carbohydrate;product containing carbohydrate (product);saccharide;saccharides","fatty liver, nonalcoholic;fatty livers, nonalcoholic;liver, nonalcoholic fatty;livers, nonalcoholic fatty;nafld;nafld - nonalcoholic fatty liver disease;non alcoholic fatty liver disease;non-alcoholic fatty liver;non-alcoholic fatty liver (disorder);non-alcoholic fatty liver disease;nonalcoholic fatty liver;nonalcoholic fatty liver (diagnosis);nonalcoholic fatty liver (disorder);nonalcoholic fatty liver disease;nonalcoholic fatty liver disease (nafld);nonalcoholic fatty livers",chemdis,cause,2,cause,1,
55,619-61c carbohydrates,hypertension,"The high-carbohydrate, high-fat diet produced obesity, dyslipidemia, hypertension, impaired glucose tolerance, hepatic steatosis, infiltration of inflammatory cells in the liver and the heart, higher cardiac stiffness, endothelial dysfunction, and higher plasma markers of oxidative stress with lower expression of markers for oxidative stress and apoptosis in the liver.","619-61c carbohydrates;carbohydrate;carbohydrate (substance);carbohydrate agent;carbohydrate agent (substance);carbohydrate product;carbohydrate product (product);carbohydrate product (substance);carbohydrate, nos;carbohydrate-containing product;carbohydrates (medication);carbs;product containing carbohydrate;product containing carbohydrate (product);saccharide;saccharides",hypertension,chemdis,cause,1,cause,1,
56,619-61c carbohydrates,"obesities, visceral","High carbohydrate, high fat-fed rats showed visceral obesity with hypertension, insulin resistance, cardiovascular remodelling, and nonalcoholic fatty liver disease.","619-61c carbohydrates;carbohydrate;carbohydrate (substance);carbohydrate agent;carbohydrate agent (substance);carbohydrate product;carbohydrate product (product);carbohydrate product (substance);carbohydrate, nos;carbohydrate-containing product;carbohydrates (medication);carbs;product containing carbohydrate;product containing carbohydrate (product);saccharide;saccharides","obesities, visceral;obesity, visceral;visceral obesities;visceral obesity",chemdis,cause,1,cause,1,
57,619-61c carbohydrates,obesity,"The high-carbohydrate, high-fat diet produced obesity, dyslipidemia, hypertension, impaired glucose tolerance, hepatic steatosis, infiltration of inflammatory cells in the liver and the heart, higher cardiac stiffness, endothelial dysfunction, and higher plasma markers of oxidative stress with lower expression of markers for oxidative stress and apoptosis in the liver.","619-61c carbohydrates;carbohydrate;carbohydrate (substance);carbohydrate agent;carbohydrate agent (substance);carbohydrate product;carbohydrate product (product);carbohydrate product (substance);carbohydrate, nos;carbohydrate-containing product;carbohydrates (medication);carbs;product containing carbohydrate;product containing carbohydrate (product);saccharide;saccharides",obesity,chemdis,cause,1,cause,1,
58,acid bile,atherosclerosis,"These differences in lipid levels and experimental atherosclerosis are thought to arise from 1) increased endogenous triglyceride synthesis, present in serum as very low-density lipoproteins; 2) impaired clearance of these lipoproteins; 3) slowed turnover of cholesterol into bile acids; and 4) possible changes in aortic connective tissue metabolism.","acid bile;acid bile salts;acid, bile;acids bile;acids, bile;ba - bile acid;bile acid (substance);bile acid product;bile acid, nos;bile acid-containing product;bile acids;product containing bile acid;product containing bile acid (product)",atherosclerosis,chemdis,cause,1,cause,,
59,acid fatty polyunsaturated,3-00 cardiovascular disorders: general terms,"The high prevalence of cardiovascular disease (CVD) is largely attributable to the contemporary lifestyle that is often sedentary and includes a diet high in saturated fats and sugars and low ingestion of polyunsaturated fatty acids (PUFAs), fruit, vegetables, and fiber.","acid fatty polyunsaturated;acid, polyunsaturated fatty;acids fatty polyunsaturated;acids, polyunsaturated fatty;fatty acid, polyunsaturated;fatty acid, total polyunsaturated;fatty acids, polyunsaturated;fatty acids.polyunsaturated;polyunsaturated fatty acid;polyunsaturated fatty acid (substance);polyunsaturated fatty acids;pufa;pufa (polyunsaturated fatty acid);pufa - polyunsat fatty acid;pufa - polyunsaturated fatty acid;pufas","3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,cause,1,cause,0,
60,acid fatty polyunsaturated,arrhythmia,"Dietary n-3 polyunsaturated fatty acids (PUFA) reduce coronary heart disease (CHD) complications, such as chronic arrhythmia and sudden cardiac death.","acid fatty polyunsaturated;acid, polyunsaturated fatty;acids fatty polyunsaturated;acids, polyunsaturated fatty;fatty acid, polyunsaturated;fatty acid, total polyunsaturated;fatty acids, polyunsaturated;fatty acids.polyunsaturated;polyunsaturated fatty acid;polyunsaturated fatty acid (substance);polyunsaturated fatty acids;pufa;pufa (polyunsaturated fatty acid);pufa - polyunsat fatty acid;pufa - polyunsaturated fatty acid;pufas",arrhythmia,chemdis,cause,1,cause,0,
61,acid fatty polyunsaturated,cardiac death,"Dietary n-3 polyunsaturated fatty acids (PUFA) reduce coronary heart disease (CHD) complications, such as chronic arrhythmia and sudden cardiac death.","acid fatty polyunsaturated;acid, polyunsaturated fatty;acids fatty polyunsaturated;acids, polyunsaturated fatty;fatty acid, polyunsaturated;fatty acid, total polyunsaturated;fatty acids, polyunsaturated;fatty acids.polyunsaturated;polyunsaturated fatty acid;polyunsaturated fatty acid (substance);polyunsaturated fatty acids;pufa;pufa (polyunsaturated fatty acid);pufa - polyunsat fatty acid;pufa - polyunsaturated fatty acid;pufas","cardiac death;cardiac deaths;cardiac; death;death, cardiac;death; cardiac",chemdis,cause,1,cause,0,
63,"acid, free fatty",diabetes,Triglycerides and free fatty acids (FFAs) are elevated in patients with diabetes and may contribute to ER stress.,"acid, free fatty;acids fatty free;acids, free fatty;acids, nonesterified fatty;fatty acid, free;fatty acids, free;fatty acids, nonesterified;fatty acids.nonesterified;ffa;ffa - free fatty acids;ffas;free fatty acid;free fatty acids;nefa;non-esterified fatty acid;non-esterified fatty acid (substance);nonesterified fatty acid;nonesterified fatty acids;unesterified fatty acid;unesterified fatty acid (substance)",diabetes,chemdis,cause,1,cause,1,
64,"acid, free fatty",obesity,The results suggest that there was no major defect in lipid mobilization in these obese pigs (only a lower minimum FFA concentration was detected) and that an increased maximum blood glucose concentration in the fasting state might contribute to the obesity.,"acid, free fatty;acids fatty free;acids, free fatty;acids, nonesterified fatty;fatty acid, free;fatty acids, free;fatty acids, nonesterified;fatty acids.nonesterified;ffa;ffa - free fatty acids;ffas;free fatty acid;free fatty acids;nefa;non-esterified fatty acid;non-esterified fatty acid (substance);nonesterified fatty acid;nonesterified fatty acids;unesterified fatty acid;unesterified fatty acid (substance)",obesity,chemdis,cause,1,cause,0,
65,"acid, monounsaturated fatty",ischaemia,"Very recent experiments with the monounsaturated fatty acid (MUFA) oleic acid clearly demonstrate that, at least in rats subjected to ligation of their coronary artery, this acid is not 'neutral' as has been suggested by some for its role in atherosclerosis, but in fact is indistinguishable from saturated fatty acids in its effect in promoting arrhythmia during either regional ischaemia or reperfusion arrhythmia in this animal model of SCD.(ABSTRACT TRUNCATED AT 400 WORDS)","acid, monounsaturated fatty;acids, monounsaturated fatty;fatty acid, monounsaturated;fatty acid, total monounsaturated;fatty acids, monounsaturated;fatty acids.monounsaturated;monounsaturated fatty acid;monounsaturated fatty acid (substance);monounsaturated fatty acids;mufa;mufa - monounsat fatty acid;mufa - monounsaturated fatty acid","ischaemia;ischaemia nos;ischaemia, nos;ischemia;ischemia (diagnosis);ischemia (disorder);ischemia nos;ischemia, nos;ischemias",chemdis,cause,1,cause,,
69,alcohol,37 hemorrhages,"Factors that interrupted INR control in our population, arranged in descending sequence, were concurrent medication use 46.9% (mainly Salicylates and Amiodarone), smoking cigarettes and shisha 17% (represented the most frequent single factor that caused non-TINR in the present study), a nonbalanced dietary vitamin K intake 16.88% caused changes in INR (lower) was related to an increase in the intake of vitamin K-rich food, were noticed to be much more in the spring season in Jordan (end of March and April mainly), herbal supplements 15.02%; Hawthorn (Crataegus, الزعرور) is an herb that lives widely in Jordan, and shockingly we found that it is used very commonly in our ACC patients and corresponded to an elevated INR <8 in 11 patients, and serious bleeding events that required hospitalization in 2 cases), noncompliance 1.49%, comorbid diseases 1%, malabsorption 0.53%, alcohol intake 0.39%, and VKORC1 A/G and CYP2C9 *1*1 genotype 0.15%.",alcohol,"37 hemorrhages;bleed;bleed_nos;bleed_nos problem;bleeding;bleeding (disorder);bleeding (finding);bleeding (symptom);bleeding -retired-;bleeding hemorrhage;bleeding problem;bleeding site unspecified;bleeding, nos;bleeding/haemorrhage nos;bleeding/hemorrhage nos;bleeds;blood loss of (nos);blood; extravasation;extravasation blood;extravasation of blood;extravasation; blood;haemorrhage;haemorrhage nos;haemorrhage nos (disorder);haemorrhage, nos;haemorrhage, unspecified;haemorrhages;hem;hemorrhage;hemorrhage (diagnosis);hemorrhage (morphologic abnormality);hemorrhage (nos);hemorrhage bleeding;hemorrhage nos;hemorrhage nos (disorder);hemorrhage, nos;hemorrhage, unspecified;hemorrhages",chemdis,cause,1,cause,,
74,alcohol,cancer of liver,"An increased risk for alcohol abuse might explain the excesses of liver cirrhosis, cancer of the liver, cancer of the larynx and motor vehicle accidents.",alcohol,cancer of liver;cancer of the liver;hepatic cancer,chemdis,cause,1,cause,1,
76,alcohol,cardiomyopathy,"Alcohol-induced cardiomyopathy including fibrosis has been recognized clinically for a long time, but its pathogenesis is incompletely understood.",alcohol,cardiomyopathy,chemdis,cause,1,cause,,
77,alcohol,coronary heart disease,"Physical activity, diet, and alcohol and tobacco use are all related to the development of obesity, diabetes, coronary heart disease, osteoporosis, and cancer.",alcohol,coronary heart disease,chemdis,cause,1,cause,,
79,alcohol,desmoplasia,"Alcohol-induced cardiomyopathy including fibrosis has been recognized clinically for a long time, but its pathogenesis is incompletely understood.",alcohol,"desmoplasia;fibroplasia;fibroplasia, nos;fibrose;fibroses;fibrosis;fibrosis (formation of excess fibrous connective tissue);fibrosis (morphologic abnormality);fibrosis (qualifier value);fibrosis nos;fibrosis, nos;fibrous repair;fibrous replacement;fibrous thickening;fibrous tissue formation",chemdis,cause,1,cause,1,
80,alcohol,diabetes,"The FOS users were less likely to have a history of diabetes, alcohol abuse, stroke, MI, and angina.___Physical activity, diet, and alcohol and tobacco use are all related to the development of obesity, diabetes, coronary heart disease, osteoporosis, and cancer.",alcohol,diabetes,chemdis,cause,2,cause,1,
81,alcohol,effects toxics,These effects have been linked to alcohol-related toxicity and diseases are considered relevant to alcohol-atherosclerosis interrelationship.,alcohol,effects toxics;tox;toxic;toxic effect;toxic effect (disorder);toxic effect of;toxicities;toxicity;toxics,chemdis,cause,1,cause,1,
82,alcohol,fatigue,"Depression and fatigue may lead some patients to overindulge in food, alcohol and/or drugs.",alcohol,fatigue,chemdis,cause,1,cause,1,
83,alcohol,obesity,"Physical activity, diet, and alcohol and tobacco use are all related to the development of obesity, diabetes, coronary heart disease, osteoporosis, and cancer.",alcohol,obesity,chemdis,cause,1,cause,1,
84,alcohol,wernicke encephalopathy,BACKGROUND Wernicke encephalopathy (WE) is a neurological condition commonly associated with sustained alcohol abuse.,alcohol,wernicke encephalopathy,chemdis,cause,1,cause,1,
86,antiplatelet prasugrel,stroke,"Elderly patients ≥75 years, patients who weigh ≥60 kg, and patients with a history of stroke or transient ischemic attack are at a higher risk of bleeding complications when prasugrel is used in combination with aspirin.",antiplatelet prasugrel;prasugrel;prasugrel (medication);prasugrel (product);prasugrel (substance);prasugrel product;prasugrel-containing product;product containing prasugrel;product containing prasugrel (medicinal product),stroke,chemdis,cause,1,cause,,
87,arginine vasopressin,cardiac congestive failure,"It is usually caused by dysregulation of arginine vasopressin (AVP) homeostasis which accompanies disorders associated with water retention such as congestive heart failure and cirrhosis, or follows euvolemic states such as syndrome of inapprioprate secretion of antidiuretic hormone.",arginine vasopressin,"cardiac congestive failure;cardiac failure congestive;cardiac failure, congestive;ccf - congestive cardiac fail;ccf - congestive cardiac failure;chf;chf (congestive heart failure);chf - congestive heart failure;chf nos;congestive cardiac fail;congestive cardiac failure;congestive disease heart;congestive diseases heart;congestive failure heart;congestive failure hearts;congestive failures heart;congestive heart disease;congestive heart failure;congestive heart failure (chf);congestive heart failure (diagnosis);congestive heart failure (disorder);congestive heart failure chf;congestive heart failure nos;congestive heart failure, unspecified;congestive; heart;congetive cardiac failure;disease congestive heart;failure congestive heart;failure heart congestive;failure; heart, congestive;failure;congestive cardiac;heart congestive failure;heart failure congestive;heart failure, congestive;heart failure/congestive heart failure;heart failure; congestive;heart; congestive;heart; disease, congestive",chemdis,cause,1,cause,1,
88,arsenic,3-00 cardiovascular disorders: general terms,"Epidemiologic studies documented that arsenic pollution caused black foot disease, cardiovascular diseases (hypertension, hypotension, cardiomyopathy), bladder cancer and skin cancer in many countries in which Taiwan is considered as high arsenic exposure country for long time ago.",arsenic,"3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,cause,1,cause,1,
89,azithromycin,ekg qt interval prolonged,"Although there is evidence that azithromycin may induce QT prolongation and adverse cardiac events, the incidence is fairly limited to patients with high baseline risk, including those with preexisting cardiovascular conditions and concomitant use of other QT-prolonging drugs.",azithromycin,"ekg qt interval prolonged;electrocardiogram qt prolonged;increased q-t interval;increased q-t interval (finding);increased q-t interval -retired-;increased qt;increased qt interval;interval prolong qt;interval prolonged qt;intervals prolong qt;intervals prolonged qt;long qt;prolong qt;prolong qt interval on ekg;prolonged qt;prolonged qt interval;prolonged qt interval (finding);prolonged qt interval by ecg finding;prolonged qt interval by ekg finding;prolonged qt interval on ekg;q-t interval, increased;qt increased;qt interval increased, electrocardiographic;qt interval prolonged;qt prolongation;qt prolonged",chemdis,cause,1,cause,1,
90,b 12 vitamin,stroke,"Increased intake of vitamin B6, B12, and folate has been associated with reduction of homocysteine levels; elevated homocysteine blood levels have been associated with the occurrence of stroke, heart attack, and cardiovascular death.","b 12 vitamin;b 12, vitamin;b-12;b12;b12 - cyanocobalamin;b12 - cyanocobalamin prep;b12 - vitamin b12;b12 vitamin;b12, vitamin;cianocobalamina;cobalamin (1+);cyanocob(iii)alamin;cyanocobalamin (medication);cyanocobalamin (substance);cyanocobalamin (vitamin b12);cyanocobalamin preparation;cyanocobalamin preparation (product);cyanocobalamin preparation (substance);cyanocobalamin product;cyanocobalamin-containing product;cyanocobalamine;cyanocobalaminum;cyanocobalmin;product containing cyanocobalamin;product containing cyanocobalamin (medicinal product);product containing vitamin b12;product containing vitamin b12 (medicinal product);product containing vitamin b12 (product);vit b12;vitamin b 12;vitamin b a 12;vitamin b-12;vitamin b12 (cyanocobalamin);vitamin b12 (medication);vitamin b12 (substance);vitamin b12 (substance) [ambiguous];vitamin b12 complex;vitamin b12 compound;vitamin b12 nos;vitamin b12 preparation;vitamin b12 preparation (product);vitamin b12 preparation (substance);vitamin b12 product;vitamin b<sub>12</sub>;vitamin b<sub>12</sub> (substance);vitamin b<sub>12</sub> (substance) [ambiguous];vitamin b<sub>12</sub> preparation;vitamin b<sub>12</sub> preparation (product);vitamin b<sub>12</sub> preparation (substance);vitamin b>12<;vitamin b>12< (substance);vitamin b>12< (substance) [ambiguous];vitamin b>12< preparation;vitamin b>12< preparation (product);vitamin b>12< preparation (substance);vitamin-b12;vitamins cyanocobalamin",stroke,chemdis,cause,1,cause,0,
91,basic copper sulfate,damage,"It can be concluded from the present study that urea above 2% and copper sulphate above 1 gm in combination cause tissue damage, especially the liver and kidneys.","basic copper sulfate;blue copperas;blue vicking;blue vitriol;bluestone;copper (as copper sulfate);copper (as cupric sulfate);copper monosulfate;copper monosulphate;copper sulfate;copper sulfate (1:1);copper sulfate (medication);copper sulfate (obsolete);copper sulfate (product);copper sulfate (substance);copper sulfate product;copper sulfate, nos;copper sulfate-containing product;copper sulphate;copper(2+) sulfate;copper(ii) sulfate;copper(ii) sulfate, pentahydrate;copper(ii) sulphate;cupric sulfate;cupric sulphate;product containing copper sulfate;product containing copper sulfate (medicinal product);sulfate, copper;sulfate, cupric;sulfuric acid copper(2+) salt (1:1);vitriol, blue","damage;damage (morphologic abnormality);damage tissues;damage, nos;damages;damages tissue;tissue damage;tissue damage, nos",chemdis,cause,1,cause,1,
92,"benz(b)indeno(1,2-d)pyran-9(6h)-one, 6a,7-dihydro-3,4,6a,10-tetrahydroxy-",blood clot,"Hyperinsulinaemia mediates thrombi development via: fibrinolysis inhibition, anticoagulation production dysregulation, increasing reactive oxygen species, decreased antioxidant capacity via nicotinamide adenine dinucleotide depletion, haem oxidation and catabolism, producing carbon monoxide, increasing deep vein thrombosis risk and pulmonary emboli.","benz(b)indeno(1,2-d)pyran-9(6h)-one, 6a,7-dihydro-3,4,6a,10-tetrahydroxy-;ferrate(2-), (7,12-diethenyl-3,8,13,17-tetramethyl-21h,23h-porphine-2,18-dipropanoato(4-)-n21,n22,n23,n24)-, dihydrogen, (sp-4-2)-;ferroheme;ferroprotoporphyrin;haem;haeme;hem;heme;heme (substance);heme b;heme group;hemes;protoheme;protoheme ix;reduced hematin",blood clot;blood clots;thrombi;thrombus,chemdis,cause,1,cause,,
93,"benz(b)indeno(1,2-d)pyran-9(6h)-one, 6a,7-dihydro-3,4,6a,10-tetrahydroxy-",blood clot in artery of lung,"Hyperinsulinaemia mediates thrombi development via: fibrinolysis inhibition, anticoagulation production dysregulation, increasing reactive oxygen species, decreased antioxidant capacity via nicotinamide adenine dinucleotide depletion, haem oxidation and catabolism, producing carbon monoxide, increasing deep vein thrombosis risk and pulmonary emboli.","benz(b)indeno(1,2-d)pyran-9(6h)-one, 6a,7-dihydro-3,4,6a,10-tetrahydroxy-;ferrate(2-), (7,12-diethenyl-3,8,13,17-tetramethyl-21h,23h-porphine-2,18-dipropanoato(4-)-n21,n22,n23,n24)-, dihydrogen, (sp-4-2)-;ferroheme;ferroprotoporphyrin;haem;haeme;hem;heme;heme (substance);heme b;heme group;hemes;protoheme;protoheme ix;reduced hematin","blood clot in artery of lung;blood clot in lungs;blood clots in the lung;emboli, pulmonary;embolism lung;embolism pulm;embolism pulmonary;embolism, pulmonary;embolism; pulmonary;embolism;pulmonary;embolisms pulm;embolisms, pulmonary;embolus - pulmonary;embolus pulmonary;lung embolism;pe;pe (pulmonary embolism);pe - pulmonary embolism;pulm embolism;pulm embolisms;pulmonary artery embolism;pulmonary emboli;pulmonary embolism;pulmonary embolism (diagnosis);pulmonary embolism (disorder);pulmonary embolism nos;pulmonary embolisms;pulmonary embolus;pulmonary; embolism",chemdis,cause,1,cause,,
94,"benz(b)indeno(1,2-d)pyran-9(6h)-one, 6a,7-dihydro-3,4,6a,10-tetrahydroxy-",deep vein thromboses,"Hyperinsulinaemia mediates thrombi development via: fibrinolysis inhibition, anticoagulation production dysregulation, increasing reactive oxygen species, decreased antioxidant capacity via nicotinamide adenine dinucleotide depletion, haem oxidation and catabolism, producing carbon monoxide, increasing deep vein thrombosis risk and pulmonary emboli.","benz(b)indeno(1,2-d)pyran-9(6h)-one, 6a,7-dihydro-3,4,6a,10-tetrahydroxy-;ferrate(2-), (7,12-diethenyl-3,8,13,17-tetramethyl-21h,23h-porphine-2,18-dipropanoato(4-)-n21,n22,n23,n24)-, dihydrogen, (sp-4-2)-;ferroheme;ferroprotoporphyrin;haem;haeme;hem;heme;heme (substance);heme b;heme group;hemes;protoheme;protoheme ix;reduced hematin",deep vein thromboses;deep vein thrombosis;dvt - deep vein thrombosis,chemdis,cause,1,cause,,
97,blood coag factor iv,aldosteronism,Secondary hyperparathyroidism (SHPT) accompanies aldosteronism due to increased urinary and fecal excretion of Ca.,"blood coag factor iv;blood coagulation factor iv;ca;ca - calcium;ca element;ca++ element;calcio;calcium (medication);calcium (nos);calcium (substance);calcium 40;calcium analyte;calcium analyte (substance);calcium coagulation factor;calcium product;calcium, coagulation factor;calcium, elemental;calcium, nos;calcium-40;calcium-containing product;calciums;coag factor iv;coagulation factor iv;coagulation factor iv (substance);coagulation factor iv -retired-;elemental calcium;factor iv;factor iv, coagulation;kalzium;product containing calcium;product containing calcium (medicinal product);product containing calcium (product)","aldosteronism;aldosteronism (diagnosis);aldosteronism (disorder);aldosteronism nos;aldosteronism, nos;elevated plasma aldosterone;hyperaldosteronaemia;hyperaldosteronism;hyperaldosteronism nos;hyperaldosteronism nos (disorder);hyperaldosteronism, nos;hyperaldosteronism, unspecified;increased aldosterone production;mineralocorticoid excess",chemdis,cause,1,cause,1,
98,blood coag factor iv,failure heart systolic,"Hence, in this study we show that systolic heart failure induced by chronic DAU administration is primarily accompanied by persistent calcium overload of cardiac tissue and the protective action of DEX is associated with the restoration of normal myocardial Ca content.","blood coag factor iv;blood coagulation factor iv;ca;ca - calcium;ca element;ca++ element;calcio;calcium (medication);calcium (nos);calcium (substance);calcium 40;calcium analyte;calcium analyte (substance);calcium coagulation factor;calcium product;calcium, coagulation factor;calcium, elemental;calcium, nos;calcium-40;calcium-containing product;calciums;coag factor iv;coagulation factor iv;coagulation factor iv (substance);coagulation factor iv -retired-;elemental calcium;factor iv;factor iv, coagulation;kalzium;product containing calcium;product containing calcium (medicinal product);product containing calcium (product)","failure heart systolic;heart failure systolic;heart failure, systolic;heart failures, systolic;systolic heart failure;systolic heart failure (disorder);systolic heart failure, unspecified;systolic heart failures;systolic hrt failure nos;unspecified systolic (congestive) heart failure",chemdis,cause,1,cause,,
99,bpa,diabetes,"Moreover, data suggesting that exposure of human to BPA may elevate risk of obesity, diabetes and coronary heart diseases will be presented.",bpa,diabetes,chemdis,cause,1,cause,1,
100,ca 2+,aldosteronism,We hypothesized that the increased urinary Ca2+ and Mg2+ excretion and bone loss that accompanies aldosteronism is aggravated with furosemide and is attenuated by spironolactone.,ca 2+;ca++;ca+2;ca2+;calcium 2+;calcium cation;calcium ion;calcium ions;free calcium;ion calcium,"aldosteronism;aldosteronism (diagnosis);aldosteronism (disorder);aldosteronism nos;aldosteronism, nos;elevated plasma aldosterone;hyperaldosteronaemia;hyperaldosteronism;hyperaldosteronism nos;hyperaldosteronism nos (disorder);hyperaldosteronism, nos;hyperaldosteronism, unspecified;increased aldosterone production;mineralocorticoid excess",chemdis,cause,1,cause,0,
101,ca 2+,bone demineralized,We hypothesized that the increased urinary Ca2+ and Mg2+ excretion and bone loss that accompanies aldosteronism is aggravated with furosemide and is attenuated by spironolactone.,ca 2+;ca++;ca+2;ca2+;calcium 2+;calcium cation;calcium ion;calcium ions;free calcium;ion calcium,"bone demineralized;bone density, low;bone loss;bone; loss;loss; bone;low bone densities;low bone mineral density;osteopaenia;osteopenia;osteopenia (diagnosis);osteopenia (disorder);osteopenia (morphologic abnormality);osteopenias",chemdis,cause,1,cause,,
102,calcium,abnormality of mitochondrial metabolism,"Treatment with anthracyclines causes heart failure in 15-17% of patients, resulting in mitochondrial dysfunction, the accumulation of reactive oxygen species, intracellular calcium dysregulation, the deterioration of the cardiomyocyte structure, and apoptotic cell death.",calcium,abnormality of mitochondrial metabolism;mitochondrial dysfunction,chemdis,cause,1,cause,0,
103,calcium,body fails to respond to insulin,"In this theory, insulin resistance and the resultant hyperinsulinemia are considered to raise blood pressure through 1) sympathetic nervous system activation, 2) renal sodium retention, 3) renin-angiotensin system stimulation, and 4) intracellular calcium accumulation in vascular smooth muscle.",calcium,"body fails to respond to insulin;drug resistance to insulin;drug resistance to insulin (disorder);insulin resistance;insulin resistance (diagnosis);insulin resistance (disorder);resistance, insulin",chemdis,cause,1,cause,,
104,calcium,failure heart systolic,"Hence, in this study we show that systolic heart failure induced by chronic DAU administration is primarily accompanied by persistent calcium overload of cardiac tissue and the protective action of DEX is associated with the restoration of normal myocardial Ca content.",calcium,"failure heart systolic;heart failure systolic;heart failure, systolic;heart failures, systolic;systolic heart failure;systolic heart failure (disorder);systolic heart failure, unspecified;systolic heart failures;systolic hrt failure nos;unspecified systolic (congestive) heart failure",chemdis,cause,1,cause,,
105,calcium,infantile osteomalacia,"In children, diagnosis of rickets (always associated with osteomalacia) is confirmed on radiographs (cupping and flaring of metaphyses) and should be suspected in high risk individuals with the above clinical manifestations in the presence of abnormal blood biochemistry (high alkaline phosphatase and parathyroid hormone, low 25-hydroxyvitamin D and calcium and/or low phosphate).",calcium,"infantile osteomalacia;infantile; osteomalacia;osteomalacia, infantile;osteomalacia; infantile;rachitides;rachitis;rickets;rickets (diagnosis);rickets (disorder);rickets nos;rickets, nos;rickett;ricketts;vitamin d deficiency disease;weak and soft bones",chemdis,cause,1,cause,,
106,carbohydrates,3-00 cardiovascular disorders: general terms,"Regular consumption of a diet high in sodium, energy dense foods, fat content, refined carbohydrates, added sugar and low in fruits and vegetables contributes to an increased risk of developing hypertension (HTN) and cardiovascular disease.",carbohydrates,"3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,cause,1,cause,1,
107,carbohydrates,hypertension,"Regular consumption of a diet high in sodium, energy dense foods, fat content, refined carbohydrates, added sugar and low in fruits and vegetables contributes to an increased risk of developing hypertension (HTN) and cardiovascular disease.",carbohydrates,hypertension,chemdis,cause,1,cause,1,
108,carbohydrates,obesity,Another hypothesis for why we get fat has surfaced in the last decade which is the idea that the overconsumption of added sugars and refined carbohydrates induce insulin resistance and high insulin levels causing obesity.,carbohydrates,obesity,chemdis,cause,1,cause,1,
109,carbohydrates,weight gain,"On the other hand, refeeding carbohydrates causes water retention and weight gain.",carbohydrates,weight gain,chemdis,cause,1,cause,1,
110,catecholamine,3-00 cardiovascular disorders: general terms,"Individuals who smoke experience a wide range of physiologic side effects that increase the risk of cardiovascular disease (CVD), including insulin resistance, elevated catecholamine levels which contribute to an elevated heart rate and blood pressure, and hypercholesterolemia.",catecholamine,"3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,cause,1,cause,1,
111,catecholamine,abnormal heart rhythms,"Since excessive amounts of catecholamines are known to produce arrhythmias and increase the plasma level of aminochrome, an oxidation product of catecholamines, we tested the hypothesis that antioxidants may reduce the formation of aminochrome and prevent the catecholamine-induced arrhythmias.",catecholamine,"abnormal heart rhythms;arrhythmia (cardiac) nos;arrhythmia (finding);arrhythmia (nos);arrhythmia cardiac (nos);arrhythmia nos;arrhythmia, cardiac;arrhythmia, nos;arrhythmias;arrhythmias (heart);arrhythmias, cardiac;arrythmia;cardiac arrhythmia (disorder);cardiac arrhythmia (nos);cardiac arrhythmia nos;cardiac arrhythmia, irregular pulse;cardiac arrhythmia, nos;cardiac arrhythmia, unspecified;cardiac arrhythmias;cardiac dysrhythmia (disorder);cardiac dysrhythmia nos;cardiac dysrhythmia nos (disorder);cardiac dysrhythmia, nos;cardiac dysrhythmia, unspecified;cardiac dysrhythmias nos;cardiac rhythm disorder (diagnosis);cardiac rhythm disturbance;cardiac rhythm disturbances;cardiac rhythm irregular;cardiac rhythm, abnormal;cardiac; dysrhythmia;disorder of heart rhythm;disorder; rhythm, heart;disturbance; rhythm, heart;dysrhythmia;dysrhythmia(s);dysrhythmia, cardiac;dysrhythmia; cardiac;dysrhythmia;cardiac;dysrhythmias;ectopic beats all types;heart arrhythmia;heart arrhythmias;heart rhythm disorders;heart: rhythm;rhythm, heart; abnormal;rhythm; abnormal;rhythm; disorder",chemdis,cause,1,cause,1,
112,catecholamine,body fails to respond to insulin,"Individuals who smoke experience a wide range of physiologic side effects that increase the risk of cardiovascular disease (CVD), including insulin resistance, elevated catecholamine levels which contribute to an elevated heart rate and blood pressure, and hypercholesterolemia.",catecholamine,"body fails to respond to insulin;drug resistance to insulin;drug resistance to insulin (disorder);insulin resistance;insulin resistance (diagnosis);insulin resistance (disorder);resistance, insulin",chemdis,cause,1,cause,0,
113,catecholamine,high cholesterol,"Individuals who smoke experience a wide range of physiologic side effects that increase the risk of cardiovascular disease (CVD), including insulin resistance, elevated catecholamine levels which contribute to an elevated heart rate and blood pressure, and hypercholesterolemia.",catecholamine,high cholesterol;high cholesterol level;hypercholesterolemia,chemdis,cause,1,cause,1,
114,catecholamine (substance),abnormal heart rhythms,"Since excessive amounts of catecholamines are known to produce arrhythmias and increase the plasma level of aminochrome, an oxidation product of catecholamines, we tested the hypothesis that antioxidants may reduce the formation of aminochrome and prevent the catecholamine-induced arrhythmias.","catecholamine (substance);catecholamine product;catecholamine, nos;catecholamine-containing product;catecholamines;coumel;product containing catecholamine;product containing catecholamine (product);sympathin;sympathins;total catecholamines","abnormal heart rhythms;arrhythmia (cardiac) nos;arrhythmia (finding);arrhythmia (nos);arrhythmia cardiac (nos);arrhythmia nos;arrhythmia, cardiac;arrhythmia, nos;arrhythmias;arrhythmias (heart);arrhythmias, cardiac;arrythmia;cardiac arrhythmia (disorder);cardiac arrhythmia (nos);cardiac arrhythmia nos;cardiac arrhythmia, irregular pulse;cardiac arrhythmia, nos;cardiac arrhythmia, unspecified;cardiac arrhythmias;cardiac dysrhythmia (disorder);cardiac dysrhythmia nos;cardiac dysrhythmia nos (disorder);cardiac dysrhythmia, nos;cardiac dysrhythmia, unspecified;cardiac dysrhythmias nos;cardiac rhythm disorder (diagnosis);cardiac rhythm disturbance;cardiac rhythm disturbances;cardiac rhythm irregular;cardiac rhythm, abnormal;cardiac; dysrhythmia;disorder of heart rhythm;disorder; rhythm, heart;disturbance; rhythm, heart;dysrhythmia;dysrhythmia(s);dysrhythmia, cardiac;dysrhythmia; cardiac;dysrhythmia;cardiac;dysrhythmias;ectopic beats all types;heart arrhythmia;heart arrhythmias;heart rhythm disorders;heart: rhythm;rhythm, heart; abnormal;rhythm; abnormal;rhythm; disorder",chemdis,cause,1,cause,1,
115,catecholamine (substance),hypertensive,"MAOIs are known to cause hypertensive crisis when combined with soft cheese due to unopposed release of catecholamines from reduced tyramine metabolisation, leading to injury and possible myonecrosis.","catecholamine (substance);catecholamine product;catecholamine, nos;catecholamine-containing product;catecholamines;coumel;product containing catecholamine;product containing catecholamine (product);sympathin;sympathins;total catecholamines",hypertensive;hypertensive (finding);with high blood pressure,chemdis,cause,1,cause,,
116,chloride sodium,3-10 heart diseases: general terms,"Sodium chloride is an important ingredient added to most of foods which contributes to flavor enhancement and food preservation but excess intake of sodium chloride may also cause various diseases such as heart diseases, osteoporosis and so on.","chloride sodium;cloruro sódico;common salt;electrolytes sodium chloride;nacl;nacl - sodium chloride;nasal sodium chloride;natriumchlorid;natrum muriaticum;product containing sodium chloride;product containing sodium chloride (medicinal product);product containing sodium chloride in conventional release solution for irrigation (medicinal product form);salt, nos;salted;salting;sodium chloride;sodium chloride (medication);sodium chloride (nacl);sodium chloride (product);sodium chloride (substance);sodium chloride [eye];sodium chloride [eye] (product);sodium chloride [eye] (substance);sodium chloride [mouth];sodium chloride [mouth] (product);sodium chloride [mouth] (substance);sodium chloride [nose];sodium chloride [nose] (product);sodium chloride [nose] (substance);sodium chloride [skin];sodium chloride [skin] (product);sodium chloride [skin] (substance);sodium chloride chemical;sodium chloride chemical (substance);sodium chloride eye;sodium chloride nacl;sodium chloride nose;sodium chloride product;sodium chloride-containing product;sodium chloride-containing product in solution for irrigation","3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",chemdis,cause,1,cause,1,
117,chloride sodium,hypertension,For decades the notion that an excessive consumption of salt (NaCl) leads to hypertension has persisted.,"chloride sodium;cloruro sódico;common salt;electrolytes sodium chloride;nacl;nacl - sodium chloride;nasal sodium chloride;natriumchlorid;natrum muriaticum;product containing sodium chloride;product containing sodium chloride (medicinal product);product containing sodium chloride in conventional release solution for irrigation (medicinal product form);salt, nos;salted;salting;sodium chloride;sodium chloride (medication);sodium chloride (nacl);sodium chloride (product);sodium chloride (substance);sodium chloride [eye];sodium chloride [eye] (product);sodium chloride [eye] (substance);sodium chloride [mouth];sodium chloride [mouth] (product);sodium chloride [mouth] (substance);sodium chloride [nose];sodium chloride [nose] (product);sodium chloride [nose] (substance);sodium chloride [skin];sodium chloride [skin] (product);sodium chloride [skin] (substance);sodium chloride chemical;sodium chloride chemical (substance);sodium chloride eye;sodium chloride nacl;sodium chloride nose;sodium chloride product;sodium chloride-containing product;sodium chloride-containing product in solution for irrigation",hypertension,chemdis,cause,1,cause,1,
118,dabigatran etexilate,37 hemorrhages,"Acute bleeding episodes are known to occur with dabigatran etexilate therapy; however, only a few case reports in the literature describe such events.","dabigatran etexilate;dabigatran etexilate (substance);etexilate, dabigatran;ethyl 3-(((2-(((4- ((((hexyloxy)carbonyl)amino)iminomethyl)phenyl)amino)methyl)-1-methyl-1h-benzimidazol-5-yl)carbonyl)(pyridin-2- yl)amino)propanoate","37 hemorrhages;bleed;bleed_nos;bleed_nos problem;bleeding;bleeding (disorder);bleeding (finding);bleeding (symptom);bleeding -retired-;bleeding hemorrhage;bleeding problem;bleeding site unspecified;bleeding, nos;bleeding/haemorrhage nos;bleeding/hemorrhage nos;bleeds;blood loss of (nos);blood; extravasation;extravasation blood;extravasation of blood;extravasation; blood;haemorrhage;haemorrhage nos;haemorrhage nos (disorder);haemorrhage, nos;haemorrhage, unspecified;haemorrhages;hem;hemorrhage;hemorrhage (diagnosis);hemorrhage (morphologic abnormality);hemorrhage (nos);hemorrhage bleeding;hemorrhage nos;hemorrhage nos (disorder);hemorrhage, nos;hemorrhage, unspecified;hemorrhages",chemdis,cause,1,cause,1,
119,des,stent thrombosis,Patients undergoing transplant surgery soon after the placement of DES are at increased risk of stent thrombosis (ST) in the perioperative period.,des,stent thrombosis,chemdis,cause,1,cause,1,
120,estrogen,3-10 heart diseases: general terms,"Obesity, from declining estrogen levels after menopause, increases the risk of heart disease, diabetes, and hypertension.",estrogen,"3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",chemdis,cause,1,cause,0,
121,estrogen,diabetes,"Obesity, from declining estrogen levels after menopause, increases the risk of heart disease, diabetes, and hypertension.",estrogen,diabetes,chemdis,cause,1,cause,0,
122,estrogen,hypertension,"Obesity, from declining estrogen levels after menopause, increases the risk of heart disease, diabetes, and hypertension.",estrogen,hypertension,chemdis,cause,1,cause,,
123,estrogen,osteoporosis,Postmenopausal osteoporosis is mostly caused by increased bone remodeling resulting from estrogen deficiency.,estrogen,osteoporosis,chemdis,cause,1,cause,0,
124,estrogens,hypoglycemia,"Different mechanisms are suggested to be involved in TC pathogenesis, including low estrogens levels or dyselectrolitemia, but hypoglycemia, which results in sympathetic stimulation, seems to be more important.",estrogens,hypoglycemia,chemdis,cause,1,cause,0,
125,ethanol,cirrhosis,"Liver was carrying steatosis in 66.3% and/or hepatitis in 64.5%; acute hepatitis was more frequent in females, chronic hepatitis in older subjects and in those proven positive for hepatotropic viruses; cirrhosis occurred more often in older patients, in those carrying virus infection, and in consumers of nonnarcotics drugs such as ethanol.",ethanol,cirrhosis,chemdis,cause,1,cause,,
126,ethanol,hepatitis,"Liver was carrying steatosis in 66.3% and/or hepatitis in 64.5%; acute hepatitis was more frequent in females, chronic hepatitis in older subjects and in those proven positive for hepatotropic viruses; cirrhosis occurred more often in older patients, in those carrying virus infection, and in consumers of nonnarcotics drugs such as ethanol.",ethanol,hepatitis,chemdis,cause,1,cause,,
127,ethanol,steatosis,"Liver was carrying steatosis in 66.3% and/or hepatitis in 64.5%; acute hepatitis was more frequent in females, chronic hepatitis in older subjects and in those proven positive for hepatotropic viruses; cirrhosis occurred more often in older patients, in those carrying virus infection, and in consumers of nonnarcotics drugs such as ethanol.",ethanol,steatosis,chemdis,cause,1,cause,,
128,fatty acid,52-53 vascular scleroses,"Coronary heart disease is caused by arteriosclerosis, which is triggered by an unbalanced fatty acid profile in the body.","fatty acid;fatty acid (substance);fatty acid, nos;fatty acids","52-53 vascular scleroses;arterial sclerosis;arterioscleroses;arteriosclerosis;arteriosclerosis (morphologic abnormality);arteriosclerosis nos;arteriosclerosis, nos;arteriosclerosis/atherosclerosis;arteriosclerotic vasc.dis.nos;arteriosclerotic vascular disease;arteriosclerotic vascular disease (diagnosis);arteriosclerotic vascular disease (disorder);arteriosclerotic vascular disease nos;arteriosclerotic vascular disease nos (disorder);arteriosclerotic vascular disease, nos;arteriovascular disease;vascular scleroses;vascular sclerosis;vascular sclerosis (morphologic abnormality)",chemdis,cause,1,cause,1,
129,fatty acid,58 atrophies,"Mitochondrial dysfunctions and decreased protein synthesis lead to protein degradation, denervation, atrophy, impairment in the fatty acid oxidation, resulting in cardiomyopathy.","fatty acid;fatty acid (substance);fatty acid, nos;fatty acids","58 atrophies;atrophied;atrophies;atrophy;atrophy (morphologic abnormality);atrophy [dup] (morphologic abnormality);atrophy nos;atrophy, nos;atrophying",chemdis,cause,1,cause,,
130,fatty acid,atherosclerosis,"Excess free fatty acids may cause the enhancement of lipid synthesis and gluconeogenesis as well as insulin resistance, resulting in hyperlipidemia, glucose intolerance and hypertension and finally atherosclerosis.","fatty acid;fatty acid (substance);fatty acid, nos;fatty acids",atherosclerosis,chemdis,cause,1,cause,1,
131,fatty acid,body fails to respond to insulin,"High glucose/fatty acid toxicity, inflammation, and oxidative stress, all of which are associated with insulin resistance, can activate ERK.___In summary, although it must be emphasized that all diets high in fat cause insulin resistance relative to high-carbohydrate diets, it appears that dietary saturated, short-chain, and w6 fatty acids have the most deleterious effects on insulin action.___Excess free fatty acids may cause the enhancement of lipid synthesis and gluconeogenesis as well as insulin resistance, resulting in hyperlipidemia, glucose intolerance and hypertension and finally atherosclerosis.","fatty acid;fatty acid (substance);fatty acid, nos;fatty acids","body fails to respond to insulin;drug resistance to insulin;drug resistance to insulin (disorder);insulin resistance;insulin resistance (diagnosis);insulin resistance (disorder);resistance, insulin",chemdis,cause,3,cause,1,
132,fatty acid,cardiomyopathy,"Mitochondrial dysfunctions and decreased protein synthesis lead to protein degradation, denervation, atrophy, impairment in the fatty acid oxidation, resulting in cardiomyopathy.___Long-chain fatty acid oxidation disorders (LC-FAOD) are rare disorders characterized by acute crises of energy metabolism and severe energy deficiency that may present with cardiomyopathy, hypoglycemia, and/or rhabdomyolysis, which can lead to frequent hospitalizations and early death.","fatty acid;fatty acid (substance);fatty acid, nos;fatty acids",cardiomyopathy,chemdis,cause,2,cause,,
133,fatty acid,dysfunction endothelial,"Sepsis is initiated by the host response to infection with organ damage, increased plasma free fatty acids, high levels of cortisol, massive cytokine production, leukocyte activation, and endothelial dysfunction.","fatty acid;fatty acid (substance);fatty acid, nos;fatty acids",dysfunction endothelial;dysfunctions endothelial;endothelial dysfunction,chemdis,cause,1,cause,0,
134,fatty acid,glucose intolerance,"Excess free fatty acids may cause the enhancement of lipid synthesis and gluconeogenesis as well as insulin resistance, resulting in hyperlipidemia, glucose intolerance and hypertension and finally atherosclerosis.","fatty acid;fatty acid (substance);fatty acid, nos;fatty acids",glucose intolerance,chemdis,cause,1,cause,1,
135,fatty acid,hyperlipidemia,"Excess free fatty acids may cause the enhancement of lipid synthesis and gluconeogenesis as well as insulin resistance, resulting in hyperlipidemia, glucose intolerance and hypertension and finally atherosclerosis.","fatty acid;fatty acid (substance);fatty acid, nos;fatty acids",hyperlipidemia,chemdis,cause,1,cause,1,
136,fatty acid,hypertension,"Excess free fatty acids may cause the enhancement of lipid synthesis and gluconeogenesis as well as insulin resistance, resulting in hyperlipidemia, glucose intolerance and hypertension and finally atherosclerosis.","fatty acid;fatty acid (substance);fatty acid, nos;fatty acids",hypertension,chemdis,cause,1,cause,1,
137,fatty acid,hypertrophic cardiomyopathy,"Very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency is a severe defect of mitochondrial fatty acid oxidation characterized by hypertrophic cardiomyopathy, pericardial effusion, steatosis, and hypoglycemia, often resulting in death by 4-5 months of age.","fatty acid;fatty acid (substance);fatty acid, nos;fatty acids",hypertrophic cardiomyopathy,chemdis,cause,1,cause,1,
138,fatty acid,hypoglycemia,"Very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency is a severe defect of mitochondrial fatty acid oxidation characterized by hypertrophic cardiomyopathy, pericardial effusion, steatosis, and hypoglycemia, often resulting in death by 4-5 months of age.","fatty acid;fatty acid (substance);fatty acid, nos;fatty acids",hypoglycemia,chemdis,cause,1,cause,1,
139,fatty acid,inflamm,"High glucose/fatty acid toxicity, inflammation, and oxidative stress, all of which are associated with insulin resistance, can activate ERK.","fatty acid;fatty acid (substance);fatty acid, nos;fatty acids","inflamm;inflammation;inflammation (morphologic abnormality);inflammation (qualifier value);inflammation nos;inflammation, nos;inflammations;inflammatory reaction;inflammatory reaction, nos",chemdis,cause,1,cause,,
140,fatty acid,pericardial effusion,"Very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency is a severe defect of mitochondrial fatty acid oxidation characterized by hypertrophic cardiomyopathy, pericardial effusion, steatosis, and hypoglycemia, often resulting in death by 4-5 months of age.","fatty acid;fatty acid (substance);fatty acid, nos;fatty acids",pericardial effusion,chemdis,cause,1,cause,,
141,fatty acid,steatosis,"Very-long-chain acyl-CoA dehydrogenase (VLCAD) deficiency is a severe defect of mitochondrial fatty acid oxidation characterized by hypertrophic cardiomyopathy, pericardial effusion, steatosis, and hypoglycemia, often resulting in death by 4-5 months of age.","fatty acid;fatty acid (substance);fatty acid, nos;fatty acids",steatosis,chemdis,cause,1,cause,,
142,iodide i-131 ion,hypothyroidism,The common causes of hypothyroidism are autoimmune destruction of the thyroid gland and previous thyroid surgery or radioiodine therapy.,"iodide i-131 ion;iodide ion i 131;iodide ion i-131;iodide ion, i-131;iodide-131;radioiodine",hypothyroidism,chemdis,cause,1,cause,,
143,iodine,deficiencies micronutrient,"Specific micronutrient deficiencies can also lead to neurodisability, for example, blindness (vitamin A), intractable epilepsy (vitamin B6), and cognitive impairment (iodine and iron).",iodine,deficiencies micronutrient;deficiency of micronutrients;deficiency of micronutrients (disorder);micronutrient deficiencies;micronutrients deficiency,chemdis,cause,1,cause,,
144,iron,3-10 heart diseases: general terms,"Elevated iron stores, oxidative stress, and estrogen deficiency may place postmenopausal women at greater risk of heart disease and cancer than premenopausal women.___Despite dramatic gains in life expectancy in the deferoxamine era for patients with transfusion-dependent anemias, the leading cause of death for young adults with thalassemia major and related disorders has been cardiac disease from myocardial iron deposition.",iron,"3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",chemdis,cause,2,cause,,
145,iron,anaemia,"Despite dramatic gains in life expectancy in the deferoxamine era for patients with transfusion-dependent anemias, the leading cause of death for young adults with thalassemia major and related disorders has been cardiac disease from myocardial iron deposition.",iron,"anaemia;anaemia (disorder);anaemia nos;anaemia unspecified;anaemia unspecified (disorder);anaemia, nos;anaemia, unspecified;anaemias;anemia (diagnosis);anemia (disorder);anemia (disorder) [ambiguous];anemia [dup] (disorder);anemia nos;anemia unspecified;anemia unspecified (disorder);anemia, nos;anemia, unspecified;anemia; essential;anemia; unspecified;anemias;unspecified anaemia;unspecified anemia",chemdis,cause,1,cause,,
147,iron,anemia; thalassemia,"Despite dramatic gains in life expectancy in the deferoxamine era for patients with transfusion-dependent anemias, the leading cause of death for young adults with thalassemia major and related disorders has been cardiac disease from myocardial iron deposition.",iron,"anemia; thalassemia;c-132-136 thalassemias;hemoglobinopathy; with thalassemia;hereditary leptocytosis;hypochromic / microcytic thalassemia;hypochromic / microcytic thalassemia (diagnosis);hypochromic / microcytic thalassemia anemia;leptocytosis, hereditary;leptocytosis; hereditary;syndromes thalassemia;thalassaemia;thalassaemia (disorder);thalassaemia nos;thalassaemia syndrome;thalassaemia, unspecified;thalassaemias;thalassaemic disorders;thalassemia;thalassemia (diagnosis);thalassemia (disorder);thalassemia disorder;thalassemia nos;thalassemia nos (disorder);thalassemia syndrome;thalassemia syndrome (disorder);thalassemia syndrome, nos;thalassemia, nos;thalassemia, unspecified;thalassemia; anemia;thalassemia; disorder, hemoglobin;thalassemia; hemoglobinopathy (with thalassemia);thalassemias;thalassemic syndrome;thalassemic syndromes",chemdis,cause,1,cause,,
148,iron,atherosclerosis,"The increase in iron adds weight to the hypothesis that iron-catalyzed free radical reactions may be associated with the development of atherosclerosis.___Those with the highest incidence, such as the cardiovascular ones--including cerebrovascular accidents, atherosclerosis, and hypertension--diabetes, obesity, osteoporosis, anemias from lack of iron and folates, and some forms of cancer, reveal the influence of certain nutrients in their pathogenesis.",iron,atherosclerosis,chemdis,cause,2,cause,,
149,iron,bone demineralized,"The study of archaeological human remains from around the world reveals that this period in human dietary history saw a decline in health, including increased evidence of morbidity (poorer dental health, increased occlusal abnormalities, increased iron deficiency anemia, increased infection and bone loss).",iron,"bone demineralized;bone density, low;bone loss;bone; loss;loss; bone;low bone densities;low bone mineral density;osteopaenia;osteopenia;osteopenia (diagnosis);osteopenia (disorder);osteopenia (morphologic abnormality);osteopenias",chemdis,cause,1,cause,0,
150,iron,cardiac dysfunction,Increased iron deposition in the myocardium in alcoholics may lead to increased risk of cardiac dysfunction.,iron,cardiac dysfunction,chemdis,cause,1,cause,1,
151,iron,deficiencies micronutrient,"Specific micronutrient deficiencies can also lead to neurodisability, for example, blindness (vitamin A), intractable epilepsy (vitamin B6), and cognitive impairment (iodine and iron).",iron,deficiencies micronutrient;deficiency of micronutrients;deficiency of micronutrients (disorder);micronutrient deficiencies;micronutrients deficiency,chemdis,cause,1,cause,0,
152,iron,dysfunction thyroid,"Heart failure (HF) is a growing public health issue; its risk factors include inappropriate dietary intake of microelements such as iodine, selenium, zinc and iron, which may lead to thyroid dysfunction.",iron,dysfunction thyroid;dysfunction; thyroid;thryoid dysfunction;thyroid dysfunction;thyroid dysfunction (disorder),chemdis,cause,1,cause,1,
153,iron,heart failure,Iron deficiency is prevalent in patients with heart failure.,iron,heart failure,chemdis,cause,1,cause,0,
154,l-thyroxine sodium preparation,amyotrophy,"The major risk of levothyroxine sodium therapy is over-replacement, with anxiety, muscle wasting, osteoporosis and atrial fibrillation as adverse effects.",l-thyroxine sodium preparation;laevothyroxine sodium;laevothyroxine sodium preparation;levothyroxine sodium;levothyroxine sodium (medication);levothyroxine sodium (substance);levothyroxine sodium preparation;levothyroxine sodium preparation (product);levothyroxine sodium preparation (substance);product containing levothyroxine sodium;product containing levothyroxine sodium (medicinal product);sodium levothyroxine;sodium thyroxine;t4 thyroxine sodium preparation;t<sub>4</sub> thyroxine sodium preparation;t>4< thyroxine sodium preparation;therapeutic levothyroxine;thyroxine sodium;thyroxine sodium (product);thyroxine sodium (substance),amyotrophy;muscle atrophy;muscle wasting;muscular atrophy,chemdis,cause,1,cause,1,
155,l-thyroxine sodium preparation,anxiety,"The major risk of levothyroxine sodium therapy is over-replacement, with anxiety, muscle wasting, osteoporosis and atrial fibrillation as adverse effects.",l-thyroxine sodium preparation;laevothyroxine sodium;laevothyroxine sodium preparation;levothyroxine sodium;levothyroxine sodium (medication);levothyroxine sodium (substance);levothyroxine sodium preparation;levothyroxine sodium preparation (product);levothyroxine sodium preparation (substance);product containing levothyroxine sodium;product containing levothyroxine sodium (medicinal product);sodium levothyroxine;sodium thyroxine;t4 thyroxine sodium preparation;t<sub>4</sub> thyroxine sodium preparation;t>4< thyroxine sodium preparation;therapeutic levothyroxine;thyroxine sodium;thyroxine sodium (product);thyroxine sodium (substance),anxiety,chemdis,cause,1,cause,1,
156,l-thyroxine sodium preparation,atrial fibrillation,"The major risk of levothyroxine sodium therapy is over-replacement, with anxiety, muscle wasting, osteoporosis and atrial fibrillation as adverse effects.",l-thyroxine sodium preparation;laevothyroxine sodium;laevothyroxine sodium preparation;levothyroxine sodium;levothyroxine sodium (medication);levothyroxine sodium (substance);levothyroxine sodium preparation;levothyroxine sodium preparation (product);levothyroxine sodium preparation (substance);product containing levothyroxine sodium;product containing levothyroxine sodium (medicinal product);sodium levothyroxine;sodium thyroxine;t4 thyroxine sodium preparation;t<sub>4</sub> thyroxine sodium preparation;t>4< thyroxine sodium preparation;therapeutic levothyroxine;thyroxine sodium;thyroxine sodium (product);thyroxine sodium (substance),atrial fibrillation,chemdis,cause,1,cause,1,
158,magnesium,diabete mellitus,"Among subjects with low magnesium status, there was a higher prevalence of hypertension, hypercholesterolemia and diabetes mellitus showing a significant increasing trend with decrease in magnesium status.",magnesium,"diabete mellitus;diabetes (dm);diabetes mellitus;diabetes mellitus (diagnosis);diabetes mellitus (disorder);diabetes mellitus (dm);diabetes mellitus (e08-e13);diabetes mellitus nos;diabetes mellitus nos diagnosed;diabetes mellitus, nos;disorder diabetes mellitus;dm - diabetes mellitus;unspecified diabetes mellitus",chemdis,cause,1,cause,0,
159,magnesium,disease of kidney,"As the kidney is a major regulator of magnesium homeostasis, kidney disorders can potentially lead to both magnesium depletion and overload, and as such increase the risk of cardiovascular disease.",magnesium,"disease of kidney;disease, kidney;diseases kidneys;diseases, kidney;disorder kidney;disorder of kidney;disorder renal;disorder;kidney;kidney dis;kidney disease;kidney disease (disorder);kidney disease nos;kidney disease nos (disorder);kidney disease, nos;kidney diseases;kidney disorder;kidney disorders;kidneys--diseases;nephrologic disease;nephropathies;nephropathy;nephropathy (diagnosis);nephropathy nos;nephropathy, nos;renal disease;renal disease (diagnosis);renal disease nos;renal disease, nos;renal diseases;renal disorder;renal disorder (diagnosis);renal disorder nos;renal disorder, nos;renal disorders;renal disorders: nonspecific;renal; disease",chemdis,cause,1,cause,0,
160,magnesium 2+,bone demineralized,We hypothesized that the increased urinary Ca2+ and Mg2+ excretion and bone loss that accompanies aldosteronism is aggravated with furosemide and is attenuated by spironolactone.,"magnesium 2+;magnesium cation;magnesium ion;magnesium ions;magnesium, ion(mg2+);mg(ii);mg++;mg++ element;mg+2;mg2+;mn 2+","bone demineralized;bone density, low;bone loss;bone; loss;loss; bone;low bone densities;low bone mineral density;osteopaenia;osteopenia;osteopenia (diagnosis);osteopenia (disorder);osteopenia (morphologic abnormality);osteopenias",chemdis,cause,1,cause,0,
161,potassium,de pointe torsades,"Drug-induced torsades de pointes (TdP) is a potentially lethal ventricular arrhythmia that is associated with drugs that prolong the QT interval on the electrocardiogram (ECG) due to their interference with the cardiac potassium current,",potassium,"de pointe torsades;de pointes, torsade;de pointes, torsades;des pointe torsade;des pointes torsade;des pointes torsades;pointes, torsade de;pointes, torsades de;tdp ventricular tachycardia;torsade de pointe;torsades de pointes;torsades de pointes (diagnosis);torsades de pointes (disorder);torsades de pointes by ecg finding;torsades de pointes by ekg finding;twisting spikes;vent tach polymorp+q-t prolong;ventricular tachycardia, polymorphic with q-t prolongation;ventricular tachycardia, torsades de pointes",chemdis,cause,1,cause,,
162,potassium,disease of kidney,Hyperkalemia (potassium >5.0 mEq/L) affects heart failure patients with renal disease regardless of the use of renin-angiotensin-aldosterone system inhibitors (RAASi).,potassium,"disease of kidney;disease, kidney;diseases kidneys;diseases, kidney;disorder kidney;disorder of kidney;disorder renal;disorder;kidney;kidney dis;kidney disease;kidney disease (disorder);kidney disease nos;kidney disease nos (disorder);kidney disease, nos;kidney diseases;kidney disorder;kidney disorders;kidneys--diseases;nephrologic disease;nephropathies;nephropathy;nephropathy (diagnosis);nephropathy nos;nephropathy, nos;renal disease;renal disease (diagnosis);renal disease nos;renal disease, nos;renal diseases;renal disorder;renal disorder (diagnosis);renal disorder nos;renal disorder, nos;renal disorders;renal disorders: nonspecific;renal; disease",chemdis,cause,1,cause,,
163,potassium,heart failure,Hyperkalemia (potassium >5.0 mEq/L) affects heart failure patients with renal disease regardless of the use of renin-angiotensin-aldosterone system inhibitors (RAASi).,potassium,heart failure,chemdis,cause,1,cause,,
164,potassium,hyperkalemia,"In one case the cause was unknown while, in the last case, hyperkalemia was due to rapid infusion of stored blood and solutions containing high concentrations of potassium.",potassium,hyperkalemia,chemdis,cause,1,cause,,
165,potassium,ventricular arrhythmia,"Drug-induced torsades de pointes (TdP) is a potentially lethal ventricular arrhythmia that is associated with drugs that prolong the QT interval on the electrocardiogram (ECG) due to their interference with the cardiac potassium current,",potassium,ventricular arrhythmia,chemdis,cause,1,cause,,
166,product containing salicylate,37 hemorrhages,"Factors that interrupted INR control in our population, arranged in descending sequence, were concurrent medication use 46.9% (mainly Salicylates and Amiodarone), smoking cigarettes and shisha 17% (represented the most frequent single factor that caused non-TINR in the present study), a nonbalanced dietary vitamin K intake 16.88% caused changes in INR (lower) was related to an increase in the intake of vitamin K-rich food, were noticed to be much more in the spring season in Jordan (end of March and April mainly), herbal supplements 15.02%; Hawthorn (Crataegus, الزعرور) is an herb that lives widely in Jordan, and shockingly we found that it is used very commonly in our ACC patients and corresponded to an elevated INR <8 in 11 patients, and serious bleeding events that required hospitalization in 2 cases), noncompliance 1.49%, comorbid diseases 1%, malabsorption 0.53%, alcohol intake 0.39%, and VKORC1 A/G and CYP2C9 *1*1 genotype 0.15%.","product containing salicylate;product containing salicylate (product);products salicylates;salicylate (product);salicylate product;salicylate product (product);salicylate product (substance);salicylate, nos;salicylate-containing product;salicylates;salicylates (medication)","37 hemorrhages;bleed;bleed_nos;bleed_nos problem;bleeding;bleeding (disorder);bleeding (finding);bleeding (symptom);bleeding -retired-;bleeding hemorrhage;bleeding problem;bleeding site unspecified;bleeding, nos;bleeding/haemorrhage nos;bleeding/hemorrhage nos;bleeds;blood loss of (nos);blood; extravasation;extravasation blood;extravasation of blood;extravasation; blood;haemorrhage;haemorrhage nos;haemorrhage nos (disorder);haemorrhage, nos;haemorrhage, unspecified;haemorrhages;hem;hemorrhage;hemorrhage (diagnosis);hemorrhage (morphologic abnormality);hemorrhage (nos);hemorrhage bleeding;hemorrhage nos;hemorrhage nos (disorder);hemorrhage, nos;hemorrhage, unspecified;hemorrhages",chemdis,cause,1,cause,,
167,salt sodium,3-10 heart diseases: general terms,"Excessive dietary salt (sodium chloride and other sodium salts) is a major cause of increased blood pressure, which increases risk for stroke, heart disease, and kidney disease.",salt sodium;sodium salt;sodium salts;sodium salts (substance),"3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",chemdis,cause,1,cause,1,
168,salt sodium,disease of kidney,"Excessive dietary salt (sodium chloride and other sodium salts) is a major cause of increased blood pressure, which increases risk for stroke, heart disease, and kidney disease.",salt sodium;sodium salt;sodium salts;sodium salts (substance),"disease of kidney;disease, kidney;diseases kidneys;diseases, kidney;disorder kidney;disorder of kidney;disorder renal;disorder;kidney;kidney dis;kidney disease;kidney disease (disorder);kidney disease nos;kidney disease nos (disorder);kidney disease, nos;kidney diseases;kidney disorder;kidney disorders;kidneys--diseases;nephrologic disease;nephropathies;nephropathy;nephropathy (diagnosis);nephropathy nos;nephropathy, nos;renal disease;renal disease (diagnosis);renal disease nos;renal disease, nos;renal diseases;renal disorder;renal disorder (diagnosis);renal disorder nos;renal disorder, nos;renal disorders;renal disorders: nonspecific;renal; disease",chemdis,cause,1,cause,1,
169,salt sodium,stroke,"Excessive dietary salt (sodium chloride and other sodium salts) is a major cause of increased blood pressure, which increases risk for stroke, heart disease, and kidney disease.",salt sodium;sodium salt;sodium salts;sodium salts (substance),stroke,chemdis,cause,1,cause,1,
170,simple carbohydrate,3-00 cardiovascular disorders: general terms,"The present review article suggests that the consumption of a high-salt diet is not the cause of hypertension and that there are other factors, such as added sugars, which are causative for inducing hypertension and cardiovascular disease.___Despite strong indications that increased consumption of added sugars correlates with greater risks of developing cardiometabolic syndrome (CMS) and cardiovascular disease (CVD), independent of the caloric intake, the worldwide sugar consumption remains high.___A diet high in added sugars has been found to cause a 3-fold increased risk of death due to cardiovascular disease, but sugars, like saturated fats, are a diverse class of compounds.___Some investigators have argued that added sugars increase the risk of obesity, diabetes and cardiovascular disease.","simple carbohydrate;simple carbohydrate (substance);sugar (substance);sugar, nos;sugars","3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,cause,4,cause,1,
171,simple carbohydrate,cardiometabolic syndrome,"Despite strong indications that increased consumption of added sugars correlates with greater risks of developing cardiometabolic syndrome (CMS) and cardiovascular disease (CVD), independent of the caloric intake, the worldwide sugar consumption remains high.","simple carbohydrate;simple carbohydrate (substance);sugar (substance);sugar, nos;sugars",cardiometabolic syndrome,chemdis,cause,1,cause,1,
172,simple carbohydrate,diabetes,"Some investigators have argued that added sugars increase the risk of obesity, diabetes and cardiovascular disease.","simple carbohydrate;simple carbohydrate (substance);sugar (substance);sugar, nos;sugars",diabetes,chemdis,cause,1,cause,1,
173,simple carbohydrate,hypertension,"The present review article suggests that the consumption of a high-salt diet is not the cause of hypertension and that there are other factors, such as added sugars, which are causative for inducing hypertension and cardiovascular disease.","simple carbohydrate;simple carbohydrate (substance);sugar (substance);sugar, nos;sugars",hypertension,chemdis,cause,1,cause,1,
174,simple carbohydrate,obesity,"Some investigators have argued that added sugars increase the risk of obesity, diabetes and cardiovascular disease.","simple carbohydrate;simple carbohydrate (substance);sugar (substance);sugar, nos;sugars",obesity,chemdis,cause,1,cause,1,
175,sodium,3-00 cardiovascular disorders: general terms,"Both excessive sodium intake and obesity are risk factors for hypertension and cardiovascular disease.___Excess sodium intake can increase blood pressure, and high blood pressure is a major risk factor for cardiovascular disease.",sodium,"3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,cause,2,cause,1,
176,sodium,3-10 heart diseases: general terms,"Excessive sodium consumption can result in hypertension, diabetes, heart diseases, stroke, and kidney diseases.___In the United States, tens of thousands of Americans die each year of heart disease, stroke, or other chronic conditions tied to hypertension from long-term overconsumption of sodium compounds.",sodium,"3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",chemdis,cause,2,cause,1,
177,sodium,adult onset diabetes,"First, both obesity and type 2 diabetes are characterized by glomerular hyperfiltration, which may result from increased proximal tubular reabsorption of sodium (due to enhanced glucose and sodium transport) coupled with activation of the renin-angiotensin system.",sodium,"adult onset diabetes;adult onset diabetes mellitus;adult-onset diabetes;adult-onset diabetes mellitus;adult-onset; diabetes;aodm;diabete type 2;diabetes mellitus (adult onset);diabetes mellitus (niddm);diabetes mellitus - adult ons;diabetes mellitus - adult onset;diabetes mellitus -adult onset;diabetes mellitus maturity onset;diabetes mellitus non insulin dependent;diabetes mellitus non insulin-dep;diabetes mellitus non-insulin-dependent;diabetes mellitus nos late onset;diabetes mellitus type 02;diabetes mellitus type 2;diabetes mellitus type 2 (disorder);diabetes mellitus type ii;diabetes mellitus, adult onset;diabetes mellitus, adult onset type;diabetes mellitus, adult-onset;diabetes mellitus, ketosis resistant;diabetes mellitus, ketosis-resistant;diabetes mellitus, maturity onset;diabetes mellitus, maturity-onset;diabetes mellitus, non insulin dependent;diabetes mellitus, non-insulin dependent;diabetes mellitus, non-insulin-dependent;diabetes mellitus, noninsulin dependent;diabetes mellitus, noninsulin-dependent;diabetes mellitus, slow onset;diabetes mellitus, slow-onset;diabetes mellitus, stable;diabetes mellitus, type 2;diabetes mellitus, type ii;diabetes mellitus: [adult onset] or [noninsulin dependent];diabetes mellitus: [adult onset] or [noninsulin dependent] (disorder);diabetes non-insulin dependent;diabetes type 2;diabetes type ii;diabetes, adult onset;diabetes, ketosis resistant;diabetes, maturity onset;diabetes, maturity-onset;diabetes, type 2;diabetes, type ii;diabetes; adult-onset;diabetes; maturity-onset;diabetes; niddm;diabetes; non-insulin-dependent;diabetes; nonketotic;diabetes; type ii;diabetes;adult onset;diabetes;non insulin depend;diabetes;type 2;ketosis resistant diabetes;ketosis-resistant diabetes mellitus;late onset diabetes;maturity onset diabetes;maturity onset diabetes mellit;maturity onset diabetes mellitus;maturity-onset diabetes;maturity-onset diabetes mellitus;maturity-onset; diabetes;mod;ncdmm;niddm;niddm - non-insulin dependent diabetes mellitus;niddm diabetes mellitus;niddm-non-ins dep diabetes mel;niddm; diabetes;non insulin dependent diabetes;non-ins-dep diabetes mellitus;non-insulin dependent diabetes;non-insulin dependent diabetes mellitus;non-insulin-dependent diabetes;non-insulin-dependent diabetes mellitus;non-insulin-dependent; diabetes;noninsulin dependent diab.mell;noninsulin dependent diabetes;noninsulin dependent diabetes mellitus;noninsulin-dependent diabetes;noninsulin-dependent diabetes mellitus;nonketotic; diabetes;slow-onset diabetes mellitus;stable diabetes mellitus;t2dm - type 2 diabetes mellitus;type 2 diabetes;type 2 diabetes mellitus;type 2 diabetes mellitus (diagnosis);type 2 diabetes mellitus non-insulin dependent;type ii diabetes;type ii diabetes mellitus;type ii diabetes mellitus (disorder);type ii; diabetes",chemdis,cause,1,cause,1,
178,sodium,body fails to respond to insulin,"In this theory, insulin resistance and the resultant hyperinsulinemia are considered to raise blood pressure through 1) sympathetic nervous system activation, 2) renal sodium retention, 3) renin-angiotensin system stimulation, and 4) intracellular calcium accumulation in vascular smooth muscle.",sodium,"body fails to respond to insulin;drug resistance to insulin;drug resistance to insulin (disorder);insulin resistance;insulin resistance (diagnosis);insulin resistance (disorder);resistance, insulin",chemdis,cause,1,cause,,
179,sodium,cardiac congestive failure,"Excess sodium in the diet has been shown to contribute to problems such as blood pressure abnormalities, kidney function problems, and congestive heart failure, which account for a large sum of health care costs in the United States.___The resulting excess of sodium has been implicated as an important factor in the development of hypertension and congestive heart failure.",sodium,"cardiac congestive failure;cardiac failure congestive;cardiac failure, congestive;ccf - congestive cardiac fail;ccf - congestive cardiac failure;chf;chf (congestive heart failure);chf - congestive heart failure;chf nos;congestive cardiac fail;congestive cardiac failure;congestive disease heart;congestive diseases heart;congestive failure heart;congestive failure hearts;congestive failures heart;congestive heart disease;congestive heart failure;congestive heart failure (chf);congestive heart failure (diagnosis);congestive heart failure (disorder);congestive heart failure chf;congestive heart failure nos;congestive heart failure, unspecified;congestive; heart;congetive cardiac failure;disease congestive heart;failure congestive heart;failure heart congestive;failure; heart, congestive;failure;congestive cardiac;heart congestive failure;heart failure congestive;heart failure, congestive;heart failure/congestive heart failure;heart failure; congestive;heart; congestive;heart; disease, congestive",chemdis,cause,2,cause,1,
180,sodium,diabetes,"Excessive sodium consumption can result in hypertension, diabetes, heart diseases, stroke, and kidney diseases.",sodium,diabetes,chemdis,cause,1,cause,1,
181,sodium,disease of kidney,"Excessive sodium consumption can result in hypertension, diabetes, heart diseases, stroke, and kidney diseases.",sodium,"disease of kidney;disease, kidney;diseases kidneys;diseases, kidney;disorder kidney;disorder of kidney;disorder renal;disorder;kidney;kidney dis;kidney disease;kidney disease (disorder);kidney disease nos;kidney disease nos (disorder);kidney disease, nos;kidney diseases;kidney disorder;kidney disorders;kidneys--diseases;nephrologic disease;nephropathies;nephropathy;nephropathy (diagnosis);nephropathy nos;nephropathy, nos;renal disease;renal disease (diagnosis);renal disease nos;renal disease, nos;renal diseases;renal disorder;renal disorder (diagnosis);renal disorder nos;renal disorder, nos;renal disorders;renal disorders: nonspecific;renal; disease",chemdis,cause,1,cause,1,
182,sodium,heart failure,Sodium-glucose cotransporter 2 inhibitors (SGLT2i) is the first class of anti-diabetes treatment that reduces mortality and risk for hospitalization due to heart failure.,sodium,heart failure,chemdis,cause,1,cause,0,
183,sodium,hyperinsulinemia,"In this theory, insulin resistance and the resultant hyperinsulinemia are considered to raise blood pressure through 1) sympathetic nervous system activation, 2) renal sodium retention, 3) renin-angiotensin system stimulation, and 4) intracellular calcium accumulation in vascular smooth muscle.___In pancreatic beta cells, this would produce hyperinsulinemia; in fat and skeletal muscle, cause peripheral insulin resistance; and in renal tissue, increase proximal sodium resorption and increase urinary calcium excretion--all features of essential hypertension.",sodium,hyperinsulinemia;hyperinsulinism;increased insulin level,chemdis,cause,2,cause,0,
184,sodium,hypertension,"Excessive sodium consumption can result in hypertension, diabetes, heart diseases, stroke, and kidney diseases.___Greater consumption of sodium can increase the risk for hypertension.___The resulting excess of sodium has been implicated as an important factor in the development of hypertension and congestive heart failure.",sodium,hypertension,chemdis,cause,3,cause,1,
185,sodium,stroke,"Excessive sodium consumption can result in hypertension, diabetes, heart diseases, stroke, and kidney diseases.",sodium,stroke,chemdis,cause,1,cause,1,
186,sugar,abnormality of mitochondrial metabolism,"It has been hypothesized that a high-saturated-fat, high-sugar diet (HFHS) causes worse cardiometabolic dysfunction than a high-saturated-fat diet (HFD) due to severe mitochondrial dysfunction, oxidative stress, and apoptosis in obese insulin-resistant rats.",sugar,abnormality of mitochondrial metabolism;mitochondrial dysfunction,chemdis,cause,1,cause,1,
187,sugar,adult onset diabetes,The prestage of type 2 diabetes mellitus can be identified by an impaired glucose tolerance and/or by an impaired fasting blood sugar.,sugar,"adult onset diabetes;adult onset diabetes mellitus;adult-onset diabetes;adult-onset diabetes mellitus;adult-onset; diabetes;aodm;diabete type 2;diabetes mellitus (adult onset);diabetes mellitus (niddm);diabetes mellitus - adult ons;diabetes mellitus - adult onset;diabetes mellitus -adult onset;diabetes mellitus maturity onset;diabetes mellitus non insulin dependent;diabetes mellitus non insulin-dep;diabetes mellitus non-insulin-dependent;diabetes mellitus nos late onset;diabetes mellitus type 02;diabetes mellitus type 2;diabetes mellitus type 2 (disorder);diabetes mellitus type ii;diabetes mellitus, adult onset;diabetes mellitus, adult onset type;diabetes mellitus, adult-onset;diabetes mellitus, ketosis resistant;diabetes mellitus, ketosis-resistant;diabetes mellitus, maturity onset;diabetes mellitus, maturity-onset;diabetes mellitus, non insulin dependent;diabetes mellitus, non-insulin dependent;diabetes mellitus, non-insulin-dependent;diabetes mellitus, noninsulin dependent;diabetes mellitus, noninsulin-dependent;diabetes mellitus, slow onset;diabetes mellitus, slow-onset;diabetes mellitus, stable;diabetes mellitus, type 2;diabetes mellitus, type ii;diabetes mellitus: [adult onset] or [noninsulin dependent];diabetes mellitus: [adult onset] or [noninsulin dependent] (disorder);diabetes non-insulin dependent;diabetes type 2;diabetes type ii;diabetes, adult onset;diabetes, ketosis resistant;diabetes, maturity onset;diabetes, maturity-onset;diabetes, type 2;diabetes, type ii;diabetes; adult-onset;diabetes; maturity-onset;diabetes; niddm;diabetes; non-insulin-dependent;diabetes; nonketotic;diabetes; type ii;diabetes;adult onset;diabetes;non insulin depend;diabetes;type 2;ketosis resistant diabetes;ketosis-resistant diabetes mellitus;late onset diabetes;maturity onset diabetes;maturity onset diabetes mellit;maturity onset diabetes mellitus;maturity-onset diabetes;maturity-onset diabetes mellitus;maturity-onset; diabetes;mod;ncdmm;niddm;niddm - non-insulin dependent diabetes mellitus;niddm diabetes mellitus;niddm-non-ins dep diabetes mel;niddm; diabetes;non insulin dependent diabetes;non-ins-dep diabetes mellitus;non-insulin dependent diabetes;non-insulin dependent diabetes mellitus;non-insulin-dependent diabetes;non-insulin-dependent diabetes mellitus;non-insulin-dependent; diabetes;noninsulin dependent diab.mell;noninsulin dependent diabetes;noninsulin dependent diabetes mellitus;noninsulin-dependent diabetes;noninsulin-dependent diabetes mellitus;nonketotic; diabetes;slow-onset diabetes mellitus;stable diabetes mellitus;t2dm - type 2 diabetes mellitus;type 2 diabetes;type 2 diabetes mellitus;type 2 diabetes mellitus (diagnosis);type 2 diabetes mellitus non-insulin dependent;type ii diabetes;type ii diabetes mellitus;type ii diabetes mellitus (disorder);type ii; diabetes",chemdis,cause,1,cause,1,
188,sugar,cancer,"Of the many other toxic effects of excessive sugar consumption, immunocompromisation, kidney damage, atherosclerosis, oxidative stress and cancer are highlighted.",sugar,cancer,chemdis,cause,1,cause,1,
189,sugar,cardiometabolic syndrome,"Despite strong indications that increased consumption of added sugars correlates with greater risks of developing cardiometabolic syndrome (CMS) and cardiovascular disease (CVD), independent of the caloric intake, the worldwide sugar consumption remains high.",sugar,cardiometabolic syndrome,chemdis,cause,1,cause,1,
190,sugar,diabetes,"Patients with smell impairment are reported to use larger quantities of sugar and salt to highlight flavours, thus worsening their general health condition and increasing the risk of developing diabetes and hypertension.___Additionally, reduced ability to differentiate between various intensities or concentrations of a tastant can result in increased intake of salt and sugar and exacerbation of chronic diseases such as heart failure and diabetes.",sugar,diabetes,chemdis,cause,2,cause,1,
191,sugar,hypertension,"Patients with smell impairment are reported to use larger quantities of sugar and salt to highlight flavours, thus worsening their general health condition and increasing the risk of developing diabetes and hypertension.",sugar,hypertension,chemdis,cause,1,cause,1,
192,sugar,obesity,"The consumption of sugar-sweetened beverages has been linked to rising rates of obesity, which in turn is a risk factor for development of T2DM.",sugar,obesity,chemdis,cause,1,cause,1,
193,sugar,weight gain,Previous studies have linked full-calorie sugar-sweetened beverages (SSBs) with greater weight gain and an increased risk of type 2 diabetes.,sugar,weight gain,chemdis,cause,1,cause,1,
194,tg - triglyceride,3-00 cardiovascular disorders: general terms,"Circulating levels of triacylglycerol (TG) is a recognized risk factor for developing cardiovascular disease, a leading cause of death worldwide.___Triglyceride deposit cardiomyovasculopathy (TGCV), a rare cardiovascular disorder caused by genetic or acquired dysfunction of adipose triglyceride lipase (ATGL), is marked by defective intracellular lipolysis that results in excessive accumulation of triglycerides (TGs) in the myocardium and coronary arteries, leading to intractable heart failure (HF).",tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,"3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,cause,2,cause,1,
195,tg - triglyceride,71 hypertrophies,"The adipocytes store triglycerides in lipid droplets, leading to adipocyte hypertrophy.",tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,"71 hypertrophies;enlargement, nos;enlargements;hypertrophied;hypertrophies;hypertrophy;hypertrophy (morphologic abnormality);hypertrophy [dup] (morphologic abnormality);hypertrophy nos;hypertrophy, nos",chemdis,cause,1,cause,1,
196,tg - triglyceride,adult onset diabetes,"The increased risk of coronary heart disease associated with type 2 diabetes may be partially explained by dyslipidemia characterized by high plasma triacylglycerol (TAG), low HDL cholesterol, and a predominance of atherogenic small dense LDLs.___Background The accumulation of myocardial triglycerides and remodeling of the left ventricle are common features in type 2 diabetes mellitus and represent potential risk factors for the development of diastolic and systolic dysfunction.",tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,"adult onset diabetes;adult onset diabetes mellitus;adult-onset diabetes;adult-onset diabetes mellitus;adult-onset; diabetes;aodm;diabete type 2;diabetes mellitus (adult onset);diabetes mellitus (niddm);diabetes mellitus - adult ons;diabetes mellitus - adult onset;diabetes mellitus -adult onset;diabetes mellitus maturity onset;diabetes mellitus non insulin dependent;diabetes mellitus non insulin-dep;diabetes mellitus non-insulin-dependent;diabetes mellitus nos late onset;diabetes mellitus type 02;diabetes mellitus type 2;diabetes mellitus type 2 (disorder);diabetes mellitus type ii;diabetes mellitus, adult onset;diabetes mellitus, adult onset type;diabetes mellitus, adult-onset;diabetes mellitus, ketosis resistant;diabetes mellitus, ketosis-resistant;diabetes mellitus, maturity onset;diabetes mellitus, maturity-onset;diabetes mellitus, non insulin dependent;diabetes mellitus, non-insulin dependent;diabetes mellitus, non-insulin-dependent;diabetes mellitus, noninsulin dependent;diabetes mellitus, noninsulin-dependent;diabetes mellitus, slow onset;diabetes mellitus, slow-onset;diabetes mellitus, stable;diabetes mellitus, type 2;diabetes mellitus, type ii;diabetes mellitus: [adult onset] or [noninsulin dependent];diabetes mellitus: [adult onset] or [noninsulin dependent] (disorder);diabetes non-insulin dependent;diabetes type 2;diabetes type ii;diabetes, adult onset;diabetes, ketosis resistant;diabetes, maturity onset;diabetes, maturity-onset;diabetes, type 2;diabetes, type ii;diabetes; adult-onset;diabetes; maturity-onset;diabetes; niddm;diabetes; non-insulin-dependent;diabetes; nonketotic;diabetes; type ii;diabetes;adult onset;diabetes;non insulin depend;diabetes;type 2;ketosis resistant diabetes;ketosis-resistant diabetes mellitus;late onset diabetes;maturity onset diabetes;maturity onset diabetes mellit;maturity onset diabetes mellitus;maturity-onset diabetes;maturity-onset diabetes mellitus;maturity-onset; diabetes;mod;ncdmm;niddm;niddm - non-insulin dependent diabetes mellitus;niddm diabetes mellitus;niddm-non-ins dep diabetes mel;niddm; diabetes;non insulin dependent diabetes;non-ins-dep diabetes mellitus;non-insulin dependent diabetes;non-insulin dependent diabetes mellitus;non-insulin-dependent diabetes;non-insulin-dependent diabetes mellitus;non-insulin-dependent; diabetes;noninsulin dependent diab.mell;noninsulin dependent diabetes;noninsulin dependent diabetes mellitus;noninsulin-dependent diabetes;noninsulin-dependent diabetes mellitus;nonketotic; diabetes;slow-onset diabetes mellitus;stable diabetes mellitus;t2dm - type 2 diabetes mellitus;type 2 diabetes;type 2 diabetes mellitus;type 2 diabetes mellitus (diagnosis);type 2 diabetes mellitus non-insulin dependent;type ii diabetes;type ii diabetes mellitus;type ii diabetes mellitus (disorder);type ii; diabetes",chemdis,cause,2,cause,1,
197,tg - triglyceride,body fails to respond to insulin,"Insulin resistance syndrome is the theory that glucose intolerance, hyperinsulinemia, increased very low density lipoprotein triglyceride level, decreased high density lipoprotein cholesterol level, and hypertension are proposed consequences of insulin resistance.",tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,"body fails to respond to insulin;drug resistance to insulin;drug resistance to insulin (disorder);insulin resistance;insulin resistance (diagnosis);insulin resistance (disorder);resistance, insulin",chemdis,cause,1,cause,,
198,tg - triglyceride,cardiomyopathy,Cardiomyopathy in diabetic MHC-PPAR mice was accompanied by myocardial long-chain triglyceride accumulation.,tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,cardiomyopathy,chemdis,cause,1,cause,,
199,tg - triglyceride,"cardiovascular syndrome, metabolic","The metabolic syndrome (MetS) is manifested by a lipid triad which includes elevated serum triglycerides, small LDL particles, and low high-density lipoprotein (HDL) cholesterol, by central obesity (central adiposity), insulin resistance, glucose intolerance and elevated blood pressure, and it is associated with an increased risk of type 2 diabetes and coronary heart disease.",tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,"cardiovascular syndrome, metabolic;cardiovascular syndromes, metabolic;dysmetabolic syndrome x;dysmetabolic syndrome x (diagnosis);equine metabolic syndrome;insulin resistance syndrome x;metabolic cardiovascular syndrome;metabolic syndrome;metabolic syndrome x;metabolic syndrome x (disorder);metabolic syndromes;metabolic x syndrome;reaven syndrome x;reaven's syndrome;syndrome metabolic;syndrome x (metabolic);syndrome x insulin resistance;syndrome x, dysmetabolic;syndrome x, insulin resistance;syndrome x, metabolic;syndrome x, reaven;syndrome, metabolic;syndrome, metabolic cardiovascular;syndrome, metabolic x;syndromes, metabolic;x syndrome, metabolic",chemdis,cause,1,cause,,
200,tg - triglyceride,coronary heart disease,"Patients with highly increased plasma triglyceride levels are at risk of developing serious complications such as pancreatitis, coronary heart disease and stroke.",tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,coronary heart disease,chemdis,cause,1,cause,1,
201,tg - triglyceride,diabetic,Cardiomyopathy in diabetic MHC-PPAR mice was accompanied by myocardial long-chain triglyceride accumulation.,tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,diabetic;diabetics,chemdis,cause,1,cause,,
202,tg - triglyceride,diabetic dyslipidaemia,"The diabetic dyslipidemia in these patients is characterized by moderately high levels of (1) serum cholesterol and triglycerides; (2) small, dense low-density lipoprotein (LDL) particles; and (3) low high-density lipoprotein (HDL) cho-lesterol concentrations.",tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,diabetic dyslipidaemia;diabetic dyslipidemia,chemdis,cause,1,cause,,
203,tg - triglyceride,dis metab,"Obesity is a metabolic disorder that can lead to adverse metabolic effects on blood pressure, cholesterol, triglycerides and insulin resistance and also increases the risk of coronary heart disease, ischemic stroke and type 2 diabetes mellitus.",tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,"dis metab;disease, metabolic;disease;metabolic;diseases, metabolic;disorder of metabolism nos;disorder of metabolism nos (disorder);disorder; metabolism;disorder;metabolic;general; metabolic disorder;generalised metabolic disorder;generalized metabolic disorder;generalized metabolic disorder (disorder);md - metabolic disorders;metab dis;metabolic derangement;metabolic disease;metabolic disease (disorder);metabolic disease, nos;metabolic diseases;metabolic disorder;metabolic disorder nos;metabolic disorder, nos;metabolic disorder, unspecified;metabolic disorder; general;metabolic disorders;metabolic disorders (diagnosis);metabolic disorders (disorder);metabolic disorders: general;metabolism disorder;metabolism disorder nos;metabolism disorders;metabolism--disorders;metabolism; disorder;metabolism; disorder, general;rndx metabolic;rndx metabolic (diagnosis);thesaurismoses;thesaurismosis;unspecified disorder of metabolism",chemdis,cause,1,cause,0,
204,tg - triglyceride,heart failure,"Triglyceride deposit cardiomyovasculopathy (TGCV), a rare cardiovascular disorder caused by genetic or acquired dysfunction of adipose triglyceride lipase (ATGL), is marked by defective intracellular lipolysis that results in excessive accumulation of triglycerides (TGs) in the myocardium and coronary arteries, leading to intractable heart failure (HF).",tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,heart failure,chemdis,cause,1,cause,,
205,tg - triglyceride,hepatic injury,"Female offspring exposed to a postweaning obesogenic diet (OffCon-OD) demonstrated evidence of liver injury, which was exacerbated by previous exposure to maternal obesity (OffOb-OD), as demonstrated by raised alanine aminotransferase, hepatic triglycerides, and hepatic expression of interleukin (IL)-6, tumor necrosis factor alpha, transforming growth factor beta, alpha smooth muscle actin, and collagen (P < 0.01).",tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,"hepatic injury;hepatic injury, nos;hepatic trauma;injuries liver;injury hepatic;injury liver;injury of liver;injury of liver (diagnosis);injury of liver (disorder);injury of liver, nos;injury of liver, unspecified;injury to liver;injury to liver, nos;injury to liver, nos (disorder);injury; liver;liver injury;liver; injury;of liver injury;unspecified injury of liver",chemdis,cause,1,cause,,
206,tg - triglyceride,pancreatitis,"Patients with highly increased plasma triglyceride levels are at risk of developing serious complications such as pancreatitis, coronary heart disease and stroke.",tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,pancreatitis,chemdis,cause,1,cause,,
207,tg - triglyceride,stroke,"Patients with highly increased plasma triglyceride levels are at risk of developing serious complications such as pancreatitis, coronary heart disease and stroke.",tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,stroke,chemdis,cause,1,cause,,
208,vitamin a,deficiencies micronutrient,"Specific micronutrient deficiencies can also lead to neurodisability, for example, blindness (vitamin A), intractable epilepsy (vitamin B6), and cognitive impairment (iodine and iron).",vitamin a,deficiencies micronutrient;deficiency of micronutrients;deficiency of micronutrients (disorder);micronutrient deficiencies;micronutrients deficiency,chemdis,cause,1,cause,0,
209,vitamin a,gastroduodenal ulcer,This suggests that increased consumption of vitamin A may prove to reduce mortality rates due to heart disease and peptic ulcer.,vitamin a,"gastroduodenal ulcer;gastroduodenal ulcer nos;gastroduodenal ulcer, nos;gastroduodenal ulcers;gdu;peptic ulcer;peptic ulcer (diagnosis);peptic ulcer (disorder);peptic ulcer (ulcer);peptic ulcer - (pu) site unsp.;peptic ulcer - (pu) site unspecified;peptic ulcer - (pu) site unspecified (disorder);peptic ulcer disease;peptic ulcer disorder;peptic ulcer nos (disorder);peptic ulcer nos = pu;peptic ulcer syndrome;peptic ulcer, nos;peptic ulcer, site unspecified;peptic ulcer; site unspecified;peptic ulceration;peptic ulcers;peptic; ulcer;pu - peptic ulcer;pud;pud - peptic ulcer disease;sore in the lining of gastrointestinal tract;syndrome peptic ulcer;ulcer disease;ulcer gastroduodenal;ulcer of the gastrointestinal tract;ulcer peptic;ulcer syndrome peptic;ulcer, gastroduodenal;ulcer, peptic;ulcer; peptic;ulcer;peptic;ulcers, gastroduodenal;ulcers, peptic;unspecified peptic ulcer;unspecified peptic ulcer (disorder);unspecified peptic ulcer nos;unspecified peptic ulcer nos (disorder)",chemdis,cause,1,cause,0,
210,vitamin a,neurodisability,"Specific micronutrient deficiencies can also lead to neurodisability, for example, blindness (vitamin A), intractable epilepsy (vitamin B6), and cognitive impairment (iodine and iron).",vitamin a,neurodisability;neurodisability (finding),chemdis,cause,1,cause,0,
211,vitamin b6,deficiencies micronutrient,"Specific micronutrient deficiencies can also lead to neurodisability, for example, blindness (vitamin A), intractable epilepsy (vitamin B6), and cognitive impairment (iodine and iron).",vitamin b6,deficiencies micronutrient;deficiency of micronutrients;deficiency of micronutrients (disorder);micronutrient deficiencies;micronutrients deficiency,chemdis,cause,1,cause,0,
212,vitamin b6,neurodisability,"Specific micronutrient deficiencies can also lead to neurodisability, for example, blindness (vitamin A), intractable epilepsy (vitamin B6), and cognitive impairment (iodine and iron).",vitamin b6,neurodisability;neurodisability (finding),chemdis,cause,1,cause,0,
213,vitamin b6,stroke,"Increased intake of vitamin B6, B12, and folate has been associated with reduction of homocysteine levels; elevated homocysteine blood levels have been associated with the occurrence of stroke, heart attack, and cardiovascular death.",vitamin b6,stroke,chemdis,cause,1,cause,,
214,vitamin c,bone pain,"As this disease can lead to severe complications, such as bone pain, heart failure or gastrointestinal symptoms, nothing should delay vitamin C supplementation, which is a simple and rapidly effective treatment.",vitamin c,bone pain,chemdis,cause,1,cause,1,
218,vitamin d,"[x]mal neoplasm/skin,unspecfd","Although some have suggested increased sun exposure to increase serum vitamin D levels, this has the potential to induce photoaging and skin cancer, especially in patients at risk for these conditions.",vitamin d,"[x]mal neoplasm/skin,unspecfd;[x]malignant neoplasm of skin, unspecified;[x]malignant neoplasm of skin, unspecified (disorder);ca - skin cancer;cancer of skin;cancer of the skin;cancer skin;cancer, skin;cancers skin;cancers, skin;mal neoplasm/skin,unspecfd;malignant neoplasm of skin;malignant neoplasm of skin (diagnosis);malignant neoplasm of skin (disorder);malignant neoplasm of skin nos;malignant neoplasm of skin nos (disorder);malignant neoplasm of skin, nos;malignant neoplasm of skin, unspecified;malignant neoplasm of the skin;malignant neoplasm skin;malignant neoplasm skin nos;malignant neoplasms of skin;malignant neosplasm of the skin;malignant skin neoplasm;malignant skin neoplasm nos;malignant skin tumor;malignant tumor of skin;malignant tumor of the skin;malignant tumour of skin;malignant tumour of skin (disorder);melanoma and non-melanoma skin cancer;neoplasm malig;skin;of skin cancer;of the skin cancer;skin cancer;skin cancer (diagnosis);skin cancer, including melanoma;skin cancer, nonmelanomatous (squamous and basal cell);skin cancer, nos;skin cancers;skin malignant neoplasm nos;skin neoplasm malignant;skin neoplasm malignant nos;skin neoplasm, malignant;skin neoplasms malignant and unspecified;skin--cancer",chemdis,cause,1,cause,1,
219,vitamin d,abnormally low blood calcium levels,She was diagnosed with severe hypocalcaemia secondary to severe vitamin D deficiency.,vitamin d,abnormally low blood calcium levels;calcium deficiency disease;hypocalcaemia;hypocalcaemia syndrome;hypocalcemia (diagnosis);hypocalcemia (disorder);hypocalcemia syndrome;hypocalcemias;low blood calcium levels,chemdis,cause,1,cause,0,
220,vitamin d,autonomic dysfunction,"Moreover, patients with ESKD are often vitamin D deficient, which we have shown may be linked to autonomic dysfunction in humans.",vitamin d,autonomic dysfunction,chemdis,cause,1,cause,0,
221,vitamin d,bone demineralized,"High spread of osteopenia among patients with CVD was expected because of deficiency in calcium consumption and their lowe supply with vitamin D, that appears risk factors of osteoporosis.___Homebound and institutionalized elderly persons often do not expose their skin to sunlight; because the skin of older persons has a decreased ability to form vitamin D, the vitamin D status in these persons is precarious and they are at risk for osteopenia.",vitamin d,"bone demineralized;bone density, low;bone loss;bone; loss;loss; bone;low bone densities;low bone mineral density;osteopaenia;osteopenia;osteopenia (diagnosis);osteopenia (disorder);osteopenia (morphologic abnormality);osteopenias",chemdis,cause,2,cause,0,
222,vitamin d,"calcification, vascular","However, using vitamin D entails possible adverse risks of hypercalcemia, hyperphosphatemia, and vascular calcifications.___Both the high prevalence of vitamin D deficiency in the general population and the identification of the vitamin D receptor in the heart and blood vessels raised interest in the potential cardiovascular effects of vitamin D. Experimental studies have demonstrated various cardiovascular protective actions of vitamin D, but vitamin D intoxication in animals is known to induce vascular calcification.",vitamin d,"calcification, vascular;calcifications vascular;calcifications, vascular;calcinoses, vascular;calcinosis, vascular;vascular calcification;vascular calcification (disorder);vascular calcifications;vascular calcinoses;vascular calcinosis",chemdis,cause,2,cause,1,
223,vitamin d,"cardiomyopathies, dilated",We identified three infants with dilated cardiomyopathy (DCM) secondary to severe vitamin D deficieny and hypocalcaemia.,vitamin d,"cardiomyopathies, dilated;cardiomyopathy congestive;cardiomyopathy dilated;cardiomyopathy, dilated;cardiomyopathy; cardiomyopathy, dilated;cardiomyopathy;congestive;ccm - congestive cardiomyopath;ccm - congestive cardiomyopathy;cocm - congestive cardiomyop;cocm - congestive cardiomyopathy;cocm congestive (dilated) cardiomyopathy;congestive (dilated) cardiomyopathy;congestive cardiomyopathy (diagnosis);congestive cardiomyopathy (disorder);congestive dilated cardiomyopathy;dcm - dilated cardiomyopathy;dilated cardiomyopathies;dilated cardiomyopathy;dilated cardiomyopathy (diagnosis);heart; dilatation, cardiomyopathy;primary dilated cardiomyopathy;primary dilated cardiomyopathy (disorder);stretched and thinned heart muscle",chemdis,cause,1,cause,,
224,vitamin d,cognitive defects,"Low levels of serum 25-hydroxyvitamin D [25(OH)D], a stable marker of vitamin D status, are also associated with increased odds of prevalent cognitive dysfunction, Alzheimer's disease and all-cause dementia in a number of studies, raising the possibility that vitamin D plays a role in the aetiology of cognitive dysfunction and dementia.",vitamin d,"cognitive defects;cognitive disturbances;cognitive dysfunction;cognitive dysfunctions;cognitive function abnormal;cognitive impairment;cognitive impairments;disturbance in cognition;dysfunction, cognitive;dysfunctions, cognitive;impaired cognition;impaired cognition (finding);impairment, cognitive;impairment;cognitive;impairments, cognitive;neurocognitive disturbance;neurocognitive dysfunction",chemdis,cause,1,cause,,
227,vitamin d,hypercalcemia,"However, using vitamin D entails possible adverse risks of hypercalcemia, hyperphosphatemia, and vascular calcifications.",vitamin d,hypercalcemia,chemdis,cause,1,cause,1,
229,vitamin d,thrombosis,"Hyperinsulinaemia decreases cholesterol sulfurylation to cholesterol sulfate, as low vitamin D regulation due to magnesium depletion and/or vitamin D sequestration and/or diminished activation capacity decreases sulfotransferase enzyme SULT2B1b activity, consequently decreasing plasma membrane negative charge between red blood cells, platelets and endothelial cells, thus increasing agglutination and thrombosis.",vitamin d,thrombosis,chemdis,cause,1,cause,,
231,vitamin e,atherosclerosis,High doses of vitamin E may confer an increased risk of calcified atherosclerosis.,vitamin e,atherosclerosis,chemdis,cause,1,cause,1,
232,vitamin e,heart failure,"Yet, high doses of supplemental vitamin E have been associated with an elevated risk of heart failure and all-cause mortality.___Vitamin E supplementation might be associated with an increase in total mortality, heart failure, and hemorrhagic stroke.",vitamin e,heart failure,chemdis,cause,2,cause,1,
233,vitamin k,37 hemorrhages,"Factors that interrupted INR control in our population, arranged in descending sequence, were concurrent medication use 46.9% (mainly Salicylates and Amiodarone), smoking cigarettes and shisha 17% (represented the most frequent single factor that caused non-TINR in the present study), a nonbalanced dietary vitamin K intake 16.88% caused changes in INR (lower) was related to an increase in the intake of vitamin K-rich food, were noticed to be much more in the spring season in Jordan (end of March and April mainly), herbal supplements 15.02%; Hawthorn (Crataegus, الزعرور) is an herb that lives widely in Jordan, and shockingly we found that it is used very commonly in our ACC patients and corresponded to an elevated INR <8 in 11 patients, and serious bleeding events that required hospitalization in 2 cases), noncompliance 1.49%, comorbid diseases 1%, malabsorption 0.53%, alcohol intake 0.39%, and VKORC1 A/G and CYP2C9 *1*1 genotype 0.15%.",vitamin k,"37 hemorrhages;bleed;bleed_nos;bleed_nos problem;bleeding;bleeding (disorder);bleeding (finding);bleeding (symptom);bleeding -retired-;bleeding hemorrhage;bleeding problem;bleeding site unspecified;bleeding, nos;bleeding/haemorrhage nos;bleeding/hemorrhage nos;bleeds;blood loss of (nos);blood; extravasation;extravasation blood;extravasation of blood;extravasation; blood;haemorrhage;haemorrhage nos;haemorrhage nos (disorder);haemorrhage, nos;haemorrhage, unspecified;haemorrhages;hem;hemorrhage;hemorrhage (diagnosis);hemorrhage (morphologic abnormality);hemorrhage (nos);hemorrhage bleeding;hemorrhage nos;hemorrhage nos (disorder);hemorrhage, nos;hemorrhage, unspecified;hemorrhages",chemdis,cause,1,cause,,
234,acid fatty trans,3-10 heart diseases: general terms,In the early 1990s it was shown that trans fatty acids increase the risk of heart disease.,"acid fatty trans;acid trans fatty;acid, trans fatty;acids fatty tran;acids fatty trans;acids trans-fatty;acids, trans fatty;acids, trans-fatty;fatty acid, trans;fatty acids, trans;trans fat;trans fat (substance);trans fats;trans fatty acid;trans fatty acids;trans-fatty acids","3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",foodis,cause,1,cause,1,
235,acid fatty trans,coronary heart disease,Current scientific evidence indicates that consumption of industrial trans fatty acids (TFA) produced via partial hydrogenation of vegetable oils increases the risk of coronary heart disease.___Some data indicate that consumption of trans fatty acids increases the risk of coronary heart disease (CHD).___High consumption of trans fat has been linked to the risk of coronary heart disease (CHD).,"acid fatty trans;acid trans fatty;acid, trans fatty;acids fatty tran;acids fatty trans;acids trans-fatty;acids, trans fatty;acids, trans-fatty;fatty acid, trans;fatty acids, trans;trans fat;trans fat (substance);trans fats;trans fatty acid;trans fatty acids;trans-fatty acids",coronary heart disease,foodis,cause,3,cause,1,
236,acid fatty trans,obesity,"Saturated and trans fatty acids have been implicated in obesity, heart disease, diabetes and cancer while polyunsaturated fatty acids (PUFAs) generally have a positive effect on health.","acid fatty trans;acid trans fatty;acid, trans fatty;acids fatty tran;acids fatty trans;acids trans-fatty;acids, trans fatty;acids, trans-fatty;fatty acid, trans;fatty acids, trans;trans fat;trans fat (substance);trans fats;trans fatty acid;trans fatty acids;trans-fatty acids",obesity,foodis,cause,1,cause,1,
237,"acid, saturated fatty",3-00 cardiovascular disorders: general terms,"Although livestock products are a source of some essential nutrients, they provide large amounts of saturated fat, which is a known risk factor for cardiovascular disease.","acid, saturated fatty;acids fatty saturated;fat saturated;fats saturated;fatty acid, saturated;fatty acids, saturated;fatty acids.saturated;saturated fat;saturated fat (substance);saturated fatty acid;saturated fatty acid (substance);saturated fatty acid, nos;saturated fatty acids","3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",foodis,cause,1,cause,1,
238,"acid, saturated fatty",3-10 heart diseases: general terms,"It is also a source of saturated fatty acids, which observational evidence suggests are associated with heart disease, although recent data challenge this.___Meat consumption has been related to a higher risk of heart disease due to its saturated fat content.___"" What we actually know is that: red meat consumption is an order of magnitude higher now than through most of human history; red meat is a probable, and processed meat is a definite, human carcinogen; saturated fat increases risk of heart disease; and vegans and vegetarians have better lipid profiles, lower risk of chronic disease, and greater longevity than meat eaters.","acid, saturated fatty;acids fatty saturated;fat saturated;fats saturated;fatty acid, saturated;fatty acids, saturated;fatty acids.saturated;saturated fat;saturated fat (substance);saturated fatty acid;saturated fatty acid (substance);saturated fatty acid, nos;saturated fatty acids","3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",foodis,cause,3,cause,1,
239,"acid, saturated fatty",angiopathy,"Elevated serum cholesterol, a major cause of vascular disease, has been strongly correlated with eating greater than normal amounts of cholesterol and saturated fatty acids.","acid, saturated fatty;acids fatty saturated;fat saturated;fats saturated;fatty acid, saturated;fatty acids, saturated;fatty acids.saturated;saturated fat;saturated fat (substance);saturated fatty acid;saturated fatty acid (substance);saturated fatty acid, nos;saturated fatty acids","angiopathy;angiopathy, nos;blood vessel disease;blood vessel disorder;blood vessels; disorder;blood-vessels--diseases;disease (or disorder); blood vessels;disease (or disorder); vascular;disease, vascular;diseases, vascular;disorder of blood vessel;disorder of blood vessel (disorder);disorder vascular;disorder; vascular;section 3-8 vascular diseases;unspecified vascular problem;vasc;vascular (extracardiac) disorders;vascular dis;vascular disease;vascular disease (disorder);vascular disease or syndrome;vascular disease, nos;vascular diseases;vascular diseases and syndromes;vascular disorder;vascular disorder nos;vascular disorder, nos;vascular disorders;vascular problem;vascular problem, nos;vascular system disorders;vascular system disorders (diagnosis);vascular; disorder;vascular_nos;vascular_nos problem;vasculopathy",foodis,cause,1,cause,1,
240,"acid, saturated fatty","arterioscleroses, coronary","Similarly, dietary saturated fat has been implicated in the development of coronary atherosclerosis while polyunsaturated fatty acids are reported to provide protection.","acid, saturated fatty;acids fatty saturated;fat saturated;fats saturated;fatty acid, saturated;fatty acids, saturated;fatty acids.saturated;saturated fat;saturated fat (substance);saturated fatty acid;saturated fatty acid (substance);saturated fatty acid, nos;saturated fatty acids","arterioscleroses, coronary;arteriosclerosis coronary artery;arteriosclerosis, coronary;arteriosclerosis; coronary;arteriosclerosis; coronary (artery);arteriosclerosis; heart;arteriosclerotic coronary artery disease;arteriosclerotic heart disease;ashd;ashd - atherosclerotic heart disease;atheroscleroses, coronary;atherosclerosis coronary artery;atherosclerosis of coronary artery;atherosclerosis of coronary artery (diagnosis);atherosclerosis of coronary artery (disorder);atherosclerosis of native coronary artery;atherosclerosis, coronary;atherosclerotic coronary vascular disease;atherosclerotic heart disease;atherosclerotic heart disease nos;cardiac sclerosis;cardiac; sclerosis;coronary (artery) atherosclerosis;coronary (artery) sclerosis;coronary arterioscleroses;coronary arteriosclerosis;coronary arteriosclerosis (diagnosis);coronary arteriosclerosis (disorder);coronary artery arteriosclerosis;coronary artery atherosclerosis;coronary artery sclerosis;coronary atheroscleroses;coronary atherosclerosis;coronary atherosclerosis (disorder);coronary atherosclerotic heart disease;coronary sclerosis;coronary; arteriosclerosis;coronary; sclerosis;disease (or disorder); arteriosclerotic, coronary (artery);disease (or disorder); arteriosclerotic, heart;disease;atherosclerotic;heart;heart; arteriosclerosis;obsolete coronary atherosclerosis;plaque build-up in arteries supplying blood to heart;sclerosis; cardiac;sclerosis; coronary",foodis,cause,1,cause,1,
241,"acid, saturated fatty",coronary heart disease,"Saturated fatty acids and trans fats are associated with an increased risk of coronary heart disease.___It has been thought, particularly by consumers, that dairy fats may increase the risk of coronary heart disease because of the contribution they make to total saturated fat intake.","acid, saturated fatty;acids fatty saturated;fat saturated;fats saturated;fatty acid, saturated;fatty acids, saturated;fatty acids.saturated;saturated fat;saturated fat (substance);saturated fatty acid;saturated fatty acid (substance);saturated fatty acid, nos;saturated fatty acids",coronary heart disease,foodis,cause,2,cause,1,
242,"acid, saturated fatty",dysfunction endothelial,"Cardiovascular risk factors are known to exacerbate high-saturated fatty acid meal (HSFAM)-induced endothelial dysfunction, but the influence of subclinical metabolic dysregulations and the acute impact of a single mixed Mediterranean-type meal (MMM) remains unknown.","acid, saturated fatty;acids fatty saturated;fat saturated;fats saturated;fatty acid, saturated;fatty acids, saturated;fatty acids.saturated;saturated fat;saturated fat (substance);saturated fatty acid;saturated fatty acid (substance);saturated fatty acid, nos;saturated fatty acids",dysfunction endothelial;dysfunctions endothelial;endothelial dysfunction,foodis,cause,1,cause,0,
243,calorie foods high,adiposity,"As people in both developed and developing countries eat more and more energy dense food, and have ever less physical activity, the number of overweight and obese people increases to epidemic proportions.",calorie foods high;energy dense food;energy foods high;high calorie food;high energy food;high energy food (substance),"adiposity;having too much body fat;obese;obese (finding);obesities;obesity (diagnosis);obesity (disorder);obesity [ambiguous];obesity nos;obesity, nos;obesity, unspecified",foodis,cause,1,cause,1,
244,calorie foods high,atherosclerosis,"Obesity is significantly increasing worldwide because of increased high calorie food intake and decreased physical activity leading to hypertension, dyslipidemia, atherosclerosis, and insulin resistance.",calorie foods high;energy dense food;energy foods high;high calorie food;high energy food;high energy food (substance),atherosclerosis,foodis,cause,1,cause,1,
245,calorie foods high,body fails to respond to insulin,"Obesity is significantly increasing worldwide because of increased high calorie food intake and decreased physical activity leading to hypertension, dyslipidemia, atherosclerosis, and insulin resistance.",calorie foods high;energy dense food;energy foods high;high calorie food;high energy food;high energy food (substance),"body fails to respond to insulin;drug resistance to insulin;drug resistance to insulin (disorder);insulin resistance;insulin resistance (diagnosis);insulin resistance (disorder);resistance, insulin",foodis,cause,1,cause,1,
246,calorie foods high,clinical overweight,"As people in both developed and developing countries eat more and more energy dense food, and have ever less physical activity, the number of overweight and obese people increases to epidemic proportions.",calorie foods high;energy dense food;energy foods high;high calorie food;high energy food;high energy food (substance),clinical overweight;over weight;overweight;overweight (bmi 25-30);overweight (bmi <30);overweight (bmi<30);overweight (diagnosis);overweight (finding);overweight (physical finding);patient overweight,foodis,cause,1,cause,1,
247,calorie foods high,diabetes,"Due to the consumption of energy dense food (i.e. unhealthy food habits), sedentary life style, lack of health care services and financial support, the developing countries are facing high risk of obesity and their adverse consequences (i.e. diabetes, ischemic heart disease, etc).",calorie foods high;energy dense food;energy foods high;high calorie food;high energy food;high energy food (substance),diabetes,foodis,cause,1,cause,1,
248,calorie foods high,dyslipidaemia,"Obesity is significantly increasing worldwide because of increased high calorie food intake and decreased physical activity leading to hypertension, dyslipidemia, atherosclerosis, and insulin resistance.",calorie foods high;energy dense food;energy foods high;high calorie food;high energy food;high energy food (substance),dyslipidaemia;dyslipidemia;dyslipidemia (diagnosis);dyslipidemia (disorder);dyslipidemias;high blood cholesterol/triglycerides,foodis,cause,1,cause,1,
249,calorie foods high,hypertension,"Obesity is significantly increasing worldwide because of increased high calorie food intake and decreased physical activity leading to hypertension, dyslipidemia, atherosclerosis, and insulin resistance.",calorie foods high;energy dense food;energy foods high;high calorie food;high energy food;high energy food (substance),hypertension,foodis,cause,1,cause,1,
250,calorie foods high,ischemic heart disease,"Due to the consumption of energy dense food (i.e. unhealthy food habits), sedentary life style, lack of health care services and financial support, the developing countries are facing high risk of obesity and their adverse consequences (i.e. diabetes, ischemic heart disease, etc).",calorie foods high;energy dense food;energy foods high;high calorie food;high energy food;high energy food (substance),ischemic heart disease,foodis,cause,1,cause,1,
251,calorie foods high,obesity,"Due to the consumption of energy dense food (i.e. unhealthy food habits), sedentary life style, lack of health care services and financial support, the developing countries are facing high risk of obesity and their adverse consequences (i.e. diabetes, ischemic heart disease, etc).",calorie foods high;energy dense food;energy foods high;high calorie food;high energy food;high energy food (substance),obesity,foodis,cause,1,cause,1,
252,"chloride, dietary sodium",3-00 cardiovascular disorders: general terms,"The present review article suggests that the consumption of a high-salt diet is not the cause of hypertension and that there are other factors, such as added sugars, which are causative for inducing hypertension and cardiovascular disease.___Most populations are consuming too much salt which is the main contributor of high blood pressure, a leading risk factor of cardiovascular disease and stroke.","chloride, dietary sodium;dietary salt;dietary salt (sodium chloride);dietary sodium chloride;salt;salt, table;sodium chloride, dietary;table salt","3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",foodis,cause,2,cause,1,
253,"chloride, dietary sodium",3-10 heart diseases: general terms,"Excessive dietary salt (sodium chloride and other sodium salts) is a major cause of increased blood pressure, which increases risk for stroke, heart disease, and kidney disease.","chloride, dietary sodium;dietary salt;dietary salt (sodium chloride);dietary sodium chloride;salt;salt, table;sodium chloride, dietary;table salt","3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",foodis,cause,1,cause,1,
254,"chloride, dietary sodium",atherogenic dyslipidaemia,"A decreasing intake of coarse cereals, pulses, fruits and vegetables, an increasing intake of meat products and salt, coupled with declining levels of physical activity due to rapid urbanization have resulted in escalating levels of obesity, atherogenic dyslipidemia, subclinical inflammation, metabolic syndrome, type 2 diabetes mellitus, and coronary heart disease in Indians.","chloride, dietary sodium;dietary salt;dietary salt (sodium chloride);dietary sodium chloride;salt;salt, table;sodium chloride, dietary;table salt",atherogenic dyslipidaemia;atherogenic dyslipidemia,foodis,cause,1,cause,1,
255,"chloride, dietary sodium",atherosclerosis,"Risk factors for atherosclerosis related to nutrition are hypercholesterolemia, hyperglycemia-diabetes, and for hypertension, obesity, high salt intake, and excessive use of alcohol.","chloride, dietary sodium;dietary salt;dietary salt (sodium chloride);dietary sodium chloride;salt;salt, table;sodium chloride, dietary;table salt",atherosclerosis,foodis,cause,1,cause,1,
256,"chloride, dietary sodium",cardiac congestive failure,"Congestive heart failure (CHF) is a clinical syndrome that features a failing heart together with signs and symptoms arising from renal retention of salt and water, mediated by attendant neurohormonal activation, and which prominently includes the renin-angiotensin-aldosterone system.","chloride, dietary sodium;dietary salt;dietary salt (sodium chloride);dietary sodium chloride;salt;salt, table;sodium chloride, dietary;table salt","cardiac congestive failure;cardiac failure congestive;cardiac failure, congestive;ccf - congestive cardiac fail;ccf - congestive cardiac failure;chf;chf (congestive heart failure);chf - congestive heart failure;chf nos;congestive cardiac fail;congestive cardiac failure;congestive disease heart;congestive diseases heart;congestive failure heart;congestive failure hearts;congestive failures heart;congestive heart disease;congestive heart failure;congestive heart failure (chf);congestive heart failure (diagnosis);congestive heart failure (disorder);congestive heart failure chf;congestive heart failure nos;congestive heart failure, unspecified;congestive; heart;congetive cardiac failure;disease congestive heart;failure congestive heart;failure heart congestive;failure; heart, congestive;failure;congestive cardiac;heart congestive failure;heart failure congestive;heart failure, congestive;heart failure/congestive heart failure;heart failure; congestive;heart; congestive;heart; disease, congestive",foodis,cause,1,cause,1,
257,"chloride, dietary sodium","cardiovascular syndrome, metabolic","A decreasing intake of coarse cereals, pulses, fruits and vegetables, an increasing intake of meat products and salt, coupled with declining levels of physical activity due to rapid urbanization have resulted in escalating levels of obesity, atherogenic dyslipidemia, subclinical inflammation, metabolic syndrome, type 2 diabetes mellitus, and coronary heart disease in Indians.","chloride, dietary sodium;dietary salt;dietary salt (sodium chloride);dietary sodium chloride;salt;salt, table;sodium chloride, dietary;table salt","cardiovascular syndrome, metabolic;cardiovascular syndromes, metabolic;dysmetabolic syndrome x;dysmetabolic syndrome x (diagnosis);equine metabolic syndrome;insulin resistance syndrome x;metabolic cardiovascular syndrome;metabolic syndrome;metabolic syndrome x;metabolic syndrome x (disorder);metabolic syndromes;metabolic x syndrome;reaven syndrome x;reaven's syndrome;syndrome metabolic;syndrome x (metabolic);syndrome x insulin resistance;syndrome x, dysmetabolic;syndrome x, insulin resistance;syndrome x, metabolic;syndrome x, reaven;syndrome, metabolic;syndrome, metabolic cardiovascular;syndrome, metabolic x;syndromes, metabolic;x syndrome, metabolic",foodis,cause,1,cause,1,
258,"chloride, dietary sodium",coronary heart disease,"A decreasing intake of coarse cereals, pulses, fruits and vegetables, an increasing intake of meat products and salt, coupled with declining levels of physical activity due to rapid urbanization have resulted in escalating levels of obesity, atherogenic dyslipidemia, subclinical inflammation, metabolic syndrome, type 2 diabetes mellitus, and coronary heart disease in Indians.","chloride, dietary sodium;dietary salt;dietary salt (sodium chloride);dietary sodium chloride;salt;salt, table;sodium chloride, dietary;table salt",coronary heart disease,foodis,cause,1,cause,1,
259,"chloride, dietary sodium",diabetes,"Patients with smell impairment are reported to use larger quantities of sugar and salt to highlight flavours, thus worsening their general health condition and increasing the risk of developing diabetes and hypertension.","chloride, dietary sodium;dietary salt;dietary salt (sodium chloride);dietary sodium chloride;salt;salt, table;sodium chloride, dietary;table salt",diabetes,foodis,cause,1,cause,1,
260,"chloride, dietary sodium",disease of kidney,"Excessive dietary salt (sodium chloride and other sodium salts) is a major cause of increased blood pressure, which increases risk for stroke, heart disease, and kidney disease.","chloride, dietary sodium;dietary salt;dietary salt (sodium chloride);dietary sodium chloride;salt;salt, table;sodium chloride, dietary;table salt","disease of kidney;disease, kidney;diseases kidneys;diseases, kidney;disorder kidney;disorder of kidney;disorder renal;disorder;kidney;kidney dis;kidney disease;kidney disease (disorder);kidney disease nos;kidney disease nos (disorder);kidney disease, nos;kidney diseases;kidney disorder;kidney disorders;kidneys--diseases;nephrologic disease;nephropathies;nephropathy;nephropathy (diagnosis);nephropathy nos;nephropathy, nos;renal disease;renal disease (diagnosis);renal disease nos;renal disease, nos;renal diseases;renal disorder;renal disorder (diagnosis);renal disorder nos;renal disorder, nos;renal disorders;renal disorders: nonspecific;renal; disease",foodis,cause,1,cause,1,
261,"chloride, dietary sodium",heart failure,"In patients who already have heart failure, a high salt intake aggravates the retention of salt and water, thereby exacerbating heart failure symptoms and progression of the disease.","chloride, dietary sodium;dietary salt;dietary salt (sodium chloride);dietary sodium chloride;salt;salt, table;sodium chloride, dietary;table salt",heart failure,foodis,cause,1,cause,1,
262,"chloride, dietary sodium",hypertension,"For decades the notion that an excessive consumption of salt (NaCl) leads to hypertension has persisted.___Patients with smell impairment are reported to use larger quantities of sugar and salt to highlight flavours, thus worsening their general health condition and increasing the risk of developing diabetes and hypertension.","chloride, dietary sodium;dietary salt;dietary salt (sodium chloride);dietary sodium chloride;salt;salt, table;sodium chloride, dietary;table salt",hypertension,foodis,cause,2,cause,1,
263,"chloride, dietary sodium",inflamm,"A decreasing intake of coarse cereals, pulses, fruits and vegetables, an increasing intake of meat products and salt, coupled with declining levels of physical activity due to rapid urbanization have resulted in escalating levels of obesity, atherogenic dyslipidemia, subclinical inflammation, metabolic syndrome, type 2 diabetes mellitus, and coronary heart disease in Indians.","chloride, dietary sodium;dietary salt;dietary salt (sodium chloride);dietary sodium chloride;salt;salt, table;sodium chloride, dietary;table salt","inflamm;inflammation;inflammation (morphologic abnormality);inflammation (qualifier value);inflammation nos;inflammation, nos;inflammations;inflammatory reaction;inflammatory reaction, nos",foodis,cause,1,cause,1,
264,"chloride, dietary sodium",obesity,"A decreasing intake of coarse cereals, pulses, fruits and vegetables, an increasing intake of meat products and salt, coupled with declining levels of physical activity due to rapid urbanization have resulted in escalating levels of obesity, atherogenic dyslipidemia, subclinical inflammation, metabolic syndrome, type 2 diabetes mellitus, and coronary heart disease in Indians.","chloride, dietary sodium;dietary salt;dietary salt (sodium chloride);dietary sodium chloride;salt;salt, table;sodium chloride, dietary;table salt",obesity,foodis,cause,1,cause,1,
265,"chloride, dietary sodium",stroke,"Most populations are consuming too much salt which is the main contributor of high blood pressure, a leading risk factor of cardiovascular disease and stroke.___Excessive dietary salt (sodium chloride and other sodium salts) is a major cause of increased blood pressure, which increases risk for stroke, heart disease, and kidney disease.","chloride, dietary sodium;dietary salt;dietary salt (sodium chloride);dietary sodium chloride;salt;salt, table;sodium chloride, dietary;table salt",stroke,foodis,cause,2,cause,1,
266,dietary fat,3-00 cardiovascular disorders: general terms,Introduction: dietary fat has been reported as one of the significant risk factors in the development of cardiovascular diseases (CVD).,"dietary fat;dietary fat (substance);dietary fat nos;dietary fat nos (finding);dietary fats;dietary lipid;fat - dietary;fat - dietary (substance);fat, dietary;fats, dietary;total dietary fat;total dietary lipid","3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",foodis,cause,1,cause,1,
267,dietary fat,atherosclerosis,"Dietary fats containing saturated fatty acids at the beta-position tend to raise plasma total and LDL-cholesterol, which, of course, contribute to atherosclerosis and coronary heart disease.","dietary fat;dietary fat (substance);dietary fat nos;dietary fat nos (finding);dietary fats;dietary lipid;fat - dietary;fat - dietary (substance);fat, dietary;fats, dietary;total dietary fat;total dietary lipid",atherosclerosis,foodis,cause,1,cause,1,
268,dietary fat,cardiac dysfunction,The results support the hypotheses that SDS in broilers is a cardiac dysfunction associated with defective cardiac SR membrane function and that dietary fat type is implicated with the syndrome.,"dietary fat;dietary fat (substance);dietary fat nos;dietary fat nos (finding);dietary fats;dietary lipid;fat - dietary;fat - dietary (substance);fat, dietary;fats, dietary;total dietary fat;total dietary lipid",cardiac dysfunction,foodis,cause,1,cause,1,
269,dietary fat,chronic dis,"Dietary fat intake has been associated with the development of chronic diseases, including heart disease and cancer, in human populations; however, associations demonstrated between disease and fat intake may be confounded by related dietary factors.___Excess consumption of dietary fat promotes chronic disease such as heart disease and cancer.","dietary fat;dietary fat (substance);dietary fat nos;dietary fat nos (finding);dietary fats;dietary lipid;fat - dietary;fat - dietary (substance);fat, dietary;fats, dietary;total dietary fat;total dietary lipid","chronic dis;chronic disease;chronic disease (disorder);chronic disease, nos;chronic disease/disorder;chronic diseases;chronic disorder;chronic disorders;chronic illnesses;disease, chronic;diseases, chronic;illness, chronic;illnesses, chronic",foodis,cause,2,cause,1,
270,dietary fat,coronary heart disease,"Dietary fats containing saturated fatty acids at the beta-position tend to raise plasma total and LDL-cholesterol, which, of course, contribute to atherosclerosis and coronary heart disease.","dietary fat;dietary fat (substance);dietary fat nos;dietary fat nos (finding);dietary fats;dietary lipid;fat - dietary;fat - dietary (substance);fat, dietary;fats, dietary;total dietary fat;total dietary lipid",coronary heart disease,foodis,cause,1,cause,1,
271,dietary fat,inflamm,Dietary fat-type and copper (Cu) deficiency have been independently identified as potentially important factors in the etiology of ischemic heart disease (IHD); a disease that has been linked to inflammation and oxygen free radical (OFR) mediated damage.,"dietary fat;dietary fat (substance);dietary fat nos;dietary fat nos (finding);dietary fats;dietary lipid;fat - dietary;fat - dietary (substance);fat, dietary;fats, dietary;total dietary fat;total dietary lipid","inflamm;inflammation;inflammation (morphologic abnormality);inflammation (qualifier value);inflammation nos;inflammation, nos;inflammations;inflammatory reaction;inflammatory reaction, nos",foodis,cause,1,cause,1,
275,dietary fruit,obesity,"A decreasing intake of coarse cereals, pulses, fruits and vegetables, an increasing intake of meat products and salt, coupled with declining levels of physical activity due to rapid urbanization have resulted in escalating levels of obesity, atherogenic dyslipidemia, subclinical inflammation, metabolic syndrome, type 2 diabetes mellitus, and coronary heart disease in Indians.",dietary fruit;fructus;fruit (substance);fruits,obesity,foodis,cause,1,cause,0,
276,dietary gum,atrial fibrillation,The temporal relation between more frequent gum usage and the excessive consumption of nicotine polacrilex chewing gum with a probable high serum nicotine level at the time the patient developed his first episode of atrial fibrillation suggests a causal relationship.,dietary gum;gum,atrial fibrillation,foodis,cause,1,cause,1,0
277,dietary potassium,de pointe torsades,"Drug-induced torsades de pointes (TdP) is a potentially lethal ventricular arrhythmia that is associated with drugs that prolong the QT interval on the electrocardiogram (ECG) due to their interference with the cardiac potassium current,","dietary potassium;k;potassium;potassium dietary;potassium, dietary","de pointe torsades;de pointes, torsade;de pointes, torsades;des pointe torsade;des pointes torsade;des pointes torsades;pointes, torsade de;pointes, torsades de;tdp ventricular tachycardia;torsade de pointe;torsades de pointes;torsades de pointes (diagnosis);torsades de pointes (disorder);torsades de pointes by ecg finding;torsades de pointes by ekg finding;twisting spikes;vent tach polymorp+q-t prolong;ventricular tachycardia, polymorphic with q-t prolongation;ventricular tachycardia, torsades de pointes",foodis,cause,1,cause,,
278,dietary potassium,disease of kidney,Hyperkalemia (potassium >5.0 mEq/L) affects heart failure patients with renal disease regardless of the use of renin-angiotensin-aldosterone system inhibitors (RAASi).,"dietary potassium;k;potassium;potassium dietary;potassium, dietary","disease of kidney;disease, kidney;diseases kidneys;diseases, kidney;disorder kidney;disorder of kidney;disorder renal;disorder;kidney;kidney dis;kidney disease;kidney disease (disorder);kidney disease nos;kidney disease nos (disorder);kidney disease, nos;kidney diseases;kidney disorder;kidney disorders;kidneys--diseases;nephrologic disease;nephropathies;nephropathy;nephropathy (diagnosis);nephropathy nos;nephropathy, nos;renal disease;renal disease (diagnosis);renal disease nos;renal disease, nos;renal diseases;renal disorder;renal disorder (diagnosis);renal disorder nos;renal disorder, nos;renal disorders;renal disorders: nonspecific;renal; disease",foodis,cause,1,cause,,
279,dietary potassium,heart failure,Hyperkalemia (potassium >5.0 mEq/L) affects heart failure patients with renal disease regardless of the use of renin-angiotensin-aldosterone system inhibitors (RAASi).,"dietary potassium;k;potassium;potassium dietary;potassium, dietary",heart failure,foodis,cause,1,cause,,
280,dietary potassium,hyperkalemia,"In one case the cause was unknown while, in the last case, hyperkalemia was due to rapid infusion of stored blood and solutions containing high concentrations of potassium.","dietary potassium;k;potassium;potassium dietary;potassium, dietary",hyperkalemia,foodis,cause,1,cause,,
281,dietary potassium,ventricular arrhythmia,"Drug-induced torsades de pointes (TdP) is a potentially lethal ventricular arrhythmia that is associated with drugs that prolong the QT interval on the electrocardiogram (ECG) due to their interference with the cardiac potassium current,","dietary potassium;k;potassium;potassium dietary;potassium, dietary",ventricular arrhythmia,foodis,cause,1,cause,,
282,dietary supplement,effects toxics,"Cobalt (Co) toxicity is a potential public health problem due to recent renewed use of Co in orthopedic implants, dietary supplements, and blood doping in athletes and horses.","dietary supplement;dietary supplementations;dietary supplements;dietary supplements (medication);food supplement;food supplementations;food supplements;foods supplements;nutrient supplementation;nutrient supplementation (product);nutrient supplementation (substance);nutritional supplement;nutritional supplement (product);nutritional supplement (substance);nutritional supplement,special formulas;nutritional supplementation;nutritional supplements;supplement;supplement, food;supplemental nutrition;supplementations, dietary;supplements, dietary;supplements, food",effects toxics;tox;toxic;toxic effect;toxic effect (disorder);toxic effect of;toxicities;toxicity;toxics,foodis,cause,1,cause,,
283,dietary vegetable,(hypertensive disease) or (hypertension),"Regular consumption of a diet high in sodium, energy dense foods, fat content, refined carbohydrates, added sugar and low in fruits and vegetables contributes to an increased risk of developing hypertension (HTN) and cardiovascular disease.",dietary vegetable;vegetable;vegetable (substance);vegetables,"(hypertensive disease) or (hypertension);(hypertensive disease) or (hypertension) (disorder);3-02 hypertensive diseases;[x]hypertensive diseases;[x]hypertensive diseases (disorder);arterial hypertension;arterial hypertension systemic;blood high pressure;blood pressure high;blood pressure, high;blood pressure; high;blood pressures, high;bp - high blood pressure;bp+ - hypertension;complications affecting other specified body systems, not elsewhere classified, hypertension;hbp;hbp - high blood pressure;high blood pressure;high blood pressure disorder;high blood pressure/hypertension;high blood pressures;high bp;high; arterial tension;high; blood pressure;ht - hypertension;htn;htn - hypertension;hyperpiesia;hyperpiesis;hypertension arterial;hypertension, arterial;hypertension, nos;hypertensive cardiovascular disease or syndrome;hypertensive disease;hypertensive disease (disorder);hypertensive disease nos;hypertensive disease nos (disorder);hypertensive disease, nos;hypertensive diseases;hypertensive disorder;hypertensive disorder, systemic arterial (disorder);hypertensive vascular degeneration;hypertensive vascular disease;raised blood pressure (disorder);surg comp - hypertension;systemic arterial hypertension;systemic htn;systemic hypertension;systemic hypertension (diagnosis);vascular hypertension;vascular hypertensive disorder;vascular hypertensive disorders",foodis,cause,1,cause,0,
284,dietary vegetable,3-00 cardiovascular disorders: general terms,"Regular consumption of a diet high in sodium, energy dense foods, fat content, refined carbohydrates, added sugar and low in fruits and vegetables contributes to an increased risk of developing hypertension (HTN) and cardiovascular disease.___Physical inactivity, low fruit and vegetable intake, high fast food consumption and high cholesterol are predominant causes of cardiovascular disease and some cancers.",dietary vegetable;vegetable;vegetable (substance);vegetables,"3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",foodis,cause,2,cause,0,
285,dietary vegetable,atherogenic dyslipidaemia,"A decreasing intake of coarse cereals, pulses, fruits and vegetables, an increasing intake of meat products and salt, coupled with declining levels of physical activity due to rapid urbanization have resulted in escalating levels of obesity, atherogenic dyslipidemia, subclinical inflammation, metabolic syndrome, type 2 diabetes mellitus, and coronary heart disease in Indians.",dietary vegetable;vegetable;vegetable (substance);vegetables,atherogenic dyslipidaemia;atherogenic dyslipidemia,foodis,cause,1,cause,0,
286,dietary vegetable,hypertension,"Regular consumption of a diet high in sodium, energy dense foods, fat content, refined carbohydrates, added sugar and low in fruits and vegetables contributes to an increased risk of developing hypertension (HTN) and cardiovascular disease.",dietary vegetable;vegetable;vegetable (substance);vegetables,hypertension,foodis,cause,1,cause,0,
287,dietary vegetable,obesity,"A decreasing intake of coarse cereals, pulses, fruits and vegetables, an increasing intake of meat products and salt, coupled with declining levels of physical activity due to rapid urbanization have resulted in escalating levels of obesity, atherogenic dyslipidemia, subclinical inflammation, metabolic syndrome, type 2 diabetes mellitus, and coronary heart disease in Indians.",dietary vegetable;vegetable;vegetable (substance);vegetables,obesity,foodis,cause,1,cause,0,
288,fruit,3-00 cardiovascular disorders: general terms,"Physical inactivity, low fruit and vegetable intake, high fast food consumption and high cholesterol are predominant causes of cardiovascular disease and some cancers.",fruit,"3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",foodis,cause,1,cause,,
289,meat,3-10 heart diseases: general terms,"Meat protein is associated with an increase in risk of heart disease.___Meat consumption has been related to a higher risk of heart disease due to its saturated fat content.___"" What we actually know is that: red meat consumption is an order of magnitude higher now than through most of human history; red meat is a probable, and processed meat is a definite, human carcinogen; saturated fat increases risk of heart disease; and vegans and vegetarians have better lipid profiles, lower risk of chronic disease, and greater longevity than meat eaters.",meat,"3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",foodis,cause,3,cause,1,
290,meat,"[x]toxoplasmosis, unspecified","Foodborne toxoplasmosis in humans can be due to the exposure to tissue cysts of Toxoplasma gondii through the consumption of meat, including pork, of infected animals.",meat,"[x]toxoplasmosis, unspecified;[x]toxoplasmosis, unspecified (disorder);disease (or disorder); toxoplasmosis;infect toxoplasma gondii;infection by toxoplasma gondii;infection by toxoplasma gondii (disorder);infection by toxoplasma gondii (disorder) [ambiguous];infection due to toxoplasma gondii;infection, toxoplasma gondii;infection; toxoplasma gondii;toxoplasma gondii infect;toxoplasma gondii infection;toxoplasma gondii; infection;toxoplasmoses;toxoplasmosis;toxoplasmosis (diagnosis);toxoplasmosis (disorder);toxoplasmosis nos;toxoplasmosis nos (disorder);toxoplasmosis, unspecified",foodis,cause,1,cause,1,
291,meat,adult onset diabetes,"Several prospective studies have reported that risk of type 2 diabetes (T2DM) is elevated in meat consumers, especially when processed meats are consumed.",meat,"adult onset diabetes;adult onset diabetes mellitus;adult-onset diabetes;adult-onset diabetes mellitus;adult-onset; diabetes;aodm;diabete type 2;diabetes mellitus (adult onset);diabetes mellitus (niddm);diabetes mellitus - adult ons;diabetes mellitus - adult onset;diabetes mellitus -adult onset;diabetes mellitus maturity onset;diabetes mellitus non insulin dependent;diabetes mellitus non insulin-dep;diabetes mellitus non-insulin-dependent;diabetes mellitus nos late onset;diabetes mellitus type 02;diabetes mellitus type 2;diabetes mellitus type 2 (disorder);diabetes mellitus type ii;diabetes mellitus, adult onset;diabetes mellitus, adult onset type;diabetes mellitus, adult-onset;diabetes mellitus, ketosis resistant;diabetes mellitus, ketosis-resistant;diabetes mellitus, maturity onset;diabetes mellitus, maturity-onset;diabetes mellitus, non insulin dependent;diabetes mellitus, non-insulin dependent;diabetes mellitus, non-insulin-dependent;diabetes mellitus, noninsulin dependent;diabetes mellitus, noninsulin-dependent;diabetes mellitus, slow onset;diabetes mellitus, slow-onset;diabetes mellitus, stable;diabetes mellitus, type 2;diabetes mellitus, type ii;diabetes mellitus: [adult onset] or [noninsulin dependent];diabetes mellitus: [adult onset] or [noninsulin dependent] (disorder);diabetes non-insulin dependent;diabetes type 2;diabetes type ii;diabetes, adult onset;diabetes, ketosis resistant;diabetes, maturity onset;diabetes, maturity-onset;diabetes, type 2;diabetes, type ii;diabetes; adult-onset;diabetes; maturity-onset;diabetes; niddm;diabetes; non-insulin-dependent;diabetes; nonketotic;diabetes; type ii;diabetes;adult onset;diabetes;non insulin depend;diabetes;type 2;ketosis resistant diabetes;ketosis-resistant diabetes mellitus;late onset diabetes;maturity onset diabetes;maturity onset diabetes mellit;maturity onset diabetes mellitus;maturity-onset diabetes;maturity-onset diabetes mellitus;maturity-onset; diabetes;mod;ncdmm;niddm;niddm - non-insulin dependent diabetes mellitus;niddm diabetes mellitus;niddm-non-ins dep diabetes mel;niddm; diabetes;non insulin dependent diabetes;non-ins-dep diabetes mellitus;non-insulin dependent diabetes;non-insulin dependent diabetes mellitus;non-insulin-dependent diabetes;non-insulin-dependent diabetes mellitus;non-insulin-dependent; diabetes;noninsulin dependent diab.mell;noninsulin dependent diabetes;noninsulin dependent diabetes mellitus;noninsulin-dependent diabetes;noninsulin-dependent diabetes mellitus;nonketotic; diabetes;slow-onset diabetes mellitus;stable diabetes mellitus;t2dm - type 2 diabetes mellitus;type 2 diabetes;type 2 diabetes mellitus;type 2 diabetes mellitus (diagnosis);type 2 diabetes mellitus non-insulin dependent;type ii diabetes;type ii diabetes mellitus;type ii diabetes mellitus (disorder);type ii; diabetes",foodis,cause,1,cause,1,
292,meat,coronary heart disease,Elevated risks of coronary heart disease (CHD) and stroke in meat consumers have also been reported.,meat,coronary heart disease,foodis,cause,1,cause,1,
293,meat (substance),adult onset diabetes,"Several prospective studies have reported that risk of type 2 diabetes (T2DM) is elevated in meat consumers, especially when processed meats are consumed.",meat (substance);meats,"adult onset diabetes;adult onset diabetes mellitus;adult-onset diabetes;adult-onset diabetes mellitus;adult-onset; diabetes;aodm;diabete type 2;diabetes mellitus (adult onset);diabetes mellitus (niddm);diabetes mellitus - adult ons;diabetes mellitus - adult onset;diabetes mellitus -adult onset;diabetes mellitus maturity onset;diabetes mellitus non insulin dependent;diabetes mellitus non insulin-dep;diabetes mellitus non-insulin-dependent;diabetes mellitus nos late onset;diabetes mellitus type 02;diabetes mellitus type 2;diabetes mellitus type 2 (disorder);diabetes mellitus type ii;diabetes mellitus, adult onset;diabetes mellitus, adult onset type;diabetes mellitus, adult-onset;diabetes mellitus, ketosis resistant;diabetes mellitus, ketosis-resistant;diabetes mellitus, maturity onset;diabetes mellitus, maturity-onset;diabetes mellitus, non insulin dependent;diabetes mellitus, non-insulin dependent;diabetes mellitus, non-insulin-dependent;diabetes mellitus, noninsulin dependent;diabetes mellitus, noninsulin-dependent;diabetes mellitus, slow onset;diabetes mellitus, slow-onset;diabetes mellitus, stable;diabetes mellitus, type 2;diabetes mellitus, type ii;diabetes mellitus: [adult onset] or [noninsulin dependent];diabetes mellitus: [adult onset] or [noninsulin dependent] (disorder);diabetes non-insulin dependent;diabetes type 2;diabetes type ii;diabetes, adult onset;diabetes, ketosis resistant;diabetes, maturity onset;diabetes, maturity-onset;diabetes, type 2;diabetes, type ii;diabetes; adult-onset;diabetes; maturity-onset;diabetes; niddm;diabetes; non-insulin-dependent;diabetes; nonketotic;diabetes; type ii;diabetes;adult onset;diabetes;non insulin depend;diabetes;type 2;ketosis resistant diabetes;ketosis-resistant diabetes mellitus;late onset diabetes;maturity onset diabetes;maturity onset diabetes mellit;maturity onset diabetes mellitus;maturity-onset diabetes;maturity-onset diabetes mellitus;maturity-onset; diabetes;mod;ncdmm;niddm;niddm - non-insulin dependent diabetes mellitus;niddm diabetes mellitus;niddm-non-ins dep diabetes mel;niddm; diabetes;non insulin dependent diabetes;non-ins-dep diabetes mellitus;non-insulin dependent diabetes;non-insulin dependent diabetes mellitus;non-insulin-dependent diabetes;non-insulin-dependent diabetes mellitus;non-insulin-dependent; diabetes;noninsulin dependent diab.mell;noninsulin dependent diabetes;noninsulin dependent diabetes mellitus;noninsulin-dependent diabetes;noninsulin-dependent diabetes mellitus;nonketotic; diabetes;slow-onset diabetes mellitus;stable diabetes mellitus;t2dm - type 2 diabetes mellitus;type 2 diabetes;type 2 diabetes mellitus;type 2 diabetes mellitus (diagnosis);type 2 diabetes mellitus non-insulin dependent;type ii diabetes;type ii diabetes mellitus;type ii diabetes mellitus (disorder);type ii; diabetes",foodis,cause,1,cause,1,
294,meat agents,atherogenic dyslipidaemia,"A decreasing intake of coarse cereals, pulses, fruits and vegetables, an increasing intake of meat products and salt, coupled with declining levels of physical activity due to rapid urbanization have resulted in escalating levels of obesity, atherogenic dyslipidemia, subclinical inflammation, metabolic syndrome, type 2 diabetes mellitus, and coronary heart disease in Indians.","meat agents;meat agents (substance);meat product;meat products;meat products (substance);product, meat;products, meat",atherogenic dyslipidaemia;atherogenic dyslipidemia,foodis,cause,1,cause,1,
295,meat agents,"cardiovascular syndrome, metabolic","A decreasing intake of coarse cereals, pulses, fruits and vegetables, an increasing intake of meat products and salt, coupled with declining levels of physical activity due to rapid urbanization have resulted in escalating levels of obesity, atherogenic dyslipidemia, subclinical inflammation, metabolic syndrome, type 2 diabetes mellitus, and coronary heart disease in Indians.","meat agents;meat agents (substance);meat product;meat products;meat products (substance);product, meat;products, meat","cardiovascular syndrome, metabolic;cardiovascular syndromes, metabolic;dysmetabolic syndrome x;dysmetabolic syndrome x (diagnosis);equine metabolic syndrome;insulin resistance syndrome x;metabolic cardiovascular syndrome;metabolic syndrome;metabolic syndrome x;metabolic syndrome x (disorder);metabolic syndromes;metabolic x syndrome;reaven syndrome x;reaven's syndrome;syndrome metabolic;syndrome x (metabolic);syndrome x insulin resistance;syndrome x, dysmetabolic;syndrome x, insulin resistance;syndrome x, metabolic;syndrome x, reaven;syndrome, metabolic;syndrome, metabolic cardiovascular;syndrome, metabolic x;syndromes, metabolic;x syndrome, metabolic",foodis,cause,1,cause,1,
296,meat agents,coronary heart disease,"A decreasing intake of coarse cereals, pulses, fruits and vegetables, an increasing intake of meat products and salt, coupled with declining levels of physical activity due to rapid urbanization have resulted in escalating levels of obesity, atherogenic dyslipidemia, subclinical inflammation, metabolic syndrome, type 2 diabetes mellitus, and coronary heart disease in Indians.","meat agents;meat agents (substance);meat product;meat products;meat products (substance);product, meat;products, meat",coronary heart disease,foodis,cause,1,cause,1,
297,meat agents,heart failure,Thermal processing of meat products generates cardiotoxic compounds capable of inducing heart failure in both humans and laboratory animals.,"meat agents;meat agents (substance);meat product;meat products;meat products (substance);product, meat;products, meat",heart failure,foodis,cause,1,cause,1,
298,meat agents,obesity,"A decreasing intake of coarse cereals, pulses, fruits and vegetables, an increasing intake of meat products and salt, coupled with declining levels of physical activity due to rapid urbanization have resulted in escalating levels of obesity, atherogenic dyslipidemia, subclinical inflammation, metabolic syndrome, type 2 diabetes mellitus, and coronary heart disease in Indians.","meat agents;meat agents (substance);meat product;meat products;meat products (substance);product, meat;products, meat",obesity,foodis,cause,1,cause,1,
299,meat red,3-10 heart diseases: general terms,""" What we actually know is that: red meat consumption is an order of magnitude higher now than through most of human history; red meat is a probable, and processed meat is a definite, human carcinogen; saturated fat increases risk of heart disease; and vegans and vegetarians have better lipid profiles, lower risk of chronic disease, and greater longevity than meat eaters.","meat red;meat, red;meats red;meats, red;red meat;red meat (substance);red meats","3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",foodis,cause,1,cause,0,
300,meat red,chronic dis,"At the same time, there has been growing evidence that high consumption of red meat, especially of processed meat, may be associated with an increased risk of several major chronic diseases.___The consumption of red and processed meat has been associated with increased mortality from chronic diseases, and as a result, it has been classified by the World Health Organization as carcinogenic (processed meat) and probably carcinogenic (red meat) to humans.","meat red;meat, red;meats red;meats, red;red meat;red meat (substance);red meats","chronic dis;chronic disease;chronic disease (disorder);chronic disease, nos;chronic disease/disorder;chronic diseases;chronic disorder;chronic disorders;chronic illnesses;disease, chronic;diseases, chronic;illness, chronic;illnesses, chronic",foodis,cause,2,cause,1,
301,meats processed,3-10 heart diseases: general terms,""" What we actually know is that: red meat consumption is an order of magnitude higher now than through most of human history; red meat is a probable, and processed meat is a definite, human carcinogen; saturated fat increases risk of heart disease; and vegans and vegetarians have better lipid profiles, lower risk of chronic disease, and greater longevity than meat eaters.",meats processed;processed meat;processed meat (substance),"3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",foodis,cause,1,cause,0,
302,meats processed,chronic dis,"A high consumption of red and/or processed meat is associated with a higher risk to develop several chronic diseases in which oxidative stress, trimethylamine-N-oxide (TMAO) and/or inflammation are involved.",meats processed;processed meat;processed meat (substance),"chronic dis;chronic disease;chronic disease (disorder);chronic disease, nos;chronic disease/disorder;chronic diseases;chronic disorder;chronic disorders;chronic illnesses;disease, chronic;diseases, chronic;illness, chronic;illnesses, chronic",foodis,cause,1,cause,1,
303,milk,3-10 heart diseases: general terms,Other studies have suggested that a high consumption of A1/B milk may affect human health by increasing the risk of diabetes and heart diseases.,milk,"3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",foodis,cause,1,cause,,
304,oil vegetable,coronary artery disease,Consequently it was stated in a Lancet Editorial that hydrogenation of vegetable oils could have contributed to the causation of coronary artery disease and predicted that a decade would probably be required to resolve this question.,"oil vegetable;oil, vegetable;oils, vegetable;vegetable oil;vegetable oil (substance);vegetable oil oil;vegetable oil, nos;vegetable oils",coronary artery disease;coronary artery diseases,foodis,cause,1,cause,1,
305,oil vegetable,coronary heart disease,Current scientific evidence indicates that consumption of industrial trans fatty acids (TFA) produced via partial hydrogenation of vegetable oils increases the risk of coronary heart disease.,"oil vegetable;oil, vegetable;oils, vegetable;vegetable oil;vegetable oil (substance);vegetable oil oil;vegetable oil, nos;vegetable oils",coronary heart disease,foodis,cause,1,cause,1,
306,"oil, palm",effects toxics,"Additionally, oxidized palm oil induces reproductive toxicity and organotoxicity particularly of the kidneys, lungs, liver and heart.","oil, palm;palm oil;palm oil (substance);palm oil miscell oil (ml);palm oil oil;palm oil@@miscell@oil (ml);palmolein",effects toxics;tox;toxic;toxic effect;toxic effect (disorder);toxic effect of;toxicities;toxicity;toxics,foodis,cause,1,cause,1,
307,pork,"[x]toxoplasmosis, unspecified","Foodborne toxoplasmosis in humans can be due to the exposure to tissue cysts of Toxoplasma gondii through the consumption of meat, including pork, of infected animals.",pork;pork (substance),"[x]toxoplasmosis, unspecified;[x]toxoplasmosis, unspecified (disorder);disease (or disorder); toxoplasmosis;infect toxoplasma gondii;infection by toxoplasma gondii;infection by toxoplasma gondii (disorder);infection by toxoplasma gondii (disorder) [ambiguous];infection due to toxoplasma gondii;infection, toxoplasma gondii;infection; toxoplasma gondii;toxoplasma gondii infect;toxoplasma gondii infection;toxoplasma gondii; infection;toxoplasmoses;toxoplasmosis;toxoplasmosis (diagnosis);toxoplasmosis (disorder);toxoplasmosis nos;toxoplasmosis nos (disorder);toxoplasmosis, unspecified",foodis,cause,1,cause,1,
309,(+)-aldosterone,heart failure,"Spironolactone, an antagonist of aldosterone, initially used as a potassium-sparing diuretic, was subsequently shown to be a very effective adjunctive agent in the treatment of patients with heart failure with reduced ejection fraction, by halting the disease progression, with significant beneficial effects on both morbidity and mortality.","(+)-aldosterone;(11β)-11,21-dihydroxy-3,20-dioxopregn-4-en-18-al;11beta,21-dihydroxy-3,20-dioxo-4-pregnen-18-al;11beta,21-dihydroxy-3,20-dioxopregn-4-en-18-al;aldosterona;aldosterone;aldosterone (substance);aldosterone preparation;aldosterone preparation (product);aldosterone preparation (substance);aldosterone product;aldosterone-containing product;aldosteronum;pregn-4-en-18-al, 11,21-dihydroxy-3,20-dioxo-, (11beta)-;product containing aldosterone;product containing aldosterone (medicinal product)",heart failure,chemdis,treat,1,treat,0,
310,(+)-aldosterone,hyperkalemia,The evidence needed to support a treatment claim (reduction in serum potassium) differs from that needed to support a prevention claim (preventing hyperkalemia to allow renin angiotensin aldosterone system inhibitor treatment).___Hyperkalemia (potassium >5.0 mEq/L) affects heart failure patients with renal disease regardless of the use of renin-angiotensin-aldosterone system inhibitors (RAASi).,"(+)-aldosterone;(11β)-11,21-dihydroxy-3,20-dioxopregn-4-en-18-al;11beta,21-dihydroxy-3,20-dioxo-4-pregnen-18-al;11beta,21-dihydroxy-3,20-dioxopregn-4-en-18-al;aldosterona;aldosterone;aldosterone (substance);aldosterone preparation;aldosterone preparation (product);aldosterone preparation (substance);aldosterone product;aldosterone-containing product;aldosteronum;pregn-4-en-18-al, 11,21-dihydroxy-3,20-dioxo-, (11beta)-;product containing aldosterone;product containing aldosterone (medicinal product)",hyperkalemia,chemdis,treat,2,treat,,
311,(+)-quinidine,abnormal heart rhythms,"Digoxin, quinidine, and furosemide can be used effectively to control signs of CHF and cardiac arrhythmias.","(+)-quinidine;(8r,9s)-quinidine;(r)-(6-methoxyquinolin-4-yl)((3s,4r,7s)-3-vinylquinuclidin-7-yl)methanol;(s)-(6-methoxy-quinolin-4-yl)-((2r,5r)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol;(s)-(6-methoxyquinolin-4-yl)((2r,5r)-5-vinylquinuclidin-2-yl)methanol;6-methoxy-α-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol;beta-quinine;chinidin;chinidinum;cin-quin;cinchonan-9-ol, 6'-methoxy-, (9s)-;product containing quinidine;product containing quinidine (medicinal product);quinidina;quinidine;quinidine (medication);quinidine (product);quinidine (substance);quinidine product;quinidine-containing product;α-(6-methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol;β-quinine","abnormal heart rhythms;arrhythmia (cardiac) nos;arrhythmia (finding);arrhythmia (nos);arrhythmia cardiac (nos);arrhythmia nos;arrhythmia, cardiac;arrhythmia, nos;arrhythmias;arrhythmias (heart);arrhythmias, cardiac;arrythmia;cardiac arrhythmia (disorder);cardiac arrhythmia (nos);cardiac arrhythmia nos;cardiac arrhythmia, irregular pulse;cardiac arrhythmia, nos;cardiac arrhythmia, unspecified;cardiac arrhythmias;cardiac dysrhythmia (disorder);cardiac dysrhythmia nos;cardiac dysrhythmia nos (disorder);cardiac dysrhythmia, nos;cardiac dysrhythmia, unspecified;cardiac dysrhythmias nos;cardiac rhythm disorder (diagnosis);cardiac rhythm disturbance;cardiac rhythm disturbances;cardiac rhythm irregular;cardiac rhythm, abnormal;cardiac; dysrhythmia;disorder of heart rhythm;disorder; rhythm, heart;disturbance; rhythm, heart;dysrhythmia;dysrhythmia(s);dysrhythmia, cardiac;dysrhythmia; cardiac;dysrhythmia;cardiac;dysrhythmias;ectopic beats all types;heart arrhythmia;heart arrhythmias;heart rhythm disorders;heart: rhythm;rhythm, heart; abnormal;rhythm; abnormal;rhythm; disorder",chemdis,treat,1,treat,1,
312,(+)-quinidine,arrhythmia ventricular,Tocainide and mexiletine are similar to lidocaine and are as effective as quinidine in patients with ventricular arrhythmias.,"(+)-quinidine;(8r,9s)-quinidine;(r)-(6-methoxyquinolin-4-yl)((3s,4r,7s)-3-vinylquinuclidin-7-yl)methanol;(s)-(6-methoxy-quinolin-4-yl)-((2r,5r)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol;(s)-(6-methoxyquinolin-4-yl)((2r,5r)-5-vinylquinuclidin-2-yl)methanol;6-methoxy-α-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol;beta-quinine;chinidin;chinidinum;cin-quin;cinchonan-9-ol, 6'-methoxy-, (9s)-;product containing quinidine;product containing quinidine (medicinal product);quinidina;quinidine;quinidine (medication);quinidine (product);quinidine (substance);quinidine product;quinidine-containing product;α-(6-methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol;β-quinine","arrhythmia ventricular;arrhythmia ventricular (nos);arrhythmia, ventricular;arrhythmias ventricular;dysrhythmias ventricular;ventricular arrhythmia (diagnosis);ventricular arrhythmia (disorder);ventricular arrhythmia, nos;ventricular arrhythmias;ventricular dysrhythmia;ventricular dysrhythmia (finding)",chemdis,treat,1,treat,1,
313,(+)-quinidine,"beats; ectopia, ventricular",Encainide and flecainide are superior to quinidine for the control of ventricular ectopic beats and as effective as quinidine for patients with ventricular tachycardia.,"(+)-quinidine;(8r,9s)-quinidine;(r)-(6-methoxyquinolin-4-yl)((3s,4r,7s)-3-vinylquinuclidin-7-yl)methanol;(s)-(6-methoxy-quinolin-4-yl)-((2r,5r)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol;(s)-(6-methoxyquinolin-4-yl)((2r,5r)-5-vinylquinuclidin-2-yl)methanol;6-methoxy-α-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol;beta-quinine;chinidin;chinidinum;cin-quin;cinchonan-9-ol, 6'-methoxy-, (9s)-;product containing quinidine;product containing quinidine (medicinal product);quinidina;quinidine;quinidine (medication);quinidine (product);quinidine (substance);quinidine product;quinidine-containing product;α-(6-methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol;β-quinine","beats; ectopia, ventricular;contraction; premature, ventricular;ectopia; beats, ventricular;ectopia; ventricular beats;ectopic beat(s);ventricular;ectopic beat, ventricular;ectopic beats (ventricular);ectopic beats, ventricular;extra heart beat;extra ventricular systoles;extrasystole ventricular;extrasystole, ventricular;extrasystoles ventricular;extrasystoles; ventricular;premature depolarization ventricular;premature veb's;premature ventricular beat;premature ventricular beats;premature ventricular contraction;premature ventricular contraction (pvc);premature ventricular contractions;premature ventricular contractions (diagnosis);premature ventricular contractions, nos (pvcs) (vpcs);premature ventricular ectopic beats;premature; contraction, ventricular;premature; ventricular systole;pvc - premature ventricular complex;pvc - premature ventricular contraction;pvc's;systoles;ventricular (extra);vbp;veb's;ventric premature depolarisatn;ventricular beat premature;ventricular beat, premature;ventricular beats, premature;ventricular complex, premature;ventricular contraction, premature;ventricular contractions premature;ventricular contractions, premature;ventricular ectopic;ventricular ectopic activity;ventricular ectopic beat;ventricular ectopic beat(s);ventricular ectopic beats;ventricular ectopic beats (disorder);ventricular ectopic beats (finding);ventricular ectopic complex;ventricular ectopic complex (pvc);ventricular ectopic complex (pvc) [heart disease];ventricular ectopics;ventricular ectopy;ventricular extrasystole;ventricular extrasystoles;ventricular premature beat;ventricular premature beats;ventricular premature beats (disorder);ventricular premature complex (disorder);ventricular premature contractions;ventricular premature depolarisation;ventricular premature depolarization (diagnosis);ventricular premature systoles;ventricular; ectopic beats;ventricular; extrasystoles;ventricular; premature contraction;ventricular; premature systole;vpb;vpbs;vpc - ventricular premature complex;vpc - ventricular premature contraction;vpc's",chemdis,treat,1,treat,1,
314,(+)-quinidine,ventricular tachycardia,Encainide and flecainide are superior to quinidine for the control of ventricular ectopic beats and as effective as quinidine for patients with ventricular tachycardia.,"(+)-quinidine;(8r,9s)-quinidine;(r)-(6-methoxyquinolin-4-yl)((3s,4r,7s)-3-vinylquinuclidin-7-yl)methanol;(s)-(6-methoxy-quinolin-4-yl)-((2r,5r)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol;(s)-(6-methoxyquinolin-4-yl)((2r,5r)-5-vinylquinuclidin-2-yl)methanol;6-methoxy-α-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol;beta-quinine;chinidin;chinidinum;cin-quin;cinchonan-9-ol, 6'-methoxy-, (9s)-;product containing quinidine;product containing quinidine (medicinal product);quinidina;quinidine;quinidine (medication);quinidine (product);quinidine (substance);quinidine product;quinidine-containing product;α-(6-methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol;β-quinine",ventricular tachycardia,chemdis,treat,1,treat,1,
315,(-)-cholesterol,3-00 cardiovascular disorders: general terms,Reduction in dietary cholesterol is widely recommended for the prevention of cardiovascular disease.,"(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)","3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,treat,1,treat,0,
316,(-)-cholesterol,3-10 heart diseases: general terms,"The United States Food and Drug Administration (FDA) approved a health claim for β-glucan soluble fiber from oats for reducing plasma cholesterol levels and risk of heart disease in 1997.___Beans, peas, and lentils are all types of pulses that are extensively used as foods around the world due to their beneficial effects on human health including their low glycaemic index, cholesterol lowering effects, ability to decrease the risk of heart diseases and their protective effects against some cancers.___Thus, a lower intake of saturated fats to decrease the levels of LDL cholesterol, together with an adequate intake of antioxidants, is the optimal approach to lower heart disease risk.___While cholesterol-lowering drug therapy (statins) has been effective in reducing the risk of heart disease, there are those individuals who are unwilling or because of muscle pains or raised levels of liver or muscle enzymes are unable to take cholesterol-lowering medication.___When used as a dietary supplement to achieve and maintain healthy cholesterol levels, Chinese red yeast rice has significant potential to reduce health care costs and contribute to public health by reducing heart disease risk in individuals with moderate elevations of circulating cholesterol levels.___Soy protein isolate (SPI) is known to reduce the risk of heart disease by lowering serum cholesterol and triacylglycerol (TG) levels.___Low GI/GL may protect against heart disease in women, and cross-sectional studies indicate low GI/GL may reduce high-density-lipoprotein cholesterol and triacylglycerol levels in both sexes.___Consumption of oats has been proven to lower blood LDL cholesterol levels and blood pressure, thus reducing the risk of heart disease, as well as reducing blood-sugar and insulin levels.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)","3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",chemdis,treat,8,treat,0,
317,(-)-cholesterol,3-14-15 ischemic heart diseases,"Results of primary prevention trials, however, suggested that lowering the cholesterol concentration had a beneficial effect in reducing morbidity from IHD.___There is no sound evidence that reduction of serum cholesterol below 200-210 mg/dl will reduce IHD incidence.___While the three major primary prevention trials of lowering raised serum cholesterol were all associated with reduction in the non-fatal mortality from IHD--thereby supporting the lipid hypothesis--all also showed an increase in non-cardiovascular mortality.___It is probably of little value to reduce raised serum cholesterol concentrations in patients with overt IHD, since their prognosis is largely determined by the extent of myocardial damage sustained and of coexisting thrombogenic tendency.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)","3-14-15 ischemic heart diseases;disease, ischemic heart;disease;ischaemic heart;disease;ischemic heart;diseases, ischemic heart;heart dis ischemic;heart disease, ischemic;heart diseases, ischemic;heart, ischemic disease;ihd;ihd - ischaemic heart disease;ihd - ischemic heart disease;ischaemia myocardial;ischaemic heart disease (disorder);ischaemic heart disease nos;ischaemic heart disease nos (disorder);ischaemic heart disease, nos;ischaemic heart diseases;ischemia myocardial;ischemia, myocardial;ischemia; heart;ischemia; myocardial;ischemias, myocardial;ischemic heart dis;ischemic heart disease (diagnosis);ischemic heart disease (disorder);ischemic heart disease nos;ischemic heart disease nos (disorder);ischemic heart disease or syndrome;ischemic heart disease, nos;ischemic heart diseases;ischemic heart diseases (i20-i25);ischemic heart diseases and syndromes;myocardial ischaemia (disorder);myocardial ischaemia, nos;myocardial ischemia (diagnosis);myocardial ischemia (disorder);myocardial ischemia, nos;myocardial ischemia/hypoxia;myocardial ischemias;myocardium; ischemic",chemdis,treat,4,treat,0,
318,(-)-cholesterol,abnormal narrowing,"Cholesterol lowering over 1- to 3-year trials is associated with modest regression or no progression of focal coronary artery stenoses compared with progression in controls, a decrease in cardiac events proportionately more than the modest improvement in percent stenosis, and in experimental animals improved endothelial-mediated coronary vasodilation.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)","abnormal narrowing;abnormal narrowing of a duct or passage;constriction;constriction (qualifier value);constriction pathol;constriction, nos;constriction, pathologic;constriction, pathological;constrictions, pathologic;pathol constriction;pathologic constriction;pathologic constrictions;pathological constriction;stenose;stenoses;stenosi;stenosis;stenosis (morphologic abnormality);stenosis nos;stenosis, nos;stricture;stricture (morphologic abnormality);stricture, nos;strictures;unspecified stenosis;unspecified stenosis (disorder)",chemdis,treat,1,treat,0,
319,(-)-cholesterol,acs - acute coronary syndrome,Reduction in plasma low-density lipoprotein cholesterol (LDL-C) is a fundamental treatment for the prevention of acute coronary syndromes (ACS).,"(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)","acs - acute coronary syndrome;acute coronary syndrome;acute coronary syndrome (diagnosis);acute coronary syndrome (disorder);acute coronary syndromes;coronary syndrome, acute;coronary syndromes, acute;syndrome acute coronary;syndrome, acute coronary;syndromes, acute coronary",chemdis,treat,1,treat,0,
320,(-)-cholesterol,adult onset diabetes,Bile acid sequestrants are effective cholesterol-lowering agents in normotriglyceridemic patients with non-insulin-dependent diabetes mellitus (NIDDM).,"(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)","adult onset diabetes;adult onset diabetes mellitus;adult-onset diabetes;adult-onset diabetes mellitus;adult-onset; diabetes;aodm;diabete type 2;diabetes mellitus (adult onset);diabetes mellitus (niddm);diabetes mellitus - adult ons;diabetes mellitus - adult onset;diabetes mellitus -adult onset;diabetes mellitus maturity onset;diabetes mellitus non insulin dependent;diabetes mellitus non insulin-dep;diabetes mellitus non-insulin-dependent;diabetes mellitus nos late onset;diabetes mellitus type 02;diabetes mellitus type 2;diabetes mellitus type 2 (disorder);diabetes mellitus type ii;diabetes mellitus, adult onset;diabetes mellitus, adult onset type;diabetes mellitus, adult-onset;diabetes mellitus, ketosis resistant;diabetes mellitus, ketosis-resistant;diabetes mellitus, maturity onset;diabetes mellitus, maturity-onset;diabetes mellitus, non insulin dependent;diabetes mellitus, non-insulin dependent;diabetes mellitus, non-insulin-dependent;diabetes mellitus, noninsulin dependent;diabetes mellitus, noninsulin-dependent;diabetes mellitus, slow onset;diabetes mellitus, slow-onset;diabetes mellitus, stable;diabetes mellitus, type 2;diabetes mellitus, type ii;diabetes mellitus: [adult onset] or [noninsulin dependent];diabetes mellitus: [adult onset] or [noninsulin dependent] (disorder);diabetes non-insulin dependent;diabetes type 2;diabetes type ii;diabetes, adult onset;diabetes, ketosis resistant;diabetes, maturity onset;diabetes, maturity-onset;diabetes, type 2;diabetes, type ii;diabetes; adult-onset;diabetes; maturity-onset;diabetes; niddm;diabetes; non-insulin-dependent;diabetes; nonketotic;diabetes; type ii;diabetes;adult onset;diabetes;non insulin depend;diabetes;type 2;ketosis resistant diabetes;ketosis-resistant diabetes mellitus;late onset diabetes;maturity onset diabetes;maturity onset diabetes mellit;maturity onset diabetes mellitus;maturity-onset diabetes;maturity-onset diabetes mellitus;maturity-onset; diabetes;mod;ncdmm;niddm;niddm - non-insulin dependent diabetes mellitus;niddm diabetes mellitus;niddm-non-ins dep diabetes mel;niddm; diabetes;non insulin dependent diabetes;non-ins-dep diabetes mellitus;non-insulin dependent diabetes;non-insulin dependent diabetes mellitus;non-insulin-dependent diabetes;non-insulin-dependent diabetes mellitus;non-insulin-dependent; diabetes;noninsulin dependent diab.mell;noninsulin dependent diabetes;noninsulin dependent diabetes mellitus;noninsulin-dependent diabetes;noninsulin-dependent diabetes mellitus;nonketotic; diabetes;slow-onset diabetes mellitus;stable diabetes mellitus;t2dm - type 2 diabetes mellitus;type 2 diabetes;type 2 diabetes mellitus;type 2 diabetes mellitus (diagnosis);type 2 diabetes mellitus non-insulin dependent;type ii diabetes;type ii diabetes mellitus;type ii diabetes mellitus (disorder);type ii; diabetes",chemdis,treat,1,treat,0,
321,(-)-cholesterol,arrhythmia,"On the contrary, HCQ and azithromycin were both found to substantially reduce cardiac mortality and also decrease thrombosis, arrhythmia and cholesterol in treated patients in recent peer-reviewed studies and meeting presentations.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",arrhythmia,chemdis,treat,1,treat,0,
322,(-)-cholesterol,atherosclerosis,"Soy protein lowers total cholesterol, low-density lipoprotein cholesterol, and triglycerides in humans and inhibits atherosclerosis in animals.___Increased expression of the low-density lipoprotein receptor (LDLR) is generally considered beneficial for reducing plasma cholesterol and atherosclerosis, and its downregulation has been thought to explain the association between apolipoprotein (apo) E4 and increased risk of coronary heart disease in humans.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",atherosclerosis,chemdis,treat,2,treat,0,
323,(-)-cholesterol,body fails to respond to insulin,Soluble fiber decreases serum total and low-density lipoprotein cholesterol concentrations and improves insulin resistance.,"(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)","body fails to respond to insulin;drug resistance to insulin;drug resistance to insulin (disorder);insulin resistance;insulin resistance (diagnosis);insulin resistance (disorder);resistance, insulin",chemdis,treat,1,treat,0,
324,(-)-cholesterol,cardiac congestive failure,"The Chinese herbal compound berberine, used to treat diabetes and congestive heart failure in China, has been shown to increase hepatic expression of LDL receptors and, hence, to lower LDL cholesterol, by extending the half-life of LDL receptor messenger ribonucleic acid (mRNA).","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)","cardiac congestive failure;cardiac failure congestive;cardiac failure, congestive;ccf - congestive cardiac fail;ccf - congestive cardiac failure;chf;chf (congestive heart failure);chf - congestive heart failure;chf nos;congestive cardiac fail;congestive cardiac failure;congestive disease heart;congestive diseases heart;congestive failure heart;congestive failure hearts;congestive failures heart;congestive heart disease;congestive heart failure;congestive heart failure (chf);congestive heart failure (diagnosis);congestive heart failure (disorder);congestive heart failure chf;congestive heart failure nos;congestive heart failure, unspecified;congestive; heart;congetive cardiac failure;disease congestive heart;failure congestive heart;failure heart congestive;failure; heart, congestive;failure;congestive cardiac;heart congestive failure;heart failure congestive;heart failure, congestive;heart failure/congestive heart failure;heart failure; congestive;heart; congestive;heart; disease, congestive",chemdis,treat,1,treat,0,
325,(-)-cholesterol,"cholesterol level, high","Functional foods' supplemented with phytosterols are recommended for the management of hypercholesterolaemia and have become a widely used non-prescription approach to lower plasma cholesterol levels.___A low-saturated, low-cholesterol diet is important in the treatment of hypercholesterolaemia in patients with coronary heart disease.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)","cholesterol level, high;cholesterol levels, high;cholesterol, elevated;cholesterols, elevated;elevated cholesterol;elevated cholesterols;elevated total cholesterol;high blood cholesterol level;high cholesterol levels;hypercholesteraemia;hypercholesteremia;hypercholesteremias;hypercholesterolaemia;hypercholesterolaemia, nos;hypercholesterolemia (diagnosis);hypercholesterolemia (disorder);hypercholesterolemia (elevated plasma cholesterol);hypercholesterolemia, nos;hypercholesterolemias;increased total cholesterol;level, high cholesterol;levels, high cholesterol",chemdis,treat,2,treat,0,
326,(-)-cholesterol,coronary artery disease,"Many specific dietary modifications, including increased intake of omega-9 and omega-3 fatty acids and soluble fiber, may also help reduce cholesterol levels and prevent coronary artery disease.___These data, combined with our previous results on cholesterol-lowering effects of macadamia nuts, suggest that regular consumption of macadamia nuts may play a role in the prevention of coronary artery disease.___Recent clinical trials have demonstrated the benefits of cholesterol-lowering therapy in both diabetic and nondiabetic patients, thus supporting aggressive treatment of diabetic dyslipidemia for coronary artery disease prevention.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",coronary artery disease;coronary artery diseases,chemdis,treat,3,treat,0,
327,(-)-cholesterol,coronary heart disease,"These results indicate that a diet beneficial with respect to the risk of coronary heart disease is also likely to reduce the risk of colorectal cancer, even though low levels of serum total cholesterol and particularly HDL cholesterol represent important independent correlates of clinically overt colorectal cancer.___The soy protein beverage, compared to cow's milk, induced significant reductions in plasma triglycerides and very-low-density lipoprotein cholesterol, as well as a significant increase in high-density lipoprotein cholesterol, indicating that consumption of soy protein beverage may be beneficial for the prevention of coronary heart disease in children with familial hypercholesterolemia.___It is concluded that, on the basis of present knowledge, limitation of dietary fat and cholesterol intake is a prudent public health measure for the prevention of both coronary heart disease and cancer.___These findings suggest a possible explanation for the known protective effect of exercise against coronary heart disease, even when taken in amounts insufficient to raise HDL-cholesterol.___Vegetarianism A high intake of plant foods reduces the risk of coronary heart disease through several mechanisms, including lowering serum cholesterol and blood pressure levels.___Healthy men and women with cholesterol levels of 4.0-7.2 mmol/L, consumed four capsules daily of either a quercetin-containing supplement (1.0 g quercetin/d) or rice flour placebo for 28 d. Quercetin intakes were approximately 50-fold greater than the dietary intakes associated with lower coronary heart disease mortality on the basis of epidemiologic studies.___The National Cholesterol Education Program advocates dietary interventions in persons with high and moderate blood cholesterol levels and in the general population as a preventive measure for coronary heart disease.___It is concluded that the significantly longer lag phase for oxidation of LDL, the higher HDL cholesterol level and the lower triacylglycerol level in subjects following a carotenoid-controlled, MUFA-enriched diet may decrease the risk of coronary heart disease.___A low-saturated, low-cholesterol diet is important in the treatment of hypercholesterolaemia in patients with coronary heart disease.___Lowering of low-density lipoprotein (LDL) cholesterol reduces coronary heart disease morbidity and mortality, not only in secondary but also in primary prevention.___The traditional diet-heart hypothesis predicts that replacing saturated fat with vegetable oil rich in linoleic acid will reduce coronary heart disease events and deaths by lowering serum cholesterol.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",coronary heart disease,chemdis,treat,11,treat,0,
328,(-)-cholesterol,diabetic,"Recent clinical trials have demonstrated the benefits of cholesterol-lowering therapy in both diabetic and nondiabetic patients, thus supporting aggressive treatment of diabetic dyslipidemia for coronary artery disease prevention.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",diabetic;diabetics,chemdis,treat,1,treat,0,
329,(-)-cholesterol,diabetic dyslipidaemia,"Recent clinical trials have demonstrated the benefits of cholesterol-lowering therapy in both diabetic and nondiabetic patients, thus supporting aggressive treatment of diabetic dyslipidemia for coronary artery disease prevention.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",diabetic dyslipidaemia;diabetic dyslipidemia,chemdis,treat,1,treat,0,
330,(-)-cholesterol,dis metab,"Omega-3 fatty acids reduce the risk of irregular heartbeat, stabilize arterial pressure, and restore balance in cholesterol metabolism disorders.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)","dis metab;disease, metabolic;disease;metabolic;diseases, metabolic;disorder of metabolism nos;disorder of metabolism nos (disorder);disorder; metabolism;disorder;metabolic;general; metabolic disorder;generalised metabolic disorder;generalized metabolic disorder;generalized metabolic disorder (disorder);md - metabolic disorders;metab dis;metabolic derangement;metabolic disease;metabolic disease (disorder);metabolic disease, nos;metabolic diseases;metabolic disorder;metabolic disorder nos;metabolic disorder, nos;metabolic disorder, unspecified;metabolic disorder; general;metabolic disorders;metabolic disorders (diagnosis);metabolic disorders (disorder);metabolic disorders: general;metabolism disorder;metabolism disorder nos;metabolism disorders;metabolism--disorders;metabolism; disorder;metabolism; disorder, general;rndx metabolic;rndx metabolic (diagnosis);thesaurismoses;thesaurismosis;unspecified disorder of metabolism",chemdis,treat,1,treat,0,
331,(-)-cholesterol,dyslipidaemia,"Ezetimibe, approved by the U.S. Food and Drug Administration (FDA) in October 2002, is the first in a new class of selective cholesterol absorption inhibitors and offers a novel approach to the treatment of dyslipidemia.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",dyslipidaemia;dyslipidemia;dyslipidemia (diagnosis);dyslipidemia (disorder);dyslipidemias;high blood cholesterol/triglycerides,chemdis,treat,1,treat,0,
332,(-)-cholesterol,heart problem,Ability of PSs to reduce cholesterol levels and risks associated with heart problems has made them a class of favorite food supplements.,"(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",heart problem;heart problems;heart troubled;problem;heart,chemdis,treat,1,treat,0,
333,(-)-cholesterol,high cholesterol,Total plasma cholesterol reduction in populations suffering from primary hypercholesterolemia may lower CHD incidence.,"(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",high cholesterol;high cholesterol level;hypercholesterolemia,chemdis,treat,1,treat,0,
334,(-)-cholesterol,hyperlipidemia,"There is a critical need for alternative, potent agents that can reduce low-density lipoprotein cholesterol (LDL-C) levels in patients with heterozygous familial hyperlipidemia and statin intolerance and those not reaching lipid-lowering treatment goals who are at high risk for cardiovascular (CV) events.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",hyperlipidemia,chemdis,treat,1,treat,0,
335,(-)-cholesterol,hypertension,"While a number of reports have established the beneficial abilities of certain probiotic bacterial strains to reduce cholesterol and hypertension, recent research suggests that their use could be more widely applied.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",hypertension,chemdis,treat,1,treat,0,
336,(-)-cholesterol,inflamm,"There are persuasive evidences that dietary substitution of monounsaturated fatty acids (MUFA) or n-6 polyunsaturated fatty acids (PUFA) for SFA lowers blood cholesterol and may have beneficial effects on inflammation, thrombosis, and vascular reactivity.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)","inflamm;inflammation;inflammation (morphologic abnormality);inflammation (qualifier value);inflammation nos;inflammation, nos;inflammations;inflammatory reaction;inflammatory reaction, nos",chemdis,treat,1,treat,0,
337,(-)-cholesterol,lf,"Low-cholesterol feeding decreased plasma total cholesterol in all three groups, but triglycerides only in LF and F. Lipid infiltration of the aortic wall was similar in I, L, LF and F.","(-)-cholesterol;(3beta)-cholest-5-en-3-ol;(3β,14β,17α)-cholest-5-en-3-ol;5-cholesten-3b-ol;cholest-5-en-3-ol (3beta)-;cholest-5-en-3beta-ol;cholesterol;cholesterol (substance)",lf;lf genotype,chemdis,treat,1,treat,0,
338,(-)-ephedrine,osteoporosis,"Dietary supplements of ephedrine plus caffeine for weight loss (weight loss being the current first line recommendation of physicians for osteoporosis) show some promise, but are not sufficient in number of study subjects.","(-)-ephedrine;(1r,2s)-1-phenyl-1-hydroxy-2-methylaminopropane;(1r,2s)-2-methylamino-1-phenyl-propan-1-ol;[r-(r*,s*)]-alpha-[1-(methylamino)ethyl]benzenemethanol;antiasthmatics ephedrine;antiasthmatics ephedrine (medication);efedrina;ephedrine;ephedrine (medication);ephedrine (product);ephedrine (substance);ephedrine erythro isomer;ephedrine product;ephedrine products;ephedrine-containing product;ephedrines;erythro isomer of ephedrine;l(-)-ephedrine;l-ephedrine;l-erythro-2-(methylamino)-1-phenylpropan-1-ol;product containing ephedrine;product containing ephedrine (medicinal product)",osteoporosis,chemdis,treat,1,treat,0,
339,(-)-ephedrine,weight loss,"Dietary supplements of ephedrine plus caffeine for weight loss (weight loss being the current first line recommendation of physicians for osteoporosis) show some promise, but are not sufficient in number of study subjects.","(-)-ephedrine;(1r,2s)-1-phenyl-1-hydroxy-2-methylaminopropane;(1r,2s)-2-methylamino-1-phenyl-propan-1-ol;[r-(r*,s*)]-alpha-[1-(methylamino)ethyl]benzenemethanol;antiasthmatics ephedrine;antiasthmatics ephedrine (medication);efedrina;ephedrine;ephedrine (medication);ephedrine (product);ephedrine (substance);ephedrine erythro isomer;ephedrine product;ephedrine products;ephedrine-containing product;ephedrines;erythro isomer of ephedrine;l(-)-ephedrine;l-ephedrine;l-erythro-2-(methylamino)-1-phenylpropan-1-ol;product containing ephedrine;product containing ephedrine (medicinal product)",weight loss,chemdis,treat,1,treat,1,
340,(±)-flecainide,arrhythmia ventricular,"Tocainide, mexiletine, flecainide, encainide, and amiodarone are antiarrhythmic agents that have recently been approved by the Food and Drug Administration for general use in the treatment of ventricular arrhythmias.","(±)-flecainide;benzamide, n-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)-;flecaine;flecainida;flecainide;flecainide (medication);flecainide (product);flecainide (substance);flecainide product;flecainide-containing product;flecainidum;flécanide;n-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide;product containing flecainide;product containing flecainide (medicinal product)","arrhythmia ventricular;arrhythmia ventricular (nos);arrhythmia, ventricular;arrhythmias ventricular;dysrhythmias ventricular;ventricular arrhythmia (diagnosis);ventricular arrhythmia (disorder);ventricular arrhythmia, nos;ventricular arrhythmias;ventricular dysrhythmia;ventricular dysrhythmia (finding)",chemdis,treat,1,treat,1,
341,(±)-flecainide,"beats; ectopia, ventricular",Encainide and flecainide are superior to quinidine for the control of ventricular ectopic beats and as effective as quinidine for patients with ventricular tachycardia.,"(±)-flecainide;benzamide, n-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)-;flecaine;flecainida;flecainide;flecainide (medication);flecainide (product);flecainide (substance);flecainide product;flecainide-containing product;flecainidum;flécanide;n-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide;product containing flecainide;product containing flecainide (medicinal product)","beats; ectopia, ventricular;contraction; premature, ventricular;ectopia; beats, ventricular;ectopia; ventricular beats;ectopic beat(s);ventricular;ectopic beat, ventricular;ectopic beats (ventricular);ectopic beats, ventricular;extra heart beat;extra ventricular systoles;extrasystole ventricular;extrasystole, ventricular;extrasystoles ventricular;extrasystoles; ventricular;premature depolarization ventricular;premature veb's;premature ventricular beat;premature ventricular beats;premature ventricular contraction;premature ventricular contraction (pvc);premature ventricular contractions;premature ventricular contractions (diagnosis);premature ventricular contractions, nos (pvcs) (vpcs);premature ventricular ectopic beats;premature; contraction, ventricular;premature; ventricular systole;pvc - premature ventricular complex;pvc - premature ventricular contraction;pvc's;systoles;ventricular (extra);vbp;veb's;ventric premature depolarisatn;ventricular beat premature;ventricular beat, premature;ventricular beats, premature;ventricular complex, premature;ventricular contraction, premature;ventricular contractions premature;ventricular contractions, premature;ventricular ectopic;ventricular ectopic activity;ventricular ectopic beat;ventricular ectopic beat(s);ventricular ectopic beats;ventricular ectopic beats (disorder);ventricular ectopic beats (finding);ventricular ectopic complex;ventricular ectopic complex (pvc);ventricular ectopic complex (pvc) [heart disease];ventricular ectopics;ventricular ectopy;ventricular extrasystole;ventricular extrasystoles;ventricular premature beat;ventricular premature beats;ventricular premature beats (disorder);ventricular premature complex (disorder);ventricular premature contractions;ventricular premature depolarisation;ventricular premature depolarization (diagnosis);ventricular premature systoles;ventricular; ectopic beats;ventricular; extrasystoles;ventricular; premature contraction;ventricular; premature systole;vpb;vpbs;vpc - ventricular premature complex;vpc - ventricular premature contraction;vpc's",chemdis,treat,1,treat,1,
342,(±)-flecainide,rapid and irregular heartbeat,"Flecainide is a class IC antiarrhythmic agent, used frequently in all age groups for the treatment of tachyarrhythmias.","(±)-flecainide;benzamide, n-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)-;flecaine;flecainida;flecainide;flecainide (medication);flecainide (product);flecainide (substance);flecainide product;flecainide-containing product;flecainidum;flécanide;n-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide;product containing flecainide;product containing flecainide (medicinal product)","rapid and irregular heartbeat;tachyarrhythmia;tachyarrhythmia (disorder);tachyarrhythmia, nos;tachyarrhythmias;tachyrhythmia",chemdis,treat,1,treat,1,
343,(±)-flecainide,ventricular tachycardia,Encainide and flecainide are superior to quinidine for the control of ventricular ectopic beats and as effective as quinidine for patients with ventricular tachycardia.,"(±)-flecainide;benzamide, n-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)-;flecaine;flecainida;flecainide;flecainide (medication);flecainide (product);flecainide (substance);flecainide product;flecainide-containing product;flecainidum;flécanide;n-(2-piperidinylmethyl)-2,5-bis(2,2,2-trifluoroethoxy)benzamide;product containing flecainide;product containing flecainide (medicinal product)",ventricular tachycardia,chemdis,treat,1,treat,1,
345,.alpha.-linolenic acid,3-10 heart diseases: general terms,"Extensive research has shown that increased consumption of long-chain omega-3 polyunsaturated fatty acids (n-3 LCPUFAs), namely α-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), may lower the risk of chronic diseases, such as heart disease, cancer, and arthritis.",".alpha.-linolenic acid;9,12,15-octadecatrienoic acid, (z,z,z)-;acid alpha linolenic;acids alpha linolenic;alpha linolenic acid;alpha-linolenic acid;fatty acid cis, cis, cis 18:3 n-3;α-linolenic acid","3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",chemdis,treat,1,treat,1,
346,.alpha.-linolenic acid,abnormal heart rhythms,"In a meta-analysis of 13 studies using rat models, fish oil but not alpha-linolenic acid supplementation showed a significant protective effect for ischemia- and reperfusion-induced arrhythmias by reducing the incidence of VT and VF.",".alpha.-linolenic acid;9,12,15-octadecatrienoic acid, (z,z,z)-;acid alpha linolenic;acids alpha linolenic;alpha linolenic acid;alpha-linolenic acid;fatty acid cis, cis, cis 18:3 n-3;α-linolenic acid","abnormal heart rhythms;arrhythmia (cardiac) nos;arrhythmia (finding);arrhythmia (nos);arrhythmia cardiac (nos);arrhythmia nos;arrhythmia, cardiac;arrhythmia, nos;arrhythmias;arrhythmias (heart);arrhythmias, cardiac;arrythmia;cardiac arrhythmia (disorder);cardiac arrhythmia (nos);cardiac arrhythmia nos;cardiac arrhythmia, irregular pulse;cardiac arrhythmia, nos;cardiac arrhythmia, unspecified;cardiac arrhythmias;cardiac dysrhythmia (disorder);cardiac dysrhythmia nos;cardiac dysrhythmia nos (disorder);cardiac dysrhythmia, nos;cardiac dysrhythmia, unspecified;cardiac dysrhythmias nos;cardiac rhythm disorder (diagnosis);cardiac rhythm disturbance;cardiac rhythm disturbances;cardiac rhythm irregular;cardiac rhythm, abnormal;cardiac; dysrhythmia;disorder of heart rhythm;disorder; rhythm, heart;disturbance; rhythm, heart;dysrhythmia;dysrhythmia(s);dysrhythmia, cardiac;dysrhythmia; cardiac;dysrhythmia;cardiac;dysrhythmias;ectopic beats all types;heart arrhythmia;heart arrhythmias;heart rhythm disorders;heart: rhythm;rhythm, heart; abnormal;rhythm; abnormal;rhythm; disorder",chemdis,treat,1,treat,0,
347,.alpha.-linolenic acid,arrhythmia,Experimental studies in laboratory animals and humans suggest that alpha-linolenic acid (18:3n-3) may reduce the risk of arrhythmia.,".alpha.-linolenic acid;9,12,15-octadecatrienoic acid, (z,z,z)-;acid alpha linolenic;acids alpha linolenic;alpha linolenic acid;alpha-linolenic acid;fatty acid cis, cis, cis 18:3 n-3;α-linolenic acid",arrhythmia,chemdis,treat,1,treat,1,
348,.alpha.-linolenic acid,arrhythmia ventricular,"We tested the hypothesis that in these patients an increased intake of the n-3 fatty acids eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and α-linolenic acid (ALA) will reduce the incidence of ventricular arrhythmias and fatal MI.",".alpha.-linolenic acid;9,12,15-octadecatrienoic acid, (z,z,z)-;acid alpha linolenic;acids alpha linolenic;alpha linolenic acid;alpha-linolenic acid;fatty acid cis, cis, cis 18:3 n-3;α-linolenic acid","arrhythmia ventricular;arrhythmia ventricular (nos);arrhythmia, ventricular;arrhythmias ventricular;dysrhythmias ventricular;ventricular arrhythmia (diagnosis);ventricular arrhythmia (disorder);ventricular arrhythmia, nos;ventricular arrhythmias;ventricular dysrhythmia;ventricular dysrhythmia (finding)",chemdis,treat,1,treat,0,
349,.alpha.-linolenic acid,arthritis,"Extensive research has shown that increased consumption of long-chain omega-3 polyunsaturated fatty acids (n-3 LCPUFAs), namely α-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), may lower the risk of chronic diseases, such as heart disease, cancer, and arthritis.",".alpha.-linolenic acid;9,12,15-octadecatrienoic acid, (z,z,z)-;acid alpha linolenic;acids alpha linolenic;alpha linolenic acid;alpha-linolenic acid;fatty acid cis, cis, cis 18:3 n-3;α-linolenic acid",arthritis,chemdis,treat,1,treat,1,
350,.alpha.-linolenic acid,cancer,"Extensive research has shown that increased consumption of long-chain omega-3 polyunsaturated fatty acids (n-3 LCPUFAs), namely α-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), may lower the risk of chronic diseases, such as heart disease, cancer, and arthritis.",".alpha.-linolenic acid;9,12,15-octadecatrienoic acid, (z,z,z)-;acid alpha linolenic;acids alpha linolenic;alpha linolenic acid;alpha-linolenic acid;fatty acid cis, cis, cis 18:3 n-3;α-linolenic acid",cancer,chemdis,treat,1,treat,1,
351,.alpha.-linolenic acid,chronic dis,"Extensive research has shown that increased consumption of long-chain omega-3 polyunsaturated fatty acids (n-3 LCPUFAs), namely α-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA), may lower the risk of chronic diseases, such as heart disease, cancer, and arthritis.",".alpha.-linolenic acid;9,12,15-octadecatrienoic acid, (z,z,z)-;acid alpha linolenic;acids alpha linolenic;alpha linolenic acid;alpha-linolenic acid;fatty acid cis, cis, cis 18:3 n-3;α-linolenic acid","chronic dis;chronic disease;chronic disease (disorder);chronic disease, nos;chronic disease/disorder;chronic diseases;chronic disorder;chronic disorders;chronic illnesses;disease, chronic;diseases, chronic;illness, chronic;illnesses, chronic",chemdis,treat,1,treat,1,
352,.alpha.-linolenic acid,coronary heart disease,"Intake of the plant-derived ω-3 (n-3) fatty acid α-linolenic acid (ALA, 18:3; n-3) may reduce coronary heart disease (CHD) risk, but the results of previous studies have been inconsistent.___Although important roles of dietary n-3 fatty acids in the prevention of coronary heart disease (CHD) have been suggested, long-term effects of dietary alpha-linolenic acid (ALA, 18:3n-3) have not yet been established under controlled conditions.",".alpha.-linolenic acid;9,12,15-octadecatrienoic acid, (z,z,z)-;acid alpha linolenic;acids alpha linolenic;alpha linolenic acid;alpha-linolenic acid;fatty acid cis, cis, cis 18:3 n-3;α-linolenic acid",coronary heart disease,chemdis,treat,2,treat,1,
353,.alpha.-linolenic acid,"tachyarrhythmia, ventricular","In a meta-analysis of 13 studies using rat models, fish oil but not alpha-linolenic acid supplementation showed a significant protective effect for ischemia- and reperfusion-induced arrhythmias by reducing the incidence of VT and VF.",".alpha.-linolenic acid;9,12,15-octadecatrienoic acid, (z,z,z)-;acid alpha linolenic;acids alpha linolenic;alpha linolenic acid;alpha-linolenic acid;fatty acid cis, cis, cis 18:3 n-3;α-linolenic acid","tachyarrhythmia, ventricular;tachycardia - ventric.;tachycardia ventricular;tachycardia, ventricular;tachycardia; ventricular;tachycardia;ventricular;v tach;v.tach;ventricular tachyarrhythmia;ventricular tachyarrhythmia (disorder);ventricular tachyarrhythmias;ventricular tachycardia (diagnosis);ventricular tachycardia (disorder);ventricular tachycardia (v-tach);ventricular tachycardia (vtach);ventricular tachycardia, nos;ventricular tachycardias;ventricular techycardia;ventricular; tachycardia;vt;vt - ventricular tachycardia",chemdis,treat,1,treat,0,
355,11-deoxycorticosterone acetate,cardiac fibrosis,"Thus, inhibition of the renin-angiotensin system reverses cardiac fibrosis in DOCA-salt rats and returns some indices of myocardial function to normal.","11-deoxycorticosterone acetate;acetate, desoxycortone;deoxycorticosterone 21 acetate;deoxycorticosterone acetate;deoxycorticosterone-21-acetate;desoxycorticosterone 21 acetate;desoxycorticosterone acetate;desoxycorticosterone acetate (doca);desoxycorticosterone acetate (medication);desoxycorticosterone acetate (substance);desoxycorticosterone-21-acetate;desoxycortone acetate;doc 21 acetate;doc-21-acetate;doca",cardiac fibrosis;cardiac; fibrosis;fibrosis; cardiac;fibrosis; heart;heart; fibrosis,chemdis,treat,1,treat,,
356,11-deoxycorticosterone acetate,hypertension,ET-A receptor antagonism both reverses and prevents the cardiac and vascular remodelling in DOCA-salt hypertension and improves cardiovascular function.,"11-deoxycorticosterone acetate;acetate, desoxycortone;deoxycorticosterone 21 acetate;deoxycorticosterone acetate;deoxycorticosterone-21-acetate;desoxycorticosterone 21 acetate;desoxycorticosterone acetate;desoxycorticosterone acetate (doca);desoxycorticosterone acetate (medication);desoxycorticosterone acetate (substance);desoxycorticosterone-21-acetate;desoxycortone acetate;doc 21 acetate;doc-21-acetate;doca",hypertension,chemdis,treat,1,treat,,
357,11-deoxycorticosterone acetate,hypertensive,These findings suggest that treatment with manidipine in DOCA/salt hypertensive rats lowered high blood pressure and improved impaired coronary circulation with a reduction in left ventricular and vascular hypertrophy.,"11-deoxycorticosterone acetate;acetate, desoxycortone;deoxycorticosterone 21 acetate;deoxycorticosterone acetate;deoxycorticosterone-21-acetate;desoxycorticosterone 21 acetate;desoxycorticosterone acetate;desoxycorticosterone acetate (doca);desoxycorticosterone acetate (medication);desoxycorticosterone acetate (substance);desoxycorticosterone-21-acetate;desoxycortone acetate;doc 21 acetate;doc-21-acetate;doca",hypertensive;hypertensive (finding);with high blood pressure,chemdis,treat,1,treat,,
358,619-61c carbohydrates,3-10 heart diseases: general terms,"High-protein, low-carbohydrate diets have been found to have positive effects on reducing risk factors for heart disease, including reducing serum triacylglycerol, increasing HDL cholesterol, increasing LDL particle size, and reducing blood pressure.","619-61c carbohydrates;carbohydrate;carbohydrate (substance);carbohydrate agent;carbohydrate agent (substance);carbohydrate product;carbohydrate product (product);carbohydrate product (substance);carbohydrate, nos;carbohydrate-containing product;carbohydrates (medication);carbs;product containing carbohydrate;product containing carbohydrate (product);saccharide;saccharides","3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",chemdis,treat,1,treat,,
360,619-61c carbohydrates,cardiomyopathy,"These findings show that synthetic ketone bodies as well as low-carbohydrate, high-lipid, and high-protein diet may be a more beneficial therapeutic choice therapeutic choice for GSD III patients with cardiomyopathy.","619-61c carbohydrates;carbohydrate;carbohydrate (substance);carbohydrate agent;carbohydrate agent (substance);carbohydrate product;carbohydrate product (product);carbohydrate product (substance);carbohydrate, nos;carbohydrate-containing product;carbohydrates (medication);carbs;product containing carbohydrate;product containing carbohydrate (product);saccharide;saccharides",cardiomyopathy,chemdis,treat,1,treat,0,
361,619-61c carbohydrates,"cardiovascular syndrome, metabolic",Dietary carbohydrate restriction in the treatment of diabetes and metabolic syndrome is based on an underlying principle of control of insulin secretion and the theory that insulin resistance is a response to chronic hyperglycemia and hyperinsulinemia.,"619-61c carbohydrates;carbohydrate;carbohydrate (substance);carbohydrate agent;carbohydrate agent (substance);carbohydrate product;carbohydrate product (product);carbohydrate product (substance);carbohydrate, nos;carbohydrate-containing product;carbohydrates (medication);carbs;product containing carbohydrate;product containing carbohydrate (product);saccharide;saccharides","cardiovascular syndrome, metabolic;cardiovascular syndromes, metabolic;dysmetabolic syndrome x;dysmetabolic syndrome x (diagnosis);equine metabolic syndrome;insulin resistance syndrome x;metabolic cardiovascular syndrome;metabolic syndrome;metabolic syndrome x;metabolic syndrome x (disorder);metabolic syndromes;metabolic x syndrome;reaven syndrome x;reaven's syndrome;syndrome metabolic;syndrome x (metabolic);syndrome x insulin resistance;syndrome x, dysmetabolic;syndrome x, insulin resistance;syndrome x, metabolic;syndrome x, reaven;syndrome, metabolic;syndrome, metabolic cardiovascular;syndrome, metabolic x;syndromes, metabolic;x syndrome, metabolic",chemdis,treat,1,treat,,
362,619-61c carbohydrates,coronary artery disease,"High-carbohydrate, high-fiber diets combined with regular exercise and healthy life-style hold great potential to reduce hyperlipidemia and the incidence of coronary artery disease in the United States.","619-61c carbohydrates;carbohydrate;carbohydrate (substance);carbohydrate agent;carbohydrate agent (substance);carbohydrate product;carbohydrate product (product);carbohydrate product (substance);carbohydrate, nos;carbohydrate-containing product;carbohydrates (medication);carbs;product containing carbohydrate;product containing carbohydrate (product);saccharide;saccharides",coronary artery disease;coronary artery diseases,chemdis,treat,1,treat,1,
363,619-61c carbohydrates,coronary heart disease,"OmniHeart demonstrated that partial replacement of carbohydrate with either protein (about half from plant sources) or with unsaturated fat (mostly monounsaturated fat) can further reduce blood pressure, low-density lipoprotein cholesterol, and coronary heart disease risk.___High-carbohydrate (HC) diets are recommended for lowering the risk of coronary heart disease because they decrease plasma LDL-cholesterol concentrations.___Low-fat, high-carbohydrate diets have been used successfully to prevent and treat coronary heart disease, although these diets have been shown to cause elevations in fasting plasma triglyceride concentrations.","619-61c carbohydrates;carbohydrate;carbohydrate (substance);carbohydrate agent;carbohydrate agent (substance);carbohydrate product;carbohydrate product (product);carbohydrate product (substance);carbohydrate, nos;carbohydrate-containing product;carbohydrates (medication);carbs;product containing carbohydrate;product containing carbohydrate (product);saccharide;saccharides",coronary heart disease,chemdis,treat,3,treat,1,
365,619-61c carbohydrates,dehydration,"Fluid replacement reduces the risk of heat illness and improves exercise performance by preventing or reducing dehydration and by providing a convenient means of ingesting carbohydrate.___Carbohydrate ingestion also improves exercise performance, an effect that is independent of and additive to preventing dehydration.","619-61c carbohydrates;carbohydrate;carbohydrate (substance);carbohydrate agent;carbohydrate agent (substance);carbohydrate product;carbohydrate product (product);carbohydrate product (substance);carbohydrate, nos;carbohydrate-containing product;carbohydrates (medication);carbs;product containing carbohydrate;product containing carbohydrate (product);saccharide;saccharides",dehydration,chemdis,treat,2,treat,1,
366,619-61c carbohydrates,diabetes,Dietary carbohydrate restriction in the treatment of diabetes and metabolic syndrome is based on an underlying principle of control of insulin secretion and the theory that insulin resistance is a response to chronic hyperglycemia and hyperinsulinemia.,"619-61c carbohydrates;carbohydrate;carbohydrate (substance);carbohydrate agent;carbohydrate agent (substance);carbohydrate product;carbohydrate product (product);carbohydrate product (substance);carbohydrate, nos;carbohydrate-containing product;carbohydrates (medication);carbs;product containing carbohydrate;product containing carbohydrate (product);saccharide;saccharides",diabetes,chemdis,treat,1,treat,,
367,619-61c carbohydrates,hyperglycemia,Dietary carbohydrate restriction in the treatment of diabetes and metabolic syndrome is based on an underlying principle of control of insulin secretion and the theory that insulin resistance is a response to chronic hyperglycemia and hyperinsulinemia.,"619-61c carbohydrates;carbohydrate;carbohydrate (substance);carbohydrate agent;carbohydrate agent (substance);carbohydrate product;carbohydrate product (product);carbohydrate product (substance);carbohydrate, nos;carbohydrate-containing product;carbohydrates (medication);carbs;product containing carbohydrate;product containing carbohydrate (product);saccharide;saccharides",hyperglycemia,chemdis,treat,1,treat,,
368,619-61c carbohydrates,hyperinsulinemia,Dietary carbohydrate restriction in the treatment of diabetes and metabolic syndrome is based on an underlying principle of control of insulin secretion and the theory that insulin resistance is a response to chronic hyperglycemia and hyperinsulinemia.,"619-61c carbohydrates;carbohydrate;carbohydrate (substance);carbohydrate agent;carbohydrate agent (substance);carbohydrate product;carbohydrate product (product);carbohydrate product (substance);carbohydrate, nos;carbohydrate-containing product;carbohydrates (medication);carbs;product containing carbohydrate;product containing carbohydrate (product);saccharide;saccharides",hyperinsulinemia;hyperinsulinism;increased insulin level,chemdis,treat,1,treat,,
369,619-61c carbohydrates,hyperlipidemia,"High-carbohydrate, high-fiber diets combined with regular exercise and healthy life-style hold great potential to reduce hyperlipidemia and the incidence of coronary artery disease in the United States.","619-61c carbohydrates;carbohydrate;carbohydrate (substance);carbohydrate agent;carbohydrate agent (substance);carbohydrate product;carbohydrate product (product);carbohydrate product (substance);carbohydrate, nos;carbohydrate-containing product;carbohydrates (medication);carbs;product containing carbohydrate;product containing carbohydrate (product);saccharide;saccharides",hyperlipidemia,chemdis,treat,1,treat,1,
370,619-61c carbohydrates,weight loss,"Its predicted effectiveness was based largely on the hypothesis that insulin is the causa prima of weight gain and regain via hyperphagia and hypometabolism during and after weight reduction, and therefore reduced carbohydrate intake would promote and sustain weight loss.___The high-protein, low-carbohydrate diet is effective for weight loss over the short term, but its long-term benefits remain unproved.___Short-term studies of high-protein, low-carbohydrate diets have shown weight loss and improvements in plasma lipid profiles.","619-61c carbohydrates;carbohydrate;carbohydrate (substance);carbohydrate agent;carbohydrate agent (substance);carbohydrate product;carbohydrate product (product);carbohydrate product (substance);carbohydrate, nos;carbohydrate-containing product;carbohydrates (medication);carbs;product containing carbohydrate;product containing carbohydrate (product);saccharide;saccharides",weight loss,chemdis,treat,3,treat,0,
372,a09 estrogenic preparations,3-81-82 diseases of the arteries,"In the primary prevention of arterial disease, there may be a role for anti-oxidant vitamins and for oestrogen replacement therapy in postmenopausal women.","a09 estrogenic preparations;agents, estrogenic;agonists, estrogen receptor;compounds, estrogenic;estrogen (substance);estrogen preparation;estrogen preparation, nos;estrogen product;estrogen products;estrogen receptor agonist;estrogen receptor agonist-containing product;estrogen receptor agonists;estrogen substance;estrogen, nos;estrogen-containing product;estrogenic agents;estrogenic compounds;estrogenic drug;estrogenic drug, nos;estrogenic preparation;estrogenic preparation (product);estrogenic preparation (substance);estrogenic preparations;estrogens (medication);estrogens (product);estrogens (substance);oestrogen;oestrogen preparation, nos;oestrogen product;oestrogen products;oestrogen, nos;oestrogenic drug;oestrogenic drug, nos;oestrogenic preparation;oestrogens;product containing estrogen;product containing estrogen (product);product containing estrogen receptor agonist (product);product containing oestrogen;receptor agonists, estrogen;substance with estrogen receptor agonist mechanism of action (substance);therapeutic estrogen","3-81-82 diseases of the arteries;arterial disease;arterial disease (disorder);arterial diseases;arterial disorder;arterial disorder nos;arterial disorders;arterial vascular disease;arteriopath;arteriopathic disease;arteriopathy;artery disease;artery diseases;artery disorder;artery disorders;artery; disorder;disease (or disorder); artery;disease of arteries, arterioles and capillaries;disease of artery;disease of artery (disorder);disease of artery [ambiguous];disease of artery, nos;diseases of the arteries;disorder of artery;disorder of artery (disorder);disorder of artery [ambiguous];disorder of artery, nos;generalised arterial disease;generalized arterial disease;vascular arterial disease",chemdis,treat,1,treat,,
373,acid fatty polyunsaturated,3-00 cardiovascular disorders: general terms,"Consumption of polyunsaturated fatty acids (PUFA), especially the n3-series, may protect against cardiovascular disease (CVD), but recent randomized studies have failed to demonstrate these benefits.___Increased consumption of omega-3 polyunsaturated fatty acids (PUFA) together with lifestyle measures and medications is recommended for the prevention of cardiovascular diseases.___Omega-6 polyunsaturated fatty acids (n-6 PUFA) are well known for their critical role in many physiological functions and reduce risks of cardiovascular disease (CVD).","acid fatty polyunsaturated;acid, polyunsaturated fatty;acids fatty polyunsaturated;acids, polyunsaturated fatty;fatty acid, polyunsaturated;fatty acid, total polyunsaturated;fatty acids, polyunsaturated;fatty acids.polyunsaturated;polyunsaturated fatty acid;polyunsaturated fatty acid (substance);polyunsaturated fatty acids;pufa;pufa (polyunsaturated fatty acid);pufa - polyunsat fatty acid;pufa - polyunsaturated fatty acid;pufas","3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,treat,3,treat,1,
374,acid fatty polyunsaturated,3-10 heart diseases: general terms,The UK dietary guidelines for cardiovascular disease acknowledge the importance of long-chain omega-3 polyunsaturated fatty acids (PUFA) - a component of fish oils - in reducing heart disease risk.,"acid fatty polyunsaturated;acid, polyunsaturated fatty;acids fatty polyunsaturated;acids, polyunsaturated fatty;fatty acid, polyunsaturated;fatty acid, total polyunsaturated;fatty acids, polyunsaturated;fatty acids.polyunsaturated;polyunsaturated fatty acid;polyunsaturated fatty acid (substance);polyunsaturated fatty acids;pufa;pufa (polyunsaturated fatty acid);pufa - polyunsat fatty acid;pufa - polyunsaturated fatty acid;pufas","3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",chemdis,treat,1,treat,1,
375,acid fatty polyunsaturated,arrhythmia,"Also, PUFA and vitamin C might be able to significantly decrease the incidence of arrhythmia; however, reno-protective effects and impact on overall mortality of these supplements seem to be less impressive.","acid fatty polyunsaturated;acid, polyunsaturated fatty;acids fatty polyunsaturated;acids, polyunsaturated fatty;fatty acid, polyunsaturated;fatty acid, total polyunsaturated;fatty acids, polyunsaturated;fatty acids.polyunsaturated;polyunsaturated fatty acid;polyunsaturated fatty acid (substance);polyunsaturated fatty acids;pufa;pufa (polyunsaturated fatty acid);pufa - polyunsat fatty acid;pufa - polyunsaturated fatty acid;pufas",arrhythmia,chemdis,treat,1,treat,1,
376,acid fatty polyunsaturated,arrhythmic,"Marine n-3 PUFA have a number of anti-atherosclerotic effects, including anti-arrhythmic properties and, at relatively high doses, reduce serum triglycerides.","acid fatty polyunsaturated;acid, polyunsaturated fatty;acids fatty polyunsaturated;acids, polyunsaturated fatty;fatty acid, polyunsaturated;fatty acid, total polyunsaturated;fatty acids, polyunsaturated;fatty acids.polyunsaturated;polyunsaturated fatty acid;polyunsaturated fatty acid (substance);polyunsaturated fatty acids;pufa;pufa (polyunsaturated fatty acid);pufa - polyunsat fatty acid;pufa - polyunsaturated fatty acid;pufas",arrhythmic,chemdis,treat,1,treat,1,
377,acid fatty polyunsaturated,arterial stiffness,"The positive influence of PUFAs might be via lowering arterial stiffness, resulting in a better CVD risk profile","acid fatty polyunsaturated;acid, polyunsaturated fatty;acids fatty polyunsaturated;acids, polyunsaturated fatty;fatty acid, polyunsaturated;fatty acid, total polyunsaturated;fatty acids, polyunsaturated;fatty acids.polyunsaturated;polyunsaturated fatty acid;polyunsaturated fatty acid (substance);polyunsaturated fatty acids;pufa;pufa (polyunsaturated fatty acid);pufa - polyunsat fatty acid;pufa - polyunsaturated fatty acid;pufas","arterial stiffness;arterial stiffnesses;stiffness, arterial",chemdis,treat,1,treat,1,
378,acid fatty polyunsaturated,atrial fibrillation,Prophylactic supplementation with omega-3 polyunsaturated fatty acids (PUFAs) reduce vulnerability to atrial fibrillation (AF).,"acid fatty polyunsaturated;acid, polyunsaturated fatty;acids fatty polyunsaturated;acids, polyunsaturated fatty;fatty acid, polyunsaturated;fatty acid, total polyunsaturated;fatty acids, polyunsaturated;fatty acids.polyunsaturated;polyunsaturated fatty acid;polyunsaturated fatty acid (substance);polyunsaturated fatty acids;pufa;pufa (polyunsaturated fatty acid);pufa - polyunsat fatty acid;pufa - polyunsaturated fatty acid;pufas",atrial fibrillation,chemdis,treat,1,treat,1,
379,acid fatty polyunsaturated,cardiac hypertrophies,"The enrichment of myocardial membranes with n-3 PUFA also reduces vulnerability to cardiac arrhythmias, particularly ventricular fibrillation during myocardial ischaemia and reperfusion, and attenuates heart failure and cardiac hypertrophy.","acid fatty polyunsaturated;acid, polyunsaturated fatty;acids fatty polyunsaturated;acids, polyunsaturated fatty;fatty acid, polyunsaturated;fatty acid, total polyunsaturated;fatty acids, polyunsaturated;fatty acids.polyunsaturated;polyunsaturated fatty acid;polyunsaturated fatty acid (substance);polyunsaturated fatty acids;pufa;pufa (polyunsaturated fatty acid);pufa - polyunsat fatty acid;pufa - polyunsaturated fatty acid;pufas","cardiac hypertrophies;cardiac hypertrophy;cardiac hypertrophy nos;cardiac hypertrophy nos (disorder);cardiac; hypertrophy;heart hypertrophies;heart hypertrophy;heart--hypertrophy;heart; hypertrophy;hypertrophic heart;hypertrophic;heart;hypertrophies, cardiac;hypertrophies, heart;hypertrophy, cardiac;hypertrophy, heart;hypertrophy; cardiac;hypertrophy; heart",chemdis,treat,1,treat,1,
380,acid fatty polyunsaturated,cardiac ischaemia,"Polyunsaturated fatty acids (PUFA), in the form of marine oils, contain a large proportion of n-3 long chain fatty acids and have been recommended as a dietary supplement for patients with ischaemic heart disease.","acid fatty polyunsaturated;acid, polyunsaturated fatty;acids fatty polyunsaturated;acids, polyunsaturated fatty;fatty acid, polyunsaturated;fatty acid, total polyunsaturated;fatty acids, polyunsaturated;fatty acids.polyunsaturated;polyunsaturated fatty acid;polyunsaturated fatty acid (substance);polyunsaturated fatty acids;pufa;pufa (polyunsaturated fatty acid);pufa - polyunsat fatty acid;pufa - polyunsaturated fatty acid;pufas",cardiac ischaemia;cardiac ischemia;ischaemic heart disease;myocardial ischaemia;myocardial ischemia,chemdis,treat,1,treat,1,
381,acid fatty polyunsaturated,cognitive decline,Fish intake and the long-chain omega-3 polyunsaturated fatty acids (PUFAs) in fish have been suggested to lower the risk of cognitive decline.,"acid fatty polyunsaturated;acid, polyunsaturated fatty;acids fatty polyunsaturated;acids, polyunsaturated fatty;fatty acid, polyunsaturated;fatty acid, total polyunsaturated;fatty acids, polyunsaturated;fatty acids.polyunsaturated;polyunsaturated fatty acid;polyunsaturated fatty acid (substance);polyunsaturated fatty acids;pufa;pufa (polyunsaturated fatty acid);pufa - polyunsat fatty acid;pufa - polyunsaturated fatty acid;pufas",cognitive decline,chemdis,treat,1,treat,1,
382,acid fatty polyunsaturated,coronary heart disease,"Evidence from appropriately designed and vigorously executed randomized controlled trials support that high-PUFA (predominantly linoleic acid) and low-SFA diets, compared to high-SFA diets, reduced the risk of coronary heart disease.___Multiple trials over the past two decades testing omega-3 polyunsaturated fatty acids (PUFAs), containing eicosapentaenoic acid (EPA) and or docosahexaenoic acid (DHA), have shown substantial benefits for reducing major coronary heart disease (CHD) events, all-cause mortality, cardiovascular (CV) death, sudden cardiac death (SCD), and stroke.___Dietary n-3 polyunsaturated fatty acids (PUFA) reduce coronary heart disease (CHD) complications, such as chronic arrhythmia and sudden cardiac death.___Consumption of polyunsaturated fatty acids (PUFAs) may reduce coronary heart disease (CHD) risk, but n-6 PUFAs may compete with n-3 PUFA metabolism and attenuate benefits.___2006, 296:1885-99) have made a strong case for the beneficial effects of PUFAs in reducing the risk of coronary heart disease, but at the same time, have also broadly discounted the increased risks of coronary heart disease posed by MeHg in fish, stating that ""... among adults... the benefits of fish intake exceed the potential risks.","acid fatty polyunsaturated;acid, polyunsaturated fatty;acids fatty polyunsaturated;acids, polyunsaturated fatty;fatty acid, polyunsaturated;fatty acid, total polyunsaturated;fatty acids, polyunsaturated;fatty acids.polyunsaturated;polyunsaturated fatty acid;polyunsaturated fatty acid (substance);polyunsaturated fatty acids;pufa;pufa (polyunsaturated fatty acid);pufa - polyunsat fatty acid;pufa - polyunsaturated fatty acid;pufas",coronary heart disease,chemdis,treat,5,treat,1,
383,acid fatty polyunsaturated,"damage, reperfusion",We hypothesized that a specific dietary fatty acid profile (low in saturated and n-6 PUFA but high in plant and marine n-3 PUFA) may improve myocardial resistance to ischemia-reperfusion injury and reduce infarct size.,"acid fatty polyunsaturated;acid, polyunsaturated fatty;acids fatty polyunsaturated;acids, polyunsaturated fatty;fatty acid, polyunsaturated;fatty acid, total polyunsaturated;fatty acids, polyunsaturated;fatty acids.polyunsaturated;polyunsaturated fatty acid;polyunsaturated fatty acid (substance);polyunsaturated fatty acids;pufa;pufa (polyunsaturated fatty acid);pufa - polyunsat fatty acid;pufa - polyunsaturated fatty acid;pufas","damage, reperfusion;damages, reperfusion;inj ischemia reperfusion;inj reperfusion;injuries, ischemia-reperfusion;injuries, reperfusion;injury reperfusion;injury, ischemia reperfusion;injury, ischemia-reperfusion;injury, reperfusion;ischaemia-reperfusion injury;ischemia reperfusion inj;ischemia reperfusion injury;ischemia-reperfusion injuries;ischemia-reperfusion injury;ischemia-reperfusion injury (morphologic abnormality);reperfusion damage;reperfusion damages;reperfusion inj;reperfusion injuries;reperfusion injury",chemdis,treat,1,treat,0,
384,acid fatty polyunsaturated,degenerative disease,"The role at omega-3 polyunsaturated fatty acids (PUFA), especially eicosa pentanoic acid (EPA) and decosahexaconic (DHA), has been associated with the prevention of degenerative disease.","acid fatty polyunsaturated;acid, polyunsaturated fatty;acids fatty polyunsaturated;acids, polyunsaturated fatty;fatty acid, polyunsaturated;fatty acid, total polyunsaturated;fatty acids, polyunsaturated;fatty acids.polyunsaturated;polyunsaturated fatty acid;polyunsaturated fatty acid (substance);polyunsaturated fatty acids;pufa;pufa (polyunsaturated fatty acid);pufa - polyunsat fatty acid;pufa - polyunsaturated fatty acid;pufas",degenerative disease;degenerative disorder;degenerative disorder (diagnosis);degenerative disorder (disorder);degenerative disorders,chemdis,treat,1,treat,1,
389,acid fatty polyunsaturated,ischemic heart disease,"There is evidence that replacing saturated fat (SFA) with polyunsaturated fat (PUFA) lowers ischemic heart disease (IHD).___In regards to studies examined in this narrative review, recommendation for n-6 PUFA intake above 5%, and ideally about 10% of total energy appears justified for the prevention of ischemic heart disease.","acid fatty polyunsaturated;acid, polyunsaturated fatty;acids fatty polyunsaturated;acids, polyunsaturated fatty;fatty acid, polyunsaturated;fatty acid, total polyunsaturated;fatty acids, polyunsaturated;fatty acids.polyunsaturated;polyunsaturated fatty acid;polyunsaturated fatty acid (substance);polyunsaturated fatty acids;pufa;pufa (polyunsaturated fatty acid);pufa - polyunsat fatty acid;pufa - polyunsaturated fatty acid;pufas",ischemic heart disease,chemdis,treat,2,treat,1,
390,"acid, monounsaturated fatty",3-00 cardiovascular disorders: general terms,"Caryocar brasiliense (pequi) oil is high in monounsaturated fat acids (MUFA), especially oleic, and in carotenoids, which have been associated with protection against cardiovascular disease.","acid, monounsaturated fatty;acids, monounsaturated fatty;fatty acid, monounsaturated;fatty acid, total monounsaturated;fatty acids, monounsaturated;fatty acids.monounsaturated;monounsaturated fatty acid;monounsaturated fatty acid (substance);monounsaturated fatty acids;mufa;mufa - monounsat fatty acid;mufa - monounsaturated fatty acid","3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,treat,1,treat,1,
391,"acid, monounsaturated fatty",coronary heart disease,"Evidence is accumulating that diets low in saturated fatty acids and high in monounsaturated fatty acids are effective in controlling blood lipid levels; a likely consequence could be a beneficial effect on the risk of coronary heart disease.___It is concluded that the significantly longer lag phase for oxidation of LDL, the higher HDL cholesterol level and the lower triacylglycerol level in subjects following a carotenoid-controlled, MUFA-enriched diet may decrease the risk of coronary heart disease.","acid, monounsaturated fatty;acids, monounsaturated fatty;fatty acid, monounsaturated;fatty acid, total monounsaturated;fatty acids, monounsaturated;fatty acids.monounsaturated;monounsaturated fatty acid;monounsaturated fatty acid (substance);monounsaturated fatty acids;mufa;mufa - monounsat fatty acid;mufa - monounsaturated fatty acid",coronary heart disease,chemdis,treat,2,treat,0,
392,"acid, monounsaturated fatty",inflamm,"There are persuasive evidences that dietary substitution of monounsaturated fatty acids (MUFA) or n-6 polyunsaturated fatty acids (PUFA) for SFA lowers blood cholesterol and may have beneficial effects on inflammation, thrombosis, and vascular reactivity.","acid, monounsaturated fatty;acids, monounsaturated fatty;fatty acid, monounsaturated;fatty acid, total monounsaturated;fatty acids, monounsaturated;fatty acids.monounsaturated;monounsaturated fatty acid;monounsaturated fatty acid (substance);monounsaturated fatty acids;mufa;mufa - monounsat fatty acid;mufa - monounsaturated fatty acid","inflamm;inflammation;inflammation (morphologic abnormality);inflammation (qualifier value);inflammation nos;inflammation, nos;inflammations;inflammatory reaction;inflammatory reaction, nos",chemdis,treat,1,treat,0,
393,"acid, monounsaturated fatty",thrombosis,"There are persuasive evidences that dietary substitution of monounsaturated fatty acids (MUFA) or n-6 polyunsaturated fatty acids (PUFA) for SFA lowers blood cholesterol and may have beneficial effects on inflammation, thrombosis, and vascular reactivity.","acid, monounsaturated fatty;acids, monounsaturated fatty;fatty acid, monounsaturated;fatty acid, total monounsaturated;fatty acids, monounsaturated;fatty acids.monounsaturated;monounsaturated fatty acid;monounsaturated fatty acid (substance);monounsaturated fatty acids;mufa;mufa - monounsat fatty acid;mufa - monounsaturated fatty acid",thrombosis,chemdis,treat,1,treat,0,
394,"acid, n-3 fatty",(neoplasms) or (cancers),"Epidemiological studies and animal experiments indicate that n-3 fatty acids exert protective effects against some common cancers, especially cancers of the breast, colon and prostate.","acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids","(neoplasms) or (cancers);(neoplasms) or (cancers) (disorder);[x]mal neo w'out specfctn/site;[x]malignant neoplasm without specification of site;[x]malignant neoplasm without specification of site (disorder);^cancer;ca;ca - cancer;ca - unspecified site;ca - unspecified site nos;ca - unspecified site nos (disorder);cancer (diagnosis);cancer (nos);cancer nos;cancer, nos;cancer, unspecified site;cancers;mal neo w'out specfctn/site;malig neop of unspec site;malig neop of unspec site nos;malignancies;malignancy nos;malignancy, unspecified site;malignant growth;malignant neoplasm (diagnosis);malignant neoplasm of unspecified site;malignant neoplasm of unspecified site (disorder);malignant neoplasm of unspecified site nos;malignant neoplasm of unspecified site nos (disorder);malignant neoplasm without specification of site;malignant neoplastic disease;malignant neoplastic disease (disorder);malignant tumor;malignant tumor (disorder);malignant tumoral disease;malignant tumors;malignant tumour;malignant tumour (disorder);malignant tumours;neoplasm malignant;neoplasm/cancer;neoplasms - malignant;neoplasms, malignant;neoplastic disease, malignant;tumor; malignant, unclassified;tumor; unclassified, malignant",chemdis,treat,1,treat,1,
395,"acid, n-3 fatty",3-00 cardiovascular disorders: general terms,"Epidemiologic data suggest that omega-3 fatty acids derived from fish oil reduce cardiovascular disease.___Cardioceuticals are nutritional supplements that contain all the essential nutrients including vitamins, minerals, omega-3-fatty acids and other antioxidants like a-lipoic acid and coenzyme Q10 in the right proportion that provide all round protection to the heart by reducing the most common risks associated with the cardiovascular disease including high low-density lipoprotein cholesterol and triglyceride levels and factors that contribute to coagulation of blood.___Results from prospective cohort studies and randomized, controlled trials have provided evidence of a protective effect of n-3 fatty acids against cardiovascular diseases.___Omega-3 fatty acids are increasingly used for the protection of cardiovascular disease.___Data supporting the efficacy of omega-3 fatty acids in the prevention of cardiovascular disease have been inconsistent and controversial.___Increased consumption of omega-3 polyunsaturated fatty acids (PUFA) together with lifestyle measures and medications is recommended for the prevention of cardiovascular diseases.___Consumption of active food ingredients such as omega-3 polyunsaturated fatty acids, flavanols and phytosterols has many beneficial effects on cardiovascular disease.___The results support the view that Lp-PLA(2) may relate to CAD and that intake of marine n-3 fatty acids might reduce plasma Lp-PLA(2) suggesting another mechanism by which n-3 fatty acids could reduce the risk of cardiovascular disease.___Results of epidemiologic studies and clinical trials indicate that moderate doses of n-3 fatty acids reduce the risk of cardiovascular disease and may improve prognosis.___We found that omega-3 fatty acids have shown to significantly reduce coronary mortality and sudden death in people without prior cardiovascular disease and reduce all-cause death and cardiac mortality in secondary prevention studies.","acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids","3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,treat,10,treat,1,
396,"acid, n-3 fatty",3-10 heart diseases: general terms,"Supplementation of nutrients such as taurine, carnitine, coenzyme Q10, and omega-3 polyunsaturated fatty acids may have benefits in dogs or cats with cardiac disease through a number of different mechanisms.___There is a large body of evidence supporting beneficial effects of omega-3 fatty acids for both primary and secondary prevention of cardiac disease in people.___The UK dietary guidelines for cardiovascular disease acknowledge the importance of long-chain omega-3 polyunsaturated fatty acids (PUFA) - a component of fish oils - in reducing heart disease risk.","acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids","3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",chemdis,treat,3,treat,1,
397,"acid, n-3 fatty",3-14-15 ischemic heart diseases,Epidemiological studies have connected a high dietary intake of n-3 fatty acids with a low occurrence of IHD.,"acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids","3-14-15 ischemic heart diseases;disease, ischemic heart;disease;ischaemic heart;disease;ischemic heart;diseases, ischemic heart;heart dis ischemic;heart disease, ischemic;heart diseases, ischemic;heart, ischemic disease;ihd;ihd - ischaemic heart disease;ihd - ischemic heart disease;ischaemia myocardial;ischaemic heart disease (disorder);ischaemic heart disease nos;ischaemic heart disease nos (disorder);ischaemic heart disease, nos;ischaemic heart diseases;ischemia myocardial;ischemia, myocardial;ischemia; heart;ischemia; myocardial;ischemias, myocardial;ischemic heart dis;ischemic heart disease (diagnosis);ischemic heart disease (disorder);ischemic heart disease nos;ischemic heart disease nos (disorder);ischemic heart disease or syndrome;ischemic heart disease, nos;ischemic heart diseases;ischemic heart diseases (i20-i25);ischemic heart diseases and syndromes;myocardial ischaemia (disorder);myocardial ischaemia, nos;myocardial ischemia (diagnosis);myocardial ischemia (disorder);myocardial ischemia, nos;myocardial ischemia/hypoxia;myocardial ischemias;myocardium; ischemic",chemdis,treat,1,treat,1,
398,"acid, n-3 fatty",351 thrombi,"N-3 fatty acids, through their anti-inflammatory and anti-thrombotic properties, might reduce the levels of these proatherosclerotic markers and thereby the development of ACS.","acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids","351 thrombi;clot, blood;clots, blood;thrombotic;thrombus (morphologic abnormality);thrombus, nos",chemdis,treat,1,treat,1,
399,"acid, n-3 fatty",[d]microalbuminuria,"The consumption of fish or fish oil containing omega-3 polyunsaturated fatty acids reduces the risk of coronary heart disease, decreases triglyceride, blood pressure, and inflammatory markers, improves endothelial function, prevents certain cardiac arrhythmias, reduces platelet aggregation (including reactivity and adhesion), reduces vasoconstriction, enhances fibrinolysis, reduces fibrin formation, and decreases the risk of microalbuminuria and sudden cardiac death.","acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids",[d]microalbuminuria;[d]microalbuminuria (context-dependent category);[d]microalbuminuria (situation);albuminuria micro;microalbuminuria;microalbuminuria (diagnosis);microalbuminuria (finding);moderately increased albuminuria,chemdis,treat,1,treat,1,
400,"acid, n-3 fatty",a fib,Prophylactic supplementation with omega-3 polyunsaturated fatty acids (PUFAs) reduce vulnerability to atrial fibrillation (AF).,"acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids","a fib;af;af - atrial fibrillation;afib;atrial fibrillation (af);atrial fibrillation (diagnosis);atrial fibrillation (disorder);atrial fibrillations;atrium; fibrillation;auricular fibrillation;auricular fibrillations;auricular; fibrillation;fibrillation - atrial;fibrillation atrial;fibrillation, atrial;fibrillation, auricular;fibrillation; atrial or auricular;fibrillation;atrial;fibrillations, atrial;fibrillations, auricular;quivering upper heart chambers resulting in irregular heartbeat",chemdis,treat,1,treat,1,
401,"acid, n-3 fatty",abnormal heart rhythms,"The consumption of fish or fish oil containing omega-3 polyunsaturated fatty acids reduces the risk of coronary heart disease, decreases triglyceride, blood pressure, and inflammatory markers, improves endothelial function, prevents certain cardiac arrhythmias, reduces platelet aggregation (including reactivity and adhesion), reduces vasoconstriction, enhances fibrinolysis, reduces fibrin formation, and decreases the risk of microalbuminuria and sudden cardiac death.___n-3 Fatty acids may protect against heart disease mortality by preventing fatal arrhythmias.___As omega-3 fatty acids have been considered a cardioprotector agent, reducing cardiac arrhythmias and hence sudden cardiac deaths and given their relative safety and general health benefits, our update article summarizes the knowledge by the possible positive effects of omega-3 supplementation and fish consumption against sudden cardiac death in patients with schizophrenia.","acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids","abnormal heart rhythms;arrhythmia (cardiac) nos;arrhythmia (finding);arrhythmia (nos);arrhythmia cardiac (nos);arrhythmia nos;arrhythmia, cardiac;arrhythmia, nos;arrhythmias;arrhythmias (heart);arrhythmias, cardiac;arrythmia;cardiac arrhythmia (disorder);cardiac arrhythmia (nos);cardiac arrhythmia nos;cardiac arrhythmia, irregular pulse;cardiac arrhythmia, nos;cardiac arrhythmia, unspecified;cardiac arrhythmias;cardiac dysrhythmia (disorder);cardiac dysrhythmia nos;cardiac dysrhythmia nos (disorder);cardiac dysrhythmia, nos;cardiac dysrhythmia, unspecified;cardiac dysrhythmias nos;cardiac rhythm disorder (diagnosis);cardiac rhythm disturbance;cardiac rhythm disturbances;cardiac rhythm irregular;cardiac rhythm, abnormal;cardiac; dysrhythmia;disorder of heart rhythm;disorder; rhythm, heart;disturbance; rhythm, heart;dysrhythmia;dysrhythmia(s);dysrhythmia, cardiac;dysrhythmia; cardiac;dysrhythmia;cardiac;dysrhythmias;ectopic beats all types;heart arrhythmia;heart arrhythmias;heart rhythm disorders;heart: rhythm;rhythm, heart; abnormal;rhythm; abnormal;rhythm; disorder",chemdis,treat,3,treat,1,
402,"acid, n-3 fatty",arrhythmia,"Omega-3 fatty acids have been shown to reduce arrhythmia in animal models and people.___Omega-3 polyunsaturated fatty acids (long-chain omega-3 PUFA) have proved to be beneficial in atherosclerosis, arrhythmia and hypertriglyceridemia in several studies, which has led national and international societies to recommend an intake of 1 g/d long-chain omega-3 PUFA for anti-atherosclerotic and antiarrhythmic purposes or 2-4 g/d for a lipid lowering effect.___The beneficial effects of omega-3 fatty acids might be the result of their ability to reduce triglyceride levels, blood pressure, platelet aggregation, arrhythmia, and atherogenesis.","acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids",arrhythmia,chemdis,treat,3,treat,1,
403,"acid, n-3 fatty",arrhythmic,This article presents a systematic analysis of anti-arrhythmic effects of omega-3 PUFA and of standardized ethyl esters of omega-3 PUFA.___Omega-3 fatty acids' anti-inflammatory and anti-arrhythmic effects may be beneficial in managing the loss of lean body mass and arrhythmias that are common in heart failure.___Omega-3 polyunsaturated fatty acids (ω-3 PUFA) supplementation is an attractive therapeutic option for patients undergoing open-heart surgery due to their anti-inflammatory and anti-arrhythmic properties.,"acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids",arrhythmic,chemdis,treat,3,treat,1,
404,"acid, n-3 fatty",atherosclerosis,"In this regard, long-chain omega-3 fatty acids have a plethora of data for stabilizing vulnerable atherosclerotic plaques as well as reversing atherosclerosis.___Omega-3 polyunsaturated fatty acids (long-chain omega-3 PUFA) have proved to be beneficial in atherosclerosis, arrhythmia and hypertriglyceridemia in several studies, which has led national and international societies to recommend an intake of 1 g/d long-chain omega-3 PUFA for anti-atherosclerotic and antiarrhythmic purposes or 2-4 g/d for a lipid lowering effect.","acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids",atherosclerosis,chemdis,treat,2,treat,1,
405,"acid, n-3 fatty",atrial fibrillation,Prophylactic supplementation with omega-3 polyunsaturated fatty acids (PUFAs) reduce vulnerability to atrial fibrillation (AF).,"acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids",atrial fibrillation,chemdis,treat,1,treat,1,
407,"acid, n-3 fatty",cardiac death,"The GISSI-Prevenzione Trial found a significant reduction in relative reduction of death, cardiac death, nonfatal myocardial infarction, and stroke in subjects consuming n-3 fatty acids.___The consumption of fish or fish oil containing omega-3 polyunsaturated fatty acids reduces the risk of coronary heart disease, decreases triglyceride, blood pressure, and inflammatory markers, improves endothelial function, prevents certain cardiac arrhythmias, reduces platelet aggregation (including reactivity and adhesion), reduces vasoconstriction, enhances fibrinolysis, reduces fibrin formation, and decreases the risk of microalbuminuria and sudden cardiac death.___As omega-3 fatty acids have been considered a cardioprotector agent, reducing cardiac arrhythmias and hence sudden cardiac deaths and given their relative safety and general health benefits, our update article summarizes the knowledge by the possible positive effects of omega-3 supplementation and fish consumption against sudden cardiac death in patients with schizophrenia.___Clinical studies of omega-3 polyunsaturated fatty acids (PUFAs) have shown a reduction in sudden cardiac death, suggesting that omega-3 PUFAs may have antiarrhythmic effects.","acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids","cardiac death;cardiac deaths;cardiac; death;death, cardiac;death; cardiac",chemdis,treat,4,treat,1,
408,"acid, n-3 fatty",cognitive decline,Fish intake and the long-chain omega-3 polyunsaturated fatty acids (PUFAs) in fish have been suggested to lower the risk of cognitive decline.,"acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids",cognitive decline,chemdis,treat,1,treat,1,
409,"acid, n-3 fatty",coronary disease,"Accelerated coronary arteriosclerosis remains the most important factor limiting long-term survival of heart transplant recipients, and dietary fish oil supplementation with omega-3 polyunsaturated fatty acids has been suggested to have a protective effect against coronary disease in epidemiologic studies and to inhibit arteriosclerosis in animal experiments.","acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids",coronary disease,chemdis,treat,1,treat,1,
410,"acid, n-3 fatty",coronary heart disease,"Epidemiological and interventional studies indicate that dietary n-3 PUFA reduces mortality due to coronary heart disease (CHD).___Multiple trials over the past two decades testing omega-3 polyunsaturated fatty acids (PUFAs), containing eicosapentaenoic acid (EPA) and or docosahexaenoic acid (DHA), have shown substantial benefits for reducing major coronary heart disease (CHD) events, all-cause mortality, cardiovascular (CV) death, sudden cardiac death (SCD), and stroke.___The consumption of fish or fish oil containing omega-3 polyunsaturated fatty acids reduces the risk of coronary heart disease, decreases triglyceride, blood pressure, and inflammatory markers, improves endothelial function, prevents certain cardiac arrhythmias, reduces platelet aggregation (including reactivity and adhesion), reduces vasoconstriction, enhances fibrinolysis, reduces fibrin formation, and decreases the risk of microalbuminuria and sudden cardiac death.___Current guidelines advocate the use of marine-derived omega-3 fatty acids supplements for the prevention of coronary heart disease and major vascular events in people with prior coronary heart disease, but large trials of omega-3 fatty acids have produced conflicting results.___Although important roles of dietary n-3 fatty acids in the prevention of coronary heart disease (CHD) have been suggested, long-term effects of dietary alpha-linolenic acid (ALA, 18:3n-3) have not yet been established under controlled conditions.___The 2017 American Heart Association science advisory on omega-3 fatty acid supplements suggested that it is reasonable to use omega-3 fatty acids for secondary prevention in people with coronary heart disease and heart failure.","acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids",coronary heart disease,chemdis,treat,6,treat,1,
411,"acid, n-3 fatty",cvd,"For food nutrients, two SRMAs of RCTs found that high intake of n-3 polyunsaturated fatty acid (PUFA) significantly reduced CVD risks, with pooled RRs ranging from 0.89 (95%CI: 0.82, 0.98) to 0.90 (95%CI: 0.85-0.96), while evidence of efficacy of n-6 PUFA and combined n-3 and n-6 PUFA were inconsistent.___This review briefly summarizes the effects of omega-3 fatty acids in primary and secondary prevention of CVD.","acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids",cvd,chemdis,treat,2,treat,1,
412,"acid, n-3 fatty",dis metab,"Omega-3 fatty acids reduce the risk of irregular heartbeat, stabilize arterial pressure, and restore balance in cholesterol metabolism disorders.","acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids","dis metab;disease, metabolic;disease;metabolic;diseases, metabolic;disorder of metabolism nos;disorder of metabolism nos (disorder);disorder; metabolism;disorder;metabolic;general; metabolic disorder;generalised metabolic disorder;generalized metabolic disorder;generalized metabolic disorder (disorder);md - metabolic disorders;metab dis;metabolic derangement;metabolic disease;metabolic disease (disorder);metabolic disease, nos;metabolic diseases;metabolic disorder;metabolic disorder nos;metabolic disorder, nos;metabolic disorder, unspecified;metabolic disorder; general;metabolic disorders;metabolic disorders (diagnosis);metabolic disorders (disorder);metabolic disorders: general;metabolism disorder;metabolism disorder nos;metabolism disorders;metabolism--disorders;metabolism; disorder;metabolism; disorder, general;rndx metabolic;rndx metabolic (diagnosis);thesaurismoses;thesaurismosis;unspecified disorder of metabolism",chemdis,treat,1,treat,1,
413,"acid, n-3 fatty",heart failure,"Evidence from epidemiological, clinical and experimental studies indicates a beneficial role of the omega-3 polyunsaturated fatty acids (omega-3 PUFA) found in fish oils in the prevention and management of heart failure.___This review summarise the data related to use of omega-3 PUFA supplementation as a potential treatment for heart failure and discussed possible mechanism of action.___The 2017 American Heart Association science advisory on omega-3 fatty acid supplements suggested that it is reasonable to use omega-3 fatty acids for secondary prevention in people with coronary heart disease and heart failure.","acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids",heart failure,chemdis,treat,3,treat,1,
414,"acid, n-3 fatty",hypertriglyceridemia,"Fish oil, and omega-3 fatty acids in particular, have been found to reduce plasma levels of triglycerides and increase levels of high-density lipoprotein in patients with marked hypertriglyceridemia, and a pharmaceutical-grade preparation has recently received approval from the US Food and Drug Administration to market for this purpose.","acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids",hypertriglyceridemia,chemdis,treat,1,treat,1,
416,"acid, n-3 fatty",inflamm,"The OMEGA-PAD I Trial, a randomized, double-blinded, placebo-controlled trial, addressed the hypothesis that short-duration, high-dose n-3 polyunsaturated fatty acids (n-3 PUFA) oral supplementation improves endothelial function and inflammation in PAD.","acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids","inflamm;inflammation;inflammation (morphologic abnormality);inflammation (qualifier value);inflammation nos;inflammation, nos;inflammations;inflammatory reaction;inflammatory reaction, nos",chemdis,treat,1,treat,1,
417,"acid, n-3 fatty",myocardial infarction,"The most compelling evidence for CV benefits of omega-3 PUFA comes from 4 controlled trials of nearly 40,000 participants randomized to receive eicosapentaenoic acid (EPA) with or without docosahexaenoic acid (DHA) in studies of patients in primary prevention, after myocardial infarction, and most recently, with heart failure (HF).___Two clinical intervention trials show that prescription of fish or n-3 fatty acids to patients with prior myocardial infarction is effective in preventing mortality due to CHD.","acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids",myocardial infarction,chemdis,treat,2,treat,1,
418,"acid, n-3 fatty",stroke,"Multiple trials over the past two decades testing omega-3 polyunsaturated fatty acids (PUFAs), containing eicosapentaenoic acid (EPA) and or docosahexaenoic acid (DHA), have shown substantial benefits for reducing major coronary heart disease (CHD) events, all-cause mortality, cardiovascular (CV) death, sudden cardiac death (SCD), and stroke.","acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids",stroke,chemdis,treat,1,treat,1,
419,"acid, n-3 fatty",sudden cardiac death,"Multiple trials over the past two decades testing omega-3 polyunsaturated fatty acids (PUFAs), containing eicosapentaenoic acid (EPA) and or docosahexaenoic acid (DHA), have shown substantial benefits for reducing major coronary heart disease (CHD) events, all-cause mortality, cardiovascular (CV) death, sudden cardiac death (SCD), and stroke.","acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids",sudden cardiac death,chemdis,treat,1,treat,1,
420,"acid, n-3 fatty",sudden death,We found that omega-3 fatty acids have shown to significantly reduce coronary mortality and sudden death in people without prior cardiovascular disease and reduce all-cause death and cardiac mortality in secondary prevention studies.,"acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids",sudden death,chemdis,treat,1,treat,1,
421,"acid, unsaturated fatty",arterial ischemic stroke,Only further studies will show whether changes in diet and/or supplement of unsaturated fatty acids might reduce the incidence of ischaemic stroke.,"acid, unsaturated fatty;acids, unsaturated fatty;dietary supplements fatty acids (unsaturated);fatty acid, unsaturated;fatty acids, unsaturated;unsaturated fatty acid;unsaturated fatty acid (substance);unsaturated fatty acid, nos;unsaturated fatty acids;unsaturated fatty acids (medication)","arterial ischemic stroke;ischaemic stroke;ischaemic stroke nos;ischaemic strokes;ischemia stroke;ischemic cerebrovascular accident;ischemic stroke;ischemic stroke (diagnosis);ischemic stroke (disorder);ischemic stroke nos;ischemic strokes;stroke ischemic;stroke, ischaemic;stroke, ischemic",chemdis,treat,1,treat,0,
422,"acid, unsaturated fatty",coronary heart disease,"These results confirm a possible protective role of unsaturated fatty acids against vascular diseases; however, we did not find any difference in the content of omega3 acids, which have been considered in the past to protect against coronary heart disease.","acid, unsaturated fatty;acids, unsaturated fatty;dietary supplements fatty acids (unsaturated);fatty acid, unsaturated;fatty acids, unsaturated;unsaturated fatty acid;unsaturated fatty acid (substance);unsaturated fatty acid, nos;unsaturated fatty acids;unsaturated fatty acids (medication)",coronary heart disease,chemdis,treat,1,treat,1,
426,alcohol,hypertension,"Optimal nutrition, nutraceuticals, vitamins, antioxidants, minerals, weight loss, exercise, smoking cessation, and moderate restriction of alcohol and caffeine, in addition to other lifestyle modifications, can prevent, delay the onset, reduce the severity, treat and control hypertension in many patients.___Optimal nutrition, nutraceuticals, vitamins, antioxidants, minerals, weight loss, exercise, smoking cessation, and moderate restriction of alcohol and caffeine in addition to other lifestyle modifications can prevent, delay the onset, reduce the severity, treat, and control hypertension in many patients.",alcohol,hypertension,chemdis,treat,2,treat,,
427,aldactone,heart failure,"A population-based study and anecdotal reports have indicated that the publication of the Randomized Aldactone Evaluation Study (RALES) was associated with not merely a broader use of spironolactone in the treatment of heart failure, but also with a coinciding sharp increase in hyperkalemia-associated morbidity/mortality in patients also being treated with ACE-inhibitors.",aldactone,heart failure,chemdis,treat,1,treat,0,
428,amino acids,3-10 heart diseases: general terms,"Many supplements such as vitamins, minerals, herbs and amino acids have been reported to be helpful in chronic conditions (i.e., heart disease, cancer and osteoporosis).",amino acids,"3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",chemdis,treat,1,treat,1,
429,antiarrhythmics dronedarone,a fib,Dronedarone is approved by the U.S. Food and Drug Administration for the treatment of patients with atrial fibrillation (AF) as a safe alternative to amiodarone.___There are no full-length published reports describing the effectiveness of acute dronedarone use against AF in experimental or clinical studies.,"antiarrhythmics dronedarone;dronedarona;dronedarone;dronedarone (medication);dronedarone (product);dronedarone (substance);dronedarone product;dronedarone-containing product;methanesulfonamide, n-(2-butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-;n-(2-butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide;n-(2-butyl-3-(p-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide;product containing dronedarone;product containing dronedarone (medicinal product)","a fib;af;af - atrial fibrillation;afib;atrial fibrillation (af);atrial fibrillation (diagnosis);atrial fibrillation (disorder);atrial fibrillations;atrium; fibrillation;auricular fibrillation;auricular fibrillations;auricular; fibrillation;fibrillation - atrial;fibrillation atrial;fibrillation, atrial;fibrillation, auricular;fibrillation; atrial or auricular;fibrillation;atrial;fibrillations, atrial;fibrillations, auricular;quivering upper heart chambers resulting in irregular heartbeat",chemdis,treat,2,treat,1,
430,antiarrhythmics dronedarone,atrial fibrillation,"Dronedarone is approved by the U.S. Food and Drug Administration for the treatment of patients with atrial fibrillation (AF) as a safe alternative to amiodarone.___More recently, the combination of dronedarone with ranolazine has demonstrated in initial studies to have a synergistic effect in the reduction of burden of atrial fibrillation.","antiarrhythmics dronedarone;dronedarona;dronedarone;dronedarone (medication);dronedarone (product);dronedarone (substance);dronedarone product;dronedarone-containing product;methanesulfonamide, n-(2-butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-;n-(2-butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide;n-(2-butyl-3-(p-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide;product containing dronedarone;product containing dronedarone (medicinal product)",atrial fibrillation,chemdis,treat,2,treat,1,
431,antiarrhythmics dronedarone,death,"In the ATHENA trial, dronedarone therapy was associated with a significant reduction in the combined primary endpoint of death from any cause or hospitalization due to cardiovascular causes.","antiarrhythmics dronedarone;dronedarona;dronedarone;dronedarone (medication);dronedarone (product);dronedarone (substance);dronedarone product;dronedarone-containing product;methanesulfonamide, n-(2-butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-;n-(2-butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)-methanesulfonamide;n-(2-butyl-3-(p-(3-(dibutylamino)propoxy)benzoyl)-5-benzofuranyl)methanesulfonamide;product containing dronedarone;product containing dronedarone (medicinal product)",death,chemdis,treat,1,treat,1,
432,antidiabetics canagliflozin,3-00 cardiovascular disorders: general terms,"It has been concluded that canagliflozin, dapagliflozin, empagliflozin, or ertugliflozin can be recommended for preventing hospitalization associated with heart failure in patients with type 2 diabetes and established cardiovascular disease or those at high cardiovascular risk.",antidiabetics canagliflozin;canagliflozin;canagliflozin (medication);canagliflozin (product);canagliflozin (substance);canagliflozin product;canagliflozin-containing product;canagliflozina;product containing canagliflozin;product containing canagliflozin (medicinal product),"3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,treat,1,treat,1,
433,antidiabetics canagliflozin,adult onset diabetes,"Sodium-glucose co-transporter 2 inhibitors (SGLT2is) such as dapagliflozin, canagliflozin, and empagliflozin, are a promising new therapy in the treatment of type 2 diabetes mellitus (T2DM).___It has been concluded that canagliflozin, dapagliflozin, empagliflozin, or ertugliflozin can be recommended for preventing hospitalization associated with heart failure in patients with type 2 diabetes and established cardiovascular disease or those at high cardiovascular risk.",antidiabetics canagliflozin;canagliflozin;canagliflozin (medication);canagliflozin (product);canagliflozin (substance);canagliflozin product;canagliflozin-containing product;canagliflozina;product containing canagliflozin;product containing canagliflozin (medicinal product),"adult onset diabetes;adult onset diabetes mellitus;adult-onset diabetes;adult-onset diabetes mellitus;adult-onset; diabetes;aodm;diabete type 2;diabetes mellitus (adult onset);diabetes mellitus (niddm);diabetes mellitus - adult ons;diabetes mellitus - adult onset;diabetes mellitus -adult onset;diabetes mellitus maturity onset;diabetes mellitus non insulin dependent;diabetes mellitus non insulin-dep;diabetes mellitus non-insulin-dependent;diabetes mellitus nos late onset;diabetes mellitus type 02;diabetes mellitus type 2;diabetes mellitus type 2 (disorder);diabetes mellitus type ii;diabetes mellitus, adult onset;diabetes mellitus, adult onset type;diabetes mellitus, adult-onset;diabetes mellitus, ketosis resistant;diabetes mellitus, ketosis-resistant;diabetes mellitus, maturity onset;diabetes mellitus, maturity-onset;diabetes mellitus, non insulin dependent;diabetes mellitus, non-insulin dependent;diabetes mellitus, non-insulin-dependent;diabetes mellitus, noninsulin dependent;diabetes mellitus, noninsulin-dependent;diabetes mellitus, slow onset;diabetes mellitus, slow-onset;diabetes mellitus, stable;diabetes mellitus, type 2;diabetes mellitus, type ii;diabetes mellitus: [adult onset] or [noninsulin dependent];diabetes mellitus: [adult onset] or [noninsulin dependent] (disorder);diabetes non-insulin dependent;diabetes type 2;diabetes type ii;diabetes, adult onset;diabetes, ketosis resistant;diabetes, maturity onset;diabetes, maturity-onset;diabetes, type 2;diabetes, type ii;diabetes; adult-onset;diabetes; maturity-onset;diabetes; niddm;diabetes; non-insulin-dependent;diabetes; nonketotic;diabetes; type ii;diabetes;adult onset;diabetes;non insulin depend;diabetes;type 2;ketosis resistant diabetes;ketosis-resistant diabetes mellitus;late onset diabetes;maturity onset diabetes;maturity onset diabetes mellit;maturity onset diabetes mellitus;maturity-onset diabetes;maturity-onset diabetes mellitus;maturity-onset; diabetes;mod;ncdmm;niddm;niddm - non-insulin dependent diabetes mellitus;niddm diabetes mellitus;niddm-non-ins dep diabetes mel;niddm; diabetes;non insulin dependent diabetes;non-ins-dep diabetes mellitus;non-insulin dependent diabetes;non-insulin dependent diabetes mellitus;non-insulin-dependent diabetes;non-insulin-dependent diabetes mellitus;non-insulin-dependent; diabetes;noninsulin dependent diab.mell;noninsulin dependent diabetes;noninsulin dependent diabetes mellitus;noninsulin-dependent diabetes;noninsulin-dependent diabetes mellitus;nonketotic; diabetes;slow-onset diabetes mellitus;stable diabetes mellitus;t2dm - type 2 diabetes mellitus;type 2 diabetes;type 2 diabetes mellitus;type 2 diabetes mellitus (diagnosis);type 2 diabetes mellitus non-insulin dependent;type ii diabetes;type ii diabetes mellitus;type ii diabetes mellitus (disorder);type ii; diabetes",chemdis,treat,2,treat,1,
434,antidiabetics canagliflozin,diabete mellitus,"After Food and Drug Administration mandates for more rigorous safety data, recent studies have not only demonstrated CVD safety for many diabetes mellitus agents, but have also shown that certain newer medications such as empagliflozin, canagliflozin, liraglutide, and semaglutide reduce CVD.",antidiabetics canagliflozin;canagliflozin;canagliflozin (medication);canagliflozin (product);canagliflozin (substance);canagliflozin product;canagliflozin-containing product;canagliflozina;product containing canagliflozin;product containing canagliflozin (medicinal product),"diabete mellitus;diabetes (dm);diabetes mellitus;diabetes mellitus (diagnosis);diabetes mellitus (disorder);diabetes mellitus (dm);diabetes mellitus (e08-e13);diabetes mellitus nos;diabetes mellitus nos diagnosed;diabetes mellitus, nos;disorder diabetes mellitus;dm - diabetes mellitus;unspecified diabetes mellitus",chemdis,treat,1,treat,0,
435,antidiabetics canagliflozin,dm,"Empagliglozin, canagliflozin, ertugliflozin and dapagliflozin are the standard medications which have been authorized recently, for the management of DM by The Food and Drug Administration (FDA).",antidiabetics canagliflozin;canagliflozin;canagliflozin (medication);canagliflozin (product);canagliflozin (substance);canagliflozin product;canagliflozin-containing product;canagliflozina;product containing canagliflozin;product containing canagliflozin (medicinal product),dm,chemdis,treat,1,treat,1,
436,antidiabetics canagliflozin,heart failure,"It has been concluded that canagliflozin, dapagliflozin, empagliflozin, or ertugliflozin can be recommended for preventing hospitalization associated with heart failure in patients with type 2 diabetes and established cardiovascular disease or those at high cardiovascular risk.",antidiabetics canagliflozin;canagliflozin;canagliflozin (medication);canagliflozin (product);canagliflozin (substance);canagliflozin product;canagliflozin-containing product;canagliflozina;product containing canagliflozin;product containing canagliflozin (medicinal product),heart failure,chemdis,treat,1,treat,1,
437,antiplatelet prasugrel,37 hemorrhages,"TRITON-TIMI 38 showed that in patients with acute coronary syndrome undergoing percutaneous coronary intervention prasugrel decreased ischemic events compared to standard clopidogrel, but with more bleeding.",antiplatelet prasugrel;prasugrel;prasugrel (medication);prasugrel (product);prasugrel (substance);prasugrel product;prasugrel-containing product;product containing prasugrel;product containing prasugrel (medicinal product),"37 hemorrhages;bleed;bleed_nos;bleed_nos problem;bleeding;bleeding (disorder);bleeding (finding);bleeding (symptom);bleeding -retired-;bleeding hemorrhage;bleeding problem;bleeding site unspecified;bleeding, nos;bleeding/haemorrhage nos;bleeding/hemorrhage nos;bleeds;blood loss of (nos);blood; extravasation;extravasation blood;extravasation of blood;extravasation; blood;haemorrhage;haemorrhage nos;haemorrhage nos (disorder);haemorrhage, nos;haemorrhage, unspecified;haemorrhages;hem;hemorrhage;hemorrhage (diagnosis);hemorrhage (morphologic abnormality);hemorrhage (nos);hemorrhage bleeding;hemorrhage nos;hemorrhage nos (disorder);hemorrhage, nos;hemorrhage, unspecified;hemorrhages",chemdis,treat,1,treat,0,
438,antiplatelet prasugrel,myocardial infarction,"Patients in group I (n = 10,804, 79%) treated with prasugrel had a clinically significant and robust decrease in the primary end point of cardiovascular death, myocardial infarction, or stroke (8.3 vs 11.0%, hazard ratio [HR] 0.74, 95% confidence interval 0.66 to 0.84, p <0.0001), whereas patients in group II (n = 2149, 16%) had limited efficacy (15.3% vs 16.3%, HR 0.94, 0.76 to 1.18, p = 0.61, p for interaction = 0.07).",antiplatelet prasugrel;prasugrel;prasugrel (medication);prasugrel (product);prasugrel (substance);prasugrel product;prasugrel-containing product;product containing prasugrel;product containing prasugrel (medicinal product),myocardial infarction,chemdis,treat,1,treat,1,
439,antiplatelet prasugrel,stent thrombosis,"The results of the large TRITON-TIMI 38 trial, which compared prasugrel and clopidogrel in patients with acute coronary syndrome who were scheduled to receive coronary stents, demonstrated a significant reduction in ischemic events, including stent thrombosis, with prasugrel, but with an increased risk of major bleeding.",antiplatelet prasugrel;prasugrel;prasugrel (medication);prasugrel (product);prasugrel (substance);prasugrel product;prasugrel-containing product;product containing prasugrel;product containing prasugrel (medicinal product),stent thrombosis,chemdis,treat,1,treat,1,
440,antiplatelet prasugrel,stroke,"The primary end point was the rate of cardiovascular death, nonfatal myocardial infarction (MI), or stroke, and was reached in 12.1% of patients treated with clopidogrel and in 9.9% of patients randomized to prasugrel, suggesting impressive vascular outcome benefit of prasugrel over clopidogrel.___Patients in group I (n = 10,804, 79%) treated with prasugrel had a clinically significant and robust decrease in the primary end point of cardiovascular death, myocardial infarction, or stroke (8.3 vs 11.0%, hazard ratio [HR] 0.74, 95% confidence interval 0.66 to 0.84, p <0.0001), whereas patients in group II (n = 2149, 16%) had limited efficacy (15.3% vs 16.3%, HR 0.94, 0.76 to 1.18, p = 0.61, p for interaction = 0.07).___In TRITON-TIMI 38 patients without previous stroke, <75 years old, and weighing >60 kg had substantial decreases in ischemic events with prasugrel compared to clopidogrel.",antiplatelet prasugrel;prasugrel;prasugrel (medication);prasugrel (product);prasugrel (substance);prasugrel product;prasugrel-containing product;product containing prasugrel;product containing prasugrel (medicinal product),stroke,chemdis,treat,3,treat,1,
441,b 12 vitamin,coronary heart disease,A biomarker profile of high folate and vitamin B-12 and low plasma homocysteine concentrations reduces the risk of coronary heart disease (CHD) and may be linked to diet.,"b 12 vitamin;b 12, vitamin;b-12;b12;b12 - cyanocobalamin;b12 - cyanocobalamin prep;b12 - vitamin b12;b12 vitamin;b12, vitamin;cianocobalamina;cobalamin (1+);cyanocob(iii)alamin;cyanocobalamin (medication);cyanocobalamin (substance);cyanocobalamin (vitamin b12);cyanocobalamin preparation;cyanocobalamin preparation (product);cyanocobalamin preparation (substance);cyanocobalamin product;cyanocobalamin-containing product;cyanocobalamine;cyanocobalaminum;cyanocobalmin;product containing cyanocobalamin;product containing cyanocobalamin (medicinal product);product containing vitamin b12;product containing vitamin b12 (medicinal product);product containing vitamin b12 (product);vit b12;vitamin b 12;vitamin b a 12;vitamin b-12;vitamin b12 (cyanocobalamin);vitamin b12 (medication);vitamin b12 (substance);vitamin b12 (substance) [ambiguous];vitamin b12 complex;vitamin b12 compound;vitamin b12 nos;vitamin b12 preparation;vitamin b12 preparation (product);vitamin b12 preparation (substance);vitamin b12 product;vitamin b<sub>12</sub>;vitamin b<sub>12</sub> (substance);vitamin b<sub>12</sub> (substance) [ambiguous];vitamin b<sub>12</sub> preparation;vitamin b<sub>12</sub> preparation (product);vitamin b<sub>12</sub> preparation (substance);vitamin b>12<;vitamin b>12< (substance);vitamin b>12< (substance) [ambiguous];vitamin b>12< preparation;vitamin b>12< preparation (product);vitamin b>12< preparation (substance);vitamin-b12;vitamins cyanocobalamin",coronary heart disease,chemdis,treat,1,treat,1,
443,calcium,3-12 anginal syndromes,"Calcium channel blockers have been widely used for treatment of hypertension, angina pectoris, arrhythmia, and other heart diseases.",calcium,"3-12 anginal syndromes;angina (disorder);angina nos;angina pain;angina pectoris;angina pectoris (diagnosis);angina pectoris (disorder);angina pectoris (disorder) [ambiguous];angina pectoris nos;angina pectoris nos (disorder);angina pectoris syndrome;angina pectoris, nos;angina pectoris, unspecified;angina syndrome;angina, cardiac;angina, nos;anginal discomfort;anginal pain;anginal syndrome;anginal syndromes;anginal; syndrome;anginas;angor pectoris;ap - angina pectoris;cardiac angina;cardiac angina syndrome;chest pain ischemic;chest; pain, ischemic;ischaemic chest pain;ischaemic chest pain (disorder);ischaemic heart dis with angina;ischaemic heart disease - angina;ischaemic heart disease with angina;ischaemic ht dis - angina;ischemic chest pain;ischemic chest pain (diagnosis);ischemic chest pain (finding);ischemic heart dis with angina;ischemic heart disease - angina;ischemic heart disease with angina;ischemic ht dis - angina;pain angina;pain; chest, ischemic;pain;angina;pectoris angina;stenocardia;stenocardia (disorder);stenocardias;syndrome; anginal",chemdis,treat,1,treat,,
446,calcium,circulation disorder,Today calcium antagonists (Ca-antagonists) are widely used agents in the management of various diseases of the circulatory system.,calcium,"circulation disorder;circulation disorders;circulation, disorders of;circulatory disease;circulatory disease nos;circulatory disease system;circulatory diseases system;circulatory disorder;circulatory disorder system;circulatory disorders;circulatory disorders system;circulatory system disease;circulatory system disease nos;circulatory system disease nos (disorder);circulatory system diseases;circulatory system disorder;circulatory system disorder (nos);circulatory; disorder;disease (or disorder); circulatory;disease circulatory system;diseases of the circulatory system;diseases of the circulatory system (i00-i99);disorder circulatory system;disorder of circulat system;disorder of circulatory system;disorder of circulatory system, nos;disorder of the circulatory system;unspecified circulatory system disorder;unspecified disorder of circulatory system",chemdis,treat,1,treat,,
447,calcium,coronary artery disease,A few observational investigations in the past showed positive results of calcium channel blocker therapy in patients with angiographically proven coronary artery disease (CAD).,calcium,coronary artery disease;coronary artery diseases,chemdis,treat,1,treat,,
448,calcium,dis metab,"Dietary and medicinal supplementation of lysine, calcium and vitamin D may improve the body composition of young adult women in the form of proportionally more muscle mass, bone mass and lesser fat mass, which in turn, may prove helpful in improving general well-being, physical fitness as well as preventing metabolic diseases in developing countries.",calcium,"dis metab;disease, metabolic;disease;metabolic;diseases, metabolic;disorder of metabolism nos;disorder of metabolism nos (disorder);disorder; metabolism;disorder;metabolic;general; metabolic disorder;generalised metabolic disorder;generalized metabolic disorder;generalized metabolic disorder (disorder);md - metabolic disorders;metab dis;metabolic derangement;metabolic disease;metabolic disease (disorder);metabolic disease, nos;metabolic diseases;metabolic disorder;metabolic disorder nos;metabolic disorder, nos;metabolic disorder, unspecified;metabolic disorder; general;metabolic disorders;metabolic disorders (diagnosis);metabolic disorders (disorder);metabolic disorders: general;metabolism disorder;metabolism disorder nos;metabolism disorders;metabolism--disorders;metabolism; disorder;metabolism; disorder, general;rndx metabolic;rndx metabolic (diagnosis);thesaurismoses;thesaurismosis;unspecified disorder of metabolism",chemdis,treat,1,treat,1,
449,calcium,fracture,"We conclude that (1) calcium and vitamin D supplementation leads to a modest reduction in fracture risk, although population-level intervention has not been shown to be an effective public health strategy; (2) supplementation with calcium alone for fracture reduction is not supported by the literature; (3) side effects of calcium supplementation include renal stones and gastrointestinal symptoms; (4) vitamin D supplementation, rather than calcium supplementation, may reduce falls risk; and (5) assertions of increased cardiovascular risk consequent to calcium supplementation are not convincingly supported by current evidence.___Only one RCT of co-administered calcium and vitamin D in frail, institutionalized, elderly women with low dietary calcium intake and vitamin D levels showed significant reductions in fracture risk.",calcium,fracture,chemdis,treat,2,treat,1,
451,calcium,hyperkalemia,"RDX7675, a novel potassium binder in development for the treatment of hyperkalemia, is a calcium salt of a reengineered polystyrene sulfonate-based resin designed to have enhanced palatability.",calcium,hyperkalemia,chemdis,treat,1,treat,1,
452,calcium,hypertension,"Calcium channel blockers have been widely used for treatment of hypertension, angina pectoris, arrhythmia, and other heart diseases.",calcium,hypertension,chemdis,treat,1,treat,1,
453,calcium,osteoporosis,"Calcium supplementation has been widely accepted as a key strategy in the prevention and treatment of osteoporosis.___For those consuming inadequate dietary calcium, calcium supplements have been a standard strategy for prevention of osteoporosis.___These data suggest the role for calcium and vitamin D supplements in osteoporosis management is very limited.",calcium,osteoporosis,chemdis,treat,3,treat,1,
454,calcium,stroke,"In conclusion, dietary calcium intake may be beneficial for the prevention of stroke in Japanese whose average intake of calcium is low.",calcium,stroke,chemdis,treat,1,treat,1,
455,carbohydrates,diabetes,"Diets low in fat (particularly saturated fat), and high in fibre and complex carbohydrates are effective in reducing the risk of developing diabetes.",carbohydrates,diabetes,chemdis,treat,1,treat,1,
456,carbohydrates,obesity,"Diets with increased protein and reduced carbohydrates have been shown to improve body composition, lipid and lipoprotein profiles, and glycemic regulations associated with treatment of obesity and weight loss.",carbohydrates,obesity,chemdis,treat,1,treat,0,
457,carbohydrates,weight loss,"Diets with increased protein and reduced carbohydrates have been shown to improve body composition, lipid and lipoprotein profiles, and glycemic regulations associated with treatment of obesity and weight loss.",carbohydrates,weight loss,chemdis,treat,1,treat,0,
458,chemical oxygen,aerobullosis,Oxygen is the most widely used therapeutic strategy to prevent and treat decompression sickness (DCS).,"chemical oxygen;elemental oxygen;o;o 2;o element;o2;o2 - oxygen;o2 element;o<sub>2</sub>;o>2<;oxygen;oxygen (substance);oxygen 16;oxygen product;oxygen usp;oxygen, nos;oxygen-16;oxygen-containing product;product containing oxygen;product containing oxygen (medicinal product);product containing oxygen (product);pure oxygen","aerobullosis;bends (disorder);caisson dis;caisson disease;caisson disease (disorder);caisson disease [ambiguous];caisson disease [decompression sickness];caisson diseases;caisson; disease;caissons disease;chokes;compressed air disease;compressed air disease nos;compressed air disease nos (disorder);compressed-air disease;compression; diver's squeeze;decompression sickness;decompression sickness (diagnosis);decompression; disease;disease (or disorder); caisson;disease (or disorder); compressed air;disease (or disorder); decompression;disease divers;disease, caisson;diseases, caisson;diver disease;diver's palsy or paralysis;diver's palsy, paralysis or squeeze;diver's squeeze; compression;diver's; paralysis;divers' palsy or paralysis;effects of caisson disease [decompression sickness];rapture of the deep syndrome;sickness, decompression;the bends",chemdis,treat,1,treat,1,
460,chemical oxygen,cardiac congestive failure,"Heart rate reduction (HRR) improves left ventricular (LV) filling, increases myocardial O2 supply, and reduces myocardial O2 consumption, which are all beneficial in congestive heart failure (CHF).","chemical oxygen;elemental oxygen;o;o 2;o element;o2;o2 - oxygen;o2 element;o<sub>2</sub>;o>2<;oxygen;oxygen (substance);oxygen 16;oxygen product;oxygen usp;oxygen, nos;oxygen-16;oxygen-containing product;product containing oxygen;product containing oxygen (medicinal product);product containing oxygen (product);pure oxygen","cardiac congestive failure;cardiac failure congestive;cardiac failure, congestive;ccf - congestive cardiac fail;ccf - congestive cardiac failure;chf;chf (congestive heart failure);chf - congestive heart failure;chf nos;congestive cardiac fail;congestive cardiac failure;congestive disease heart;congestive diseases heart;congestive failure heart;congestive failure hearts;congestive failures heart;congestive heart disease;congestive heart failure;congestive heart failure (chf);congestive heart failure (diagnosis);congestive heart failure (disorder);congestive heart failure chf;congestive heart failure nos;congestive heart failure, unspecified;congestive; heart;congetive cardiac failure;disease congestive heart;failure congestive heart;failure heart congestive;failure; heart, congestive;failure;congestive cardiac;heart congestive failure;heart failure congestive;heart failure, congestive;heart failure/congestive heart failure;heart failure; congestive;heart; congestive;heart; disease, congestive",chemdis,treat,1,treat,,
462,chemical oxygen,effects toxics,"Together, the findings from this study show that vigabatrin therapy is efficacious at preventing CNS oxygen toxicity in swine, and a single dose is not acutely associated with retinotoxicity.","chemical oxygen;elemental oxygen;o;o 2;o element;o2;o2 - oxygen;o2 element;o<sub>2</sub>;o>2<;oxygen;oxygen (substance);oxygen 16;oxygen product;oxygen usp;oxygen, nos;oxygen-16;oxygen-containing product;product containing oxygen;product containing oxygen (medicinal product);product containing oxygen (product);pure oxygen",effects toxics;tox;toxic;toxic effect;toxic effect (disorder);toxic effect of;toxicities;toxicity;toxics,chemdis,treat,1,treat,0,
463,chemical oxygen,haemorrhagic shock,"Hemoglobin-based blood substitutes (HBBSs) are infusible oxygen-carrying liquids that have long shelf lives, have no need for refrigeration or cross-matching, and are ideal for treating hemorrhagic shock in remote settings.","chemical oxygen;elemental oxygen;o;o 2;o element;o2;o2 - oxygen;o2 element;o<sub>2</sub>;o>2<;oxygen;oxygen (substance);oxygen 16;oxygen product;oxygen usp;oxygen, nos;oxygen-16;oxygen-containing product;product containing oxygen;product containing oxygen (medicinal product);product containing oxygen (product);pure oxygen","haemorrhagic shock;hemorrhagic shock;hemorrhagic shock (diagnosis);hemorrhagic shock (disorder);shock haemorrhagic;shock hemorrhagic;shock, hemorrhagic",chemdis,treat,1,treat,1,
464,clopidogrel,a fib,"Antiplatelet agents such as clopidogrel have proven efficacy and superiority compared to aspirin to prevent systemic vascular events in at-risk patient populations, but currently they do not play an important role in the prevention of AF related thromboembolic events.","clopidogrel;clopidogrel (product);clopidogrel (substance);clopidogrel product;clopidogrel-containing product;clopidogrelum;methyl 2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno(3,2-c)pyridin-5-yl)acetate;product containing clopidogrel;product containing clopidogrel (medicinal product)","a fib;af;af - atrial fibrillation;afib;atrial fibrillation (af);atrial fibrillation (diagnosis);atrial fibrillation (disorder);atrial fibrillations;atrium; fibrillation;auricular fibrillation;auricular fibrillations;auricular; fibrillation;fibrillation - atrial;fibrillation atrial;fibrillation, atrial;fibrillation, auricular;fibrillation; atrial or auricular;fibrillation;atrial;fibrillations, atrial;fibrillations, auricular;quivering upper heart chambers resulting in irregular heartbeat",chemdis,treat,1,treat,0,
465,clopidogrel,stemi,Recent post hoc analysis of the TRITON trial suggests vascular outcome superiority of prasugrel over clopidogrel in STEMI patients at both 30 days and 15 months.,"clopidogrel;clopidogrel (product);clopidogrel (substance);clopidogrel product;clopidogrel-containing product;clopidogrelum;methyl 2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno(3,2-c)pyridin-5-yl)acetate;product containing clopidogrel;product containing clopidogrel (medicinal product)",stemi,chemdis,treat,1,treat,,
466,clopidogrel,stent thrombosis,"The results of the large TRITON-TIMI 38 trial, which compared prasugrel and clopidogrel in patients with acute coronary syndrome who were scheduled to receive coronary stents, demonstrated a significant reduction in ischemic events, including stent thrombosis, with prasugrel, but with an increased risk of major bleeding.","clopidogrel;clopidogrel (product);clopidogrel (substance);clopidogrel product;clopidogrel-containing product;clopidogrelum;methyl 2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno(3,2-c)pyridin-5-yl)acetate;product containing clopidogrel;product containing clopidogrel (medicinal product)",stent thrombosis,chemdis,treat,1,treat,,
467,clopidogrel,stroke,"In TRITON-TIMI 38 patients without previous stroke, <75 years old, and weighing >60 kg had substantial decreases in ischemic events with prasugrel compared to clopidogrel.","clopidogrel;clopidogrel (product);clopidogrel (substance);clopidogrel product;clopidogrel-containing product;clopidogrelum;methyl 2-(2-chlorophenyl)-2-(4,5,6,7-tetrahydrothieno(3,2-c)pyridin-5-yl)acetate;product containing clopidogrel;product containing clopidogrel (medicinal product)",stroke,chemdis,treat,1,treat,,
468,coumadin,37 hemorrhages,"One such drug is dabigatran, with the promise of less frequent monitoring and decreased bleeding tendencies as compared to Coumadin.",coumadin;marevan,"37 hemorrhages;bleed;bleed_nos;bleed_nos problem;bleeding;bleeding (disorder);bleeding (finding);bleeding (symptom);bleeding -retired-;bleeding hemorrhage;bleeding problem;bleeding site unspecified;bleeding, nos;bleeding/haemorrhage nos;bleeding/hemorrhage nos;bleeds;blood loss of (nos);blood; extravasation;extravasation blood;extravasation of blood;extravasation; blood;haemorrhage;haemorrhage nos;haemorrhage nos (disorder);haemorrhage, nos;haemorrhage, unspecified;haemorrhages;hem;hemorrhage;hemorrhage (diagnosis);hemorrhage (morphologic abnormality);hemorrhage (nos);hemorrhage bleeding;hemorrhage nos;hemorrhage nos (disorder);hemorrhage, nos;hemorrhage, unspecified;hemorrhages",chemdis,treat,1,treat,0,
469,coumadin,stroke,"Historically, Coumadin has been the drug of choice for chronic anticoagulation and stroke prevention in AF patients however, given the need for constant monitoring and multiple drug interactions, newer anticoagulants have been developed.",coumadin;marevan,stroke,chemdis,treat,1,treat,1,
470,d-fructose,3-00 cardiovascular disorders: general terms,These findings indicate a novel role for naringin in protecting against fructose-induced cardiac hypertrophy and suggest unique therapeutic strategies for prevention of cardiovascular diseases.,d-fructose;d-fructose preparation;foods fructose;fructose;fructose (medication);fructose (substance);fructose agent;fructose agent (substance);fructose preparation;fructose preparation (product);fructose preparation (substance);fructose product;fructose-containing product;fruit sugar;fruit sugar preparation;laevulose;laevulose preparation;laevulose product;levulose;levulose preparation;levulose product;product containing fructose;product containing fructose (medicinal product),"3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,treat,1,treat,0,
471,d-fructose,cardiac hypertrophies,These findings indicate a novel role for naringin in protecting against fructose-induced cardiac hypertrophy and suggest unique therapeutic strategies for prevention of cardiovascular diseases.,d-fructose;d-fructose preparation;foods fructose;fructose;fructose (medication);fructose (substance);fructose agent;fructose agent (substance);fructose preparation;fructose preparation (product);fructose preparation (substance);fructose product;fructose-containing product;fruit sugar;fruit sugar preparation;laevulose;laevulose preparation;laevulose product;levulose;levulose preparation;levulose product;product containing fructose;product containing fructose (medicinal product),"cardiac hypertrophies;cardiac hypertrophy;cardiac hypertrophy nos;cardiac hypertrophy nos (disorder);cardiac; hypertrophy;heart hypertrophies;heart hypertrophy;heart--hypertrophy;heart; hypertrophy;hypertrophic heart;hypertrophic;heart;hypertrophies, cardiac;hypertrophies, heart;hypertrophy, cardiac;hypertrophy, heart;hypertrophy; cardiac;hypertrophy; heart",chemdis,treat,1,treat,0,
472,dabigatran,37 hemorrhages,"One such drug is dabigatran, with the promise of less frequent monitoring and decreased bleeding tendencies as compared to Coumadin.___Evaluation of the results of randomized clinical trials (RCTs), meta-analyzes of RCTs demonstrated the advantages of the new oral anticoagulants (NOAC), such as dabigatran, rivaroxaban, apixaban, compared with warfarin in reducing the risk of bleeding in patients with AF and CKD in predialysis stage.",dabigatran;dabigatran (product);dabigatran (substance);dabigatran product;dabigatran-containing product;n-((2-(((4-(aminoiminomethyl)phenyl)amino)methyl)-1-methyl-1h-benzimidazol-5-yl)carbonyl)-n-2-pyridinyl-beta-alanine;product containing dabigatran;product containing dabigatran (medicinal product),"37 hemorrhages;bleed;bleed_nos;bleed_nos problem;bleeding;bleeding (disorder);bleeding (finding);bleeding (symptom);bleeding -retired-;bleeding hemorrhage;bleeding problem;bleeding site unspecified;bleeding, nos;bleeding/haemorrhage nos;bleeding/hemorrhage nos;bleeds;blood loss of (nos);blood; extravasation;extravasation blood;extravasation of blood;extravasation; blood;haemorrhage;haemorrhage nos;haemorrhage nos (disorder);haemorrhage, nos;haemorrhage, unspecified;haemorrhages;hem;hemorrhage;hemorrhage (diagnosis);hemorrhage (morphologic abnormality);hemorrhage (nos);hemorrhage bleeding;hemorrhage nos;hemorrhage nos (disorder);hemorrhage, nos;hemorrhage, unspecified;hemorrhages",chemdis,treat,2,treat,1,
473,dabigatran,a fib,"Recently, the direct thrombin inhibitor dabigatran was approved by the US FDA for use in AF, and several factor Xa inhibitors are in late-stage clinical testing.",dabigatran;dabigatran (product);dabigatran (substance);dabigatran product;dabigatran-containing product;n-((2-(((4-(aminoiminomethyl)phenyl)amino)methyl)-1-methyl-1h-benzimidazol-5-yl)carbonyl)-n-2-pyridinyl-beta-alanine;product containing dabigatran;product containing dabigatran (medicinal product),"a fib;af;af - atrial fibrillation;afib;atrial fibrillation (af);atrial fibrillation (diagnosis);atrial fibrillation (disorder);atrial fibrillations;atrium; fibrillation;auricular fibrillation;auricular fibrillations;auricular; fibrillation;fibrillation - atrial;fibrillation atrial;fibrillation, atrial;fibrillation, auricular;fibrillation; atrial or auricular;fibrillation;atrial;fibrillations, atrial;fibrillations, auricular;quivering upper heart chambers resulting in irregular heartbeat",chemdis,treat,1,treat,1,
474,dabigatran,adverse event associated with coagulation,"The oral anticoagulant dabigatran has been used increasingly due to its good tolerance, predictable pharmacokinetics, effective anticoagulant effects, and absence of requirement of coagulation monitoring.",dabigatran;dabigatran (product);dabigatran (substance);dabigatran product;dabigatran-containing product;n-((2-(((4-(aminoiminomethyl)phenyl)amino)methyl)-1-methyl-1h-benzimidazol-5-yl)carbonyl)-n-2-pyridinyl-beta-alanine;product containing dabigatran;product containing dabigatran (medicinal product),adverse event associated with coagulation;coagulation,chemdis,treat,1,treat,1,
475,dabigatran,atrial fibrillation,Dabigatran is widely used for stroke prevention in atrial fibrillation.,dabigatran;dabigatran (product);dabigatran (substance);dabigatran product;dabigatran-containing product;n-((2-(((4-(aminoiminomethyl)phenyl)amino)methyl)-1-methyl-1h-benzimidazol-5-yl)carbonyl)-n-2-pyridinyl-beta-alanine;product containing dabigatran;product containing dabigatran (medicinal product),atrial fibrillation,chemdis,treat,1,treat,1,
476,dabigatran,bleed intracranial,The RE-LY trial confirmed effectiveness and safety of both doses of dabigatran for prevention of stroke and both doses of dabigatran had much lower risks of intracranial bleeding compared with warfarin.,dabigatran;dabigatran (product);dabigatran (substance);dabigatran product;dabigatran-containing product;n-((2-(((4-(aminoiminomethyl)phenyl)amino)methyl)-1-methyl-1h-benzimidazol-5-yl)carbonyl)-n-2-pyridinyl-beta-alanine;product containing dabigatran;product containing dabigatran (medicinal product),"bleed intracranial;bleeding intracranial;bleeding within the skull;bleedings intracranial;bleeds intracranial;haemorrhage intracranial;haemorrhage;intracranial;hemorrhage intracranial;hemorrhage, intracranial;hemorrhage;intracranial;hemorrhages, intracranial;intracranial bleed;intracranial bleeding;intracranial haemorrhage;intracranial haemorrhage nos;intracranial haemorrhage, nos;intracranial haemorrhage, unspecified;intracranial hemorr nos;intracranial hemorrhage (diagnosis);intracranial hemorrhage (disorder);intracranial hemorrhage nos;intracranial hemorrhage nos (disorder);intracranial hemorrhage, nos;intracranial hemorrhage, unspecified;intracranial hemorrhages;intracranial; hemorrhage;unspecified intracranial haemorrhage;unspecified intracranial hemorrhage",chemdis,treat,1,treat,1,
477,dabigatran,embolism,"Dabigatran is an oral thrombin inhibitor which has been approved for prevention of stroke or embolism in atrial fibrillation patients as an alternative to vitamin K antagonists.___Dabigatran (Pradaxa) is a new oral anticoagulant approved by the Food and Drug Administration (FDA), available internationally and indicated as an alternative to warfarin for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.",dabigatran;dabigatran (product);dabigatran (substance);dabigatran product;dabigatran-containing product;n-((2-(((4-(aminoiminomethyl)phenyl)amino)methyl)-1-methyl-1h-benzimidazol-5-yl)carbonyl)-n-2-pyridinyl-beta-alanine;product containing dabigatran;product containing dabigatran (medicinal product),"embolism;embolism, nos",chemdis,treat,2,treat,1,
478,dabigatran,stroke,"Dabigatran and rivaroxaban are non-vitamin K oral anticoagulants approved for stroke prevention in patients with nonvalvular atrial fibrillation (AF).___Dabigatran is an oral thrombin inhibitor which has been approved for prevention of stroke or embolism in atrial fibrillation patients as an alternative to vitamin K antagonists.___Dabigatran (Pradaxa) is a new oral anticoagulant approved by the Food and Drug Administration (FDA), available internationally and indicated as an alternative to warfarin for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.___Direct thrombin inhibitor dabigatran and factor Xa inhibitors rivaroxaban and apixaban have proven, in large, multicenter, randomized, phase III, clinical studies, to be at least as efficient as warfarin in stroke prevention in patients with AF.___Dabigatran is an oral direct thrombin inhibitor that is Food and Drug Administration-approved for prevention of stroke in patients with atrial fibrillation.___Dabigatran etexelate is a new oral direct thrombin inhibitor that has been approved by the US Food and Drug Administration to prevent stroke in patients with nonvalvular atrial fibrillation.___The RE-LY trial confirmed effectiveness and safety of both doses of dabigatran for prevention of stroke and both doses of dabigatran had much lower risks of intracranial bleeding compared with warfarin.___Dabigatran is widely used for stroke prevention in atrial fibrillation.___Dabigatran is at least as effective as warfarin at preventing stroke with advantages of less serious bleeding except for gastrointestinal bleeding, which occurs more often than with warfarin.___Completed phase-III clinical trials have demonstrated the therapeutic potential of dabigatran, rivaroxaban, and apixaban in comparison with warfarin for stroke prevention in patients with nonvalvular AF (NVAF).",dabigatran;dabigatran (product);dabigatran (substance);dabigatran product;dabigatran-containing product;n-((2-(((4-(aminoiminomethyl)phenyl)amino)methyl)-1-methyl-1h-benzimidazol-5-yl)carbonyl)-n-2-pyridinyl-beta-alanine;product containing dabigatran;product containing dabigatran (medicinal product),stroke,chemdis,treat,10,treat,1,
479,dabigatran etexilate,a fib,"The efficacy and safety of the direct thrombin inhibitor dabigatran etexilate, as well as of the selective factor Xa inhibitors rivaroxaban and apixaban, have been demonstrated in Phase III trials for stroke prevention in AF and the treatment and secondary prophylaxis of venous thrombo-embolism.___In particular, the novel, oral, direct thrombin inhibitor, dabigatran etexilate, recently licensed by the US Food and Drug Administration (FDA) and Health Canada has shown improved efficacy and safety compared with warfarin for stroke prevention in AF, and has the potential to replace warfarin in this indication.","dabigatran etexilate;dabigatran etexilate (substance);etexilate, dabigatran;ethyl 3-(((2-(((4- ((((hexyloxy)carbonyl)amino)iminomethyl)phenyl)amino)methyl)-1-methyl-1h-benzimidazol-5-yl)carbonyl)(pyridin-2- yl)amino)propanoate","a fib;af;af - atrial fibrillation;afib;atrial fibrillation (af);atrial fibrillation (diagnosis);atrial fibrillation (disorder);atrial fibrillations;atrium; fibrillation;auricular fibrillation;auricular fibrillations;auricular; fibrillation;fibrillation - atrial;fibrillation atrial;fibrillation, atrial;fibrillation, auricular;fibrillation; atrial or auricular;fibrillation;atrial;fibrillations, atrial;fibrillations, auricular;quivering upper heart chambers resulting in irregular heartbeat",chemdis,treat,2,treat,1,
480,dabigatran etexilate,atrial fibrillation,"The new oral anticoagulants (NOAC) dabigatran etexilate, rivaroxaban, and apixaban show similar efficacy for stroke prevention in patients with atrial fibrillation (AF) as the vitamin K antagonist warfarin.","dabigatran etexilate;dabigatran etexilate (substance);etexilate, dabigatran;ethyl 3-(((2-(((4- ((((hexyloxy)carbonyl)amino)iminomethyl)phenyl)amino)methyl)-1-methyl-1h-benzimidazol-5-yl)carbonyl)(pyridin-2- yl)amino)propanoate",atrial fibrillation,chemdis,treat,1,treat,1,
481,dabigatran etexilate,embolism,"The efficacy and safety of the direct thrombin inhibitor dabigatran etexilate, as well as of the selective factor Xa inhibitors rivaroxaban and apixaban, have been demonstrated in Phase III trials for stroke prevention in AF and the treatment and secondary prophylaxis of venous thrombo-embolism.___Dabigatran etexilate is a promising new option for the prevention of stroke and systemic embolism in patients with atrial fibrillation.___The DTI dabigatran etexilate was recently shown to provide superior risk reduction to warfarin for stroke and systemic embolism for patients with nonvalvular AF and recently gained US Food and Drug Administration approval for this indication.","dabigatran etexilate;dabigatran etexilate (substance);etexilate, dabigatran;ethyl 3-(((2-(((4- ((((hexyloxy)carbonyl)amino)iminomethyl)phenyl)amino)methyl)-1-methyl-1h-benzimidazol-5-yl)carbonyl)(pyridin-2- yl)amino)propanoate","embolism;embolism, nos",chemdis,treat,3,treat,1,
482,dabigatran etexilate,stroke,"Dabigatran etexilate, a direct thrombin inhibitor, has become an alternative to warfarin for stroke prevention in patients with nonvalvular atrial fibrillation.___The efficacy and safety of the direct thrombin inhibitor dabigatran etexilate, as well as of the selective factor Xa inhibitors rivaroxaban and apixaban, have been demonstrated in Phase III trials for stroke prevention in AF and the treatment and secondary prophylaxis of venous thrombo-embolism.___Dabigatran etexilate is a promising new option for the prevention of stroke and systemic embolism in patients with atrial fibrillation.___Dabigatran etexilate and rivaroxaban are already approved in the United States and Europe for stroke prevention in nonvalvular AF, and dabigatran etexilate has entered current AF guidelines as an alternative to warfarin.___In particular, the novel, oral, direct thrombin inhibitor, dabigatran etexilate, recently licensed by the US Food and Drug Administration (FDA) and Health Canada has shown improved efficacy and safety compared with warfarin for stroke prevention in AF, and has the potential to replace warfarin in this indication.___The DTI dabigatran etexilate was recently shown to provide superior risk reduction to warfarin for stroke and systemic embolism for patients with nonvalvular AF and recently gained US Food and Drug Administration approval for this indication.___The new oral anticoagulants (NOAC) dabigatran etexilate, rivaroxaban, and apixaban show similar efficacy for stroke prevention in patients with atrial fibrillation (AF) as the vitamin K antagonist warfarin.","dabigatran etexilate;dabigatran etexilate (substance);etexilate, dabigatran;ethyl 3-(((2-(((4- ((((hexyloxy)carbonyl)amino)iminomethyl)phenyl)amino)methyl)-1-methyl-1h-benzimidazol-5-yl)carbonyl)(pyridin-2- yl)amino)propanoate",stroke,chemdis,treat,7,treat,1,
483,dabigatran etexilate,"thromboembolism, venous","Dabigatran etexilate is a selective, specific, reversible direct thrombin inhibitor that has been approved in United States, European countries and in India for SPAF and primary venous thromboembolism prevention and treatment.","dabigatran etexilate;dabigatran etexilate (substance);etexilate, dabigatran;ethyl 3-(((2-(((4- ((((hexyloxy)carbonyl)amino)iminomethyl)phenyl)amino)methyl)-1-methyl-1h-benzimidazol-5-yl)carbonyl)(pyridin-2- yl)amino)propanoate","thromboembolism, venous;venous thromboembolism",chemdis,treat,1,treat,1,
484,dag,hypertrophic,"We previously reported that the anti-hypertrophic effect of the dietary polyunsaturated fatty acid, conjugated linoleic acid (CLA), was associated with the upregulation of diacylglycerol (DAG)",dag,hypertrophic,chemdis,treat,1,treat,1,
485,"derivative, stilbene",hypertrophic,"These data suggest that the anti-hypertrophic actions of resveratrol (and other stilbenoids?) do not extend to the SHHF rat, which models heart failure superimposed on hypertension.","derivative, stilbene;derivatives, stilbene;stilbene;stilbene derivative;stilbene derivatives;stilbenes;stilbenoids",hypertrophic,chemdis,treat,1,treat,,
486,des,neointimal hyperplasia,DES (sirolimus and paclitaxel) prevent restenosis by inhibiting neointimal hyperplasia.,des,neointimal hyperplasia,chemdis,treat,1,treat,1,
487,des,restenosis,DES (sirolimus and paclitaxel) prevent restenosis by inhibiting neointimal hyperplasia.,des,"restenosis;restenosis (morphologic abnormality);restenosis, nos",chemdis,treat,1,treat,1,
488,dha,3-00 cardiovascular disorders: general terms,"Recommendations to consume fish for prevention of cardiovascular disease (CVD), along with the U.S. Food and Drug Administration-approved generally recognized as safe (GRAS) status for long chain omega-3 fatty acids, may have had the unanticipated consequence of encouraging long-chain omega-3 (ω-3) fatty acid [(eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)] supplementation and fortification practices.___There is considerable evidence that EPA and DHA are protective against cardiovascular disease (heart disease and stroke), particularly in individuals with pre-existing disease.",dha,"3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,treat,2,treat,1,
489,dha,coronary heart disease,"Multiple trials over the past two decades testing omega-3 polyunsaturated fatty acids (PUFAs), containing eicosapentaenoic acid (EPA) and or docosahexaenoic acid (DHA), have shown substantial benefits for reducing major coronary heart disease (CHD) events, all-cause mortality, cardiovascular (CV) death, sudden cardiac death (SCD), and stroke.",dha,coronary heart disease,chemdis,treat,1,treat,1,
490,dha,degenerative disease,"The role at omega-3 polyunsaturated fatty acids (PUFA), especially eicosa pentanoic acid (EPA) and decosahexaconic (DHA), has been associated with the prevention of degenerative disease.",dha,degenerative disease;degenerative disorder;degenerative disorder (diagnosis);degenerative disorder (disorder);degenerative disorders,chemdis,treat,1,treat,1,
491,dha,heart failure,"Intake of fish oil containing docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) prevents heart failure; however, the mechanisms are unclear.",dha,heart failure,chemdis,treat,1,treat,1,
492,dha,ischaemia,"Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), the (n-3) PUFA found in fish oils, exert antiarrhythmic effects during ischemia.",dha,"ischaemia;ischaemia nos;ischaemia, nos;ischemia;ischemia (diagnosis);ischemia (disorder);ischemia nos;ischemia, nos;ischemias",chemdis,treat,1,treat,1,
493,dha,myocardial infarction,"The most compelling evidence for CV benefits of omega-3 PUFA comes from 4 controlled trials of nearly 40,000 participants randomized to receive eicosapentaenoic acid (EPA) with or without docosahexaenoic acid (DHA) in studies of patients in primary prevention, after myocardial infarction, and most recently, with heart failure (HF).",dha,myocardial infarction,chemdis,treat,1,treat,1,
494,dha,obesity,"Omega-3 fatty acids, specifically EPA and DHA, have shown promising preliminary results in animal and human studies in the prevention and treatment of obesity.",dha,obesity,chemdis,treat,1,treat,1,
495,edoxaban,embolic,"The factor Xa inhibitor edoxaban (Lixiana(®)) is a new direct oral anticoagulant recently approved in the EU for the prevention of stroke and systemic embolic events (SEE) in patients with nonvalvular atrial fibrillation and one or more risk factors.___Current guidelines recommend that the vitamin K antagonist warfarin or direct oral anticoagulants (DOACs), such as the approved direct thrombin inhibitor dabigatran and the approved direct factor Xa inhibitors apixaban, rivaroxaban, and edoxaban, should be used for thromboprophylaxis in patients with nonvalvular AF at risk for stroke or systemic embolic events (SEE).","edoxaban;edoxaban (product);edoxaban (substance);edoxaban product;edoxaban-containing product;ethanediamide, n1-(5-chloro-2-pyridinyl)-n2-((1s,2r,4s)-4- ((dimethylamino)carbonyl)- 2-(((4,5,6,7-tetrahydro-5-methylthiazolo(5,4-c)pyridin-2-yl)carbonyl)amino)cyclohexyl)-;n-(5-chloropyridin-2-yl)-n'-((1s,2r,4s)-4-(n,n-dimethylcarbamoyl)-2-(5-methyl-4,5,6,7- tetrahydro(1,3)thiazolo(5,4-c)pyridine-2-carboxamido)cyclohexyl)oxamide;n-(5-chloropyridin-2-yl)-n'-[(1s,2r,4s)-4-(n,n-dimethylcarbamoyl)-2-(5-methyl-4,5,6,7- tetrahydro[1,3]thiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl]oxamide;product containing edoxaban;product containing edoxaban (medicinal product)",embolic;embolism (diagnosis);embolism (disorder);embolism -post abortion;embolism nos;embolism/embolus;embolisms,chemdis,treat,2,treat,1,
496,edoxaban,stroke,"The factor Xa inhibitor edoxaban (Lixiana(®)) is a new direct oral anticoagulant recently approved in the EU for the prevention of stroke and systemic embolic events (SEE) in patients with nonvalvular atrial fibrillation and one or more risk factors.___The latter class includes edoxaban, which has recently been approved for stroke prevention in AF by the United States Food and Drug Administration and the European Medicine Agency.","edoxaban;edoxaban (product);edoxaban (substance);edoxaban product;edoxaban-containing product;ethanediamide, n1-(5-chloro-2-pyridinyl)-n2-((1s,2r,4s)-4- ((dimethylamino)carbonyl)- 2-(((4,5,6,7-tetrahydro-5-methylthiazolo(5,4-c)pyridin-2-yl)carbonyl)amino)cyclohexyl)-;n-(5-chloropyridin-2-yl)-n'-((1s,2r,4s)-4-(n,n-dimethylcarbamoyl)-2-(5-methyl-4,5,6,7- tetrahydro(1,3)thiazolo(5,4-c)pyridine-2-carboxamido)cyclohexyl)oxamide;n-(5-chloropyridin-2-yl)-n'-[(1s,2r,4s)-4-(n,n-dimethylcarbamoyl)-2-(5-methyl-4,5,6,7- tetrahydro[1,3]thiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl]oxamide;product containing edoxaban;product containing edoxaban (medicinal product)",stroke,chemdis,treat,2,treat,1,
497,endogenous nitrate vasodilator,angiopathy,"In conclusion, the vasoprotective effects of IPA/NO were maintained in hypercholesterolemia and, thus, HNO donors may represent future novel treatments for vascular diseases.","endogenous nitrate vasodilator;endothelial cell derived relaxing factor;endothelium-derived nitric oxide;mononitrogen monoxide;monoxide, mononitrogen;monoxide, nitrogen;monoxyde d'azote;monóxido de nitrógeno;nitrate vasodilator, endogenous;nitric oxide;nitric oxide (medication);nitric oxide (product);nitric oxide (substance);nitric oxide gas;nitric oxide product;nitric oxide, endothelium derived;nitric oxide, endothelium-derived;nitric oxide-containing product;nitric oxides;nitrogen monooxide;nitrogen monoxide;nitrogen oxide (no);nitrosyl;no;no - nitric oxide;oxide, nitric;oxyde azotique;oxyde nitrique;product containing nitric oxide;product containing nitric oxide (medicinal product);stickstoff(ii)-oxid;stickstoffmonoxid;vasodilator, endogenous nitrate;vasodilators pulmonary nitric oxide;óxido de nitrógeno(ii);óxido nítrico","angiopathy;angiopathy, nos;blood vessel disease;blood vessel disorder;blood vessels; disorder;blood-vessels--diseases;disease (or disorder); blood vessels;disease (or disorder); vascular;disease, vascular;diseases, vascular;disorder of blood vessel;disorder of blood vessel (disorder);disorder vascular;disorder; vascular;section 3-8 vascular diseases;unspecified vascular problem;vasc;vascular (extracardiac) disorders;vascular dis;vascular disease;vascular disease (disorder);vascular disease or syndrome;vascular disease, nos;vascular diseases;vascular diseases and syndromes;vascular disorder;vascular disorder nos;vascular disorder, nos;vascular disorders;vascular problem;vascular problem, nos;vascular system disorders;vascular system disorders (diagnosis);vascular; disorder;vascular_nos;vascular_nos problem;vasculopathy",chemdis,treat,1,treat,,
504,enoxaparin,"thromboembolism, venous","Dabigatran etexilate has demonstrated superiority and noninferiority to enoxaparin as prophylaxis for venous thromboembolism in patients undergoing orthopedic surgery, with the most frequent adverse effects being gastrointestinal complaints.",enoxaparin;enoxaparin (medication);enoxaparin (product);enoxaparin (substance);enoxaparin product;enoxaparin-containing product;enoxaparine;product containing enoxaparin;product containing enoxaparin (medicinal product),"thromboembolism, venous;venous thromboembolism",chemdis,treat,1,treat,1,
505,epa,3-00 cardiovascular disorders: general terms,"Recommendations to consume fish for prevention of cardiovascular disease (CVD), along with the U.S. Food and Drug Administration-approved generally recognized as safe (GRAS) status for long chain omega-3 fatty acids, may have had the unanticipated consequence of encouraging long-chain omega-3 (ω-3) fatty acid [(eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)] supplementation and fortification practices.___There is considerable evidence that EPA and DHA are protective against cardiovascular disease (heart disease and stroke), particularly in individuals with pre-existing disease.",epa,"3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,treat,2,treat,1,
506,epa,coronary heart disease,"Multiple trials over the past two decades testing omega-3 polyunsaturated fatty acids (PUFAs), containing eicosapentaenoic acid (EPA) and or docosahexaenoic acid (DHA), have shown substantial benefits for reducing major coronary heart disease (CHD) events, all-cause mortality, cardiovascular (CV) death, sudden cardiac death (SCD), and stroke.",epa,coronary heart disease,chemdis,treat,1,treat,1,
507,epa,degenerative disease,"The role at omega-3 polyunsaturated fatty acids (PUFA), especially eicosa pentanoic acid (EPA) and decosahexaconic (DHA), has been associated with the prevention of degenerative disease.",epa,degenerative disease;degenerative disorder;degenerative disorder (diagnosis);degenerative disorder (disorder);degenerative disorders,chemdis,treat,1,treat,1,
508,epa,heart failure,"Intake of fish oil containing docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA) prevents heart failure; however, the mechanisms are unclear.",epa,heart failure,chemdis,treat,1,treat,,
510,epa,myocardial infarction,"The most compelling evidence for CV benefits of omega-3 PUFA comes from 4 controlled trials of nearly 40,000 participants randomized to receive eicosapentaenoic acid (EPA) with or without docosahexaenoic acid (DHA) in studies of patients in primary prevention, after myocardial infarction, and most recently, with heart failure (HF).",epa,myocardial infarction,chemdis,treat,1,treat,1,
511,epa,obesity,"Omega-3 fatty acids, specifically EPA and DHA, have shown promising preliminary results in animal and human studies in the prevention and treatment of obesity.",epa,obesity,chemdis,treat,1,treat,1,
512,ester,angina,"Because L-carnitine and its esters help reduce oxidative stress, they have been proposed as a treatment for many conditions, i.e. heart failure, angina and weight loss.","ester;ester (substance);ester, nos;esters;organic ester",angina,chemdis,treat,1,treat,1,
513,ester,heart failure,"Because L-carnitine and its esters help reduce oxidative stress, they have been proposed as a treatment for many conditions, i.e. heart failure, angina and weight loss.","ester;ester (substance);ester, nos;esters;organic ester",heart failure,chemdis,treat,1,treat,1,
514,ester,weight loss,"Because L-carnitine and its esters help reduce oxidative stress, they have been proposed as a treatment for many conditions, i.e. heart failure, angina and weight loss.","ester;ester (substance);ester, nos;esters;organic ester",weight loss,chemdis,treat,1,treat,1,
515,estrogen,3-10 heart diseases: general terms,"Phyto-estrogens are plant-derived compounds that can exert various estrogenic and anti-estrogenic effects, and are usually used as a natural alternative to estrogen replacement due to their health benefits, including a lowered risk of osteoporosis, heart disease, breast cancer, and menopausal symptoms.___Soy protein, a good source of isoflavones that are known to bind estrogen receptors, has also been promoted as a dietary means for reducing the risk of heart disease.",estrogen,"3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",chemdis,treat,2,treat,,
516,estrogen,breast cancer,"Phyto-estrogens are plant-derived compounds that can exert various estrogenic and anti-estrogenic effects, and are usually used as a natural alternative to estrogen replacement due to their health benefits, including a lowered risk of osteoporosis, heart disease, breast cancer, and menopausal symptoms.",estrogen,breast cancer,chemdis,treat,1,treat,1,
520,estrogens,3-10 heart diseases: general terms,"Thus, it has been suggested that estrogens convey the protective effect for the female sex against heart disease.",estrogens,"3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",chemdis,treat,1,treat,1,
521,estrogens,coronary heart disease,Results of recent clinical trials indicate that mammalian estrogens may be less effective in reducing coronary heart disease risk than once thought.,estrogens,coronary heart disease,chemdis,treat,1,treat,,
524,ethyl 2-[[(1r)-1-cyclohexyl-2- [(2s)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate,a fib,"Direct thrombin inhibitors, such as ximelagatran, may be as effective as warfarin for stroke-risk reduction in patients with AF.","ethyl 2-[[(1r)-1-cyclohexyl-2- [(2s)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate;glycine, n-((1)1-cyclohexyl-2-((2)-((((4-(amino(hydroxyimino)methyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)2-oxoethyl)-ethyl ester;glycine, n-((1r)1-cyclohexyl-2-((2s)-((((4-(amino(hydroxyimino)methyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)2-oxoethyl)-ethyl ester;xi-melagatran;ximelagatran;ximelagatran (substance);ximelagatranum;ximelagatrán;ximelagratan;ximelagratan (substance);ximélagatran","a fib;af;af - atrial fibrillation;afib;atrial fibrillation (af);atrial fibrillation (diagnosis);atrial fibrillation (disorder);atrial fibrillations;atrium; fibrillation;auricular fibrillation;auricular fibrillations;auricular; fibrillation;fibrillation - atrial;fibrillation atrial;fibrillation, atrial;fibrillation, auricular;fibrillation; atrial or auricular;fibrillation;atrial;fibrillations, atrial;fibrillations, auricular;quivering upper heart chambers resulting in irregular heartbeat",chemdis,treat,1,treat,1,
525,ethyl 2-[[(1r)-1-cyclohexyl-2- [(2s)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate,accident - cerebrovascular,"The SPORTIF III and V trials have shown that ximelagatran is not inferior to warfarin in the prevention of strokes in patients with NRAF (both persistent and paroxysmal), but a side effect--consisting in the significant elevation of liver enzymes (> 3 times the upper limit of normal) in 6% of patients--was found.","ethyl 2-[[(1r)-1-cyclohexyl-2- [(2s)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate;glycine, n-((1)1-cyclohexyl-2-((2)-((((4-(amino(hydroxyimino)methyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)2-oxoethyl)-ethyl ester;glycine, n-((1r)1-cyclohexyl-2-((2s)-((((4-(amino(hydroxyimino)methyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)2-oxoethyl)-ethyl ester;xi-melagatran;ximelagatran;ximelagatran (substance);ximelagatranum;ximelagatrán;ximelagratan;ximelagratan (substance);ximélagatran","accident - cerebrovascular;accident cerebrovascular;accident; cerebral;accident; cerebrovascular;apoplexy;apoplexy, cerebral;apoplexy, cerebrovascular;apoplexy, nos;apoplexy; cerebral;apoplexy; stroke;brain attack;brain vascular accident;brain vascular accidents;cerebral apoplexy;cerebral apoplexy, nos;cerebral stroke;cerebral strokes;cerebral vascular accident;cerebral vascular events;cerebral; accident;cerebral; apoplexy;cerebrovascular accident;cerebrovascular accident (disorder);cerebrovascular accident (disorder) [ambiguous];cerebrovascular accident nos;cerebrovascular accident, nos;cerebrovascular accidents;cerebrovascular apoplexy;cerebrovascular stroke;cerebrovascular strokes;cerebrovascular; accident;cva (cerebral vascular accident);cva (cerebrovascular accident);cva - cerebrovascular accident;cva - cerebrovascular accident (& unspecified [& stroke]);cva - cerebrovascular accident (& unspecified [& stroke]) (disorder);cva - cerebrovascular accident unspecified;cva nos;cva unspecified;cva, nos;cvas (cerebrovascular accident);stroke (cerebrum);stroke and cerebrovascular accident unspecified;stroke and cerebrovascular accident unspecified (disorder);stroke cerebral;stroke nos;stroke nos (disorder);stroke unspecified;stroke, cerebral;stroke, cerebrovascular;stroke, neurological;stroke, nos;stroke, not specified as haemorrhage or infarction;stroke, not specified as hemorrhage or infarction;stroke/cerebrovasc accident;stroke/cerebrovascular accident;stroke/cva;stroke/cva - undefined;stroke/cva unspecified;stroke; apoplectic;strokes;strokes, cerebral;strokes, cerebrovascular;undetermined stroke;vascular accident, brain;vascular accidents, brain;vascular brain accident;vascular cerebral accident",chemdis,treat,1,treat,1,
526,ethyl 2-[[(1r)-1-cyclohexyl-2- [(2s)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate,blood clot in blood vessel,"Further randomized trials are clearly needed, while current data suggest that ximelagatran will be able to represent a future viable therapeutic option for prevention of thromboembolism in patients with NRAF, offering huge advantages with respect to classic oral anticoagulants.","ethyl 2-[[(1r)-1-cyclohexyl-2- [(2s)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate;glycine, n-((1)1-cyclohexyl-2-((2)-((((4-(amino(hydroxyimino)methyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)2-oxoethyl)-ethyl ester;glycine, n-((1r)1-cyclohexyl-2-((2s)-((((4-(amino(hydroxyimino)methyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)2-oxoethyl)-ethyl ester;xi-melagatran;ximelagatran;ximelagatran (substance);ximelagatranum;ximelagatrán;ximelagratan;ximelagratan (substance);ximélagatran",blood clot in blood vessel;disease thromboembolic;diseases thromboembolic;embolism and thrombosis of unspecified site;embolism; thrombus;events thromboembolic;other venous embolism and thrombosis of unspecified site;thromboembolic disease;thromboembolic disease (diagnosis);thromboembolic disorder;thromboembolic disorder (disorder);thromboembolic events;thromboembolic; disorder;thromboembolism;thromboembolism - lesion;thromboembolism - lesion (disorder);thromboembolism nos;thromboembolisms;thromboembolus;thromboembolus (morphologic abnormality);thrombus; embolism,chemdis,treat,1,treat,1,
527,ethyl 2-[[(1r)-1-cyclohexyl-2- [(2s)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate,embolic,"Data from SPORTIF III show an absolute reduction in stroke and systemic embolic events with ximelagatran compared with warfarin at 21 months (1.6 vs. 2.3% per year, respectively; p = 0.10).","ethyl 2-[[(1r)-1-cyclohexyl-2- [(2s)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate;glycine, n-((1)1-cyclohexyl-2-((2)-((((4-(amino(hydroxyimino)methyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)2-oxoethyl)-ethyl ester;glycine, n-((1r)1-cyclohexyl-2-((2s)-((((4-(amino(hydroxyimino)methyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)2-oxoethyl)-ethyl ester;xi-melagatran;ximelagatran;ximelagatran (substance);ximelagatranum;ximelagatrán;ximelagratan;ximelagratan (substance);ximélagatran",embolic;embolism (diagnosis);embolism (disorder);embolism -post abortion;embolism nos;embolism/embolus;embolisms,chemdis,treat,1,treat,1,
528,ethyl 2-[[(1r)-1-cyclohexyl-2- [(2s)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate,stroke,"In two large randomized trials comparing fixed-dose ximelagatran with warfarin in noninferiority studies, ximelagatran appears to be as effective at preventing stroke and thromboembolic events as warfarin (based on intention-to-treat analysis) and with similar, if not better, long-term risk.___Direct thrombin inhibitors, such as ximelagatran, may be as effective as warfarin for stroke-risk reduction in patients with AF.___Data from SPORTIF III show an absolute reduction in stroke and systemic embolic events with ximelagatran compared with warfarin at 21 months (1.6 vs. 2.3% per year, respectively; p = 0.10).___The results of SPORTIF III and V demonstrate that a fixed oral dose of ximelagatran, without coagulation monitoring, is comparable to dose-adjusted warfarin in preventing stroke and other thromboembolic complications among moderate- to high-risk AF patients and has a lower rate of both major and minor bleeding.___With its positive benefit-risk ratio, ximelagatran may increase the population of eligible patients for anticoagulation with AF and maximize the potential of anticoagulation in the prevention of stroke.","ethyl 2-[[(1r)-1-cyclohexyl-2- [(2s)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate;glycine, n-((1)1-cyclohexyl-2-((2)-((((4-(amino(hydroxyimino)methyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)2-oxoethyl)-ethyl ester;glycine, n-((1r)1-cyclohexyl-2-((2s)-((((4-(amino(hydroxyimino)methyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)2-oxoethyl)-ethyl ester;xi-melagatran;ximelagatran;ximelagatran (substance);ximelagatranum;ximelagatrán;ximelagratan;ximelagratan (substance);ximélagatran",stroke,chemdis,treat,5,treat,1,
530,fatty acid,52-53 vascular scleroses,"Although baPWV values may not directly indicate arteriosclerosis, the present study suggests that long-term n-3 fatty acid intake is beneficial for the vascular system.","fatty acid;fatty acid (substance);fatty acid, nos;fatty acids","52-53 vascular scleroses;arterial sclerosis;arterioscleroses;arteriosclerosis;arteriosclerosis (morphologic abnormality);arteriosclerosis nos;arteriosclerosis, nos;arteriosclerosis/atherosclerosis;arteriosclerotic vasc.dis.nos;arteriosclerotic vascular disease;arteriosclerotic vascular disease (diagnosis);arteriosclerotic vascular disease (disorder);arteriosclerotic vascular disease nos;arteriosclerotic vascular disease nos (disorder);arteriosclerotic vascular disease, nos;arteriovascular disease;vascular scleroses;vascular sclerosis;vascular sclerosis (morphologic abnormality)",chemdis,treat,1,treat,1,
531,fatty acid,[d]septic shock,"This may explain why these fatty acids could be of benefit in the management of conditions such as septicemia and septic shock, Alzheimer's disease, Parkinson's disease, inflammatory bowel diseases, diabetes mellitus, essential hypertension and atherosclerosis.","fatty acid;fatty acid (substance);fatty acid, nos;fatty acids","[d]septic shock;[d]septic shock (context-dependent category);[d]septic shock (situation);[d]septicaemic shock;[d]septicemic shock;septic shock;septic shock (diagnosis);septic shock (disorder);septic; shock;septicaemic shock;septicemic shock;shock septic;shock, septic;shock; septic;systemic septic shock",chemdis,treat,1,treat,1,
532,fatty acid,abnormal heart rhythms,The results of this study and the mechanisms by which n-3 fish oil fatty acids prevent fatal cardiac arrhythmias will be the subject of this review.,"fatty acid;fatty acid (substance);fatty acid, nos;fatty acids","abnormal heart rhythms;arrhythmia (cardiac) nos;arrhythmia (finding);arrhythmia (nos);arrhythmia cardiac (nos);arrhythmia nos;arrhythmia, cardiac;arrhythmia, nos;arrhythmias;arrhythmias (heart);arrhythmias, cardiac;arrythmia;cardiac arrhythmia (disorder);cardiac arrhythmia (nos);cardiac arrhythmia nos;cardiac arrhythmia, irregular pulse;cardiac arrhythmia, nos;cardiac arrhythmia, unspecified;cardiac arrhythmias;cardiac dysrhythmia (disorder);cardiac dysrhythmia nos;cardiac dysrhythmia nos (disorder);cardiac dysrhythmia, nos;cardiac dysrhythmia, unspecified;cardiac dysrhythmias nos;cardiac rhythm disorder (diagnosis);cardiac rhythm disturbance;cardiac rhythm disturbances;cardiac rhythm irregular;cardiac rhythm, abnormal;cardiac; dysrhythmia;disorder of heart rhythm;disorder; rhythm, heart;disturbance; rhythm, heart;dysrhythmia;dysrhythmia(s);dysrhythmia, cardiac;dysrhythmia; cardiac;dysrhythmia;cardiac;dysrhythmias;ectopic beats all types;heart arrhythmia;heart arrhythmias;heart rhythm disorders;heart: rhythm;rhythm, heart; abnormal;rhythm; abnormal;rhythm; disorder",chemdis,treat,1,treat,1,
533,fatty acid,agitans; paralysis,"This may explain why these fatty acids could be of benefit in the management of conditions such as septicemia and septic shock, Alzheimer's disease, Parkinson's disease, inflammatory bowel diseases, diabetes mellitus, essential hypertension and atherosclerosis.","fatty acid;fatty acid (substance);fatty acid, nos;fatty acids","agitans; paralysis;bodies disease lewy parkinson's;disease disorders parkinson's;disease idiopathic parkinsons;disease parkinson s;disease parkinson's;disease parkinsons's;disease;parkinsons;diseases parkinson;diseases parkinson's;diseases parkinsons;idiopathic parkinson dis;idiopathic parkinson disease;idiopathic parkinson's disease;idiopathic parkinsonism;idiopathic parkinsons dis;lewy body parkinson dis;lewy body parkinson disease;lewy body parkinson's disease;palsy shaking;palsy, shaking;palsy; shaking;paralysis agitans;paralysis agitans <parkinsonism>;paralysis agitans parkinsonism;paralysis; agitans;paralysis;agitans;parkinson dis;parkinson dis idiopathic;parkinson disease;parkinson disease (diagnosis);parkinson disease (pd);parkinson disease lewy body;parkinson disease, idiopathic;parkinson s disease;parkinson's;parkinson's dis;parkinson's disease;parkinson's disease (disorder);parkinson's disease nos;parkinson's disease nos (disorder);parkinson's disease, idiopathic;parkinson's disease, lewy body;parkinson's disease, nos;parkinson's syndrome;parkinson`s disease;parkinsonism, primary;parkinsons dis;parkinsons dis idiopathic;parkinsons dis lewy body;parkinsons disease;pd - parkinson's disease;primary parkinsonism;shaking palsy;shaking; palsy;syndrome parkinson's",chemdis,treat,1,treat,1,
539,fatty acid,ischaemia,We hypothesized that a specific dietary fatty acid profile (low in saturated and n-6 PUFA but high in plant and marine n-3 PUFA) may improve myocardial resistance to ischemia-reperfusion injury and reduce infarct size.,"fatty acid;fatty acid (substance);fatty acid, nos;fatty acids","ischaemia;ischaemia nos;ischaemia, nos;ischemia;ischemia (diagnosis);ischemia (disorder);ischemia nos;ischemia, nos;ischemias",chemdis,treat,1,treat,1,
540,fatty acid,myocardial infarction,"Currently, food sources rich in n-3 fatty acids are thought to be beneficial in secondary prophylaxis after a myocardial infarction.","fatty acid;fatty acid (substance);fatty acid, nos;fatty acids",myocardial infarction,chemdis,treat,1,treat,1,
541,fatty acid,obesity,"If these fatty acids do harbor such potential, their supplementation in many parts of the world may hold great promise in reducing the global burden of obesity.___These results suggest that ACC2 plays an essential role in controlling fatty acid oxidation and is a potential target in therapy against obesity and related diseases.","fatty acid;fatty acid (substance);fatty acid, nos;fatty acids",obesity,chemdis,treat,2,treat,1,
542,fatty acid,septicemia,"This may explain why these fatty acids could be of benefit in the management of conditions such as septicemia and septic shock, Alzheimer's disease, Parkinson's disease, inflammatory bowel diseases, diabetes mellitus, essential hypertension and atherosclerosis.","fatty acid;fatty acid (substance);fatty acid, nos;fatty acids",septicemia,chemdis,treat,1,treat,1,
543,fatty acid,sudden death,Fatty acids may reduce the risk of sudden death by preventing life-threatening cardiac arrhythmia.,"fatty acid;fatty acid (substance);fatty acid, nos;fatty acids",sudden death,chemdis,treat,1,treat,1,
544,fcm,anemia,"A good example of these new compounds is ferric carboxymaltose (FCM), which has recently been approved by the US Food and Drug Administration for the treatment of iron deficiency anemia in adult patients who are intolerant to oral iron or present an unsatisfactory response to oral iron, and in adult patients with non-dialysis-dependent chronic kidney disease (NDD-CKD).",fcm,anemia,chemdis,treat,1,treat,1,
545,ferric carboxymaltose,anemia,"A good example of these new compounds is ferric carboxymaltose (FCM), which has recently been approved by the US Food and Drug Administration for the treatment of iron deficiency anemia in adult patients who are intolerant to oral iron or present an unsatisfactory response to oral iron, and in adult patients with non-dialysis-dependent chronic kidney disease (NDD-CKD).","ferric carboxymaltose;ferric carboxymaltose (medication);ferric carboxymaltose (product);ferric carboxymaltose (substance);ferric carboxymaltose product;ferric carboxymaltose-containing product;iron (as ferric carboxymaltose);iron carboxymaltose;iron dextri-maltose;polynuclear iron (iii)-hydroxide 4(r)-(poly-(1->4)-o-alpha-d-glucopyranosyl)-oxy-2(r),3(s),5(r), 6-tetrahydroxy-hexanoate;product containing ferric carboxymaltose;product containing ferric carboxymaltose (medicinal product)",anemia,chemdis,treat,1,treat,1,
546,ferric carboxymaltose,chronic kidney disease,"A good example of these new compounds is ferric carboxymaltose (FCM), which has recently been approved by the US Food and Drug Administration for the treatment of iron deficiency anemia in adult patients who are intolerant to oral iron or present an unsatisfactory response to oral iron, and in adult patients with non-dialysis-dependent chronic kidney disease (NDD-CKD).","ferric carboxymaltose;ferric carboxymaltose (medication);ferric carboxymaltose (product);ferric carboxymaltose (substance);ferric carboxymaltose product;ferric carboxymaltose-containing product;iron (as ferric carboxymaltose);iron carboxymaltose;iron dextri-maltose;polynuclear iron (iii)-hydroxide 4(r)-(poly-(1->4)-o-alpha-d-glucopyranosyl)-oxy-2(r),3(s),5(r), 6-tetrahydroxy-hexanoate;product containing ferric carboxymaltose;product containing ferric carboxymaltose (medicinal product)",chronic kidney disease,chemdis,treat,1,treat,1,
547,iron,anemia,"A good example of these new compounds is ferric carboxymaltose (FCM), which has recently been approved by the US Food and Drug Administration for the treatment of iron deficiency anemia in adult patients who are intolerant to oral iron or present an unsatisfactory response to oral iron, and in adult patients with non-dialysis-dependent chronic kidney disease (NDD-CKD).",iron,anemia,chemdis,treat,1,treat,,
548,iron,anemia; thalassemia,The novel oral chelator deferasirox was recently approved by the Food and Drug Administration (FDA); a randomized clinical trial demonstrates that deferasirox at 20 to 30 mg/kg/d can maintain or improve hepatic iron in thalassemia as well as deferoxamine.,iron,"anemia; thalassemia;c-132-136 thalassemias;hemoglobinopathy; with thalassemia;hereditary leptocytosis;hypochromic / microcytic thalassemia;hypochromic / microcytic thalassemia (diagnosis);hypochromic / microcytic thalassemia anemia;leptocytosis, hereditary;leptocytosis; hereditary;syndromes thalassemia;thalassaemia;thalassaemia (disorder);thalassaemia nos;thalassaemia syndrome;thalassaemia, unspecified;thalassaemias;thalassaemic disorders;thalassemia;thalassemia (diagnosis);thalassemia (disorder);thalassemia disorder;thalassemia nos;thalassemia nos (disorder);thalassemia syndrome;thalassemia syndrome (disorder);thalassemia syndrome, nos;thalassemia, nos;thalassemia, unspecified;thalassemia; anemia;thalassemia; disorder, hemoglobin;thalassemia; hemoglobinopathy (with thalassemia);thalassemias;thalassemic syndrome;thalassemic syndromes",chemdis,treat,1,treat,,
549,iron,chronic disease renal,"We have previously shown that dietary iron restriction prevents the development of renal damage in a rat model of chronic kidney disease (CKD).___A good example of these new compounds is ferric carboxymaltose (FCM), which has recently been approved by the US Food and Drug Administration for the treatment of iron deficiency anemia in adult patients who are intolerant to oral iron or present an unsatisfactory response to oral iron, and in adult patients with non-dialysis-dependent chronic kidney disease (NDD-CKD).___Cumulative information from randomized, controlled, multicenter trials on a diverse range of indications, including patients with chronic heart failure, postpartum anemia/abnormal uterine bleeding, inflammatory bowel disease, NDD-CKD, and those undergoing hemodialysis, supports the efficacy of FCM for iron replacement in patients with iron deficiency and iron-deficiency anemia.",iron,"chronic disease renal;chronic diseases renal;chronic kidney dis nos;chronic kidney disease (ckd);chronic kidney disease (disorder);chronic kidney disease, unspecified;chronic kidney diseases;chronic renal diseases;ckd;ckd - chronic kidney disease;disease (or disorder); kidney, chronic;disease, chronic kidney;disease, chronic renal;diseases, chronic kidney;diseases, chronic renal;kidney disease, chronic;kidney diseases, chronic;kidney; disease, chronic;loss of renal function;renal disease chronic;renal disease, chronic;renal diseases, chronic",chemdis,treat,3,treat,,
550,iron,chronic kidney disease,"A good example of these new compounds is ferric carboxymaltose (FCM), which has recently been approved by the US Food and Drug Administration for the treatment of iron deficiency anemia in adult patients who are intolerant to oral iron or present an unsatisfactory response to oral iron, and in adult patients with non-dialysis-dependent chronic kidney disease (NDD-CKD).",iron,chronic kidney disease,chemdis,treat,1,treat,1,
551,magnesium,3-10 heart diseases: general terms,"Universal drinking water and beverages containing moderate to high levels of magnesium (10–100 ppm) could potentially prevent 4.5 million heart disease and stroke deaths per year, worldwide.",magnesium,"3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",chemdis,treat,1,treat,1,
552,magnesium,abnormal heart rhythms,"Magnesium supplementation improves myocardial metabolism, inhibits calcium accumulation and myocardial cell death; it improves vascular tone, peripheral vascular resistance, afterload and cardiac output, reduces cardiac arrhythmias and improves lipid metabolism.",magnesium,"abnormal heart rhythms;arrhythmia (cardiac) nos;arrhythmia (finding);arrhythmia (nos);arrhythmia cardiac (nos);arrhythmia nos;arrhythmia, cardiac;arrhythmia, nos;arrhythmias;arrhythmias (heart);arrhythmias, cardiac;arrythmia;cardiac arrhythmia (disorder);cardiac arrhythmia (nos);cardiac arrhythmia nos;cardiac arrhythmia, irregular pulse;cardiac arrhythmia, nos;cardiac arrhythmia, unspecified;cardiac arrhythmias;cardiac dysrhythmia (disorder);cardiac dysrhythmia nos;cardiac dysrhythmia nos (disorder);cardiac dysrhythmia, nos;cardiac dysrhythmia, unspecified;cardiac dysrhythmias nos;cardiac rhythm disorder (diagnosis);cardiac rhythm disturbance;cardiac rhythm disturbances;cardiac rhythm irregular;cardiac rhythm, abnormal;cardiac; dysrhythmia;disorder of heart rhythm;disorder; rhythm, heart;disturbance; rhythm, heart;dysrhythmia;dysrhythmia(s);dysrhythmia, cardiac;dysrhythmia; cardiac;dysrhythmia;cardiac;dysrhythmias;ectopic beats all types;heart arrhythmia;heart arrhythmias;heart rhythm disorders;heart: rhythm;rhythm, heart; abnormal;rhythm; abnormal;rhythm; disorder",chemdis,treat,1,treat,1,
553,magnesium,arrhythmia ventricular,"Furthermore, the theoretical potential benefits of magnesium supplementation as a cardioprotective agent in CAD patients, its relatively low cost, easy administration, and relatively insignificant adverse effects, gives magnesium a place in treating CAD patients, especially those at high-risk and in life-threatening ventricular arrhythmias, such as Torsades de Points and intractable ventricular tachycardia.",magnesium,"arrhythmia ventricular;arrhythmia ventricular (nos);arrhythmia, ventricular;arrhythmias ventricular;dysrhythmias ventricular;ventricular arrhythmia (diagnosis);ventricular arrhythmia (disorder);ventricular arrhythmia, nos;ventricular arrhythmias;ventricular dysrhythmia;ventricular dysrhythmia (finding)",chemdis,treat,1,treat,1,
554,magnesium,cad,"Furthermore, the theoretical potential benefits of magnesium supplementation as a cardioprotective agent in CAD patients, its relatively low cost, easy administration, and relatively insignificant adverse effects, gives magnesium a place in treating CAD patients, especially those at high-risk and in life-threatening ventricular arrhythmias, such as Torsades de Points and intractable ventricular tachycardia.___The prevalence of CAD was significantly higher among subjects consuming lower dietary magnesium.___Lower consumption of dietary magnesium and low serum Mg level in north India have a higher prevalence of CAD and of the coronary risk factors hypertension, hypercholesterolemia and diabetes mellitus.",magnesium,cad,chemdis,treat,3,treat,1,
556,omega-3 fatty acid,cardiac death,Marine omega-3 fatty acid supplements (omega-3 s) have shown efficacy in decreasing sudden cardiac death and improving the left ventricle ejection fraction percent (LVEF%).,omega-3 fatty acid,"cardiac death;cardiac deaths;cardiac; death;death, cardiac;death; cardiac",chemdis,treat,1,treat,1,
557,omega-3 fatty acid,coronary heart disease,The 2017 American Heart Association science advisory on omega-3 fatty acid supplements suggested that it is reasonable to use omega-3 fatty acids for secondary prevention in people with coronary heart disease and heart failure.,omega-3 fatty acid,coronary heart disease,chemdis,treat,1,treat,1,
558,omega-3 fatty acid,cvd,"Although previous randomized, double-blind, placebo-controlled trials reported the efficacy of omega-3 fatty acid supplements in the secondary prevention of cardiovascular disease (CVD), the evidence remains inconclusive.",omega-3 fatty acid,cvd,chemdis,treat,1,treat,1,
559,omega-3 fatty acid,heart failure,The 2017 American Heart Association science advisory on omega-3 fatty acid supplements suggested that it is reasonable to use omega-3 fatty acids for secondary prevention in people with coronary heart disease and heart failure.,omega-3 fatty acid,heart failure,chemdis,treat,1,treat,1,
560,omega-3 fatty acid,hypertension,These results suggest that different sources of ALA are effective in preventing hypertension related to omega-3 fatty acid deficiency.,omega-3 fatty acid,hypertension,chemdis,treat,1,treat,,
561,potassium,elevated serum potassium levels,"Two novel potassium binders, patiromer and sodium zirconium cyclosilicate, have recently been approved by the US Food and Drug Administration for the management of hyperkalaemia.",potassium,elevated serum potassium levels;excess k;excess potassium;excess; potassium;excessive potassium in the blood;high blood potassium level;hyperkalaemia;hyperkalaemia (disorder);hyperkalaemic syndrome;hyperkalemia (diagnosis);hyperkalemia (disorder);hyperkalemias;hyperkalemic disorder;hyperkalemic syndrome;hyperkalemic; syndrome;hyperpotassaemia;hyperpotassemia;hyperpotassemias;k excess;k overload;overload; potassium;potassium [k] excess;potassium [k] overload;potassium excess;potassium overload;potassium overload (disorder);potassium; excess;potassium; overload;raised serum potassium level;raised serum potassium level (finding);serum potassium concentration increased above normal;syndrome; hyperkalemic,chemdis,treat,1,treat,1,
562,potassium,heart failure,"Spironolactone, an antagonist of aldosterone, initially used as a potassium-sparing diuretic, was subsequently shown to be a very effective adjunctive agent in the treatment of patients with heart failure with reduced ejection fraction, by halting the disease progression, with significant beneficial effects on both morbidity and mortality.",potassium,heart failure,chemdis,treat,1,treat,,
563,potassium,hyperkalemia,"RDX7675, a novel potassium binder in development for the treatment of hyperkalemia, is a calcium salt of a reengineered polystyrene sulfonate-based resin designed to have enhanced palatability.",potassium,hyperkalemia,chemdis,treat,1,treat,1,
564,pradaxa,embolism,"Dabigatran (Pradaxa) is a new oral anticoagulant approved by the Food and Drug Administration (FDA), available internationally and indicated as an alternative to warfarin for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.",pradaxa,"embolism;embolism, nos",chemdis,treat,1,treat,1,
565,pradaxa,stroke,"Dabigatran (Pradaxa) is a new oral anticoagulant approved by the Food and Drug Administration (FDA), available internationally and indicated as an alternative to warfarin for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.",pradaxa,stroke,chemdis,treat,1,treat,1,
566,sodium,adult onset diabetes,"Sodium-glucose co-transporter 2 inhibitors (SGLT2is) such as dapagliflozin, canagliflozin, and empagliflozin, are a promising new therapy in the treatment of type 2 diabetes mellitus (T2DM).___The sodium-glucose cotransporter 2 (SGLT2) inhibitors are a class of glucose-lowering therapies that have been shown to reduce risks of heart failure (HF) events in patients with type 2 diabetes mellitus (T2DM) at high-risk for or with cardiovascular disease.___Sodium-glucose cotransporter 2 (SGLT2) inhibitors such as Empagliflozin are novel antihyperglycemic drugs approved for the treatment of type 2 diabetes (T2D).",sodium,"adult onset diabetes;adult onset diabetes mellitus;adult-onset diabetes;adult-onset diabetes mellitus;adult-onset; diabetes;aodm;diabete type 2;diabetes mellitus (adult onset);diabetes mellitus (niddm);diabetes mellitus - adult ons;diabetes mellitus - adult onset;diabetes mellitus -adult onset;diabetes mellitus maturity onset;diabetes mellitus non insulin dependent;diabetes mellitus non insulin-dep;diabetes mellitus non-insulin-dependent;diabetes mellitus nos late onset;diabetes mellitus type 02;diabetes mellitus type 2;diabetes mellitus type 2 (disorder);diabetes mellitus type ii;diabetes mellitus, adult onset;diabetes mellitus, adult onset type;diabetes mellitus, adult-onset;diabetes mellitus, ketosis resistant;diabetes mellitus, ketosis-resistant;diabetes mellitus, maturity onset;diabetes mellitus, maturity-onset;diabetes mellitus, non insulin dependent;diabetes mellitus, non-insulin dependent;diabetes mellitus, non-insulin-dependent;diabetes mellitus, noninsulin dependent;diabetes mellitus, noninsulin-dependent;diabetes mellitus, slow onset;diabetes mellitus, slow-onset;diabetes mellitus, stable;diabetes mellitus, type 2;diabetes mellitus, type ii;diabetes mellitus: [adult onset] or [noninsulin dependent];diabetes mellitus: [adult onset] or [noninsulin dependent] (disorder);diabetes non-insulin dependent;diabetes type 2;diabetes type ii;diabetes, adult onset;diabetes, ketosis resistant;diabetes, maturity onset;diabetes, maturity-onset;diabetes, type 2;diabetes, type ii;diabetes; adult-onset;diabetes; maturity-onset;diabetes; niddm;diabetes; non-insulin-dependent;diabetes; nonketotic;diabetes; type ii;diabetes;adult onset;diabetes;non insulin depend;diabetes;type 2;ketosis resistant diabetes;ketosis-resistant diabetes mellitus;late onset diabetes;maturity onset diabetes;maturity onset diabetes mellit;maturity onset diabetes mellitus;maturity-onset diabetes;maturity-onset diabetes mellitus;maturity-onset; diabetes;mod;ncdmm;niddm;niddm - non-insulin dependent diabetes mellitus;niddm diabetes mellitus;niddm-non-ins dep diabetes mel;niddm; diabetes;non insulin dependent diabetes;non-ins-dep diabetes mellitus;non-insulin dependent diabetes;non-insulin dependent diabetes mellitus;non-insulin-dependent diabetes;non-insulin-dependent diabetes mellitus;non-insulin-dependent; diabetes;noninsulin dependent diab.mell;noninsulin dependent diabetes;noninsulin dependent diabetes mellitus;noninsulin-dependent diabetes;noninsulin-dependent diabetes mellitus;nonketotic; diabetes;slow-onset diabetes mellitus;stable diabetes mellitus;t2dm - type 2 diabetes mellitus;type 2 diabetes;type 2 diabetes mellitus;type 2 diabetes mellitus (diagnosis);type 2 diabetes mellitus non-insulin dependent;type ii diabetes;type ii diabetes mellitus;type ii diabetes mellitus (disorder);type ii; diabetes",chemdis,treat,3,treat,0,
567,sodium,chronic kidney disease,"Sodium-glucose cotransporter-2 inhibitors have exhibited concordant risk reduction and clinically important benefits in chronic kidney disease with and without diabetes, diabetes and established cardiovascular disease or multiple atherosclerotic vascular disease risk factors, and heart failure with reduced ejection fraction with and without diabetes.",sodium,chronic kidney disease,chemdis,treat,1,treat,0,
568,sodium,diab.mell. with nephropathy,"Sodium-glucose cotransporter 2 inhibitors (SGLT2i) have clearly demonstrated their beneficial effect in diabetic kidney disease (DKD) on top of the standard of care [blood glucose control, renin-angiotensin system blockade, smoking cessation and blood pressure (BP) control], even in patients with overt DKD.",sodium,"diab.mell. with nephropathy;diab.mell.+nephropathy nos;diabetes + nephropathy;diabetes + nephropathy (& [kimmelstiel-wilson syndrome]);diabetes + nephropathy (& [kimmelstiel-wilson syndrome]) (disorder);diabetes mellitis with nephropathy nos;diabetes mellitis with nephropathy nos (disorder);diabetes mellitus with renal manifestation;diabetes mellitus with renal manifestation (disorder);diabetes mellitus: [with renal manifestation] or [nephropathy];diabetes mellitus: [with renal manifestation] or [nephropathy] (disorder);diabetes with renal manifestations;diabetes with renal manifestations (diagnosis);diabetes with renal manifestations (disorder);diabetes; nephropathy (manifestation);diabetic kidney disease;diabetic kidney diseases;diabetic kidney problems;diabetic nephropathies;diabetic nephropathy;diabetic nephropathy (diagnosis);diabetic nephropathy nos;diabetic nephropathy syndrome;diabetic renal disease;diabetic renal disease (disorder);diabetic renal manifestation;disorder of kidney co-occurrent and due to diabetes mellitus;disorder of kidney co-occurrent and due to diabetes mellitus (disorder);disorder of kidney due to diabetes mellitus;disorder of kidney due to diabetes mellitus (disorder);kidney disease, diabetic;kidney diseases, diabetic;kidney disorder due to diabetes mellitus;nephropathies, diabetic;nephropathy - diabetic;nephropathy diabetic;nephropathy, diabetic;nephropathy; diabetes (manifestation);nephropathy;diabetic;renal disorder associated with diabetes mellitus",chemdis,treat,1,treat,0,
569,sodium,diabetes,Sodium-glucose cotransporter 2 inhibitors (SGLT2i) is the first class of anti-diabetes treatment that reduces mortality and risk for hospitalization due to heart failure.,sodium,diabetes,chemdis,treat,1,treat,0,
570,sodium,heart failure,"The sodium-glucose cotransporter 2 (SGLT2) inhibitors are a class of glucose-lowering therapies that have been shown to reduce risks of heart failure (HF) events in patients with type 2 diabetes mellitus (T2DM) at high-risk for or with cardiovascular disease.___Self-care management of a low-sodium diet is a critical component of comprehensive heart failure (HF) treatment.___A low-sodium diet is an accepted treatment of patients with heart failure (HF), although minimal evidence exists on the appropriate amount of sodium intake for this population.",sodium,heart failure,chemdis,treat,3,treat,,
571,sugar,3-10 heart diseases: general terms,"Food reformulation is commonly used as a strategy to produce foods for improved health; for example, replacing sugar with aspartame, and salt (NaCl) with KCl may help to reduce the incidence of obesity and heart disease.",sugar,"3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",chemdis,treat,1,treat,0,
572,sugar,obesity,"Food reformulation is commonly used as a strategy to produce foods for improved health; for example, replacing sugar with aspartame, and salt (NaCl) with KCl may help to reduce the incidence of obesity and heart disease.",sugar,obesity,chemdis,treat,1,treat,0,
573,sulfate,[joint degeneration] or [osteoarthritis nos],"Glucosamine sulfate and chondroitin sulfate have sufficient controlled trials to warrant their use in osteoarthritis, having less side effects than currently used nonsteroidal anti-inflammatory drugs, and are the only treatment shown to prevent progression of the disease.",sulfate,"[joint degeneration] or [osteoarthritis nos];[joint degeneration] or [osteoarthritis nos] (disorder);a o;arthritides, degenerative;arthritis degenerative;arthritis osteoarthritis;arthritis, degenerative;arthritis, hypertrophic;arthritis, senescent;arthritis; hypertrophy;arthritis;degenerative;arthropathy, degenerative;degeneration;joint(s);degenerative arthritides;degenerative arthritis;degenerative arthritis, nos;degenerative arthropathy;degenerative arthropathy (disorder);degenerative arthropathy, nos;degenerative disease joint;degenerative disease joints;degenerative diseases joint;degenerative joint disease;degenerative joint disease (disorder);degenerative joint disease, nos;degenerative osteoarthritis;degenerative polyarthritis;degenerative polyarthritis (disorder);degenerative polyarthritis, nos;djd;hypertrophic arthritis;hypertrophic arthritis, nos;hypertrophic polyarthritis;hypertrophic polyarthritis, nos;hypertrophy; arthritis;joint degeneration;joint disease, degenerative;joint(s) degeneration;joint; osteoarthrosis;o a;o/a;oa - osteoarthritis;oa - osteoarthrosis;oa osteoarthritis;osteoarthritides;osteoarthritis;osteoarthritis (& [allied disorders]);osteoarthritis (diagnosis);osteoarthritis (disorder);osteoarthritis (m15-m19);osteoarthritis and allied disorders;osteoarthritis arthritis;osteoarthritis degenerative;osteoarthritis nos;osteoarthritis nos (disorder);osteoarthritis nos, of unspecified site;osteoarthritis nos, of unspecified site (disorder);osteoarthritis nos-site unspec;osteoarthritis, degenerative;osteoarthritis, nos;osteoarthritis, unspecified site;osteoarthritis;degenerative;osteoarthroses;osteoarthrosis (diagnosis);osteoarthrosis (disorder);osteoarthrosis (oa);osteoarthrosis, nos;osteoarthrosis, unspecified whether generalized or localized;primary oa",chemdis,treat,1,treat,,
577,tg - triglyceride,351 thrombi,"Fish (finfish or shellfish) has been classified as healthy by health professionals despite containing contaminants, since fish is high in long-chain n-3 polyunsaturated fatty acids which have multiple beneficial health effects such as decreased risk of stroke via anti-thrombotic and vasodilative effects, increased heart rate variability, reducing serum triacylglycerol and blood pressure, anti-inflammatory activities, improving visual function, improving attention-deficit conditions/ hyperactivity disorder, schizophrenic and dementia; and may be effective in managing depression in adults.",tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,"351 thrombi;clot, blood;clots, blood;thrombotic;thrombus (morphologic abnormality);thrombus, nos",chemdis,treat,1,treat,,
587,tg - triglyceride,dementia,"Fish (finfish or shellfish) has been classified as healthy by health professionals despite containing contaminants, since fish is high in long-chain n-3 polyunsaturated fatty acids which have multiple beneficial health effects such as decreased risk of stroke via anti-thrombotic and vasodilative effects, increased heart rate variability, reducing serum triacylglycerol and blood pressure, anti-inflammatory activities, improving visual function, improving attention-deficit conditions/ hyperactivity disorder, schizophrenic and dementia; and may be effective in managing depression in adults.",tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,dementia,chemdis,treat,1,treat,,
588,tg - triglyceride,depression,"Fish (finfish or shellfish) has been classified as healthy by health professionals despite containing contaminants, since fish is high in long-chain n-3 polyunsaturated fatty acids which have multiple beneficial health effects such as decreased risk of stroke via anti-thrombotic and vasodilative effects, increased heart rate variability, reducing serum triacylglycerol and blood pressure, anti-inflammatory activities, improving visual function, improving attention-deficit conditions/ hyperactivity disorder, schizophrenic and dementia; and may be effective in managing depression in adults.",tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,depression,chemdis,treat,1,treat,,
589,tg - triglyceride,diabetic,"Omega-3 intake reduced blood glucose, triglycerides, and cholesterol in diabetic rats and this was associated with improved integrity of cardiomyocytes and capillaries in the heart.___Moreover, berberine, via its ability to activate adenosine monophosphate-activated kinase (AMPK), which it shares with the drug metformin, can lower triglycerides, improve metabolic syndrome, aid glycemic control in diabetics, and act directly on the vasculature to promote vascular health.",tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,diabetic;diabetics,chemdis,treat,2,treat,0,
590,tg - triglyceride,high cholesterol,"The soy protein beverage, compared to cow's milk, induced significant reductions in plasma triglycerides and very-low-density lipoprotein cholesterol, as well as a significant increase in high-density lipoprotein cholesterol, indicating that consumption of soy protein beverage may be beneficial for the prevention of coronary heart disease in children with familial hypercholesterolemia.",tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,high cholesterol;high cholesterol level;hypercholesterolemia,chemdis,treat,1,treat,,
592,thienopyridine,37 hemorrhages,"Prasugrel is a third-generation thienopyridine antiplatelet agent with pharmacologic characteristics that overcome some of the limitations of clopidogrel, but at the expense of increased bleeding.",thienopyridine,"37 hemorrhages;bleed;bleed_nos;bleed_nos problem;bleeding;bleeding (disorder);bleeding (finding);bleeding (symptom);bleeding -retired-;bleeding hemorrhage;bleeding problem;bleeding site unspecified;bleeding, nos;bleeding/haemorrhage nos;bleeding/hemorrhage nos;bleeds;blood loss of (nos);blood; extravasation;extravasation blood;extravasation of blood;extravasation; blood;haemorrhage;haemorrhage nos;haemorrhage nos (disorder);haemorrhage, nos;haemorrhage, unspecified;haemorrhages;hem;hemorrhage;hemorrhage (diagnosis);hemorrhage (morphologic abnormality);hemorrhage (nos);hemorrhage bleeding;hemorrhage nos;hemorrhage nos (disorder);hemorrhage, nos;hemorrhage, unspecified;hemorrhages",chemdis,treat,1,treat,0,
593,thienopyridine,acs,"Prasugrel, a potent, third-generation thienopyridine, was approved by the US Food and Drug Administration in July 2009 for its use in ACS and percutaneous coronary intervention.",thienopyridine,"acs;acute chest syndrome;acute chest syndrome (disorder);acute chest syndrome in conditions classified elsewhere;acute chest syndrome in conditions classified elsewhere (diagnosis);acute chest syndrome in sickle cell disease;acute chest syndromes;chest syndrome acute;syndrome, acute chest;syndromes, acute chest",chemdis,treat,1,treat,1,
594,thyroid agent,obesity,"In conclusion, LA, resveratrol and quercetin supplementation reduces obesity thereby restoring plasma thyroid hormone levels and attenuating oxidative stress in the heart and thus may have therapeutic potential in heart diseases.",thyroid agent;thyroid hormone,obesity,chemdis,treat,1,treat,1,
597,vitamin c,atherosclerosis,"It is well established that vitamin C inhibits oxidation of LDL-protein, thereby reducing atherosclerosis, but the cardiovascular outcomes related to this action and other actions of vitamin C are not fully understood.",vitamin c,atherosclerosis,chemdis,treat,1,treat,1,
599,vitamin d,12 fractures,"Previous large trials of vitamin D for prevention of fractures and other disease outcomes have reported conflicting results, possibly because the doses tested were insufficient to maintain optimum blood levels of vitamin D (25[OH]D) predicted by the observational studies.___The latest data, based on meta-analysis of trials involving 29,000 participants, indicate that this risk is not mitigated by co-administration of vitamin D, and that the number of cardiovascular events caused is likely to be greater than the number of fractures prevented.",vitamin d,"12 fractures;bone fracture;bone fracture (diagnosis);bone fracture(s);bone fractured;bone fractures;bone, broken;bone; fracture;bones fractured;bones, broken;broken bone;broken bones;fracture (disorder);fracture (morphologic abnormality);fracture - lesion;fracture - lesion (disorder);fracture - lesion (morphologic abnormality);fracture bone;fracture nos;fracture nos (disorder);fracture of bone;fracture of bone (disorder);fracture of bones nos;fracture of bones nos (disorder);fracture of unspecified bones;fracture of unspecified bones (disorder);fracture, bone;fracture, cause nos;fracture, cause unspecified;fracture, cause unspecified (disorder);fracture, cause unspecified (finding);fracture, nos;fracture: [of unspecified bones] or [nos];fracture: [of unspecified bones] or [nos] (disorder);fracture; bone;fractured bone;fractures;fractures, bone",chemdis,treat,2,treat,,
600,vitamin d,als,"Vitamin D has also been shown to reduce the expression of biomarkers associated with oxidative stress and inflammation in patients with multiple sclerosis, rheumatoid arthritis, congestive heart failure, Parkinson's disease and Alzheimer's disease; diseases that share common pathophysiologies with ALS.",vitamin d,"als;als (amyotrophic lateral sclerosis);als - amyotroph lat sclerosis;als - amyotrophic lateral sclerosis;als amyotrophic lateral sclerosis;amyotrophic lateral sclerosis;amyotrophic lateral sclerosis (diagnosis);amyotrophic lateral sclerosis (disorder);amyotrophic lateral sclerosis/progressive muscular atrophy;amyotrophic laterals sclerosis;amyotrophic sclerosis;amyotrophy; lateral sclerosis;amytrophic lateral sclerosis;bulbar motor neuron disease;charcot disease;creeping; palsy;disease, lou-gehrigs;gehrig disease;gehrig's disease;gehrigs dis;gehrigs disease;lateral sclerosis; amyotrophy;lou gehrig dis;lou gehrig disease;lou gehrig's disease;lou gehrig's disease (als);lou gehrigs dis;lou gehrigs disease;lou-gehrigs disease;motor neuron dis amyotrophic lateral sclerosis;motor neuron disease, amyotrophic lateral sclerosis;motor neuron disease, bulbar;palsy; creeping;sclerosis, amyotrophic lateral;sclerosis; spinal, lateral (amyotrophic);spinal; sclerosis, lateral (amyotrophic)",chemdis,treat,1,treat,1,
601,vitamin d,brain damage due to hypoxia,"Furthermore, vitamin D treatment greatly attenuates hypoxic brain damage in vivo and reduces neuronal lethality of glutamate insult in vitro; a hallmark trait of ALS glutamate excitotoxicity.",vitamin d,"brain damage due to hypoxia;brain damage, hypoxic;brain disorder resulting from a period of impaired oxygen delivery to the brain;brain disorder resulting from a period of impaired oxygen delivery to the brain (disorder);damage, hypoxic brain;enceph hypoxic;encephalopathies, hypoxic;encephalopathy hypoxic;encephalopathy, hypoxic;hypoxic brain damage;hypoxic brain injuries;hypoxic brain injury;hypoxic enceph;hypoxic encephalopathies;hypoxic encephalopathy;hypoxic-ischaemic brain injury;hypoxic-ischemic brain injury",chemdis,treat,1,treat,1,
609,vitamin d3,3-00 cardiovascular disorders: general terms,Our results suggest that vitamin D3 has therapeutic effect against postmenopausal cardiovascular disease.,vitamin d3,"3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,treat,1,treat,1,
610,vitamin e,3-00 cardiovascular disorders: general terms,"Clinical studies at large have not demonstrated a benefit of vitamin E in the primary and secondary prevention of cardiovascular disease.___The American Heart Association does not support the use of vitamin E supplements to prevent cardiovascular disease, but does recommend the consumption of foods abundant in antioxidant vitamins and other nutrients.",vitamin e,"3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,treat,2,treat,0,
614,vitamin k,3-00 cardiovascular disorders: general terms,"Dietary vitamin K intake is thought to decrease the risk of cardiovascular disease (CVD) by reducing vascular calcification, although vitamin K is also involved in coagulation.",vitamin k,"3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,treat,1,treat,1,
615,vitamin k,arterial ischemic stroke,"Dose-adjusted vitamin K antagonists (VKAs) to a target international normalized ratio (INR) range of 2.0-3.0 reduce the risk of ischemic stroke and are currently recommended in all patients with AF at moderate-high risk for stroke or systemic embolism.___Vitamin K antagonists have been the cornerstone of oral antithrombotic therapy to help prevent ischemic stroke in atrial fibrillation (AF) and reduce venous thromboembolic events.___Vitamin K antagonists (VKAs) reduce the risk of ischemic stroke, especially in the elderly, but increase the bleeding risk.",vitamin k,"arterial ischemic stroke;ischaemic stroke;ischaemic stroke nos;ischaemic strokes;ischemia stroke;ischemic cerebrovascular accident;ischemic stroke;ischemic stroke (diagnosis);ischemic stroke (disorder);ischemic stroke nos;ischemic strokes;stroke ischemic;stroke, ischaemic;stroke, ischemic",chemdis,treat,3,treat,1,
616,vitamin k,atrial fibrillation,"The AVERROES trial established apixaban as superior to aspirin for stroke reduction in patients with atrial fibrillation for whom vitamin K antagonist therapy is unsuitable.___Vitamin K antagonists have been the cornerstone of oral antithrombotic therapy to help prevent ischemic stroke in atrial fibrillation (AF) and reduce venous thromboembolic events.___Non-vitamin K antagonist oral anticoagulants (NOACs) are indicated for stroke prevention in atrial fibrillation (AF) but require lower doses in certain patients.___The new oral anticoagulants (NOAC) dabigatran etexilate, rivaroxaban, and apixaban show similar efficacy for stroke prevention in patients with atrial fibrillation (AF) as the vitamin K antagonist warfarin.",vitamin k,atrial fibrillation,chemdis,treat,4,treat,1,
617,vitamin k,blood clot in blood vessel,"Thus, preventing stroke and thromboembolism is the cornerstone in AF management, with the vitamin K antagonist (VKA) -",vitamin k,blood clot in blood vessel;disease thromboembolic;diseases thromboembolic;embolism and thrombosis of unspecified site;embolism; thrombus;events thromboembolic;other venous embolism and thrombosis of unspecified site;thromboembolic disease;thromboembolic disease (diagnosis);thromboembolic disorder;thromboembolic disorder (disorder);thromboembolic events;thromboembolic; disorder;thromboembolism;thromboembolism - lesion;thromboembolism - lesion (disorder);thromboembolism nos;thromboembolisms;thromboembolus;thromboembolus (morphologic abnormality);thrombus; embolism,chemdis,treat,1,treat,1,
618,vitamin k,calcification of coronary arteries,Dietary intake of vitamin K has been reported to reduce coronary artery calcification (CAC) and cardiovascular events.,vitamin k,calcification of coronary arteries;calcification of coronary artery;calcification of coronary artery (disorder);coronary artery calcification,chemdis,treat,1,treat,1,
620,vitamin k,embolism,"In patients at risk of stroke due to atrial fibrillation, rivaroxaban was noninferior compared to warfarin in preventing stroke/systemic embolism in the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation (ROCKET-AF) trial and was associated with a similar risk of major bleeding; the incidence of intracranial hemorrhage was 33% lower with rivaroxaban.___Dabigatran is an oral thrombin inhibitor which has been approved for prevention of stroke or embolism in atrial fibrillation patients as an alternative to vitamin K antagonists.___For the last 50 years, long-term anticoagulation with vitamin K antagonists has been the most effective therapy for preventing stroke and systemic embolism in patients with AF and other risk factors, but their use has a lot of limitations and drawbacks (frequent monitoring and dose adjustment, food and drug interactions, delayed onset of action etc).___Until recently, vitamin K antagonists (VKA) such as warfarin were the only available oral anticoagulant therapy for prevention of stroke and systemic embolism in AF.",vitamin k,"embolism;embolism, nos",chemdis,treat,4,treat,1,
621,vitamin k,stroke,"Oral anticoagulation is the cornerstone for stroke prevention in AF; for many years, only vitamin K antagonists were used for this purpose, with an absolute risk reduction >60%.___The AVERROES trial established apixaban as superior to aspirin for stroke reduction in patients with atrial fibrillation for whom vitamin K antagonist therapy is unsuitable.___Vitamin K antagonists (VKAs) are the most widely used anticoagulants for stroke prevention in patients with atrial fibrillation (AF).___For decades, the vitamin K antagonists (e.g. warfarin) remained the only oral anticoagulant available for stroke prevention in AF.___Dabigatran and rivaroxaban are non-vitamin K oral anticoagulants approved for stroke prevention in patients with nonvalvular atrial fibrillation (AF).___Dose-adjusted vitamin K antagonists (VKAs) to a target international normalized ratio (INR) range of 2.0-3.0 reduce the risk of ischemic stroke and are currently recommended in all patients with AF at moderate-high risk for stroke or systemic embolism.___Dabigatran is an oral thrombin inhibitor which has been approved for prevention of stroke or embolism in atrial fibrillation patients as an alternative to vitamin K antagonists.___For the last 50 years, long-term anticoagulation with vitamin K antagonists has been the most effective therapy for preventing stroke and systemic embolism in patients with AF and other risk factors, but their use has a lot of limitations and drawbacks (frequent monitoring and dose adjustment, food and drug interactions, delayed onset of action etc).___Non-vitamin K antagonist oral anticoagulants (NOACs) are indicated for stroke prevention in atrial fibrillation (AF) but require lower doses in certain patients.___Non-vitamin K antagonist oral anticoagulants (NOACs) are increasingly used for stroke prevention in patients with atrial fibrillation (AF).___Vitamin K antagonists (VKAs) such as warfarin or acenocoumarin have long been the only oral anticoagulants for stroke prevention in AF.___Until recently, vitamin K antagonists (VKA) such as warfarin were the only available oral anticoagulant therapy for prevention of stroke and systemic embolism in AF.___The new oral anticoagulants (NOAC) dabigatran etexilate, rivaroxaban, and apixaban show similar efficacy for stroke prevention in patients with atrial fibrillation (AF) as the vitamin K antagonist warfarin.___Oral anticoagulants such as the vitamin K antagonist warfarin have been proven effective in reducing the risk of stroke in AF.",vitamin k,stroke,chemdis,treat,14,treat,1,
622,"acid, saturated fatty",3-00 cardiovascular disorders: general terms,"Medical nutrition therapy, consisting of a diet low in saturated fat, has an important role in reducing risks for cardiovascular disease and hyperlipidemia.","acid, saturated fatty;acids fatty saturated;fat saturated;fats saturated;fatty acid, saturated;fatty acids, saturated;fatty acids.saturated;saturated fat;saturated fat (substance);saturated fatty acid;saturated fatty acid (substance);saturated fatty acid, nos;saturated fatty acids","3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",foodis,treat,1,treat,0,
624,"acid, saturated fatty",cvd,"Limiting the saturated fatty acid (SAFA) consumption forms the basis of dietary fat recommendations for heart health, despite several meta-analyses demonstrating no link between dietary SAFA and the risk of cardiovascular disease (CVD).___Taking into consideration the totality of the scientific evidence, satisfying rigorous criteria for causality, we conclude strongly that lowering intake of saturated fat and replacing it with unsaturated fats, especially polyunsaturated fats, will lower the incidence of CVD.","acid, saturated fatty;acids fatty saturated;fat saturated;fats saturated;fatty acid, saturated;fatty acids, saturated;fatty acids.saturated;saturated fat;saturated fat (substance);saturated fatty acid;saturated fatty acid (substance);saturated fatty acid, nos;saturated fatty acids",cvd,foodis,treat,2,treat,0,
627,"acid, saturated fatty",high cholesterol,"Incorporating fiber sources into our diet may provide a useful adjunct to a low-saturated fat diet, and may have a further beneficial effect for individuals who have mild-to-moderate hypercholesterolemia.","acid, saturated fatty;acids fatty saturated;fat saturated;fats saturated;fatty acid, saturated;fatty acids, saturated;fatty acids.saturated;saturated fat;saturated fat (substance);saturated fatty acid;saturated fatty acid (substance);saturated fatty acid, nos;saturated fatty acids",high cholesterol;high cholesterol level;hypercholesterolemia,foodis,treat,1,treat,,
628,"acid, saturated fatty",hyperlipidemia,"Medical nutrition therapy, consisting of a diet low in saturated fat, has an important role in reducing risks for cardiovascular disease and hyperlipidemia.","acid, saturated fatty;acids fatty saturated;fat saturated;fats saturated;fatty acid, saturated;fatty acids, saturated;fatty acids.saturated;saturated fat;saturated fat (substance);saturated fatty acid;saturated fatty acid (substance);saturated fatty acid, nos;saturated fatty acids",hyperlipidemia,foodis,treat,1,treat,,
629,"acid, saturated fatty",ischemic heart disease,There is evidence that replacing saturated fat (SFA) with polyunsaturated fat (PUFA) lowers ischemic heart disease (IHD).,"acid, saturated fatty;acids fatty saturated;fat saturated;fats saturated;fatty acid, saturated;fatty acids, saturated;fatty acids.saturated;saturated fat;saturated fat (substance);saturated fatty acid;saturated fatty acid (substance);saturated fatty acid, nos;saturated fatty acids",ischemic heart disease,foodis,treat,1,treat,,
630,"acid, saturated fatty",ventricular tachycardia,"Across species, fish oil, eicosapentaenoic acid, and/or docosahexaenoic acid appear to have beneficial effects on ventricular tachycardia (VT) and fibrillation (VF) in ischemia- but not reperfusion-induced arrhythmia models; no effect on the incidence of death and infarct size; and inconsistent results with regard to arrhythmia score, VF threshold, ventricular premature beats or length of time in normal sinus rhythm, compared to omega-6, monounsaturated, or saturated fatty acids, and no treatment controls.","acid, saturated fatty;acids fatty saturated;fat saturated;fats saturated;fatty acid, saturated;fatty acids, saturated;fatty acids.saturated;saturated fat;saturated fat (substance);saturated fatty acid;saturated fatty acid (substance);saturated fatty acid, nos;saturated fatty acids",ventricular tachycardia,foodis,treat,1,treat,,
633,canola oil,abnormal heart rhythms,"These results suggest that regular substitution of canola oil for other dietary lipid sources may assist in reducing the likelihood of a transient ischemic event leading to life-threatening cardiac arrhythmias, but the effectiveness of alpha-linolenic acid is reduced by high levels of linoleic acid.",canola oil,"abnormal heart rhythms;arrhythmia (cardiac) nos;arrhythmia (finding);arrhythmia (nos);arrhythmia cardiac (nos);arrhythmia nos;arrhythmia, cardiac;arrhythmia, nos;arrhythmias;arrhythmias (heart);arrhythmias, cardiac;arrythmia;cardiac arrhythmia (disorder);cardiac arrhythmia (nos);cardiac arrhythmia nos;cardiac arrhythmia, irregular pulse;cardiac arrhythmia, nos;cardiac arrhythmia, unspecified;cardiac arrhythmias;cardiac dysrhythmia (disorder);cardiac dysrhythmia nos;cardiac dysrhythmia nos (disorder);cardiac dysrhythmia, nos;cardiac dysrhythmia, unspecified;cardiac dysrhythmias nos;cardiac rhythm disorder (diagnosis);cardiac rhythm disturbance;cardiac rhythm disturbances;cardiac rhythm irregular;cardiac rhythm, abnormal;cardiac; dysrhythmia;disorder of heart rhythm;disorder; rhythm, heart;disturbance; rhythm, heart;dysrhythmia;dysrhythmia(s);dysrhythmia, cardiac;dysrhythmia; cardiac;dysrhythmia;cardiac;dysrhythmias;ectopic beats all types;heart arrhythmia;heart arrhythmias;heart rhythm disorders;heart: rhythm;rhythm, heart; abnormal;rhythm; abnormal;rhythm; disorder",foodis,treat,1,treat,0,
634,carrot,cardiomyopathy,"Probiotic food containing Lactobacillus acidophilus, green tea, and carrots can improve membrane integrity and cardiac contractility in doxorubicin-induced cardiomyopathy by decreasing TNF-α, IL-6, MDA, increasing GSH, and modulating compensatory mediators such as Ang-II and ANP.",carrot;carrot (substance);carrots;carrots - dietary,cardiomyopathy,foodis,treat,1,treat,1,
635,cereal,3-10 heart diseases: general terms,A recent review of epidemiologic literature found consistently reduced cancer and heart disease rates in persons with high compared with low whole-grain intakes.,"cereal;cereal (substance);cereal grain;cereal grains;cereals;grain;grain, cereal;grains, cereal","3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",foodis,treat,1,treat,1,
636,cereal,cancer,A recent review of epidemiologic literature found consistently reduced cancer and heart disease rates in persons with high compared with low whole-grain intakes.,"cereal;cereal (substance);cereal grain;cereal grains;cereals;grain;grain, cereal;grains, cereal",cancer,foodis,treat,1,treat,1,
646,"chloride, dietary sodium",hyperkalemia,"RDX7675, a novel potassium binder in development for the treatment of hyperkalemia, is a calcium salt of a reengineered polystyrene sulfonate-based resin designed to have enhanced palatability.","chloride, dietary sodium;dietary salt;dietary salt (sodium chloride);dietary sodium chloride;salt;salt, table;sodium chloride, dietary;table salt",hyperkalemia,foodis,treat,1,treat,1,
648,"chloride, dietary sodium",renal dysfunction,"Antioxidant treatment with vitamins C and E improves renal dysfunction, lessens renal injury, and decreases arterial pressure in Dahl salt-sensitive hypertension.","chloride, dietary sodium;dietary salt;dietary salt (sodium chloride);dietary sodium chloride;salt;salt, table;sodium chloride, dietary;table salt",renal dysfunction,foodis,treat,1,treat,0,
649,chocolate,3-00 cardiovascular disorders: general terms,"Randomized clinical trials have shown that chocolate intake reduces systolic and diastolic blood pressure, and observational studies have found an inverse association between chocolate intake and cardiovascular disease.",chocolate,"3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",foodis,treat,1,treat,1,
650,chocolate,coronary heart disease,"For food groups, results from the SRMAs of cohort studies suggest that high intakes of legumes, nuts, and chocolate, as well as a vegetarian diet significantly reduced the risk of coronary heart disease, with pooled RRs of 0.90 (95%CI: 0.84-0.97), 0.68 (95%CI: 0.59-0.78), 0.90 (95%CI: 0.82-0.97), and 0.71 (95%CI: 0.57-0.87), respectively.",chocolate,coronary heart disease,foodis,treat,1,treat,1,
652,citrus,cvd,"However, women in the highest intake group of grapes and citrus experienced a significant reduction in risk of CVD and stroke respectively compared with non-consumers [HR 0.56 (99 % CI 0.32, 0.98) and 0.34 (0.14, 0.82) respectively].",citrus;citrus flavor,cvd,foodis,treat,1,treat,1,
0,(+)-aldosterone,hyperkalemia,Treatment with renin angiotensin aldosterone system inhibitors exacerbates the risk of hyperkalemia in these patients.___AIIA may cause severe hyperkalemia inhibiting aldosterone activity.,"(+)-aldosterone;(11β)-11,21-dihydroxy-3,20-dioxopregn-4-en-18-al;11beta,21-dihydroxy-3,20-dioxo-4-pregnen-18-al;11beta,21-dihydroxy-3,20-dioxopregn-4-en-18-al;aldosterona;aldosterone;aldosterone (substance);aldosterone preparation;aldosterone preparation (product);aldosterone preparation (substance);aldosterone product;aldosterone-containing product;aldosteronum;pregn-4-en-18-al, 11,21-dihydroxy-3,20-dioxo-, (11beta)-;product containing aldosterone;product containing aldosterone (medicinal product)",hyperkalemia,chemdis,cause,2,cause,1,
1,(+)-aldosterone,hypertensive,"Although GR(betageo/+) mice have 50% less functional GR, they have normal lipid and glucose homeostasis due to compensatory HPA axis activation but are hypertensive due to activation of the renin-angiotensin-aldosterone system (RAAS).","(+)-aldosterone;(11β)-11,21-dihydroxy-3,20-dioxopregn-4-en-18-al;11beta,21-dihydroxy-3,20-dioxo-4-pregnen-18-al;11beta,21-dihydroxy-3,20-dioxopregn-4-en-18-al;aldosterona;aldosterone;aldosterone (substance);aldosterone preparation;aldosterone preparation (product);aldosterone preparation (substance);aldosterone product;aldosterone-containing product;aldosteronum;pregn-4-en-18-al, 11,21-dihydroxy-3,20-dioxo-, (11beta)-;product containing aldosterone;product containing aldosterone (medicinal product)",hypertensive;hypertensive (finding);with high blood pressure,chemdis,cause,1,cause,,
2,(+)-sertraline,serotonin syndrome,"We present a case of serotonin syndrome, which was precipitated by this medicine in a patient who had been predisposed by long-term treatment with sertraline, a selective serotonin reuptake inhibitor.","(+)-sertraline;(1s,4s)-sertraline;(1s-cis)-1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-n-methyl-1-naphthalenamine;1-naphthalenamine,1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-n-methyl-, (1s-cis)-;cis-(+)-sertraline;product containing sertraline;product containing sertraline (medicinal product);sertralina;sertraline;sertraline (product);sertraline (substance);sertraline product;sertraline-containing product;sertralinum",serotonin syndrome;syndrome serotonin,chemdis,cause,1,cause,,
3,"(+-)-1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone",drug overdose,"Nonetheless, there is one documented report of ST after single-agent bupropion overdose and multiple reports describing polypharmacy overdoses where bupropion may have contributed to ST.","(+-)-1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone;1-propanone, 1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-;amfebutamon;amfebutamone;bupropion;bupropion (medication);bupropion (product);bupropion (substance);bupropion [dup] (substance);bupropion product;bupropion-containing product;product containing bupropion;product containing bupropion (medicinal product)","drug overdose;drug overdose (disorder);drug overdose, nos;drug overdoses;drugs--overdose;od - overdose of drug;overdose nos;overdose of drug;overdose, drug;overdose, nos;overdoses;overdoses, drug",chemdis,cause,1,cause,,
4,619-61c carbohydrates,body fails to respond to insulin,"In summary, although it must be emphasized that all diets high in fat cause insulin resistance relative to high-carbohydrate diets, it appears that dietary saturated, short-chain, and w6 fatty acids have the most deleterious effects on insulin action.___High carbohydrate, high fat-fed rats showed visceral obesity with hypertension, insulin resistance, cardiovascular remodelling, and nonalcoholic fatty liver disease.","619-61c carbohydrates;carbohydrate;carbohydrate (substance);carbohydrate agent;carbohydrate agent (substance);carbohydrate product;carbohydrate product (product);carbohydrate product (substance);carbohydrate, nos;carbohydrate-containing product;carbohydrates (medication);carbs;product containing carbohydrate;product containing carbohydrate (product);saccharide;saccharides","body fails to respond to insulin;drug resistance to insulin;drug resistance to insulin (disorder);insulin resistance;insulin resistance (diagnosis);insulin resistance (disorder);resistance, insulin",chemdis,cause,2,cause,1,
5,619-61c carbohydrates,"cardiovascular syndrome, metabolic","The high-carbohydrate, high-fat diet-fed rats showed the symptoms of metabolic syndrome leading to cardiovascular remodeling and nonalcoholic fatty liver disease.","619-61c carbohydrates;carbohydrate;carbohydrate (substance);carbohydrate agent;carbohydrate agent (substance);carbohydrate product;carbohydrate product (product);carbohydrate product (substance);carbohydrate, nos;carbohydrate-containing product;carbohydrates (medication);carbs;product containing carbohydrate;product containing carbohydrate (product);saccharide;saccharides","cardiovascular syndrome, metabolic;cardiovascular syndromes, metabolic;dysmetabolic syndrome x;dysmetabolic syndrome x (diagnosis);equine metabolic syndrome;insulin resistance syndrome x;metabolic cardiovascular syndrome;metabolic syndrome;metabolic syndrome x;metabolic syndrome x (disorder);metabolic syndromes;metabolic x syndrome;reaven syndrome x;reaven's syndrome;syndrome metabolic;syndrome x (metabolic);syndrome x insulin resistance;syndrome x, dysmetabolic;syndrome x, insulin resistance;syndrome x, metabolic;syndrome x, reaven;syndrome, metabolic;syndrome, metabolic cardiovascular;syndrome, metabolic x;syndromes, metabolic;x syndrome, metabolic",chemdis,cause,1,cause,1,
6,"acid, free fatty",angiopathy,"The reasons for this excess CHD risk are multifactorial, but in part relate to a susceptibility to diabetes mellitus - where the aberrant metabolism of non-esterified fatty acids (NEFA) and glucose are likely to underpin vascular disease in this population.","acid, free fatty;acids fatty free;acids, free fatty;acids, nonesterified fatty;fatty acid, free;fatty acids, free;fatty acids, nonesterified;fatty acids.nonesterified;ffa;ffa - free fatty acids;ffas;free fatty acid;free fatty acids;nefa;non-esterified fatty acid;non-esterified fatty acid (substance);nonesterified fatty acid;nonesterified fatty acids;unesterified fatty acid;unesterified fatty acid (substance)","angiopathy;angiopathy, nos;blood vessel disease;blood vessel disorder;blood vessels; disorder;blood-vessels--diseases;disease (or disorder); blood vessels;disease (or disorder); vascular;disease, vascular;diseases, vascular;disorder of blood vessel;disorder of blood vessel (disorder);disorder vascular;disorder; vascular;section 3-8 vascular diseases;unspecified vascular problem;vasc;vascular (extracardiac) disorders;vascular dis;vascular disease;vascular disease (disorder);vascular disease or syndrome;vascular disease, nos;vascular diseases;vascular diseases and syndromes;vascular disorder;vascular disorder nos;vascular disorder, nos;vascular disorders;vascular problem;vascular problem, nos;vascular system disorders;vascular system disorders (diagnosis);vascular; disorder;vascular_nos;vascular_nos problem;vasculopathy",chemdis,cause,1,cause,,
7,"acid, n-3 fatty",3-00 cardiovascular disorders: general terms,"Cohort studies report inconsistent associations between fish consumption, a major source of long-chain ω-3 fatty acids, and risk of cardiovascular disease (CVD) and mortality.","acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids","3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,cause,1,cause,,
8,"acid, n-3 fatty",hypertension,"Omega-3 polyunsaturated fatty acid deficiency, particularly during the prenatal period, can cause hypertension in later life.","acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids",hypertension,chemdis,cause,1,cause,0,
9,alcohol,3-00 cardiovascular disorders: general terms,"Several studies link cardiovascular diseases (CVD) with unhealthy lifestyles (unhealthy dietary habits, alcohol consumption, smoking, and low levels of physical activity).___Some important environmental factors that influence the development of cardiovascular diseases (CVD) include tobacco, excess alcohol, and unhealthy diet.",alcohol,"3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,cause,2,cause,1,
10,alcohol,9-74 sleep disorders,"The risk factors that influence the development of sleep disorders in physicians are numerous and include genetic factors (15 % of the population), age (> 50 years), undiagnosed sleep apnea,, alcohol abuse as well as multiple stress factors inherent in clinical duties (including shift work), research, teaching and family obligations.",alcohol,"9-74 sleep disorders;[d]sleep dysfunction nos;[d]sleep dysfunction nos (context-dependent category);[d]sleep dysfunction nos (situation);disorder sleep;disorder, sleep;disorder;sleep;disorders, sleep;problem;sleep;sleep dis;sleep disorder;sleep disorder (diagnosis);sleep disorder (disorder);sleep disorder (nos);sleep disorder nos;sleep disorder, nos;sleep disorder, unspecified;sleep disorders;sleep disorders and disturbances;sleep dysfunction nos;sleep-wake disorder;sleep-wake disorder (disorder);sleeping disorders;sleeping problems",chemdis,cause,1,cause,1,
11,alcohol,abnormal thyroid,"Thyroid disorders, illicit drug or stimulant use, and acute alcohol intoxication are among these causes.",alcohol,"abnormal thyroid;b-80 hypothyroidism, hyperthyroidism and other disorders;disease (or disorder); thyroid;disease of thyroid gland;disease of thyroid gland (disorder);disease of thyroid gland, nos;disease, thyroid;diseases of the thyroid gland;diseases of thyroid gland;diseases, thyroid;disorder of thyroid gland;disorder of thyroid gland (disorder);disorder of thyroid gland, nos;disorder of thyroid nos;disorder of thyroid, unspecified;disorder thyroid;disorders of thyroid gland;disorders of thyroid gland (e00-e07);hypothyroidism, hyperthyroidism and other disorders;section b-8 diseases of the thyroid gland;thyroid;thyroid abnormal;thyroid abnormalities;thyroid dis;thyroid disease, nos;thyroid diseases;thyroid disorder;thyroid disorder (diagnosis);thyroid disorder nos;thyroid disorder nos (disorder);thyroid disorder, nos;thyroid disorders;thyroid gland disease;thyroid gland diseases;thyroid gland disorder;thyroid gland disorders;thyroid gland--diseases;thyroid; disorder;unspecified disorder of thyroid",chemdis,cause,1,cause,0,
12,alcohol,arrhythmia,"Patients who are diagnosed with Brugada syndrome (BS) usually experience sudden cardiac arrest (SCA) and arrhythmia when they have a high fever, consume alcohol, and, more frequently, during their night sleep.",alcohol,arrhythmia,chemdis,cause,1,cause,1,
13,alcohol,atrial fibrillation,"Risk factors for acute atrial fibrillation include increasing age, cardiovascular disease, alcohol, diabetes, and lung disease.",alcohol,atrial fibrillation,chemdis,cause,1,cause,1,
14,alcohol,cardiac arrest,"Patients who are diagnosed with Brugada syndrome (BS) usually experience sudden cardiac arrest (SCA) and arrhythmia when they have a high fever, consume alcohol, and, more frequently, during their night sleep.",alcohol,cardiac arrest,chemdis,cause,1,cause,1,
15,alcohol,decrease in blood pressure upon standing up,"Factors like heat, food, alcohol, exercise, activities which increase intrathoraric pressure (e.g. defecation, coughing) and certain drugs (e.g. vasodilators) can worsen a probably asymptomatic orthostatic hypotension.",alcohol,"decrease in blood pressure upon standing up;hypotension orthostatic;hypotension postural;hypotension, orthostatic;hypotension, postural;hypotension; orthostatic;hypotension; postural;hypotension;orthostatic;hypotension;postural;orthostatic hypotension;orthostatic hypotension (diagnosis);orthostatic hypotension (disorder);orthostatic hypotension (physical finding);orthostatic hypotension was observed;orthostatic; hypotension;postural hypotension;postural; hypotension",chemdis,cause,1,cause,1,
21,vitamin c,cardiac tamponade,"Cardiac failure and rhythm disturbances with chest pain, hypotension, cardiac tamponade, and dyspnea are associated with vitamin C deficiency.",vitamin c,"cardiac tamponade;cardiac tamponade (diagnosis);cardiac tamponade (disorder);cardiac tamponades;heart tamponade;heart, tamponade;pericardial tamponades;rose's tamponade;tamponade cardiac;tamponade, cardiac;tamponade, pericardial;tamponade; cardiac;tamponades, cardiac;tamponades, pericardial",chemdis,cause,1,cause,0,
22,vitamin c,hypoascorbemia,"A vitamin C-deficient diet results in the onset of scurvy, which can have lethal consequences.",vitamin c,"hypoascorbemia;hypoascorbemias;scorbutus;scurvies;scurvy;scurvy (diagnosis);scurvy (disorder);vitamin c, inability to synthesize",chemdis,cause,1,cause,0,
23,vitamin d,3-00 cardiovascular disorders: general terms,"Low vitamin D status is associated with increased risk of cardiovascular disease and may be involved in atherosclerosis.___Vitamin D deficiency is associated with an increased risk of cardiovascular disease, diabetes, colon and breast cancer, infectious diseases and allergies.",vitamin d,"3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,cause,2,cause,0,
24,vitamin d,diabetes,"Vitamin D deficiency has been linked to an increased risk of hypertension, diabetes, congestive heart failure, peripheral arterial disease, myocardial infarction, stroke, and related mortality, even after adjustment for traditional cardiovascular risk factors.___Many precursor states of heart failure, such as hypertension, atherosclerosis, and diabetes are more prevalent in subjects with low vitamin D levels.",vitamin d,diabetes,chemdis,cause,2,cause,0,
26,vitamin d,infantile osteomalacia,"The leading cause of rickets worldwide is solar vitamin D deficiency and/or dietary calcium deficiency collectively termed as nutritional rickets.___In young children, vitamin D deficiency causes a mineralization defect of the skeleton, resulting in rickets.",vitamin d,"infantile osteomalacia;infantile; osteomalacia;osteomalacia, infantile;osteomalacia; infantile;rachitides;rachitis;rickets;rickets (diagnosis);rickets (disorder);rickets nos;rickets, nos;rickett;ricketts;vitamin d deficiency disease;weak and soft bones",chemdis,cause,2,cause,0,
27,vitamin e,"[x]disorder of muscle, unspec",It was concluded that the myopathy was probably caused by vitamin E deficiency due to feeding the pelicans a rancid diet.,vitamin e,"[x]disorder of muscle, unspec;[x]disorder of muscle, unspecified;[x]disorder of muscle, unspecified (disorder);a-51 myopathies;disease (or disorder); muscle;disorder muscle;disorder of muscle;disorder of muscle (diagnosis);disorder of muscle (disorder);disorder of muscle -retired-;disorder of muscle, nos;disorder of muscle, unspec;disorder of muscle, unspecified;disorder of skeletal and/or smooth muscle;disorder of skeletal and/or smooth muscle (disorder);disorders of muscles;disorders of muscles (m60-m63);muscle dis;muscle disease;muscle disease or syndrome;muscle disorder;muscle disorder nos;muscle disorders;muscle tissue disease;muscles--diseases;muscular dis;muscular disease;muscular diseases;muscular disorder;muscular disorders;myopathic changes;myopathic condition;myopathic conditions;myopathic disease;myopathic disease or syndrome;myopathic disease, nos;myopathic diseases and syndromes;myopathic syndrome;myopathic syndrome, nos;myopathies;myopathies (diagnosis);myopathy;myopathy (disorder);myopathy unspecified;myopathy, nos;myopathy, unspecified;skeletal muscle disease;skeletal muscle disorder;unspecified disorder of muscle",chemdis,cause,1,cause,0,
29,dietary fruit,atherogenic dyslipidaemia,"A decreasing intake of coarse cereals, pulses, fruits and vegetables, an increasing intake of meat products and salt, coupled with declining levels of physical activity due to rapid urbanization have resulted in escalating levels of obesity, atherogenic dyslipidemia, subclinical inflammation, metabolic syndrome, type 2 diabetes mellitus, and coronary heart disease in Indians.",dietary fruit;fructus;fruit (substance);fruits,atherogenic dyslipidaemia;atherogenic dyslipidemia,foodis,cause,1,cause,0,
39,acid fatty polyunsaturated,inflamm,"There are persuasive evidences that dietary substitution of monounsaturated fatty acids (MUFA) or n-6 polyunsaturated fatty acids (PUFA) for SFA lowers blood cholesterol and may have beneficial effects on inflammation, thrombosis, and vascular reactivity.","acid fatty polyunsaturated;acid, polyunsaturated fatty;acids fatty polyunsaturated;acids, polyunsaturated fatty;fatty acid, polyunsaturated;fatty acid, total polyunsaturated;fatty acids, polyunsaturated;fatty acids.polyunsaturated;polyunsaturated fatty acid;polyunsaturated fatty acid (substance);polyunsaturated fatty acids;pufa;pufa (polyunsaturated fatty acid);pufa - polyunsat fatty acid;pufa - polyunsaturated fatty acid;pufas","inflamm;inflammation;inflammation (morphologic abnormality);inflammation (qualifier value);inflammation nos;inflammation, nos;inflammations;inflammatory reaction;inflammatory reaction, nos",chemdis,treat,1,treat,1,
40,acid fatty polyunsaturated,ischaemia,"We hypothesized that a specific dietary fatty acid profile (low in saturated and n-6 PUFA but high in plant and marine n-3 PUFA) may improve myocardial resistance to ischemia-reperfusion injury and reduce infarct size.___Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), the (n-3) PUFA found in fish oils, exert antiarrhythmic effects during ischemia.","acid fatty polyunsaturated;acid, polyunsaturated fatty;acids fatty polyunsaturated;acids, polyunsaturated fatty;fatty acid, polyunsaturated;fatty acid, total polyunsaturated;fatty acids, polyunsaturated;fatty acids.polyunsaturated;polyunsaturated fatty acid;polyunsaturated fatty acid (substance);polyunsaturated fatty acids;pufa;pufa (polyunsaturated fatty acid);pufa - polyunsat fatty acid;pufa - polyunsaturated fatty acid;pufas","ischaemia;ischaemia nos;ischaemia, nos;ischemia;ischemia (diagnosis);ischemia (disorder);ischemia nos;ischemia, nos;ischemias",chemdis,treat,2,treat,1,
41,"acid, n-3 fatty",cad,The results support the view that Lp-PLA(2) may relate to CAD and that intake of marine n-3 fatty acids might reduce plasma Lp-PLA(2) suggesting another mechanism by which n-3 fatty acids could reduce the risk of cardiovascular disease.,"acid, n-3 fatty;acid, omega-3 fatty;dietary supplements fatty acids (unsaturated) omega-3;fatty acid omega 3;fatty acid, n-3;fatty acid, n3;fatty acid, omega-3;fatty acids n 03;fatty acids omega 03;fatty acids, omega-3;fatty acids.omega 3;n 3 fatty acid;n 3 fatty acids;n 3 oil;n 3 oils;n 3 polyunsaturated fatty acid;n 3 pufa;n-3 fatty acid;n-3 fatty acid (substance);n-3 fatty acids;n-3 oil;n-3 oils;n-3 polyunsaturated fatty acid;n-3 pufa;n3 fatty acid;n3 oil;n3 oils;n3 polyunsaturated fatty acid;n3 pufa;oil, n-3;oil, n3;omega 3;omega 3 fatty acid;omega 3 fatty acids;omega fatty acids 03;omega-3;omega-3 acid;omega-3 acid triglycerides;omega-3 fatty acids;omega-3 fatty acids (medication);omega-3 phospholipids;omega-3 polyunsaturated fatty acid;omega-3 polyunsaturated fatty acids;omega-3 pufa;omega-3-fatty acids;pufa, n-3;pufa, n3;ω-3 fatty acids",cad,chemdis,treat,1,treat,1,
44,alcohol,cardiac fibrosis,"Zinc supplementation prevented cardiac fibrosis but did not affect heart hypertrophy in the alcohol-fed MT-KO mice, suggesting a specific link between zinc homeostasis and cardiac fibrosis.",alcohol,cardiac fibrosis;cardiac; fibrosis;fibrosis; cardiac;fibrosis; heart;heart; fibrosis,chemdis,treat,1,treat,0,
45,alcohol,coronary heart disease,There is epidemiological evidence that a moderate consumption of alcohol could reduce coronary heart disease.,alcohol,coronary heart disease,chemdis,treat,1,treat,1,
48,calcium,cad,A few observational investigations in the past showed positive results of calcium channel blocker therapy in patients with angiographically proven coronary artery disease (CAD).,calcium,cad,chemdis,treat,1,treat,1,
49,calcium,heart failure,"Here we review the key observations, controversies, and discoveries that have led to the development of novel compounds targeting the RyR2/calcium release channel for treating heart failure and for preventing lethal arrhythmias.",calcium,heart failure,chemdis,treat,1,treat,1,
52,endogenous nitrate vasodilator,aortic stiffness,We hypothesized that supplementation with tetrahydrobiopterin (BH4) would recouple endothelial nitric oxide synthase and thus improve endothelial function and consequently reduce aortic stiffness.,"endogenous nitrate vasodilator;endothelial cell derived relaxing factor;endothelium-derived nitric oxide;mononitrogen monoxide;monoxide, mononitrogen;monoxide, nitrogen;monoxyde d'azote;monóxido de nitrógeno;nitrate vasodilator, endogenous;nitric oxide;nitric oxide (medication);nitric oxide (product);nitric oxide (substance);nitric oxide gas;nitric oxide product;nitric oxide, endothelium derived;nitric oxide, endothelium-derived;nitric oxide-containing product;nitric oxides;nitrogen monooxide;nitrogen monoxide;nitrogen oxide (no);nitrosyl;no;no - nitric oxide;oxide, nitric;oxyde azotique;oxyde nitrique;product containing nitric oxide;product containing nitric oxide (medicinal product);stickstoff(ii)-oxid;stickstoffmonoxid;vasodilator, endogenous nitrate;vasodilators pulmonary nitric oxide;óxido de nitrógeno(ii);óxido nítrico","aortic stiffness;aortic stiffnesses;increased aortic stiffness;stiffness, aortic",chemdis,treat,1,treat,1,
53,endogenous nitrate vasodilator,c-50 diseases of the immune system: general terms,"Similarly, nitric oxide supplementation has demonstrated cardiovascular benefits by normalizing blood pressure; enhancing blood flow; and reducing inflammation, immune dysfunction, and oxidative stress.","endogenous nitrate vasodilator;endothelial cell derived relaxing factor;endothelium-derived nitric oxide;mononitrogen monoxide;monoxide, mononitrogen;monoxide, nitrogen;monoxyde d'azote;monóxido de nitrógeno;nitrate vasodilator, endogenous;nitric oxide;nitric oxide (medication);nitric oxide (product);nitric oxide (substance);nitric oxide gas;nitric oxide product;nitric oxide, endothelium derived;nitric oxide, endothelium-derived;nitric oxide-containing product;nitric oxides;nitrogen monooxide;nitrogen monoxide;nitrogen oxide (no);nitrosyl;no;no - nitric oxide;oxide, nitric;oxyde azotique;oxyde nitrique;product containing nitric oxide;product containing nitric oxide (medicinal product);stickstoff(ii)-oxid;stickstoffmonoxid;vasodilator, endogenous nitrate;vasodilators pulmonary nitric oxide;óxido de nitrógeno(ii);óxido nítrico","c-50 diseases of the immune system: general terms;dis immune system;disease of immune system;disease of immune system (disorder);disease of immune system, nos;disease, immune;disease, immune system;disease, immunologic;disease, immunological;diseases of immune system;diseases of the immune system;diseases of the immune system: general terms;disorder immune system (nos);disorder of immune system;disorder of immune system (disorder);disorder of immune system (navigational concept);disorder of immune system, nos;disorder, immune system;disorder; immune;immun;immune disease;immune disease nos;immune diseases;immune disorder;immune disorder (nos);immune disorder, nos;immune disorders;immune dysfunction;immune system and disorders;immune system dis;immune system disease;immune system diseases;immune system disorder (nos);immune system disorder nos;immune system disorders;immune; disorder;immunity disorders;immunol dis;immunologic disease;immunologic diseases;immunologic disorder;immunologic disorders;immunologic disorders (diagnosis);immunological dis;immunological disease;immunological diseases;section c-5 diseases of the immune system;unspecified immune system problem",chemdis,treat,1,treat,1,
57,endogenous nitrate vasodilator,inflamm,"Similarly, nitric oxide supplementation has demonstrated cardiovascular benefits by normalizing blood pressure; enhancing blood flow; and reducing inflammation, immune dysfunction, and oxidative stress.","endogenous nitrate vasodilator;endothelial cell derived relaxing factor;endothelium-derived nitric oxide;mononitrogen monoxide;monoxide, mononitrogen;monoxide, nitrogen;monoxyde d'azote;monóxido de nitrógeno;nitrate vasodilator, endogenous;nitric oxide;nitric oxide (medication);nitric oxide (product);nitric oxide (substance);nitric oxide gas;nitric oxide product;nitric oxide, endothelium derived;nitric oxide, endothelium-derived;nitric oxide-containing product;nitric oxides;nitrogen monooxide;nitrogen monoxide;nitrogen oxide (no);nitrosyl;no;no - nitric oxide;oxide, nitric;oxyde azotique;oxyde nitrique;product containing nitric oxide;product containing nitric oxide (medicinal product);stickstoff(ii)-oxid;stickstoffmonoxid;vasodilator, endogenous nitrate;vasodilators pulmonary nitric oxide;óxido de nitrógeno(ii);óxido nítrico","inflamm;inflammation;inflammation (morphologic abnormality);inflammation (qualifier value);inflammation nos;inflammation, nos;inflammations;inflammatory reaction;inflammatory reaction, nos",chemdis,treat,1,treat,1,
58,epa,ischaemia,"Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), the (n-3) PUFA found in fish oils, exert antiarrhythmic effects during ischemia.",epa,"ischaemia;ischaemia nos;ischaemia, nos;ischemia;ischemia (diagnosis);ischemia (disorder);ischemia nos;ischemia, nos;ischemias",chemdis,treat,1,treat,1,
59,estrogen,cent serous retinopathy,Clinical demographics have demonstrated that postmenopausal women are predisposed to chronic stress-induced cardiomyopathy (CSC) and this has been associated with the decrease of estrogen.,estrogen,"cent serous retinopathy;centr serous chorioretinopathy;central serous chorioretinopathies;central serous chorioretinopathy;central serous chorioretinopathy (disorder);central serous choroidopathy;central serous retinopathies;central serous retinopathy;central serous retinopathy (diagnosis);central serous retinopathy (disorder);central serous; retinopathy;chorioretinopathies, central serous;chorioretinopathy, central serous;chorioretinopathy; central serous;choroidoretinopathy; central serous;csc;csc - central serous choroidopathy;csr - central serous retinopathy;csr-central serous retinopathy;retinopathies, central serous;retinopathy, central serous;retinopathy; central serous;serous chorioretinopathies, central;serous chorioretinopathy, central;serous retinopathies, central;serous retinopathy, central",chemdis,treat,1,treat,1,
60,estrogen,menopausal symptom,"Phyto-estrogens are plant-derived compounds that can exert various estrogenic and anti-estrogenic effects, and are usually used as a natural alternative to estrogen replacement due to their health benefits, including a lowered risk of osteoporosis, heart disease, breast cancer, and menopausal symptoms.___Recent clinical trials have found that lower doses of estrogen and/or progestin reduce or improve menopausal symptoms and maintain bone mineral density.",estrogen,"menopausal symptom;menopausal symptom (finding);menopausal symptom, nos;menopausal symptoms;menopausal symptoms (finding);menopausal symptoms nos;menopausal symptoms nos (disorder);symptoms, menopausal",chemdis,treat,2,treat,1,
61,estrogen,osteoporosis,"Phyto-estrogens are plant-derived compounds that can exert various estrogenic and anti-estrogenic effects, and are usually used as a natural alternative to estrogen replacement due to their health benefits, including a lowered risk of osteoporosis, heart disease, breast cancer, and menopausal symptoms.",estrogen,osteoporosis,chemdis,treat,1,treat,1,
62,ethanol,3-00 cardiovascular disorders: general terms,"The activity of lipoprotein lipase (LPL) is increased after alcohol consumption and can contribute to an increased level of HDL-cholesterol, which is considered to play a key role in the ethanol-mediated protective effect against cardiovascular disease.",ethanol,"3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,treat,1,treat,1,
63,ethyl 2-[[(1r)-1-cyclohexyl-2- [(2s)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate,37 hemorrhages,"Results of clinical trials suggest that ximelagatran is equally or more efficacious than warfarin and/or low-molecular-weight heparin therapy without increasing rates of minor or major bleeding.___The results of SPORTIF III and V demonstrate that a fixed oral dose of ximelagatran, without coagulation monitoring, is comparable to dose-adjusted warfarin in preventing stroke and other thromboembolic complications among moderate- to high-risk AF patients and has a lower rate of both major and minor bleeding.","ethyl 2-[[(1r)-1-cyclohexyl-2- [(2s)-2-[[4-(n'-hydroxycarbamimidoyl) phenyl]methylcarbamoyl]azetidin-1-yl]- 2-oxo-ethyl]amino]acetate;glycine, n-((1)1-cyclohexyl-2-((2)-((((4-(amino(hydroxyimino)methyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)2-oxoethyl)-ethyl ester;glycine, n-((1r)1-cyclohexyl-2-((2s)-((((4-(amino(hydroxyimino)methyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)2-oxoethyl)-ethyl ester;xi-melagatran;ximelagatran;ximelagatran (substance);ximelagatranum;ximelagatrán;ximelagratan;ximelagratan (substance);ximélagatran","37 hemorrhages;bleed;bleed_nos;bleed_nos problem;bleeding;bleeding (disorder);bleeding (finding);bleeding (symptom);bleeding -retired-;bleeding hemorrhage;bleeding problem;bleeding site unspecified;bleeding, nos;bleeding/haemorrhage nos;bleeding/hemorrhage nos;bleeds;blood loss of (nos);blood; extravasation;extravasation blood;extravasation of blood;extravasation; blood;haemorrhage;haemorrhage nos;haemorrhage nos (disorder);haemorrhage, nos;haemorrhage, unspecified;haemorrhages;hem;hemorrhage;hemorrhage (diagnosis);hemorrhage (morphologic abnormality);hemorrhage (nos);hemorrhage bleeding;hemorrhage nos;hemorrhage nos (disorder);hemorrhage, nos;hemorrhage, unspecified;hemorrhages",chemdis,treat,2,treat,0,
64,fatty acid,3-00 cardiovascular disorders: general terms,"The results support the view that Lp-PLA(2) may relate to CAD and that intake of marine n-3 fatty acids might reduce plasma Lp-PLA(2) suggesting another mechanism by which n-3 fatty acids could reduce the risk of cardiovascular disease.___Large controlled trials have shown that intake of fish oil (marine n-3 fatty acids, eicosapentaenoic acid, and docosahexaenoic acid), whether from dietary sources or fish oil supplements, may exhibit beneficial effects on total and cardiovascular disease mortality.","fatty acid;fatty acid (substance);fatty acid, nos;fatty acids","3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",chemdis,treat,2,treat,1,
65,fatty acid,allergic inflammation,"Dietary supplementation with essential fatty acids relieves the signs and symptoms of atopic eczema, may improve other types of allergic inflammation, and may also correct coexisting symptoms as diverse as excessive thirst and dysmenorrhea.","fatty acid;fatty acid (substance);fatty acid, nos;fatty acids","allergic inflammation;inflammation, allergic",chemdis,treat,1,treat,1,
66,fatty acid,arrhythmic,"This review aims to describe the major biological mechanisms of how diets rich in essential fatty acids, or simply essential fatty acid administration, could have anti-inflammatory, vasodilatory, anti-arrhythmic, antithrombotic, antioxidant, and anti-atherogenic effects.","fatty acid;fatty acid (substance);fatty acid, nos;fatty acids",arrhythmic,chemdis,treat,1,treat,1,
67,fatty acid,atherosclerosis,The low incidence of cardiovascular disease associated epidemiologically with high consumption of food rich in n-3 fatty acids suggests the possibility that part of the beneficial cardiovascular effects of these natural substances may be due to a reduction of atherosclerosis.,"fatty acid;fatty acid (substance);fatty acid, nos;fatty acids",atherosclerosis,chemdis,treat,1,treat,1,
68,fatty acid,cad,The results support the view that Lp-PLA(2) may relate to CAD and that intake of marine n-3 fatty acids might reduce plasma Lp-PLA(2) suggesting another mechanism by which n-3 fatty acids could reduce the risk of cardiovascular disease.,"fatty acid;fatty acid (substance);fatty acid, nos;fatty acids",cad,chemdis,treat,1,treat,1,
69,fatty acid,cardiac arrhythmia,Fatty acids may reduce the risk of sudden death by preventing life-threatening cardiac arrhythmia.,"fatty acid;fatty acid (substance);fatty acid, nos;fatty acids",cardiac arrhythmia,chemdis,treat,1,treat,1,
71,tag,coronary heart disease,"Replacement of dietary fat with carbohydrate may not reduce the overall risk of coronary heart disease (CHD), because this elevates plasma triacylglycerol (TAG) concentrations.",tag,coronary heart disease,chemdis,treat,1,treat,1,
72,tg - triglyceride,3-10 heart diseases: general terms,"Low GI/GL may protect against heart disease in women, and cross-sectional studies indicate low GI/GL may reduce high-density-lipoprotein cholesterol and triacylglycerol levels in both sexes.",tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,"3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",chemdis,treat,1,treat,0,
73,tg - triglyceride,3-14-15 ischemic heart diseases,"In conclusion, our findings indicate that lowering of postprandial triglycerides is the only n-3 VLCPUFA effect that could contribute to primary prevention of IHD in healthy middle-aged men as assessed by currently measurable lipid and hemostatic risk markers.",tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,"3-14-15 ischemic heart diseases;disease, ischemic heart;disease;ischaemic heart;disease;ischemic heart;diseases, ischemic heart;heart dis ischemic;heart disease, ischemic;heart diseases, ischemic;heart, ischemic disease;ihd;ihd - ischaemic heart disease;ihd - ischemic heart disease;ischaemia myocardial;ischaemic heart disease (disorder);ischaemic heart disease nos;ischaemic heart disease nos (disorder);ischaemic heart disease, nos;ischaemic heart diseases;ischemia myocardial;ischemia, myocardial;ischemia; heart;ischemia; myocardial;ischemias, myocardial;ischemic heart dis;ischemic heart disease (diagnosis);ischemic heart disease (disorder);ischemic heart disease nos;ischemic heart disease nos (disorder);ischemic heart disease or syndrome;ischemic heart disease, nos;ischemic heart diseases;ischemic heart diseases (i20-i25);ischemic heart diseases and syndromes;myocardial ischaemia (disorder);myocardial ischaemia, nos;myocardial ischemia (diagnosis);myocardial ischemia (disorder);myocardial ischemia, nos;myocardial ischemia/hypoxia;myocardial ischemias;myocardium; ischemic",chemdis,treat,1,treat,0,
74,tg - triglyceride,abdominal obesity,"Correcting overweight especially in those with abdominal obesity, may normalise raised plasma triglyceride, low high density lipoprotein (HDL), abnormal LDL and even glucose intolerance and hypertension, which may be associated.",tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,abdominal obesity,chemdis,treat,1,treat,0,
75,tg - triglyceride,abnormal heart rhythms,"The effects of these EFAs and their metabolites include lowering of triglycerides, elevation of high-density lipoprotein (HDL)-cholesterol, reduction of blood pressure, vasodilatation, reduction of fibrinogen levels and inhibition of platelet aggregation and of cardiac arrhythmias.",tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,"abnormal heart rhythms;arrhythmia (cardiac) nos;arrhythmia (finding);arrhythmia (nos);arrhythmia cardiac (nos);arrhythmia nos;arrhythmia, cardiac;arrhythmia, nos;arrhythmias;arrhythmias (heart);arrhythmias, cardiac;arrythmia;cardiac arrhythmia (disorder);cardiac arrhythmia (nos);cardiac arrhythmia nos;cardiac arrhythmia, irregular pulse;cardiac arrhythmia, nos;cardiac arrhythmia, unspecified;cardiac arrhythmias;cardiac dysrhythmia (disorder);cardiac dysrhythmia nos;cardiac dysrhythmia nos (disorder);cardiac dysrhythmia, nos;cardiac dysrhythmia, unspecified;cardiac dysrhythmias nos;cardiac rhythm disorder (diagnosis);cardiac rhythm disturbance;cardiac rhythm disturbances;cardiac rhythm irregular;cardiac rhythm, abnormal;cardiac; dysrhythmia;disorder of heart rhythm;disorder; rhythm, heart;disturbance; rhythm, heart;dysrhythmia;dysrhythmia(s);dysrhythmia, cardiac;dysrhythmia; cardiac;dysrhythmia;cardiac;dysrhythmias;ectopic beats all types;heart arrhythmia;heart arrhythmias;heart rhythm disorders;heart: rhythm;rhythm, heart; abnormal;rhythm; abnormal;rhythm; disorder",chemdis,treat,1,treat,0,
76,tg - triglyceride,adiposity,"In summary, rimonabant has a modest effect on body weight in freely eating obese rats and markedly reduces plasma triglyceride levels and microvascular disease, in part due to changes in intestinal metabolism, including lymphatic secretion of apolipoprotein B48 and haptoglobin.",tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,"adiposity;having too much body fat;obese;obese (finding);obesities;obesity (diagnosis);obesity (disorder);obesity [ambiguous];obesity nos;obesity, nos;obesity, unspecified",chemdis,treat,1,treat,0,
79,tg - triglyceride,body fails to respond to insulin,"These data show that acarbose reduces fasting glucose and triglyceride levels, lowers HbA1c and limits the glycaemic and insulin response to food in individuals with type 2 diabetes mellitus with Syndrome X. Pharmacological agents that improve the metabolic environment and reduce insulin resistance have the potential to limit the progression of atherogenesis associated with type 2 diabetes mellitus.",tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,"body fails to respond to insulin;drug resistance to insulin;drug resistance to insulin (disorder);insulin resistance;insulin resistance (diagnosis);insulin resistance (disorder);resistance, insulin",chemdis,treat,1,treat,0,
82,tg - triglyceride,coronary heart disease,"The soy protein beverage, compared to cow's milk, induced significant reductions in plasma triglycerides and very-low-density lipoprotein cholesterol, as well as a significant increase in high-density lipoprotein cholesterol, indicating that consumption of soy protein beverage may be beneficial for the prevention of coronary heart disease in children with familial hypercholesterolemia.___β-glucan from oats or barley, or a combination of whole oats and barley, and soluble fiber from psyllium reduces the risk of coronary heart disease; inulin-type fructans added to foods and beverages may modestly decrease serum triacylglycerols; arabinoxylan and resistant starch may improve glycemic control.___It is concluded that the significantly longer lag phase for oxidation of LDL, the higher HDL cholesterol level and the lower triacylglycerol level in subjects following a carotenoid-controlled, MUFA-enriched diet may decrease the risk of coronary heart disease.",tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,coronary heart disease,chemdis,treat,3,treat,0,
83,tg - triglyceride,weight loss,"Plant sterols or stanols lower LDL cholesterol by about 10% for a 2 g/day dose, while exercise and weight loss lower cardiovascular risk predominantly by lowering fasting triglyceride.",tg - triglyceride;triacylglycerol;triacylglycerol (substance);triacylglycerols;triglyceride;triglycerides,weight loss,chemdis,treat,1,treat,0,
84,vitamin c,3-10 heart diseases: general terms,"It would appear from the results of the present study that natural wild honey may exert its cardioprotective and therapeutic effects against epinephrine-induced cardiac disorders and vasomotor dysfunction directly, via its very pronounced total AOC and its great wealth of both enzymatic and nonenzymatic antioxidants involved in cardiovascular defense mechanisms, besides its substantial quantities of mineral elements such as magnesium, sodium, and chlorine, and/or indirectly, via the enhancement of the endothelium-derived relaxing factor nitric oxide release through the influence of ascorbic acid (vitamin C).",vitamin c,"3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",chemdis,treat,1,treat,1,
85,vitamin c,abnormal vasomotor function,"It would appear from the results of the present study that natural wild honey may exert its cardioprotective and therapeutic effects against epinephrine-induced cardiac disorders and vasomotor dysfunction directly, via its very pronounced total AOC and its great wealth of both enzymatic and nonenzymatic antioxidants involved in cardiovascular defense mechanisms, besides its substantial quantities of mineral elements such as magnesium, sodium, and chlorine, and/or indirectly, via the enhancement of the endothelium-derived relaxing factor nitric oxide release through the influence of ascorbic acid (vitamin C).",vitamin c,"abnormal vasomotor function;abnormal vasomotor function (finding);vasomotor dysfunction;vasomotor function, abnormal",chemdis,treat,1,treat,1,
86,vitamin c,decreased oxygen supply,Maternal vitamin C supplementation during hypoxic pregnancy protected against oxidative stress in the placenta and prevented the adverse effects of prenatal hypoxia on hippocampal atrophy and memory loss in the adult offspring.,vitamin c,"decreased oxygen supply;defic oxygen;deficiencies, oxygen;deficiency, oxygen;deficiency; oxygen;hypoxia (diagnosis);hypoxia (disorder);hypoxic;oxygen decrease;oxygen defic;oxygen deficiencies;oxygen deficiency;oxygen; deficiency",chemdis,treat,1,treat,1,
87,vitamin d,coronary heart disease,"Biologically plausible mechanisms have been proposed to link vitamin D to coronary heart disease (CHD) prevention, and observational studies suggest an inverse association between serum 25-hydroxyvitamin D (25OHD) concentrations and CHD.",vitamin d,coronary heart disease,chemdis,treat,1,treat,1,
88,vitamin d,diabetes,"Some evidence suggests that vitamin D may improve cardiovascular outcomes in diabetes through anti-inflammatory, antioxidative, antihypertrophic, antifibrotic, and antiatherosclerotic activities and by regulating advanced glycation end-product signaling, the renin-angiotensin system, and cardiac metabolism.",vitamin d,diabetes,chemdis,treat,1,treat,1,
89,vitamin d,dis metab,"Dietary and medicinal supplementation of lysine, calcium and vitamin D may improve the body composition of young adult women in the form of proportionally more muscle mass, bone mass and lesser fat mass, which in turn, may prove helpful in improving general well-being, physical fitness as well as preventing metabolic diseases in developing countries.",vitamin d,"dis metab;disease, metabolic;disease;metabolic;diseases, metabolic;disorder of metabolism nos;disorder of metabolism nos (disorder);disorder; metabolism;disorder;metabolic;general; metabolic disorder;generalised metabolic disorder;generalized metabolic disorder;generalized metabolic disorder (disorder);md - metabolic disorders;metab dis;metabolic derangement;metabolic disease;metabolic disease (disorder);metabolic disease, nos;metabolic diseases;metabolic disorder;metabolic disorder nos;metabolic disorder, nos;metabolic disorder, unspecified;metabolic disorder; general;metabolic disorders;metabolic disorders (diagnosis);metabolic disorders (disorder);metabolic disorders: general;metabolism disorder;metabolism disorder nos;metabolism disorders;metabolism--disorders;metabolism; disorder;metabolism; disorder, general;rndx metabolic;rndx metabolic (diagnosis);thesaurismoses;thesaurismosis;unspecified disorder of metabolism",chemdis,treat,1,treat,1,
90,vitamin d,fracture,"We conclude that (1) calcium and vitamin D supplementation leads to a modest reduction in fracture risk, although population-level intervention has not been shown to be an effective public health strategy; (2) supplementation with calcium alone for fracture reduction is not supported by the literature; (3) side effects of calcium supplementation include renal stones and gastrointestinal symptoms; (4) vitamin D supplementation, rather than calcium supplementation, may reduce falls risk; and (5) assertions of increased cardiovascular risk consequent to calcium supplementation are not convincingly supported by current evidence.",vitamin d,fracture,chemdis,treat,1,treat,1,
91,vitamin d,inflamm,Vitamin D is reported to have anti-inflammatory properties; however the effects of vitamin D supplementation on inflammation in patients with heart failure (HF) have not been established.,vitamin d,"inflamm;inflammation;inflammation (morphologic abnormality);inflammation (qualifier value);inflammation nos;inflammation, nos;inflammations;inflammatory reaction;inflammatory reaction, nos",chemdis,treat,1,treat,1,
92,vitamin d,proteinuria,"Mechanistically, emerging data have linked vitamin D administration with improved cardiac function and reduced proteinuria, and hypovitaminosis D is associated with obesity, insulin resistance, and systemic inflammation.",vitamin d,proteinuria,chemdis,treat,1,treat,1,
93,vitamin d,upper respiratory tract infections,Vitamin D is important for reducing the risk of upper respiratory tract infections and plays a role in pulmonary epithelial health.,vitamin d,upper respiratory tract infections,chemdis,treat,1,treat,1,
94,vitamin e,3-10 heart diseases: general terms,"Clinical trials of vitamin E efficacy, in hindsight, have been overly optimistic in their expectation that a vitamin could reverse poor dietary habits and a sedentary lifestyle as well as provide benefit beyond that of pharmaceutical agents in treating heart disease.",vitamin e,"3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",chemdis,treat,1,treat,,
95,vitamin e,mi,"A recent large-scale, open-label, randomized, controlled trial in 11, 324 myocardial infarction (MI) survivors has shown low-dose fish oil, but not vitamin E, to reduce significantly the cumulative rate of all-cause death, nonfatal MI, and nonfatal stroke.",vitamin e,mi,chemdis,treat,1,treat,,
97,vitamin k,"calcification, vascular","Vitamin K is associated with reduced cardiovascular disease risk such as heart failure, possibly by carboxylation of matrix-gla protein (MGP), a potent inhibitor of vascular calcification.___Vitamin K plays a role in preventing vascular calcification in CKD yet the relationship between vitamin K intake and mortality in CKD patients remains unclear.___Dietary vitamin K intake is thought to decrease the risk of cardiovascular disease (CVD) by reducing vascular calcification, although vitamin K is also involved in coagulation.___Vitamin K dependent proteins have been demonstrated to inhibit vascular calcification.",vitamin k,"calcification, vascular;calcifications vascular;calcifications, vascular;calcinoses, vascular;calcinosis, vascular;vascular calcification;vascular calcification (disorder);vascular calcifications;vascular calcinoses;vascular calcinosis",chemdis,treat,4,treat,1,
98,"acid, saturated fatty",coronary heart disease,Evidence is accumulating that diets low in saturated fatty acids and high in monounsaturated fatty acids are effective in controlling blood lipid levels; a likely consequence could be a beneficial effect on the risk of coronary heart disease.___The traditional diet-heart hypothesis predicts that replacing saturated fat with vegetable oil rich in linoleic acid will reduce coronary heart disease events and deaths by lowering serum cholesterol.,"acid, saturated fatty;acids fatty saturated;fat saturated;fats saturated;fatty acid, saturated;fatty acids, saturated;fatty acids.saturated;saturated fat;saturated fat (substance);saturated fatty acid;saturated fatty acid (substance);saturated fatty acid, nos;saturated fatty acids",coronary heart disease,foodis,treat,2,treat,1,
99,"acid, saturated fatty","fatty liver, nonalcoholic","Taken together, the data support the use of diets that have a reduced content of free sugars, refined carbohydrates and saturated fat in the treatment of NAFLD.","acid, saturated fatty;acids fatty saturated;fat saturated;fats saturated;fatty acid, saturated;fatty acids, saturated;fatty acids.saturated;saturated fat;saturated fat (substance);saturated fatty acid;saturated fatty acid (substance);saturated fatty acid, nos;saturated fatty acids","fatty liver, nonalcoholic;fatty livers, nonalcoholic;liver, nonalcoholic fatty;livers, nonalcoholic fatty;nafld;nafld - nonalcoholic fatty liver disease;non alcoholic fatty liver disease;non-alcoholic fatty liver;non-alcoholic fatty liver (disorder);non-alcoholic fatty liver disease;nonalcoholic fatty liver;nonalcoholic fatty liver (diagnosis);nonalcoholic fatty liver (disorder);nonalcoholic fatty liver disease;nonalcoholic fatty liver disease (nafld);nonalcoholic fatty livers",foodis,treat,1,treat,0,
100,"acid, saturated fatty",fh,"We have challenged the rationale for FH dietary recommendations based on the absence of support for the diet-heart hypothesis, and the lack of evidence that a low saturated fat, low cholesterol diet reduces coronary events in FH individuals.","acid, saturated fatty;acids fatty saturated;fat saturated;fats saturated;fatty acid, saturated;fatty acids, saturated;fatty acids.saturated;saturated fat;saturated fat (substance);saturated fatty acid;saturated fatty acid (substance);saturated fatty acid, nos;saturated fatty acids",fh,foodis,treat,1,treat,,
102,butter peanut,cvd,Frequent nut and peanut butter consumption was inversely associated with total CVD risk in age-adjusted analyses.,butter peanut;peanut butter;peanut butter (substance),cvd,foodis,treat,1,treat,1,
103,cereal,chronic dis,There is growing evidence that cereals and legumes play important roles in the prevention of chronic diseases.,"cereal;cereal (substance);cereal grain;cereal grains;cereals;grain;grain, cereal;grains, cereal","chronic dis;chronic disease;chronic disease (disorder);chronic disease, nos;chronic disease/disorder;chronic diseases;chronic disorder;chronic disorders;chronic illnesses;disease, chronic;diseases, chronic;illness, chronic;illnesses, chronic",foodis,treat,1,treat,1,
104,"cereal, whole grain",adult onset diabetes,"At the present state of knowledge, insoluble dietary fibers as found in whole grain cereal products are considered to be especially effective in the prevention of type 2 diabetes mellitus.","cereal, whole grain;cereals, whole grain;grain cereal, whole;grain cereals, whole;whole grain cereal;whole grain cereals","adult onset diabetes;adult onset diabetes mellitus;adult-onset diabetes;adult-onset diabetes mellitus;adult-onset; diabetes;aodm;diabete type 2;diabetes mellitus (adult onset);diabetes mellitus (niddm);diabetes mellitus - adult ons;diabetes mellitus - adult onset;diabetes mellitus -adult onset;diabetes mellitus maturity onset;diabetes mellitus non insulin dependent;diabetes mellitus non insulin-dep;diabetes mellitus non-insulin-dependent;diabetes mellitus nos late onset;diabetes mellitus type 02;diabetes mellitus type 2;diabetes mellitus type 2 (disorder);diabetes mellitus type ii;diabetes mellitus, adult onset;diabetes mellitus, adult onset type;diabetes mellitus, adult-onset;diabetes mellitus, ketosis resistant;diabetes mellitus, ketosis-resistant;diabetes mellitus, maturity onset;diabetes mellitus, maturity-onset;diabetes mellitus, non insulin dependent;diabetes mellitus, non-insulin dependent;diabetes mellitus, non-insulin-dependent;diabetes mellitus, noninsulin dependent;diabetes mellitus, noninsulin-dependent;diabetes mellitus, slow onset;diabetes mellitus, slow-onset;diabetes mellitus, stable;diabetes mellitus, type 2;diabetes mellitus, type ii;diabetes mellitus: [adult onset] or [noninsulin dependent];diabetes mellitus: [adult onset] or [noninsulin dependent] (disorder);diabetes non-insulin dependent;diabetes type 2;diabetes type ii;diabetes, adult onset;diabetes, ketosis resistant;diabetes, maturity onset;diabetes, maturity-onset;diabetes, type 2;diabetes, type ii;diabetes; adult-onset;diabetes; maturity-onset;diabetes; niddm;diabetes; non-insulin-dependent;diabetes; nonketotic;diabetes; type ii;diabetes;adult onset;diabetes;non insulin depend;diabetes;type 2;ketosis resistant diabetes;ketosis-resistant diabetes mellitus;late onset diabetes;maturity onset diabetes;maturity onset diabetes mellit;maturity onset diabetes mellitus;maturity-onset diabetes;maturity-onset diabetes mellitus;maturity-onset; diabetes;mod;ncdmm;niddm;niddm - non-insulin dependent diabetes mellitus;niddm diabetes mellitus;niddm-non-ins dep diabetes mel;niddm; diabetes;non insulin dependent diabetes;non-ins-dep diabetes mellitus;non-insulin dependent diabetes;non-insulin dependent diabetes mellitus;non-insulin-dependent diabetes;non-insulin-dependent diabetes mellitus;non-insulin-dependent; diabetes;noninsulin dependent diab.mell;noninsulin dependent diabetes;noninsulin dependent diabetes mellitus;noninsulin-dependent diabetes;noninsulin-dependent diabetes mellitus;nonketotic; diabetes;slow-onset diabetes mellitus;stable diabetes mellitus;t2dm - type 2 diabetes mellitus;type 2 diabetes;type 2 diabetes mellitus;type 2 diabetes mellitus (diagnosis);type 2 diabetes mellitus non-insulin dependent;type ii diabetes;type ii diabetes mellitus;type ii diabetes mellitus (disorder);type ii; diabetes",foodis,treat,1,treat,1,
106,"chloride, dietary sodium",3-10 heart diseases: general terms,"Food reformulation is commonly used as a strategy to produce foods for improved health; for example, replacing sugar with aspartame, and salt (NaCl) with KCl may help to reduce the incidence of obesity and heart disease.","chloride, dietary sodium;dietary salt;dietary salt (sodium chloride);dietary sodium chloride;salt;salt, table;sodium chloride, dietary;table salt","3-10 heart diseases: general terms;cardiac dis;cardiac disease;cardiac diseases;cardiac disorder;cardiac disorder nos;cardiac disorders;cardiopathies;cardiopathy;cardiopathy, nos;cordis; morbus;disease cardiac;disease disorders heart;disease hearts;disease or syndrome of heart;disease;heart;diseases and syndromes of heart;diseases disorders heart;diseases of the heart;disorder cardiac (nos);disorder heart;disorder of heart;heart dis;heart disease;heart disease (diagnosis);heart disease (disorder);heart disease disorder;heart disease nos;heart disease nos (disorder);heart disease, nos;heart disease, unspecified;heart diseases;heart diseases: general terms;heart disorder;heart disorders;heart--diseases;morbus cordis;morbus cordis nos;morbus cordis, nos;morbus; cordis;rndx cardiac;rndx cardiac (diagnosis);section 3-1 heart diseases;syndrome heart disease;unspecified heart problem",foodis,treat,1,treat,0,
107,"chloride, dietary sodium",ailment,Salt as a commodity to preserve and flavor food and to treat ailments has been in existence for hundreds of years.,"chloride, dietary sodium;dietary salt;dietary salt (sodium chloride);dietary sodium chloride;salt;salt, table;sodium chloride, dietary;table salt","ailment;ailments;illness;illness (finding);illness, nos;illness, unspecified;illnesses;sick;sickness;sickness (finding);sickness, nos;sicknesses",foodis,treat,1,treat,1,
108,"chloride, dietary sodium",cardiac congestive failure,"In Dahl salt-sensitive rats that were fed a high-salt diet, a model for hypertension-induced congestive heart failure, spermidine feeding reduced systemic blood pressure, increased titin phosphorylation and prevented cardiac hypertrophy and a decline in diastolic function, thus delaying the progression to heart failure.","chloride, dietary sodium;dietary salt;dietary salt (sodium chloride);dietary sodium chloride;salt;salt, table;sodium chloride, dietary;table salt","cardiac congestive failure;cardiac failure congestive;cardiac failure, congestive;ccf - congestive cardiac fail;ccf - congestive cardiac failure;chf;chf (congestive heart failure);chf - congestive heart failure;chf nos;congestive cardiac fail;congestive cardiac failure;congestive disease heart;congestive diseases heart;congestive failure heart;congestive failure hearts;congestive failures heart;congestive heart disease;congestive heart failure;congestive heart failure (chf);congestive heart failure (diagnosis);congestive heart failure (disorder);congestive heart failure chf;congestive heart failure nos;congestive heart failure, unspecified;congestive; heart;congetive cardiac failure;disease congestive heart;failure congestive heart;failure heart congestive;failure; heart, congestive;failure;congestive cardiac;heart congestive failure;heart failure congestive;heart failure, congestive;heart failure/congestive heart failure;heart failure; congestive;heart; congestive;heart; disease, congestive",foodis,treat,1,treat,,
110,"chloride, dietary sodium",cardiac hypertrophies,"In Dahl salt-sensitive rats that were fed a high-salt diet, a model for hypertension-induced congestive heart failure, spermidine feeding reduced systemic blood pressure, increased titin phosphorylation and prevented cardiac hypertrophy and a decline in diastolic function, thus delaying the progression to heart failure.","chloride, dietary sodium;dietary salt;dietary salt (sodium chloride);dietary sodium chloride;salt;salt, table;sodium chloride, dietary;table salt","cardiac hypertrophies;cardiac hypertrophy;cardiac hypertrophy nos;cardiac hypertrophy nos (disorder);cardiac; hypertrophy;heart hypertrophies;heart hypertrophy;heart--hypertrophy;heart; hypertrophy;hypertrophic heart;hypertrophic;heart;hypertrophies, cardiac;hypertrophies, heart;hypertrophy, cardiac;hypertrophy, heart;hypertrophy; cardiac;hypertrophy; heart",foodis,treat,1,treat,,
111,"chloride, dietary sodium",decrease weight,"Weight reduction also lowers blood pressure, a goal that can equally be reached by a low-salt diet rich in fruit and vegetables, and the practice of endurance sports.","chloride, dietary sodium;dietary salt;dietary salt (sodium chloride);dietary sodium chloride;salt;salt, table;sodium chloride, dietary;table salt","decrease weight;decreased body weight;decreased weight;decreased;weight;decreases weight;loses weight;losing weight;losing wt;loss (of);weight;loss of weight;loss weight;loss wt;loss, weight;loss; weight;losses, weight;lost weight;progressive weight loss;reduction weight;reduction, weight;reductions, weight;weight decrease;weight decreased;weight decreased (finding);weight decreased (observable entity);weight decreasing;weight decreasing (finding);weight decreasing (physical finding);weight loss (finding);weight loss (on exam);weight loss finding;weight loss finding (finding);weight loss on exam;weight loss on exam (physical finding);weight loss, progressive;weight losses;weight reduction;weight reductions;weight; loss;weightloss;wt loss",foodis,treat,1,treat,0,
112,"chloride, dietary sodium",obesity,"Food reformulation is commonly used as a strategy to produce foods for improved health; for example, replacing sugar with aspartame, and salt (NaCl) with KCl may help to reduce the incidence of obesity and heart disease.","chloride, dietary sodium;dietary salt;dietary salt (sodium chloride);dietary sodium chloride;salt;salt, table;sodium chloride, dietary;table salt",obesity,foodis,treat,1,treat,0,
113,citrus,3-00 cardiovascular disorders: general terms,"Therefore, citrus peels could help in the management of cardiovascular diseases possibly through inhibition of these enzymes.",citrus;citrus flavor,"3-00 cardiovascular disorders: general terms;[x]cardiovasc disease,unspecif;[x]cardiovascular disease, unspecified;[x]cardiovascular disease, unspecified (disorder);cardiovasc dis;cardiovasc disease,unspecif;cardiovascular disease;cardiovascular disease (cvd);cardiovascular disease, nos;cardiovascular disease, unspecified;cardiovascular diseases;cardiovascular disorder;cardiovascular disorder (nos);cardiovascular disorder nos;cardiovascular disorder, nos;cardiovascular disorders;cardiovascular disorders (diagnosis);cardiovascular disorders, general;cardiovascular disorders: general terms;cardiovascular system disease;cardiovascular system diseases;cardiovascular system--diseases;cardiovascular; disorder;chapter 3 diseases of the cardiovascular system;cv disorders;cvd - cardiovascular disease;cvd, nos;cvs - cardiovascular system diseases;cvs disease;cvs disease - cardiovascular system disease;cvs disorders nos;disease (or disorder); cardiovascular;disease of cardiovascular system;disease of cardiovascular system (disorder);disease of cardiovascular system, nos;disease or syndrome of cardiovascular system;disease, cardiovascular;disease;cardiovascular;diseases affecting the entire cardiovascular system;diseases and syndromes of cardiovascular system;diseases of the cardiovascular system;diseases, cardiovascular;disorder cardiovascular (nos);disorder of cardiovascular system;disorder of cardiovascular system (disorder);general cardiovascular system diseases and syndromes;section 3-0 diseases affecting the entire cardiovascular system",foodis,treat,1,treat,1,
114,citrus,inflamm,"Tangeretin is a citrus flavonoid that exerts several beneficial effects, including anti-inflammation, anti-oxidation and neuroprotection.",citrus;citrus flavor,"inflamm;inflammation;inflammation (morphologic abnormality);inflammation (qualifier value);inflammation nos;inflammation, nos;inflammations;inflammatory reaction;inflammatory reaction, nos",foodis,treat,1,treat,1,
